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Abstract
The  central  goal  of  the  work  presented  in  this  doctoral  dissertation  was  the  application  of  microwave 
irradiation  to  the  development  of  efficient,  straightforward and  reproducible  synthetic  methods  of  various 
interesting and broadly recognised nitrogen-containing heterocycles. Their reactivity under microwave heating 
conditions, particularly in oxidation processes, was also studied, inexpensive, undemanding and environment-
friendly synthetic strategies being employed whenever possible.
The  illustrious  Paal-Knorr  synthesis  of  pyrroles  was  revised,  some  2,5-dimethyl-1H-pyrroles  and  bis-2,5-
dimethyl-1H-pyrroles  being readily  prepared with high reaction  yields  through a  solventless  and microwave-
activated procedure. A small compound library of 3,5-diaryl-2-methyl-1H-pyrroles, incorporating both electron-
donating and electron-withdrawing scaffolds, was also synthesised under microwave irradiation using a solid-
supported  and  multicomponent  approach,  albeit  with  low  isolated  yields.  A  few  of  these  multisubstituted 
heterocycles were selected and further studied, some of their spectroscopic and photophysical properties being 
determined. The chalcone precursors required for their synthesis  were prepared with high yields through the  
classic Claisen-Schmidt reaction.
A series of  meso-substituted porphyrins was prepared through a microwave-activated one-pot methodology, 
the yields being usually higher than the ones achieved through the related conventional heating method or via our 
former  microwave-assisted  approach.  The  same  protocol  was  also  applied  to  the  preparation  of  some novel  
unsymmetrical meso-tetraarylporphyrins. A two-step synthesis of porphyrins, in which microwave-activation was 
applied in the second reaction step and the low-budget and user-friendly activated manganese dioxide was used as  
oxidant, was also examined, low to moderate reaction yields being achieved. The di-imide-promoted reduction of  
porphyrins to their hydroporphyrin analogues was investigated under microwave irradiation. The bacteriochlorins  
were easily  obtained with high yields,  although contaminated with up to  35% of the corresponding chlorins. 
Selective dehydrogenation of the bacteriochlorin derivatives was accomplished under microwave heating using 
activated manganese dioxide, the respective chlorins being isolated with good yields, albeit contaminated with 10 
to 35% of the corresponding porphyrins.
Several  Hantzsch  1,4-dihydropyridines  were  effortlessly  prepared  via  a  multicomponent  and  solvent-free  
strategy under microwave activation, moderate to good reaction yields being obtained without the requirement of  
any chromatographic isolation procedure. Some Hantzsch pyridines were also rapidly synthesised through the 
microwave-assisted  oxidative  aromatisation of  the corresponding 1,4-dihydropyridine analogues,  either  under 
heterogeneous  reaction  conditions  using  activated  manganese  dioxide  or  by  means  of  a  homogeneous  
methodology utilising potassium peroxydisulphate. An unforeseen oxidative dearylation process was observed in a  
few cases when activated manganese dioxide was employed, although further studies are necessary in order to  
elucidate the reaction mechanisms involved.
A compound library of Biginelli 3,4-dihydropyrimidines was synthesised under microwave heating conditions, 
good  reaction  yields  and  high  purity  being  generally  obtained,  without  the  requirement  of  chromatographic 
purification techniques. The same approach was also applied to the multicomponent synthesis of some Biginelli  
bis-3,4-dihydropyrimidines. A two-pot two-step method, in which microwave irradiation was used at the second 
reaction  stage,  provided  a  series  of  interesting  4,6-diaryl-3,4-dihydropyrimidine-2(1H)-thiones.  Again,  no 
chromatographic separation procedure was needed for the isolation of the target products with high yields. Some 
of  these  Biginelli-type  3,4-dihydropyrimidines  were  selected  and their  in  vitro cytotoxic  activity  was  studied 
against a few human cancer cell lines. In general, all compounds tested were more active against MCF7 breast 
cancer cells, the brominated derivatives being the most active molecules. Various pyrimidin-2(1H)-ones, bearing 
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both  electron-withdrawing  and  electron-donating  functionalities,  were  synthesised  through  the  microwave-
assisted oxidation of the related 3,4-dihydropyrimidin-2(1H)-ones. Among the various oxidising agents employed, 
potassium peroxydisulphate  was  established as  the  only  effective  one  under  the  reaction conditions  studied. 
However,  application  of  this  oxidant  to  the  dehydrogenation  of  3,4-dihydropyrimidine-2(1H)-thiones was 
unsuccessful. Oxone and hydrogen peroxide were also tested as oxidants, but either failed completely or furnished  
unpredicted  or  unidentified  by-products.  The  best  outcome was  obtained using  2,3-dichloro-5,6-dicyano-1,4-
benzoquinone,  although  further  work  is  required  in  order  to  effectively  accomplish  this  extremely  difficult  
synthetic enterprise.
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Resumo
O principal  objectivo do trabalho  apresentado  nesta  dissertação doutoral  foi  a aplicação  de irradiação  de
microondas ao desenvolvimento de métodos sintéticos simples, eficientes e reproduzíveis de vários heterociclos
nitrogenados  interessantes  e  largamente  conhecidos.  A  sua  reactividade  sob  aquecimento  por  microondas,
particularmente  em  processos  oxidativos,  também  foi  estudada,  tendo  sido  empregues  sempre  que  possível
estratégias sintéticas práticas, pouco dispendiosas e ambientalmente sustentáveis.
A célebre síntese de pirróis de Paal-Knorr foi revista, tendo sido preparados alguns 2,5-dimetil-1H-pirróis e
bis-2,5-dimetil-1H-pirróis com rendimentos elevados através de um procedimento sem solvente e activado por
microondas.  Uma  biblioteca  de  compostos  de  3,5-diaril-2-metil-1H-pirróis,  incorporando  funcionalidades
doadoras e atractoras de electrões, foi também sintetizada sob irradiação de microondas usando uma abordagem
multicomponente  em  suporte  sólido,  embora  com  baixos  rendimentos.  Alguns  destes  heterociclos
multisubstituídos foram selecionados, tendo sido determinadas algumas das suas propriedades espectroscópicas e
fotofísicas.  As chalconas  precursoras  requeridas  para a  sua síntese  foram preparadas  com bons  rendimentos
através da clássica reacção de Claisen-Schmidt.
Uma série de porfirinas  meso-substituídas foi sintetizada através de uma metodologia  one-pot activada por
microondas, sendo os rendimentos geralmente mais altos do que os obtidos através do método de aquecimento
convencional relacionado ou via a nossa anterior abordagem assistida por microondas. O mesmo protocolo foi
também  aplicado  à  preparação  de  algumas  meso-tetraarilporfirinas  assimétricas.  Uma  síntese  bietápica  de
porfirinas, em que activação por microondas foi aplicada no segundo passo reaccional e dióxido de manganésio
activado foi utilizado como agente oxidante, também foi examinada, tendo sido obtidos rendimentos baixos a
moderados. A redução de porfirinas a hidroporfirinas promovida por di-imida foi investigada sob microondas. As
bacteriolorinas  foram facilmente  obtidas  com rendimentos  elevados,  embora contaminadas  com até  35% das
clorinas correspondentes.  A desidrogenação selectiva das bacterioclorinas foi  conseguida sob aquecimento de
microondas  usando  dióxido  de  manganésio  activado,  tendo  as  respectivas  clorinas  sido  isoladas  com  bons
rendimentos, apesar de contaminadas com 10 a 25% das respectivas porfirinas.
Diversas  1,4-dihidropiridinas  de  Hantzsch  foram  preparadas  via  uma  estratégia  multicomponente  e  sem
solvente sob microondas,  tendo sido obtidos rendimentos moderados a bons sem a necessidade de qualquer
procedimento  cromatográfico  de  isolamento.  Algumas  piridinas  de  Hantzsch  foram  também  rapidamente
sintetizadas através da aromatização oxidativa assistida por microondas das respectivas 1,4-dihidropiridinas, sob
condições  heterogéneas  usando dióxido  de  manganésio  activado  ou através  de uma metodologia  homogénea
utilizando peroxidisulfato de potássio. Um inesperado processo de desarilação oxidativa foi observado em alguns
casos quando dióxido de manganésio activado foi empregue, embora mais estudos sejam necessários para elucidar
os mecanismos reaccionais envolvidos.
Uma biblioteca de compostos de 3,4-dihidropirimidinas de Biginelli foi sintetizada sob microondas, tendo sido
obtidos genericamente bons rendimentos e elevada pureza, sem recorrer a técnicas de purificação cromatográfica.
A mesma abordagem foi também aplicada à síntese muticomponente de algumas bis-3,4-dihidropirimidinas de
Biginelli. Um método bietápico two-pot, em que irradiação de microondas foi usada na segunda etapa reaccional,
providenciou  uma  série  de  4,6-diaril-3,4-dihidropirimidina-2(1H)-tionas.  Novamente,  nenhum  procedimento
cromatográfico  de separação  foi  necessário  para o  isolamento  dos  produtos  alvo  com rendimentos  elevados.
Algumas destas 3,4-dihidropirimidinas de tipo-Biginelli foram seleccionadas e a sua actividade citotóxica in vitro
foi  avaliada contra algumas linhas celulares de cancros humanos.  Em geral,  todos os compostos foram mais
activos contra células do cancro da mama MCF7, tendo os derivados bromadas sido as moléculas mais activas.
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Várias pirimidin-2(1H)-onas, contendo grupos funcionais atractores e doadores de electrões, foram sintetizadas 
através da oxidação assistida por microondas das respectivas 3,4-dihidropirimidin-2(1H)-onas. Entre os vários 
oxidantes empregues,  o peroxidisulfato de potássio provou ser  o único eficiente sob as condições reaccionais 
estudadas. Contudo, a aplicação deste oxidante à desidrogenação de 3,4-dihidropirimidina-2(1H)-tionas não foi 
bem  sucedida.  Oxone  e  peróxido  de  hidrogénio  foram  também  testados  como  oxidantes,  mas  falharam 
completamente ou conduziram a produtos secundários imprevistos ou não identificados. O melhor resultado foi  
obtido  usando  2,3-dicloro-5,6-diciano-1,4-benzoquinona,  embora  mais  estudos  sejam  requeridos  de  forma  a 
superar eficazmente esta tarefa sintética extremamente difícil.
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n-Bu n-butyl
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ν frequency (Hz or s-1)
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Nomenclature
Tetrapyrrole is a broadly used term that refers to a class of compounds whose molecules have four rings of the 
pyrrole  type,  usually  linked together by  single-atom bridges  between the  α positions  of  the  latter.  The most 
common  arrangements  of  these  four  pyrrolic  moieties  are  macrocyclic,  such  as  in  porphyrins  and  related 
structures, and linear, e.g. the bile pigments. The first nomenclature system concerning tetrapyrrolic macrocyclic 
compounds was developed in the 1930s by the German chemist and physician Hans Fischer (Figure I).[1, 2] The 
pyrrolic units are designated by the Latin alphabet letters A, B, C and D, while the carbon atoms that establish the 
connections between these structural blocks, denominated meso, are identified by the Greek alphabet letters α, β, 
γ and δ. In every pyrrolic structure one can distinguish the respective α (1' to 8') and β (1 to 8) carbon atoms, in 
agreement with the usual designation relative to the pyrrole ring. The same author also adopted trivial names to a 
wide number of compounds of this family, regarding their natural occurrence or function.
Figure I
A joint commission between IUPAC and IUB extended the systematic nomenclature to this type of compounds 
in the 1980s, aiming to facilitate the interdisciplinary communication and restrain the use of trivial names.[3] 
Hence,  in  the  IUPAC  system,  the  macrocyclic  nucleus  is  denominated  porphyrin,  replacing  the  older  name 
porphine, the carbon atoms are numbered from 1 to 20 and the nitrogen atoms from 21 to 24. Further, the meso 
positions correspond to numbers 5, 10, 15 and 20 and the substituents refer to the number of the carbon atom to 
which  they  are  attached  and  ordered  alphabetically  (Figure  II).  It  should  be  noticed  that  this  structure  is 
tautomeric  with respect  to  the location of  the  two hydrogen atoms that  do not  participate  in the  peripheral 
conjugated system, these being associated with any two of the four nitrogen atoms. Withal,  for nomenclature 
purposes, the word porphyrin implies that the saturated nitrogen atoms are located at positions 21 and 23.
Figure II
IUPAC and IUB allow the utilisation of both types of nomenclature, systematic and semi-systematic.[3] In the 
former all recommendations for the nomenclature of organic structures are adopted, while in the latter the use of 
12 of the trivial names initially proposed by Fischer is permitted (Figure III).[1, 2] Despite the introduction of the 
systematic nomenclature, some of these older designations are still broadly used today, owing to their simplicity 
and convenience.
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The use of  Roman numerals  (I  to  IV) to  identify the four possible  positional  isomers of  coproporphyrin, 
etioporphyrin and uroporphyrin, in which the substituents located at the pyrrolic positions 2, 3, 7, 8, 12, 13, 17 and 
18 are of two kinds only and one of each kind is present at each and every pyrrolic unit, is also accepted. These 
isomeric forms are generically numbered and oriented as depicted in Figure IV, substituent A being smaller than 
substituent  B.  Nevertheless,  the  employment  of  this  sort  of  notation  is  not  advisable  nor  recommended for 
porphyrins comprising more than four positional isomers.[3]
Figure IV
The  IUPAC/IUB  assignment  of  porphyrin  derivatives  displaying  different  oxidation  states  may  also  be 
replaced  by  the  corresponding  trivial  names;  thus,  the  designation  of  their  substituted  and  functionalised 
analogues is based on this nomenclature (Figure V).
Figure V
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The  IUPAC/IUB  semi-systematic  nomenclature  for  tetrapyrrolic  macrocyclic  structures  was  applied  in 
Chapter  3  of  this  dissertation.  The  denomination  of  other  organic  compounds  obeyed  the  set  of  rules  and 
regulations  recommended  by  the  same  entities,[4-6]  with  the  exception  of  the  Biginelli  and  Biginelli-type  
derivatives discussed in Chapter 5. Although the IUPAC recommendations encourage the use of the systematic  
system for the designation of these compounds, the more ancient names presented under brackets in Figure VI 
are also accepted and, it must be stressed, still widely employed in the scientific literature.
Figure VI
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Microwave Chemistry
I. Introduction & Relevance
Since the seminal reports on the use of microwave irradiation to carry-out chemical transformations by the 
research groups of Gedye and Giguere in 1986,[1, 2] more than 5000 articles have been published on this field of 
study, commonly designated as microwave-assisted organic synthesis (MAOS).[3-15] In general,  comparing to 
conventional heating methods, microwave heating has been shown to drastically reduce reaction times, increase 
reaction yields and enhance product selectivity by reducing unwanted side reactions. This technique has already 
proved to be invaluable in multi-step total synthesis,[16-18] medicinal chemistry and drug discovery,[19-25] and 
has  also  been  exploited  on  related  areas,  such  as  polymer  synthesis,[26-32]  materials  science,[33-36] 
nanotechnology[37-39] and biochemical processes.[40-44] In principle, any chemical reaction that requires heat 
can be advantageously performed under microwave conditions; hence, the use of this technology in chemistry has  
become rather popular within the scientific community, both in academia and in industry.
The short reaction times provided by microwave heating make it an ideal methodology for fast trial-and-error 
exploration and optimisation of reaction conditions. Arguably, it can be stated that one of the breakthroughs in  
MAOS,  regarding  its  progress  from  laboratory  curiosity  to  standard  practice,  started  in  the  pharmaceutical 
industry around the year 2000. Medicinal  chemists were among the  first to recognize the capabilities  of this 
enabling  technology and,  since  then,  microwave  synthesis  has  proved to  be  an important  tool  for  medicinal 
chemistry and drug discovery applications. Several reaction parameters, as well as novel reaction pathways, can 
be critically assessed in a short timespan, allowing the rapid synthesis of compound libraries, both in parallel or  
sequential/automated fashions.
In  the  early  days,  experiments  were  typically  carried-out  in  sealed  Teflon  or  glass  vessels  in  a  domestic 
microwave  oven  without  any  temperature  or  pressure  monitoring.  Understandably,  this  type  of  household 
appliance was not designed for laboratory use; solvents and acids rapidly corrode the interiors and there are no 
safety devices. Consequently, violent explosions due to fast and uncontrolled heating of organic solvents under  
closed-vessel conditions was a frequent outcome. In the 1990s various research teams started to explore dry-
media reactions, which partially averted the danger of explosions. The reagents were adsorbed onto either a more  
or less microwave-transparent inorganic support (silica, alumina or clay) or a strongly absorbing one (graphite),  
that in addition may have been doped with a catalyst. This solventless approach was very popular, since it allowed 
the  safer  use  of  domestic  microwave  ovens  and standard open-vessel  methods.  Although a  great  number  of 
interesting microwave-assisted chemical transformations using solid supports have been reported,[45-49] serious 
difficulties,  concerning  heterogeneous  heating  and/or  mixing  and  the  correct  determination  of  the  reaction 
temperature,  remained  unresolved.  Alternatively,  microwave  synthesis  was  often  performed  using  organic  
solvents under open-vessel conditions, the boiling point of the solvent typically being the limit for the reaction 
temperature.  In  order  to  achieve  high  reaction  rates,  high-boiling  and  microwave-absorbing  solvents  were 
frequently used, although this presented serious challenges upon product isolation.[50, 51] Additionally, the risks 
related to the flammability of most organic solvents in a microwave field and the lack of commercially-available 
microwave reactors permitting adequate temperature and pressure control were major concerns.
The initial slow activity of microwave chemistry in the late 1980s and 1990s has often been imputed to its lack  
of reproducibility and controllability, coupled with a deficient perception of the basics of microwave dielectric 
heating. The use of domestic microwave ovens, combined with non-reliable temperature monitoring systems, also 
led to a widespread confusion in the scientific community, in addition to the large discussion around the topic of  
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microwave  effects.[52,  53]  Historically,  the  observed  rate  accelerations  and  sometimes  different  product 
distributions, compared to conventional heating experiments, led to strong speculation on the existence of specific 
or  non-thermal  microwave  effects.[54-58]  These  were  asserted  whenever  the  outcome of  a  synthetic  process 
accomplished under microwave irradiation was different from the conventionally-heated equivalent at the same  
apparent temperature. Currently, most researchers concur that, in the vast majority of cases, the explanation for 
the observed rate enhancements is of purely thermal/kinetic nature, that is, a consequence of the high reaction  
temperatures that  are  rapidly  attained when irradiating  microwave-absorbing  materials  in a microwave  field. 
Nonetheless, effects that are caused by the uniqueness of the microwave dielectric heating mechanism should also 
be considered. Because of the recent availability of modern microwave reactors, displaying accurate monitoring of  
temperature, pressure and microwave power, some of the initial debate on microwave effects has settled.
Controlled MAOS in sealed vessels using standard solvents, a technique pioneered by Strauss and co-workers 
in the mid-1990s,[59-61] is presently the method of choice for performing microwave-heated reactions. This is 
clearly  evident  from surveying  the  recent  literature  in  the  area  of  microwave  chemistry.  Apart  from several 
books[3-10] and review articles,[11-15,  62-76] special  issues of  journals,[77-80] feature articles,[81-89] online  
databases[90-92] and educational publications[93-96] provide extensive coverage on the subject.
Innovations in dedicated microwave instrumentation allow parallel and sequential/automated protocols under 
sealed-vessel conditions and the possibility of continuous- or stop-flow processing for scale-up purposes. Specially 
designed  vessels  and  accessories  for  solid-phase  synthesis,  chemical  transformations  using  pre-pressurised 
conditions or sub-ambient temperatures and a variety of other specific applications, have also been developed. 
Continuous  temperature,  pressure  and  microwave  power  measuring,  built-in  magnetic  stirring,  software 
operation and safety devices are provided by the microwave equipment manufacturers, Anton-Paar GmbH (Graz, 
Austria),[97] Biotage AB (Uppsala, Sweden),[98] CEM Corporation (Matthews, NC, USA)[99] and Milestone S.r.l.  
(Sorisole,  Italy).[100]  However,  the  low  energy  efficiency  of  the  available  microwave  reactors  in  converting 
electrical to microwave energy, comparing to conventional heating instrumentation, particularly in small-scale  
open-vessel  laboratory  processing,  is  yet  to  be  addressed.[101-102]  Also,  this  fairly  new  technology  remains 
somewhat expensive. While prices for MAOS reactors have considerably decreased since their first introduction in 
the late 1990s, the actual price range is still much higher than that of conventional heating equipment. As with any 
new technology, the present situation is bound to change over the next years and more energy- and cost-effective 
instruments should become accessible.
II. Microwave Fundamentals
The physical principles that determine the successful application of microwaves in organic synthesis are not  
broadly known by the majority of chemists. Nevertheless, it  is essential  for the synthetic chemist working on  
MAOS to have a basic knowledge of the underlying principles of microwave-matter interactions and the nature of 
microwave effects. Hence, a brief summary of the present-day understanding of microwaves and their interactions 
with matter is given in the following sections.
A. Microwave Radiation
Microwave radiation is electromagnetic radiation in the frequency range of 0.3 to 300 GHz, corresponding to  
wavelengths of 1 mm to 1 m. Thus, the microwave region of the electromagnetic spectrum lies between infrared  
and radio frequencies (Figure 1.1). The fundamental use of microwaves is either for transmission of information or  
for transmission of energy. Wavelengths between 1 and 25 cm are largely used for RADAR transmissions, while  
the remaining wavelength range is used for telecommunications. Both domestic microwave ovens and dedicated  
microwave reactors currently available operate at a frequency of 2.45 GHz, corresponding to a wavelength of 12.25 
cm, in order to avoid interference with telecommunication,  wireless networks and cellular phone frequencies. 
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There are other frequency allocations for microwave heating applications, but these are not generally employed in 
microwave reactors designed for synthetic chemistry.[103] As can be seen from the data presented in Table 1.1,  
the energy of  a  microwave photon at  a frequency of  2.45 GHz,  1.6 x  10 -3 eV,  is  too low to cleave molecular 
bonds.[103,  104]  Therefore,  microwaves  can  not  induce  chemical  reactions  by  direct  absorption  of 
electromagnetic energy, as opposed to ultraviolet and visible radiation (photochemistry).
Figure 1.1. Wavelength and frequency ranges of the electromagnetic spectrum. 
Table 1.1. Radiation types and energies versus bond types and energies.
Radiation Type
Frequency Quantum Energy
Bond Type
Bond Energy
(Hz) (eV) (eV)
γ-Rays 3 x 1017 1.24 x 106 C-C 3.61
X-Rays 3 x 1016 1.24 x 105 C=C 6.35
Ultraviolet 1 x 1012 4.1 C-O 3.74
Visible 6 x 1011 2.5 C=O 7.71
Infrared 3 x 109 1.2 x 10-2 C-H 4.28
Microwave 2.45 x 106 1.6 x 10-3 O-H 4.80
Radiofrequency 1 x 103 4 x 10-9 Hydrogen Bond 0.04-0.44
B. Dielectric Heating
Microwave chemistry is based on the efficient heating of materials by microwave dielectric heating, which is 
dependent on the ability of a specific material, e.g. solvent, reagent or catalyst, to absorb microwave energy and 
convert it into heat.[105, 106] Microwaves are a type of electromagnetic radiation and, hence, possess both electric 
and magnetic field components (Figure 1.2). For most practical purposes related to microwave-assisted synthesis, 
only the electric component of the electromagnetic field is important for wave-material interactions, although in 
some instances, e.g. transition metal oxides, magnetic field interactions can also be relevant.[107-109] The electric 
component of an electromagnetic field causes heating by two primal mechanisms: dipolar polarisation and ionic 
conduction.  The  interaction  of  the  electric  field  component  with  the  matrix  is  called  dipolar  polarisation 
(Figure 1.3a).[105, 106] For a substance to be able to generate heat when subjected to microwave irradiation it 
must possess a dipole moment. When exposed to microwave frequencies, the dipoles of the sample align with the 
applied electric field. As the field oscillates, the dipoles attempt to realign themselves with the alternating electric 
field and,  consequently, energy is lost in the form of heat through molecular friction and dielectric loss.  The  
amount of heat rendered by this process is directly related to the capability of the matrix to align itself with the  
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frequency of the applied  field. If the dipoles do not have enough time to realign (high frequency irradiation) or 
reorient too quickly (low frequency irradiation) with the applied field, no heating occurs. The assigned frequency 
of 2.45 GHz, used in all commercially available systems, lies between these two extremes and gives the molecular  
dipoles time to align, but not to follow the alternating  field precisely. Therefore, as the dipoles reorient to align 
themselves  with  the  electric  field,  this  is  already  changing  and  generates  a  phase  difference  between  the 
orientation of the field and that of the dipoles. This phase deviation causes energy to be lost from the dipoles by  
molecular friction, giving rise to dielectric heating. Summarising,  field energy is transferred to the medium and 
electrical energy is converted into kinetic or thermal energy. It should be accented that the interaction between  
microwave  radiation  and  polar  molecules,  which  occurs  when  the  frequency  of  the  radiation  approximately 
matches the frequency of the rotational relaxation process, is not a quantum mechanical resonance phenomenon. 
Transitions between quantised rotational bands are not involved and the energy transfer is not a property of a  
specific  molecule,  but the result  of  a collective  phenomenon involving the whole  bulk.[105,  106] The heat is  
generated  by  frictional  forces  occurring  between  the  polar  molecules,  whose  rotational  velocity  has  been 
augmented by the coupling with the microwave irradiation.
Figure 1.2. Electric and magnetic field components of microwaves.
Figure 1.3. Dipolar polarisation (a) and ionic conduction (b) mechanisms typical of dielectric heating.
The second major mechanism behind dielectric heating is ionic conduction (Figure 1.3b).[105, 106] As the 
charged particles in a sample, commonly ions, oscillate back and forth under the influence of the microwave field, 
they clash with their neighbouring molecules or atoms. These collisions cause agitation and create heat. Hence, if  
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two  samples  containing  equal  amounts  of  distilled  water  and  tap  water,  respectively,  are  heated  at  a  fixed 
microwave power, the tap water sample will heat more rapidly due to its ionic content. Such ionic conduction 
effects are particularly important when considering the heating behaviour of ionic liquids in a microwave  field. 
The conductivity principle is a much more powerful effect than the dipolar rotation mechanism, regarding the  
heat-generating  capacity.  Strongly  conducting  or  semiconducting  materials,  such as  metals,  exhibit  a  related 
heating phenomenon, where microwave irradiation can induce a flow of electrons on the surface and, eventually, 
heat the material through resistance heating mechanisms.[28]
C. Dielectric Properties
The  heating  characteristics  of  a  particular  material  under  microwave  irradiation  depend  on  its  dielectric 
properties. The ability of a specific substance to convert electromagnetic energy into heat, at a given frequency and 
temperature, is determined by a parameter called loss factor, tanδ. This is expressed as a ratio, tanδ=ε''/ε', where 
ε'' is the dielectric loss, indicating the efficiency with which electromagnetic radiation is converted into heat, and ε' 
is the dielectric constant, describing the polarisability of the molecules in the electric  field. A reaction medium 
with  a  high  tanδ  value  is  required  for  efficient  microwave  absorption  and,  consequently,  for  rapid  heating. 
However, materials with a high dielectric constant, such as water (ε'=80.4 at 25 ºC), may not also have a high tanδ 
value. In fact, ethanol has a significantly lower dielectric constant (ε'=24.3 at 25 ºC), but heats much faster than 
water under a microwave field due to its higher loss factor (tanδ: ethanol=0.941, water=0.123). The boiling point, 
loss factor, dielectric loss and dielectric constant values of some commonly used organic solvents are indicated in  
Table 1.2.[10] Typically, solvents are classified as high (tanδ>0.5), medium (0.1<tanδ<0.5) and low (tanδ<0.1) 
microwave-absorbing. Other common solvents without a permanent dipole moment, such as carbon tetrachloride, 
benzene and dioxane, are more or less microwave-transparent. Nevertheless, a low tanδ value does not exclude a 
particular  solvent  from being  used in  a  microwave-assisted reaction,  since that  some of the reagents  and/or 
catalysts are likely to be polar and the overall dielectric characteristics of the reaction medium will allow sufficient 
heating by microwaves. Moreover, polar additives, e.g. alcohols or ionic liquids, or passive heating elements can  
be added to low microwave-absorbing reaction mixtures in order to increase the absorbance level of the whole  
medium.
It should also be pointed out that, while ε'' or tanδ values of a molecule can be used to assess the microwave-
absorbing efficiency, the use of any single parameter oversimplifies the issue of effective microwave heating, given  
that  a  number  of  other  factors  may  contribute  to  this.  Properties  such as specific  heat  capacity  and heat  of 
vaporisation of the substance, as well as the depth to which microwave radiation can penetrate into the sample,  
can  sometimes  have  a  bigger  impact  on  the  heating  rate  than  its  respective  dielectric  loss  or  loss  factor. 
Additionally, dielectric loss and dielectric constant values are both frequency and temperature dependent, specific 
heat changes as a function of temperature and heat of vaporisation changes as a function of pressure. These can all 
affect microwave absorption individually and/or in combination. Room temperature distilled water, for instance,  
is  most  microwave-absorbent  at  approximately  18  GHz,  but  as  temperature  increases,  so  does  the  optimum 
frequency at which water converts microwave irradiation into heat. However, when synthetic chemists refer to 
good or bad microwave-absorbing substrates, a fixed 2.45 GHz irradiation source, a small depth of field (1-10 cm) 
and synthetically relevant temperatures (50-200 ºC) are implied.
The penetration depth is defined as the point where 37% of the initially irradiated microwave power is still  
present.[103] It is inversely proportional to the loss factor and, hence, critically depends on temperature and 
irradiation  frequency.  Materials  with  relatively  high  tanδ  values  are  thus  characterised  by  low  values  of 
penetration depth and, therefore, microwave irradiation may be totally absorbed within the outer layers of these  
materials.  For a  solvent  such as water  (tanδ=0.123  at  25  ºC and 2.45 GHz),  the penetration depth at  room 
temperature is only of the order of a few centimetres (Table 1.3).[10] Beyond this penetration depth, volumetric 
heating due to absorption of microwave energy becomes minimal. Hence, when performing microwave-assisted 
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experiments on a larger scale, only the outer layers of the reaction mixture are directly heated by microwave 
irradiation through dielectric heating mechanisms, while the inner part of the reaction mixture is mostly heated 
by classical convection and conduction phenomena. Issues relating to the penetration depth are therefore crucial  
when dealing with the scale-up of MAOS.
Table 1.2. Boiling point, loss factor, dielectric loss and dielectric constant values of common organic solvents at  
25 ºC and 2.45 GHz.
Solvent bp (ºC) tanδ ε'' ε'
Ethylene Glycol 197 1.350 49.950 37.0
Ethanol 78 0.941 22.866 24.3
Dimethylsulphoxide 189 0.825 37.125 45.0
2-Propanol 82 0.799 14.622 18.3
1-Propanol 97 0.757 15.216 20.1
Formic acid 100 0.722 42.237 58.5
Methanol 65 0.659 21.483 32.6
Nitrobenzene 211 0.589 20.497 34.8
1-Butanol 118 0.571 9.764 17.1
2-Butanol 100 0.447 7.063 15.8
1,2-Dichlorobenzene 180 0.280 2.772 9.9
N-Methyl-2-Pyrrolidone 204 0.275 8.855 32.2
Acetic Acid 113 0.174 1.079 6.2
N,N-Dimethylformamide 153 0.161 6.070 37.7
1,2-Dichloroethane 83 0.127 1.321 10.4
Water 100 0.123 9.889 80.4
Chlorobenzene 132 0.101 0.263 2.6
Chloroform 61 0.091 0.437 4.8
Acetonitrile 82 0.062 2.325 37.5
Ethyl Acetate 77 0.059 0.354 6.0
Acetone 56 0.054 1.118 20.7
Tetrahydofuran 66 0.047 0.348 7.4
Dichloromethane 40 0.042 0.382 9.1
Toluene 111 0.040 0.096 2.4
n-Hexane 69 0.020 0.038 1.9
Table 1.3. Penetration depth values of common materials at a given temperature.
Material T (ºC) Penetration Depth (cm)
Water (Liquid) 25 1.4
Water (Liquid) 95 5.7
Water (Solid) -12 1100
Polyvinyl Chloride 25 210
Glass 25 35
Teflon 25 9200
Quartz 25 16000
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The loss factor and dielectric loss of pure water and many other organic solvents decrease with increasing  
temperature  and,  consequently,  the  absorption  of  microwave  radiation  in  water  diminishes  at  higher 
temperatures. Although it is relatively simple to heat water from room temperature to 100 ºC, in sealed-vessel  
conditions,  it  is  significantly  more  troublesome  to  further  heat  water  to  200  ºC  and  beyond.  Most  organic 
materials and solvents behave similarly, which might be somewhat inconvenient from a practical standpoint, since 
microwave heating at higher temperatures may often be compromised.[105, 106, 110, 111] However, the opposite  
situation, where a material becomes a stronger microwave-absorber with increasing temperature, is also possible; 
this is the case of some inorganic and polymeric materials,[105] thermal runaway and temperature overshooting 
during microwave irradiation being a frequently observed phenomenon.
Summing-up,  the  interaction  of  microwave  irradiation  with  matter  is  characterised  by  three  different 
processes: absorption, transmission and reflection. Highly dielectric materials, like polar organic solvents, usually 
lead to a strong absorption of microwaves and, accordingly, to a fast heating of the medium (Table 1.2).[28] Non-
polar microwave-transparent materials display only small interactions with microwave irradiation (Table 1.4) and 
can thus be used as insulators for reactors because of their high penetration depth values (Table 1.3). If microwave 
radiation is reflected by the material surface, there is no or negligible coupling of energy into the system and the 
temperature increase is only marginal.  This is particularly true for metals with high conductivity, although in 
some cases resistance heating for these materials can occur.
Table 1.4. Loss factor values of low-absorbing materials at 25 ºC and 2.45 GHz.
Material tanδ (x 10-4) Material tanδ (x 10-4)
Quartz 0.6 Acrylic Glass 57
Ceramic 5.5 Polyester 28
Porcelain 11 Polyethylene 31
Phosphate Glass 46 Polystyrene 3.3
Borosilicate Glass 10 Teflon 1.5
D. Microwave versus Conventional Heating
Organic synthesis is traditionally carried-out by conductive heating with an external heat source, such as an  
oil-bath or a heating mantle. This is a rather slow and ineffective means for transferring energy into the reaction 
system, since it depends on the convection currents and thermal conductivity of the diverse materials that must be  
penetrated. Hence, the temperature of the reaction vessel is generally higher than that of the reaction mixture 
(Figure 1.4b). This is particularly true if reactions are performed under reflux conditions, where the temperature 
of the bath fluid is typically kept at 10 to 30 ºC above the boiling point of the reaction mixture, in order to ensure 
an efficient reflux. Moreover, a temperature gradient can develop within the sample and local overheating can  
lead to product, reagent or catalyst  degradation. On the other hand, microwave irradiation produces efficient 
internal heating, in-core volumetric heating, by direct coupling of microwave energy with the molecules (solvents,  
reagents or catalysts) that compose the reaction mixture (Figure 1.4a). Therefore, microwave irradiation raises the 
temperature of the whole volume simultaneously, bulk heating, whereas in the conventionally-heated vessel the 
outer layer of the reaction mixture, which is in contact with the vessel wall, is heated first. Bearing in mind that 
the  reaction  vessels  employed  in  current  microwave  reactors  are  typically  made  out  of  nearly  microwave-
transparent materials, such as borosilicate glass, quartz or Teflon (Table 1.4), the radiation passes through the 
walls of the vessel and an inverted temperature gradient is achieved with minimised wall effects, comparing to  
conventional  heating.  Nevertheless,  it  should  be  pointed  out  that  microwave  dielectric  heating  and  classical  
thermal heating by conduction/convection processes are entirely different phenomena and that any comparison 
between the two is intrinsically challenging.
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   (a)    (b)
Figure 1.4. Microwave (a) and conventional (b) heating temperature gradients.
E. Microwave Effects
Currently, it is widely agreed by the scientific community that, in the vast majority of cases, the observed rate  
improvements  and  sometimes  different  product  distributions  in  microwave-assisted  reactions,  comparing  to 
conventionally-heated processes, are owed to the high reaction temperatures that can be rapidly achieved when 
irradiating polar materials and reaction mixtures in a microwave  field and, thus, are a consequence of purely 
thermal/kinetic effects.[55, 57, 58, 96, 112, 113] Similarly, the existence of specific microwave effects, which can 
not  be  duplicated  under  classical  heating  conditions  and  result  from the  singularity  of  microwave  dielectric 
heating, is largely accepted. Examples of this phenomenon are: the super-heating effect of solvents at atmospheric 
pressure, the selective heating of strongly microwave-absorbing heterogeneous catalysts or reagents in a less polar 
reaction medium and the elimination of wall effects caused by inverted temperature gradients. In opposition, the  
topic of non-thermal microwave effects is extremely debatable.[52, 53, 114] These have been proposed to result  
from the direct interaction of the electric  field with specific molecules present in the reaction medium, which is 
not related to any macroscopic temperature effect. It has been argued that the presence of an electric field leads to 
specific orientation/collision effects of dipolar molecules or intermediates, changing the pre-exponential factor  
(A) or the activation energy (Ea) in the Arrhenius equation, k=Ae-Ea/RT, where k is the rate constant of the reaction, 
R  is  the  ideal  gas  constant  and  T  is  the  reaction  temperature,  for  certain  kinds  of  chemical  processes.  An  
analogous effect has also been suggested for polar reaction mechanisms, the polarity being increased from the  
ground  state  to  the  transition  state,  resulting  in  an  improvement  of  reactivity  by  decreasing  the  activation 
energy.[55, 57, 58, 96, 112, 113 ]
Considering  that  the  application  of  microwaves  in  chemistry,  particularly  in  organic  synthesis,  is  a  fast 
growing technology, and that the available literature is full of contradictory reports, regarding the involvement of 
specific or non-thermal microwave effects in a wide assortment of chemical reactions, it becomes evident that a  
scientific rationalisation for the observed phenomena and a critical study of the related influence of the electric 
field and, consequently, of the microwave power on chemical transformations is of the essence. Three possibilities  
for justifying microwave-assisted rate enhancements can be expressed: thermal/kinetic effects, specific microwave 
effects and non-thermal microwave effects.[14] Additionally, any given combination of these contributions may be 
accountable  for  the  observed  developments,  which  makes  research  on  microwave  effects  an  exceedingly  
challenging issue.
1. Thermal/Kinetic Effects
Nowadays, most of the published work on MAOS is performed in high-power density microwave reactors.  
Using this type of equipment, moderately strong microwave-absorbing solvents, such as N-methyl-2-pyrrolidone 
(bp=204 ºC, tanδ=0.275 at 25 ºC), can be promptly heated, even in an open vessel at atmospheric pressure.  
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Under  sealed-vessel  conditions,  microwave-absorbing  solvents  with  a  relatively  low  boiling  point,  such  as 
methanol (bp=65 ºC, tanδ=0.659 at 25 ºC), can be rapidly superheated to temperatures of more than 100 ºC 
above their boiling points. In other media characterised by extreme loss factor values, like ionic liquids, rapid  
increase in temperature can be even more noticeable, temperature leaps of about 200 ºC within a few seconds 
being ordinarily observed. Naturally, such temperature profiles are very difficult, if not impossible, to reproduce 
by  classical  thermal  heating  and,  therefore,  striking  rate  enhancements  when  comparing  reactions  that  are 
performed  under  classical  oil-bath  conditions,  i.e.  heating  under  reflux,  with  high-temperature  microwave-
assisted  processes  are  not  exceptional.  It  has  been  pointed  out  that  by  simple  application  of  the  Arrhenius 
equation, a chemical transformation that requires 68 days to reach 90% conversion at 27 ºC, will exhibit the same 
degree of conversion after 1.61 s when carried-out at 227 ºC (Table 1.5).[105]
Table 1.5. Relation between temperature and time for a representative first order reaction (A=4 x 1010 mol-1 s-1, 
Ea=100 kJ mol-1).
T (ºC) k (s-1) Time (90% conversion)
27 1.55 x 10-7 68 d
77 4.76 x 10-5 13.4 h
127 3.49 x 10-3 11.4 min
177 9.86 x 10-2 23.4 s
227 1.43 1.61 s
Owing to the very fast  heating and the intense temperatures achievable in microwave chemistry,  it  seams 
obvious that  many  of  the reported rate  improvements  can be  explained by effects  of  strictly thermal/kinetic  
nature. Nevertheless, in the absence of any specific or non-thermal microwave effects, it should be expected that 
reactions performed under open-vessel conditions proceed at the same reaction rate, regardless of whether they 
are heated by microwaves or in a standard thermal process. It should be stressed that, concerning purely thermal 
effects, the pre-exponential factor (A) and the entropic energy term or activation energy (Ea) in the Arrhenius 
equation are not affected, only the temperature term changes. Moreover, the typical rapid heating and cooling of  
small-scale  microwave-assisted  transformations  may  lead  to  altered  product  distributions,  as  compared  to  a  
conventional oil-bath reflux protocol, where both heating and cooling are not as fast and the reaction temperature 
is  usually  lower.  It  has  been  reasoned  that  the  different  heating  profiles  characteristic  of  microwave  and 
conventional heating can lead to different reaction products if the product distribution is governed by complex 
temperature-dependent kinetic profiles.[3] This might explain why, in several reported cases, microwave-assisted 
reactions  have  been  found  to  be  cleaner,  i.e.  yielding  less  by-products,  comparing  to  the  classically-heated 
equivalents. Obviously, microwave heating will not always favour the desired reaction pathway and, consequently, 
there  may  be  cases  where,  because  of  the  higher  reaction  temperatures,  unwanted  reaction  products,  not  
determined during a conventionally-heated experiment performed at a lower temperature, can be formed.
2. Specific Microwave Effects
Specific microwave effects can be defined as  accelerations of chemical transformations under a microwave 
field that can not be accomplished or replicated by conventional heating. A well known example is the super-
heating of solvents at atmospheric pressure.[115-118] Several research groups have stated that the enthalpy of 
vaporisation under microwave and conventional heating is the same and that the rate of evaporation, as well as 
the  temperature  of  both  liquid  and  vapour  at  the  interface,  are  heavily  dependent  on  the  experimental  
conditions.[119, 120] It was established in the 1990s that, at atmospheric pressure, microwave-heated liquids boil 
at temperatures above the equilibrium boiling point. The super-heating temperature of various solvents can be up 
to  40  ºC  above  the  standard  boiling  point.[117,  118]  Hence,  the  average  temperature  of  a  solvent  can  be 
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significantly  higher  than  the  corresponding  atmospheric  boiling  point  in  a  microwave  reactor,  because  the 
microwave power is distributed over the entire volume of the solvent. Losing excess thermal energy by boiling  
under microwave conditions only occurs at the existing liquid-gas interface, in opposition to classically-heated 
solvents, where boiling usually occurs at nucleation points, such as cavities, pits and scratches on the glass surface  
of the reaction vessel.[115] The bulk temperature of a microwave-irradiated boiling solvent is due to numerous 
factors, like the physical properties of the solvent, the geometry of the reactor, the mass and heat transfer and the  
electric field distribution. However, it should be accented that most super-heating can be easily eliminated by an  
effective  stirring  or  the  addition of  boiling  chips.  The  kinetics  of  homogeneous  organic  reactions  exhibit  an  
extension of the typical Arrhenius behaviour into the superheated temperature area,[119, 120] up to 100-fold rate 
improvements being reached, which is generally only feasible under pressure. Nonetheless, given that dedicated  
microwave reactors offer magnetic or mechanical stirring options, and that the majority of the current microwave  
chemistry  is  carried-out  under  sealed-vessel  conditions,  super-heating  effects  at  atmospheric  pressure  are  
practically irrelevant.
The elimination of wall effects due to the inverted temperature gradients characteristic of microwave heating,  
Figure 1.4a, can be viewed as another specific microwave effect. In general, the surface of the wall is not heated,  
since the microwave energy is liberated within the bulk liquid and, thus, the temperature of the inner surface of 
the reactor wall  is  lower than that of the bulk.  In a conventional  oil-bath process,  Figure 1.4b,  temperature-
sensitive species, like catalysts,  may decompose at the hot reactor surface. The removal of such a hot surface 
usually increases the lifetime of  the catalyst  and,  consequently,  leads to  better  conversions under microwave 
irradiation, comparing to classically-heated protocols. Mass or volumetric heating, i.e. the rapid and equal heating 
of  the  full  reaction  mixture,  is  also  typical  of  microwave  dielectric  heating.  Berlan  and  co-workers  have 
exemplified this effect very plainly by heating urea at around 250 ºC to form cyanuric acid.[121] The reaction is  
sluggish and the yields are quite low under classic heating conditions, owing to the generation of various by-
products. The reason for this is that cyanuric acid, which decomposes without melting above 300 ºC and is firstly 
formed as a solid at the walls of the reactor, is a poorly heat-conductive substance and it forms an insulating crust  
which prevents heat transfer to the rest of the reaction mixture. Increasing the temperature of the oil-bath and, 
subsequently, of the wall results in partial decomposition. On the other hand, high yields of cyanuric acid are  
obtained under  microwave  irradiation,  without  any secondary product  being  detected.  However,  this  type  of  
effects can only be seen on a relatively small scale, due to microwave penetration depth issues.
Another important specific microwave effect is an outcome of the selective heating of strongly microwave-
absorbing heterogeneous catalysts or reagents in a less polar reaction medium.[122] This is based on the fact that 
in a sample containing more than one constituent, only the one which efficiently couples with microwaves is 
selectively  heated;  therefore,  the  non-absorbing  components  are  heated  by  heat  transfer.  For  heterogeneous 
reaction mixtures, particularly solid/gas systems involving heterogeneous gas-phase catalysis,[122, 123] selective 
heating  of  the  catalysts is  crucial,  the rate  improvements  and altered product  selectivity  that  sometimes  are 
observed being imputed to the formation of localised macroscopic hot spots, up to 150 ºC above the measured 
bulk temperature.[124] However, measuring the temperature distributions induced by microwave irradiation in 
solid  materials  is  fairly  complex  and,  accordingly,  many  local  temperature  variations  are  greater  than  those 
measured.  Microwave-assisted transformations in  organic solvents catalysed by a  heterogeneous catalyst,  e.g.  
solid/liquid  systems  using  palladium-on-charcoal  (Pd/C),  are  of  greater  relevance  in  organic  chemistry.  The 
reaction temperature at the catalyst surface is significantly higher than the bulk temperature of the solvent, since 
the catalyst is  a strong microwave-absorber, particularly when a low tanδ solvent is  selected (Table 1.2).  The 
selective  heating/activation  provided  by  microwave  irradiation  of  a  Pd/C  catalyst  was  exploited  in  the  Pd-
catalysed hydrogenation of various carbon-carbon double bond systems.[125] Analogous observations were made 
in similar microwave-assisted hydrogenation reactions.[126] The selective absorption of microwave energy by a 
heterogeneously-encapsulated  palladium  catalyst  was  also  proposed  for  a  series  of  very  expeditious  Suzuki 
couplings of aryl bromides, under both batch and flow microwave conditions.[127]
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Selective heating processes can also be explored for high microwave-absorbing reagents. For instance, primary  
and secondary alcohols were oxidised in toluene with a chromium dioxide reagent under microwave conditions, 
surface temperatures of up to 360 ºC being measured with an IR thermovision camera.[128, 129] Although the 
temperature of the solid oxidising agent was higher than the boiling point of the solvent, no boiling was observed 
inside the reaction vessel. The interaction of a microwave field with magnesium metal turnings was reported for 
the  formation  of  Grignard  reagents.[130]  Irradiation  of  aryl  halides  in  dry  tetrahydrofuran  with  magnesium 
turnings led to arcing of the latter. The reaction was drastically faster under microwave conditions, comparing to  
conventional  heating  at  the  same  measured  temperature  of  65  ºC.  This  could  be  due  to  a  cleansing  effect 
(electrostatic etching), the removal of a layer of magnesium oxide from the magnesium, induced by microwave 
irradiation.  It  appears  that  heterogeneity  plays  a  major  function  in  the  enhancement  of  microwave-assisted 
chemical transformations and that microwaves can change the energies and/or the real temperatures of individual  
species at the interfaces, as the result of Maxwell-Wagner interfacial microwave polarisation.[131] These reports 
furnish a clear indication for the existence of selective heating effects in MAOS involving heterogeneous reaction  
mixtures.  However,  it  should  be  emphasised  that  the  standard  methods  for  measuring  the  temperature  in 
microwave-heated reactions, i.e. external IR detectors or internal fibre-optic probes, only allow the determination 
of the average bulk temperature of  the solvent,  not the real reaction temperature on the surface of the solid 
reagent or at the interface.
Theoretically, similar arguments of selective heating can be made for liquid/liquid homogeneous mixtures, 
such as polar reagents in a microwave-transparent solvent. Sadly, the existence of such molecular radiators[44] is 
experimentally  hard  to  establish.[105,  106,  110,  111]  Moreover,  it  is  infeasible  to  selectively  activate  polar 
functional  groups,  also  known as  antenna groups,[132]  within  a larger  molecule.  Localised rotations of  such 
antenna groups are possible and microwave heating of molecules containing these structures may result in rate  
enhancements. However, dielectric heating mechanisms involve the rapid energy transfer from these groups to 
neighbouring  molecules and it  is  impossible  to  store  the energy in a specific  part  of  the molecule.[106] The 
differential heating of multiphasic liquid/liquid systems is another specific microwave effect not easily duplicated 
by classic heating procedures. This was applied in a microwave-assisted Hofmann elimination reaction using a 
two-phase water/chloroform system.[133] The temperatures of the aqueous and organic phases were 110 and 
50 ºC, respectively, due to the different dielectric properties of the solvents (Table 1.2); this difference averted  
degradation of the final product, which is soluble in the cooler chloroform phase. Equal conditions would be very  
hard to obtain using standard heating methods. A similar effect has been documented in the preparation of β,β-
diarylated aldehydes by hydrolysis of enol ethers in a two-phase toluene/aqueous hydrochloric acid system.[134]
Microwave heating of heterogeneous liquid/liquid systems will  almost always result in differential  heating 
phenomena, given that a difference in loss factor values between the two phases is highly probable. Because of the 
potentially different temperatures in the phases, mass and heat transfer across the phase boundaries may change,  
comparing  to  conventional  heating where both phases present the same temperature.  Evidently,  temperature 
monitoring in these situations must be carefully realised, since it will be critically important in which phase the  
temperature  is  measured.  Also,  effective  stirring  should  always  be  applied  when dealing  with  heterogeneous  
mixtures.[135]
Again, it should be noted that the possible rate improvements pointed above under the concept of specific 
microwave effects, such as the super-heating of solvents at atmospheric pressure, the selective heating of strongly  
microwave-absorbing heterogeneous catalysts or reagents in a less polar reaction medium, differential heating of 
liquid/liquid  multiphasic  mixtures  and  the  elimination  of  wall  effects  originated  by  inverted  temperature 
gradients, are in essence still of thermal nature, i.e. a difference in temperature compared to standard heating by 
conduction/convection  procedures,  although  it  may  be  troublesome  to  accurately  determine  the  reaction 
temperature experimentally.
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3. Non-Thermal Microwave Effects
Non-thermal  microwave  effects  can  be  outlined  as  accelerations  of  chemical  transformations  under  a 
microwave field that can not be substantiated by either purely thermal/kinetic or specific microwave effects.[14] 
Fundamentally, non-thermal effects result from a suggested direct interaction of the electric  field with specific 
molecules in the reaction medium. It has been contended by some researchers that the presence of an electric field 
leads to orientation effects of dipolar molecules and, thus, changes the pre-exponential factor (A)[136-138] or the 
activation energy (Ea)[139, 140] in the Arrhenius equation. Moreover, it has been reasoned that a related effect 
should be noticeable for polar reaction mechanisms, where the polarity increases going from the ground state to  
the transition state, resulting in the improvement of reactivity by lowering the activation energy. Various reports 
have been published using arguments like this to rationalise the outcome of a chemical reaction performed under 
microwave irradiation conditions.[55, 57, 58, 96, 112, 113] These results have been interpreted by the authors as 
proof for the participation of non-thermal microwave effects through electrostatic interactions of polar molecules 
with the electric  field, i.e. the stabilisation of the transition state and the subsequent decrease in the activation 
energy.[141] It has also been argued that reactions that occur via a late product-like transition state presenting a 
large enthalpy of activation (Figure 1.5b), compared to reactions that involve early transition states (Figure 1.5a), 
would be prone to exhibit strong microwave effects.[55, 57, 58, 96, 112, 113]
      (a) (b)
Figure 1.5. Proposed relation between early (a) and late (b) transition states and microwave effects.
As already referenced above, non-thermal microwave effects are extremely controversial.  Several scientists  
criticise the existence of dipolar orientation effects in electric  fields on the evidence of overriding disorientation 
phenomena (thermal agitation) that should prevent any statistically relevant alignment of dipoles.[110] Also, non-
thermal  microwave  effects  have  generally  been  proposed  for  processes  concerning  solventless/dry-media  
reactions and/or transformations involving polar reaction intermediates or products, which will strongly absorb 
microwave  energy.[55,  57,  58,  96,  112,  113]  Considering  the  difficulties  of  meticulous  online  temperature 
monitoring  under  these  conditions,  it  can  be  reasoned  that,  in  many  of  the  reported  cases,  the  observed  
differences  between  microwave  and  conventional  heating  may  be  justified  by  inaccurate  temperature 
measurements, often using external IR sensors, rather than being the consequence of an authentic non-thermal  
effect.[103]
The fairly recent conception that simultaneous external cooling of the reaction mixture or below-zero reaction 
temperatures under microwave irradiation leads to an improvement of the whole process is also related to the  
topic of non-thermal microwave effects.[10, 142, 143] The reaction vessel is cooled through a flow of compressed 
air during microwave irradiation, which allows a higher level of microwave power to be directly supplied to the 
reaction mixture, but prevents overheating by continuously removing latent heat. Some researchers have claimed 
that, since microwave energy is transferred into the sample much faster than molecular kinetic relaxation occurs, 
non-equilibrium  conditions  will  be  the  outcome  of  a  microwave-assisted  reaction.  Consequently,  a  higher 
instantaneous  temperature,  relative  to  the measured bulk temperature,  will  be  determined as more power is 
applied  into  the  system.[10,  143]  Nevertheless,  detailed  utilisations  of  simultaneous  air  cooling  methods  are 
rather scarce.[125, 127, 135, 144-154] Moreover, the actual reaction temperatures have not been determined in  
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many reported situations.[146-153] The standard external IR detectors that are part of most microwave reactors 
can not be utilised to determine internal reaction temperatures under simultaneous cooling conditions. Given that  
the IR sensor will only supply the surface temperature of the reaction vessel, not the real reaction temperature  
inside the reactor, external cooling of the reaction vessel will not provide a dependable temperature measurement 
and,  thus,  care  must  be  taken  not  to  misread  the  results  obtained  with  simultaneous  cooling 
approaches.[103, 135, 144, 145] Several studies have described the application of simultaneous cooling conjugated 
with  fibre-optic  temperature  monitoring.[125,  127,  135,  144,  145,  154-158]  Although the  effects  compared  to 
regular microwave heating were small in some instances,[135, 144, 145] in other cases important differences in 
conversion rates and product purity between the cooled and uncooled procedures were observed at the same 
measured bulk temperature.[125, 127, 154-158]
Besides simultaneous cooling, MAOS under sub-ambient temperature conditions is also possible. Once more,  
contradictory  reports  about  the  utility  of  this  technology  exist.[145,  155-158]  Microwave-assisted  chemistry 
carried-out by cooling the reaction mixture to as low as -176 ºC was published by Hajek and co-workers.[159] 
Reaction rates were recorded under both microwave and conventional conditions. Higher reaction rates under  
microwave  irradiation at  sub-ambient  temperatures  were  imputed to  the  super-heating  of  the heterogeneous 
catalyst used and, hence, to a specific microwave effect. Closely related to the simultaneous cooling methodology 
is  the  technique  of  using  pre-cooled  reaction vessels.[160,  161]  Also,  Ley  and  co-workers  found that  pulsed  
microwave  irradiation with periodical  cooling  afforded higher  conversions than  continuous  irradiation of  the 
reaction mixture for an equal period of time and at the same temperature.[162-165] Speculation was made on 
whether recurrent temperature overshooting by the strongly microwave-absorbing reaction mixture in the pulsed 
experiments was accountable for the observed improvements.
There  is  no  agreement  in  the  scientific  community  about  microwave  effects  and  their  consequences  in 
microwave-assisted organic synthesis  or  even about a rigorous definition of  terms.  The classification of  non-
thermal microwave effects here presented is far from perfect and probably merits to be re-examined. Appreciable  
research efforts are still required before a unequivocal resolution about the existence or non-existence of these  
effects can be presented.[135]
III. Microwave Equipment
Although  the  pioneering  experiments  in  MAOS  were  largely  carried-out  in  domestic  microwave  ovens,  
dedicated instruments for chemical synthesis are currently the most used. In a domestic microwave oven, the 
irradiation power is generally controlled by on-off cycles of  the magnetron and it  is  impossible  to accurately 
measure the reaction temperature. The inhomogeneous microwave field produced by the low-cost designs, as well 
as the lack of safety controls, make the use of such equipment highly inadvisable for scientific ends. In opposition, 
all commercially accessible microwave reactors designed for chemical synthesis feature built-in magnetic stirrers 
or  alternative  agitation  devices,  temperature  and  pressure  detectors  and  software  that  enables  on-line 
temperature and pressure  monitoring and control  by  regulation of  the microwave  power.[166] Two different 
approaches have emerged, regarding the microwave reactor design: multi-mode and single-mode. In multi-mode 
units, conceptually very similar to domestic microwave ovens, the microwaves that enter the generally large cavity 
move around and are reflected by the walls, rendering areas or modes of high and low energy as moving waves  
either reinforce or cancel each other (Figure 1.6a). In many of these systems a rotating device ensures that the  
field distribution is as homogeneous as possible. In the much smaller single-mode cavities, the electromagnetic  
irradiation is directed through a specifically designed wave-guide onto the reaction vessel, which is mounted at a 
fixed distance from the radiation source, creating a standing wave (Figure 1.6b).
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Figure 1.6. Schematics of multi-mode (a) and single-mode (b) microwave cavities.
A. Domestic Microwave Ovens
The generic lack of temperature and pressure control systems and the impossibility to stir the reaction mixture 
are some of the major practical disadvantages of using these inexpensive household appliances for performing 
chemical syntheses. Additionally, the pulsed irradiation and the resulting inhomogeneity of the microwave field 
usually  leads  to  problems  of  reproducibility.  Because  of  this  heterogeneous  energy  distribution  within  the 
microwave cavity, some areas receive high amounts of energy (hot spots) whereas others receive less energy (cold 
spots).[167] If a load is placed inside the cavity the energy distribution is altered, comparing to the unloaded  
cavity; to compensate these heterogeneities, the samples are generally rotated in order to attain a more levelled 
energy distribution. Safety is another primary concern; violent bursts caused by electric arcs inside the cavity or  
sparking resulting from the on-off switching of the magnetron could be a dangerous outcome of heating organic 
solvents in open-vessel systems using a domestic microwave oven. Furthermore, working with pressurised sealed 
vessels without monitoring the temperature and pressure values may lead to vessel failures and severe accidents.  
Modifications of the accessible domestic ovens with self-made accessories, such as mechanical stirrers and reflux 
condensers,  assembled  through  holes  in  the  cavities  have  also  been  made,  aiming  to  create  low-budget 
instrumentation  suitable  for  chemical  synthesis,  as  depicted  in  Figure  1.7.  Nevertheless,  several  safety  risks 
remain, given that those instruments are not explosion-proof and leakage of microwave radiation, harmful to the 
synthetic chemist operating the system, could occur. Undoubtedly, the employment of any microwave equipment 
not specifically designed for organic synthesis can not be recommended and, presently, is prohibited in numerous 
academic and industrial research laboratories.
Figure 1.7. Modified domestic microwave oven.
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B. Dedicated Microwave Reactors
Many of the current dedicated microwave equipment manufacturers offer a variety of different platforms with 
several  degrees  of  technological  sophistication,  such  as  built-in  magnetic  or  mechanical  stirring,  real-time 
temperature, pressure and microwave power monitoring and control, effective cooling during and/or after the 
irradiation  phase,  automation accessories,  explosion-proof  cavities  and other  safety  features,  computer-aided 
programming and database capabilities. A particularly problematic issue in microwave chemistry is the accurate 
measuring  of  the  reaction  temperature  during  the  irradiation  period.  Classical  temperature  detectors,  e.g. 
thermometers and thermocouples, are useless, given that they couple with the electromagnetic  field. However, 
temperature measurements can be easily accomplished by means of an immersed temperature sensor, like a fibre-
optic  probe  or  a  gas  balloon  thermometer,  or  via  an  external  IR  detector.  Due  to  the  volumetric  nature  of 
microwave dielectric heating, the surface temperature of the reaction vessel will not always indicate the precise  
temperature inside the reaction mixture.
Generally speaking, a microwave reactor consists of a microwave power source (magnetron), a transmission 
line (wave-guide), that delivers microwaves from the magnetron into an antenna, and a microwave applicator 
(cavity). Continuous microwaves are rendered in the magnetron, which can be viewed as a vacuum tube. The 
magnetron consists of a cylindrical cathode that is enclosed by an anode block, while a magnetic field is generated 
parallel to the axis of the cathode by external magnets. In addition, the anode block possesses small cavities. The 
electrons emitted  from the  cathode  are  deflected by the  electric  and magnetic  fields  and revolve  around the 
cathode before they can reach the anode. Electron clusters are generated due to acceleration or deceleration of  
electrons in the cavities and, consequently, transform their energy into microwave oscillation. Lastly, microwave 
energy from one of the resonant cavities is coupled to the antenna that is attached to the wave-guide. Various 
modes can be excited when the energy is  coupled into the wave-guide,  the number being determined by the  
dimensions of the wave-guide cross-section. Therefore, an infinite series of modes can exist in microwave cavities. 
According to their dimensions and geometries, multi-mode or single-mode reactors are distinguishable. A state-
of-the-art microwave reactor design should assure that all the incident power is absorbed by the load, since the  
magnetron can be severely damaged when too much energy is reflected back. Several methods to surmount this 
problem are incorporated in all dedicated microwave reactors.
In multi-mode instruments, microwave irradiation created by, normally, one or two magnetrons, is usually 
directed into the cavity through a wave-guide and distributed by a mode stirrer (Figure 1.6a). The microwaves are 
reflected from the walls of the cavity and interact with the sample in a disorganised way.  Hence, multi-mode  
cavities may exhibit several energy pockets with multiple levels of energy intensity, which leads to the formation 
of hot and cold spots. In order to supply an equal energy distribution, the samples are continuously rotated within  
the  cavity.  Nonetheless,  multi-mode  instruments  offer  convenient  platforms  for  the  increase  of  reaction 
throughput by means of multi-vessel rotors for parallel synthesis or scale-up purposes. Even so, a main problem 
for  multi-mode  equipment  is  the  fairly  weak  performance  for  small-scale  processing,  typically  under  3  ml. 
Although the generated microwave power is high, commonly ranging from 1000 to 1600 W, the power density of 
the energy field is generally quite low, heating of small individual samples being rather troublesome. Therefore, 
the  usage  of  multi-mode  instruments  for  small-scale  synthetic  organic  chemistry  is  not  so  extensive,  when  
compared  to  the  alternative  single-mode  units.  The  latter  are  capable  of  generating  a  single  and  nearly 
homogeneous energy  field of high power intensity. Hence, these systems couple efficiently with small-volume 
samples and the maximum output power is typically much lower, reaching a maximum of 300 or 400 W. A single  
magnetron is sufficient to generate microwave energy, which is usually oriented through an appropriate circular  
or  rectangular  wave-guide  to  the  sample,  positioned at  a  maximised  energy  location  (Figures  1.6b).  Further 
technological  advances  have  led  to  a  wide  variety  of  applications  for  single-mode  microwave  instruments,  
providing  flow-through  systems  and  many  other  special  features,  such  as  solid-phase  peptide  synthesis  or 
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experiments at sub-ambient temperatures. Thus, the utilisation of single-mode microwave reactors has increased 
enormously since the beginning of the 21st century and this sort of equipment has become broadly popular in 
many  research laboratories.  However,  it  should  be stressed that  the  type  of  instrumentation used should be  
supported on the desired scale and application rather than on the type of chemistry to be carried-out. Both multi- 
and single-mode microwave reactors enable various chemical transformations expeditiously and advantageously, 
comparing to conventionally-heated procedures.
C. CEM Discover S-Class
The CEM Discover unit, firstly presented in 2001, is a single-mode instrument based on a self-tuning circular  
wave-guide technology (Figure 1.8a). This automatically adjusts to ensure that the reaction receives the optimum 
amount of  energy,  irrespective  of  the reaction volume, providing access to  automation,  scale-up under open-
vessel,  closed-vessel  and  flow-through  conditions,  low-temperature  synthesis  and  various  applications  in 
biosciences.  All  Discover  instruments  are  equipped  with  a  built-in  keypad  for  programming  the  reaction 
parameters and allowing on-line modifications. The microwave power output can be set up to 300 W, which is  
more than enough to ensure an effective heating of most reaction mixtures. Regular temperature measuring is  
attained via an IR sensor positioned at the bottom of the cavity, directly below the reaction vessel (Figure 1.8b).  
This allows accurate temperature control of the reaction, even when using minimum amounts of materials. An 
optional  fibre-optic probe for internal temperature monitoring is also available. A pressure measurement and 
management system named IntelliVent was also developed (Figure 1.8c). If the pressure inside a reaction vial  
exceeds 20 bar, the IntelliVent sensor assures a controlled venting of the pressure and automatically reseals the 
vial to maintain optimum safety.
    (a)    (b)        (c)             (d)
Figure 1.8. Self-tuning circular wave-guide (a), volume-independent infrared temperature sensor (b), IntelliVent 
pressure monitoring and control system (c) and PowerMAX simultaneous cooling system (d) featured in the CEM 
Discover S-Class single-mode microwave reactor.
In  2006,  the  Discover  S-Class  model  was  introduced (Figure  1.9).  Supplemental  to  the  above-mentioned 
attributes, common to the earlier Discover systems, the BenchMate and the LabMate, this instrument integrates a 
fully automated pressure control device and a USB interface. In addition to the 10 ml vials, 35 ml vessels with 
working volumes ranging from 2.5 to  25 ml are available, allowing low-level scale-up processing under sealed-
vessel conditions. Larger volumes, up to 125 ml, can be processed in open-vessel procedures. Reactions can easily  
be run and programmed trough a computer with the Synergy software, included in the base package, which allows 
a more user-friendly interface, simple data treatment and straightforward real-time parameter regulation. A built-
in cooling system titled PowerMAX, based on a continuous flow of compressed air, can be used simultaneously 
with and/or after microwave irradiation (Figure 1.8d). An interesting yet optional feature is the integrated CCD 
camera for  in situ observation of the reaction vessels. A gas addition kit designed for reactions with gaseous 
reagents,  e.g.  hydrogenations  or  carbonylations,  or  simply  to  ensure  an  inert  atmosphere  during  microwave 
heating is also available. This accessory allows purging of the reaction vessel and back-filling it with a gas at any 
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given time. During the reaction, the gas source is completely shut-off from the reactor, thereby ensuring adequate  
safety conditions.  Another peculiar accessory of the Discover instruments is the CoolMate module, a below-zero 
cooling system designed to carry-out sub-ambient temperature chemistry, e.g. lithiations, carbohydrate synthesis 
or  other  temperature-sensitive  chemical  transformations.  The  reactor  is  equipped  with  a  jacketed  low-
temperature vessel and a microwave transparent cooling media that keep the bulk temperature as low as -80 ºC.
Figure 1.9. CEM Discover S-Class single-mode microwave reactor.
The utilisation of a single-mode microwave equipment identical  to the one portrayed in Figure 1.9 to the  
development  of  simple,  efficient  and  reproducible  microwave-assisted  synthetic  methodologies  of  several  
interesting and widely known nitrogen-containing heterocycles, namely pyrroles, porphyrins, hydroporphyrins, 
Hantzsch 1,4-dihydropyridines, Biginelli and Biginelli-type 3,4-dihydropyrimidines, was the primary objective of 
the research project that ultimately led to the present doctoral dissertation. The study of their reactivity under 
microwave  irradiation,  particularly  in  oxidation  processes,  was  also  a  goal  that  was  pursued,  environment-
friendly, low-cost and time-saving strategies being employed whenever possible.
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2
Pyrroles
I. Introduction & Relevance
Pyrrole, a five-membered nitrogen-containing heterocycle, is broadly recognised as one of the simplest and 
most  important  aromatic  heterocycles  and  can  be  found  in  a  wide  range  of  natural  products  and  synthetic  
molecules. It was discovered by Runge in the mid-1830s, as a consequence of a series of distillation experiences of 
bone  oil  and  coal  tar,  and isolated  by  Anderson  in  1857  through similar  procedures.  Its  first  synthesis  was  
accomplished  by  Schwanert  in  1860,  by  heating  the  ammonium  salt  of  mucic  acid,  and  after  its  successful  
structural  elucidation,  achieved by von Bayer in  the 1870s,  and its  identification as an essential  fragment in 
several  biologically  relevant  natural  pigments,  such  as  haem,  chlorophyll  or  vitamin  B 12,  chemists  became 
increasingly  interested  in  pyrroles  and  their  properties.[1-3]  Representative  examples  of  natural  pyrrole-
containing bioactive compounds are depicted in Figure 2.1, including some antibacterial halogenated pyrroles, e.g. 
pioluteorine and pentabromopseudiline, both isolated from bacterial sources. Pyrrole structures are particularly 
prominent in marine natural products. Some examples are nakamuric acid[4] and some marinopyrroles,[5] which  
exhibited good activity against methicillin-resistant Staphylococcus aureus strains.
Figure 2.1. Representative examples of natural pyrrole-containing bioactive compounds.
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The storniamide alkaloid family, isolated from a myriad of marine organisms, like molluscs, ascidians and 
sponges, and featuring 3,4-diarylpyrrole moieties, must also be emphasised. A series of methoxylated analogues of  
storniamide A have proved to be potent inhibitors of multidrug resistance phenomena,[6] regarded by several  
researchers as one of the primal  obstacles to the development of a successful anticancer chemotherapy.  Both 
natural and synthetic products containing polypyrrole motifs are often involved in coordination and molecular  
recognition phenomena.  Besides  the  ubiquitous tetrapyrroles,  such as porphyrins  and related structures  (see 
Chapter 3), a red dye synthesised by bacteria belonging to the  Serratia genus, prodigiosin, has shown to have 
antibiotic  properties[7]  and  behave  as  a  transporter  of  protons  and  chloride  anions  across  phospholipid 
membranes.[8] Moreover, the torsional flexibility associated with some polypyrrole systems linked by peptide 
bonds has proved to be crucial to molecular recognition phenomena involved in the interaction with DNA minor 
groove natural binders, such as netropsin, distamycin and related drugs.[9] Pyrrole substructures also exist in a  
large number of biologically active man-made molecules, including antitubercular compounds,[10, 11] and HIV 
fusion inhibitors.[12] The non-steroidal anti-inflammatory compound tolmetin,[13-16] the cholesterol-lowering 
agent  atorvastatin  (one  of  the  best-selling  drugs  in  pharmaceutical  history)[17-20]  and  the  anticancer  drug 
candidate tallimustine[21-23] are a few relevant examples of pyrrole-based synthetic drugs (Figure 2.2).
Figure 2.2. Representative examples of synthetic pyrrole-containing bioactive compounds.
Pyrrole  derivatives  are  becoming  exceedingly  important  in  materials  science.  One  can  mention 
semiconducting materials derived from hexa(N-pyrrolyl)benzene,[24] glucose sensors based on polypyrrole-latex 
hybrid structures[25] and polypyrrole compounds capable of effective detection and discrimination of volatile  
organic  compounds.[26]  The  4,4-difluoro-4-boradipyrromethene  (BODIPY)  system  and  related  dyes  are 
characterised by a strong absorption in the UV region and a very intense fluorescence, displaying many promising  
applications, such as laser manufacture, chemosensing, optical imaging and chemotherapy, among many others 
(Figure 2.3).[27]
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Figure 2.3. Representative examples of synthetic pyrrole-containing compounds relevant in materials science.
II. Classical Synthetic Methods
The synthesis of pyrroles became possible at the end of the 19 th century with the pioneering work conducted by 
Knorr,  Paal  and  Hantzsch,  who  presented  plain  and  straightforward  cyclisation  strategies  for  the  direct  
preparation of substituted pyrroles, starting from easily accessible reagents. Currently, a considerable amount of  
review literature on modified classical pyrrole synthesis is available.[28-31]
A. Paal-Knorr Synthesis
The Paal-Knorr procedure was reported independently by German chemists Carl Paal and Ludwig Knorr, in 
1884, as a method for the preparation of substituted furans, pyrroles and thiophenes.[32, 33] The treatment of 
appropriately  substituted  1,4-dicarbonyl  compounds  with  ammonia,  primary  amines  or  ammonium  or  alkyl 
ammonium salts, usually in ethanol or acetic acid, leads to 2,5-disubstituted pyrroles. Although the widespread 
utilisation of the Paal-Knorr synthesis, its reaction mechanism was not fully comprehended until it was elucidated  
by  Amarnath  and  co-workers  in  the  1990s.[34,  35]  For  instance,  2,5-hexanedione  I reacts  with  ammonia 
furnishing a double hemiaminal  II which, due to step-wise elimination of water, yields 2,5-dimethyl-1H-pyrrole 
IV through the corresponding imine III (Scheme 2.1).
Scheme 2.1. Paal-Knorr synthesis of pyrroles.
B. Knorr Synthesis
The cyclocondensation of  α-aminoketones V with β-ketoesters or β-diketones VI, which proceeds through a 
β-enaminone intermediate VII[36] and affords 3-alkoxycarbonyl- or 3-acyl-substituted pyrrole derivatives VIII, 
respectively,  was  first  published  by  Ludwig  Knorr  almost  130  years  ago  (Scheme 2.2).[37-39]  Because  most 
α-aminoketones self-condense very easily they are not employed as such, but generated in situ by reduction of the 
corresponding α-oximinoketones. The latter are commonly obtained by nitrosation of ketones with alkyl nitrites 
in the presence of sodium methoxide.
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Scheme 2.2. Knorr synthesis of pyrroles.
C. Hantzsch Synthesis
3-Alkoxycarbonyl-  or  3-acyl-substituted  pyrroles  can  also  be  prepared  by  reaction  of  α-haloketones  with 
ammonia or primary amines and β-ketoesters or β-diketones, respectively. This methodology was developed by 
the German chemist Arthur Rudolph Hantzsch over a century ago.[40, 41] The regioselectivity of the product 
depends on the substituents in the starting materials, but mainly renders the 1,2,3,5-tetrasubstituted pyrrole XI. 
Thorough investigations demonstrated that β-ketoesters VI react with ammonia or primary amines, yielding a β-
aminoacrylic  ester  intermediate  X.  C-alkylation of  the enamine group of  X by the  α-haloketone  IX provides 
1,2,3,5-tetrasubstituted  pyrroles  XI,  while  N-alkylation  leads  to  1,2,3,4-tetrasubstituted  pyrroles  XII 
(Scheme 2.3). 
Scheme 2.3. Hantzsch synthesis of pyrroles.
III. Microwave-Assisted Synthetic Methods
A variety of synthetic strategies for the synthesis of substituted pyrrole derivatives is presently available.[1-3]  
However, hazardous and/or expensive reagents, solvents and catalysts, long reaction times and harsh reaction 
conditions are sometimes required, a number of unwanted by-products is frequently obtained and reaction yields  
are often low. Furthermore, pyrroles are commonly susceptible to chemical degradation, e.g. oxidation, which 
further restrains their isolation and purification processes. Therefore, more than 120 years after the first synthetic  
methods  were  developed,  the  preparation  of  highly  substituted  pyrrole  compounds  remains  challenging. 
Microwave  irradiation  has  already  been  successfully  applied  to  the  synthesis  of  several  heterocyclic 
compounds;[42,  43]  some selected  examples regarding  pyrroles,  taken from the currently  available  scientific 
literature, are briefly described below.
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A. Literature Review & Selected Examples
Although  the  microwave-assisted  preparation  of  pyrroles  by  dehydrogenation  of  previously  synthesised 
pyrrolidines[44] and by reaction of 1,4-diketones with ammonia or other primary amines generated from urea-
type compounds pre-adsorbed in montmorillonite clays[45] was published in 1994, the first microwave-activated  
Paal-Knorr reaction report appeared in 1999.[46] Danks achieved the successful synthesis of 2,5-dimethylpyrroles 
in  less  than  2  minutes,  by  irradiating  neat  mixtures  of  the  starting  materials,  2,5-hexanedione  and primary  
amines, in a domestic microwave oven (Scheme 2.4).
Scheme 2.4. Solventless Paal-Knorr synthesis of 2,5-dimethylpyrroles.
Several highly substituted pyrrole structures were synthesised with reasonably good yields under microwave 
irradiation  by  Ranu  and  co-workers  in  the  early  2000s.[47,  48]  The  solid-supported  three-component 
condensation  of  α,β-unsaturated  aldehydes  or  ketones,  primary  amines  and  nitroalkanes  in  silicon  dioxide 
(Scheme 2.5a) and of aldehydes or ketones, primary amines and α,β-unsaturated nitroalkenes in aluminium oxide 
(Scheme 2.5b) was conducted in a domestic equipment in short reaction times.
Scheme 2.5. Solid-supported three-component synthesis of highly substituted pyrroles.
Pyrroles bearing multiple aryl groups were conveniently prepared by a one-pot microwave-assisted Paal-Knorr 
strategy, starting from ammonium, alkyl ammonium or aryl ammonium formates and but-2-ene-1,4-diones or 
but-2-yne-1,4-diones, via palladium-mediated transfer hydrogenation of the carbon-carbon double or triple bond, 
followed by a reductive amination-cyclisation process.[49, 50] Using liquid polyethylene glycol as solvent and a  
domestic microwave oven,  Rao and colleagues were able to  rapidly obtain  2,5-diarylpyrroles with high yields 
(Scheme 2.6).
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Scheme 2.6. Paal-Knorr synthesis of 2,5-diarylpyrroles in liquid polyethylene glycol.
A  three-step  synthesis  of  tetrasubstituted  pyrroles  was  developed  by  the  Taddei  research  team in  2004.  
Adequate functional  homologation of  a  β-ketoester  with  an aldehyde,  followed by oxidation with  pyridinium 
chlorochromate provided substituted 1,4-dicarbonyl compounds, which were then rapidly cyclised with primary 
amines via a Paal-Knorr procedure using a dedicated single-mode microwave reactor (Scheme 2.7).[51] A very 
similar approach was explored by the same authors to prepare more than 60 pyrrole-based amino acids and some  
related constrained oligopeptides.[52,  53] The solution-phase microwave-assisted synthesis  of a larger library 
containing 288 pyrrole-amide derivatives with medium to good yields was also accounted.[54]
Scheme 2.7. Paal-Knorr synthesis of tetrasubstituted pyrroles.
Tetrasubstituted  pyrrole  compounds  could  also  be  obtained  under  solid-supported  microwave  conditions 
through  skeletal  rearrangement  of  1,3-oxazolidines,  which  are  accessible  in  solventless  two-step  domino 
processes. The first one occurs between commercially available alkyl propiolates and aldehydes affording enol 
ethers. Subsequent microwave-promoted reaction of the latter with primary amines on a silicon dioxide support 
yields the 1,3-oxazolidine intermediates, which easily rearrange in situ to the desired pyrroles in a second domino 
procedure (Scheme 2.8).[55] Hence, performing this domino sequence in a one-pot format utilising a household 
microwave apparatus resulted in a simple and diversity-oriented synthesis of tetrasubstituted pyrroles.
Scheme 2.8. Domino synthesis of tetrasubstituted pyrroles.
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Another  interesting  example  of  the  preparation  of  tetrasubstituted  pyrrole  derivatives  was  published  by 
Bergner and Opatz in 2007.[56] The cycloaddition of α-(alkylideneamino)nitriles and nitro-olefins making use of 
a single-mode microwave reactor, followed by the elimination of hydrogen cyanide and nitrous acid, allowed the 
construction  of  the  pyrrole  ring  in  four  steps,  starting  from  a  nitroalkane  and  three  aldehydes,  with  high  
regioselectivity and low to moderate yields (Scheme 2.9).
Scheme 2.9. Synthesis of tetrasubstituted pyrroles via cycloaddition.
A  practical  solid-supported  and  microwave-activated  synthetic  method  of  1,2-disubstituted  homochiral 
pyrroles,  based  on  a  two-component  coupling  of  chloroenones  and  chiral  primary  amines,  was  devised  by 
Aydogan and co-workers in 2005 (Scheme 2.10a).[57] A related approach, comprising a ring-closure reaction of 
1,4-dichloro-but-2-ene with several amine compounds, was subsequently reported, also yielding  N-substituted 
homochiral  pyrrole  structures  (Scheme  2.10b).[58]  Both  methodologies  were  carried-out  in  a  multi-mode 
microwave digestion equipment.
Scheme 2.10. Solid-supported synthesis of N-substituted homochiral pyrroles.
The  two-step  synthesis  of  3,4-disubstituted  N-acylpyrrole  compounds was  accomplished  by  Milgram and 
colleagues,  starting  from  hydrazine  and  alkyl  aldehydes,  via  a  microwave-assisted  Piloty-Robinson  reaction 
(Scheme 2.11).[59] The utilisation of a dedicated microwave reactor greatly reduced the time necessary for this  
process comparing to classical heating conditions, notwithstanding the low to moderate reaction yields obtained.
Scheme 2.11. Piloty-Robinson synthesis of N-acylpyrroles.
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Highly  substituted and  N-unprotected pyrrole  derivatives featuring aryl,  alkyl and fused cycloalkyl  groups 
were synthesised, in relatively brief reaction times and with moderate to high reaction yields, through a ligand-
free microwave-promoted 5-endo-dig intramolecular cyclisation of previously prepared homopropargyl azides in 
the presence of zinc chloride (Scheme 2.12).[60] The catalyst proved to be more effective for aryl than for alkyl  
substituents.
Scheme 2.12. Synthesis of highly substituted pyrroles via zinc chloride catalysis.
Deb and Seidel proposed the preparation of ring-fused pyrroles, through a high-temperature condensation of 
commercially  available  cyclic  amines  and  1,3-diketones,  under  microwave  conditions  (Scheme  2.13).[61] 
A competing retro-Claisen synthetic pathway was efficiently suppressed by employing p-toluenesulphonic acid as 
an additive.
Scheme 2.13. Synthesis of N-substituted ring-fused pyrroles.
The  rapid  and  high-yielding  synthesis  of  N-substituted  pyrrole  compounds  through  condensation  of 
4-hydroxyproline with  several substituted isatins, utilising an ionic liquid as the reaction medium and a single-
mode microwave reactor, was described by Meshram and co-workers in 2010 (Scheme 2.14).[62] The recovered 
ionic liquid was reused for six cycles and the reaction proceeded without the addition of any acid promoter.
Scheme 2.14. Synthesis of N-substituted pyrroles in ionic liquids.
Recently,  highly  substituted β-iodopyrroles  were  easily  prepared  by  reacting  a  mixture  of  N-protected 
1,2-aminoalcohols, molecular iodine and a base in solid PEG-3400 as an alternative, eco-friendly and non-toxic  
reaction medium, in a short period of time and using a dedicated microwave apparatus (Scheme 2.15).[63] Albeit  
few examples were reported, the reaction yields were generally satisfactory and tedious purification procedures 
were avoided.
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Scheme 2.15. Synthesis of β-iodopyrroles in solid polyethylene glycol.
B. Paal-Knorr Synthesis of 2,5-Dimethyl-1H-Pyrroles
In order to explore the capabilities of our, at that time, recently acquired CEM Discover S-Class single-mode 
microwave reactor, it was decided to use the simple microwave-assisted Paal-Knorr protocol for the preparation of  
2,5-dimethyl-1H-pyrroles described by Danks.[46] Thence, a solventless reagent mixture comprising equimolar 
amounts of the selected amine and 2,6-hexanedione, in an appropriate and sealed glass vial, was irradiated using  
two  approaches:  a  constant  temperature  of  100  ºC  and  a  constant  microwave  power  of  100  W  (Table  2.1,  
entries 1-8; Scheme 2.16a). Isolation of the reaction product was accomplished by drying the diethyl ether solution  
of the crude product mixture with anhydrous sodium sulphate, followed by filtration and silica gel flash column  
chromatography using the same solvent as eluent or recrystallisation in methanol. Although the reaction yields  
were high when benzylamine (entries 5 and 6) and n-butylamine (entries 7 and 8) were employed as reactants 
(86-95%),  regardless  of  the  temperature  and  microwave  power  settings  used  and  after  only  one  minute  of 
microwave  heating,  the  utilisation  of  aniline  for  the  preparation  of  pyrrole  1 was  clearly  not  successful 
(entries 1-4). The best result obtained was a 47% isolated yield after irradiating for 5 minutes at 100 W (entry 4).
Table 2.1. Paal-Knorr synthesis of 2,5-dimethyl-1H-pyrroles 1-3 under microwave irradiation.
Entry Compound R Time (min) Yielda (%)
1 1 Ph 3 -b, d
2 1 Ph 10 35b
3 1 Ph 3 44c
4 1 Ph 5 47c
5 2 Bn 1 90b
6 2 Bn 1 95c
7 3 n-Bu 1 86b
8 3 n-Bu 1 93c
9 1 Ph 3 93b, e
10 1 Ph 3 -c, e, g
11 1 Ph 1 96b, f
12 2 Bn 1 97b, f
13 3 n-Bu 1 94b, f
All reactions were carried-out using the selected amine (10 mmol) and 2,6-hexanedione (10 mmol) in a closed 
vessel.  aYields refer to the isolated reaction products.  bConstant temperature of 100 ºC.  cConstant microwave 
power of 100 W. dOnly trace amounts of pyrrole 1 were detected by TLC analysis of the crude product mixture, 
along  with  the  initial  reagents.  eMontmorillonite  K-10  (5  g)  was  used  as  reaction  medium.  fFormic  acid 
(1.5 mmol) was used as catalyst.  gOnly trace amounts of pyrrole  1 were detected by TLC analysis of the crude 
product mixture, along with several unidentified by-products.
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A solid-supported strategy was then adapted, following part of the work reported by Abid and co-workers,[64] 
in an attempt to improve the reaction yield of 2,5-dimethyl-1-phenyl-1H-pyrrole 1. Thus, a mixture of aniline and 
2,6-hexanedione pre-adsorbed on the surface of montmorillonite K-10, a commercially available, inexpensive, 
non-corrosive, highly acidic and reusable solid catalyst,[65] was subjected to microwave irradiation for 3 minutes 
under  closed-vessel  conditions  (Table  2.1,  entries  9  and 10;  Scheme 2.16b).  While  a  93% reaction yield  was 
attained when a constant temperature of 100 ºC was applied (entry 9), after washing the crude product mixture 
with  diethyl  ether,  removal  of  the  inorganic  solid  support  by  filtration  and  chromatographic  purification,  
irradiating the reaction system at a fixed power setting of 100 W proved to be deleterious, since TLC analysis of  
the  crude  product  mixture  revealed  several  unidentified  by-products  and  only  traces  of  the  desired  pyrrole 
(entry 10).
Another remarkably fast and effective alternative concerning the synthesis of this compound was found by 
adding a small amount of formic acid to the solvent-free reagent mixture referenced above, a 96% reaction yield 
being obtained after work-up (Table 2.1, entry 11; Scheme 2.16c). Zhu and colleagues used the same acid catalyst  
to prepare similar 2,5-dimethylpyrroles at room temperature;[66] however, reaction times of up to 6 hours were 
required to complete the synthetic process. Lastly, the same procedure was applied to the synthesis of 1-benzyl-
2,5-dimethyl-1H-pyrrole 2 and 1-n-butyl-2,5-dimethyl-1H-pyrrole 3 with superior results (entries 12 and 13).[67]
Scheme 2.16. Paal-Knorr synthesis of 2,5-dimethyl-1H-pyrroles 1-3 under microwave irradiation.
Figure 2.4. Structures and isolated yields of 2,5-dimethyl-1H-pyrroles 1-3 synthesised via a solventless, formic 
acid-catalysed, microwave-assisted, Paal-Knorr method.
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C. Paal-Knorr Synthesis of Bis-2,5-Dimethyl-1H-Pyrroles
The microwave-promoted methodologies described in the previous section were subsequently applied to the 
preparation of some bis-2,5-dimethyl-1H-pyrroles, which are far less investigated than their pyrrole analogues, 
starting  from  the  selected  diamine  and  a  three-fold  molar  excess  of  2,6-hexanedione,  again,  using  either  a 
constant reaction temperature of 100 ºC or a fixed microwave power setting of 100 W (Table 2.2; Scheme 2.17).
Table 2.2. Paal-Knorr synthesis of bis-2,5-dimethyl-1H-pyrroles 4-7 under microwave irradiation.
Entry Compound X Time (min) Yielda (%)
1 4 C2H4 3 82b
2 4 C2H4 3 92c
3 5 C6H4 3 80b, d
4 5 C6H4 10 93c, d
5 5 C6H4 3 85b, e
6 5 C6H4 3 92c, e
7 6 C6H4C2H4C6H4 3 90b, e
8 6 C6H4C2H4C6H4 3 94c, e
9 4 C2H4 3 95b, f
10 5 C6H4 3 92b, f
11 6 C6H4C2H4C6H4 3 96b, f
12 7 C2H4OC2H4OC2H4 3 90b, f
All reactions were carried-out using the selected diamine (10 mmol) and 2,6-hexanedione (30 mmol) in a closed 
vessel.  aYields refer to the isolated reaction products.  bConstant temperature of 100 ºC.  cConstant microwave 
power of 100 W. dGC-MS and NMR analyses confirmed that the reaction product obtained was in fact 1-aniline-
2,5-dimethyl-1H-pyrrole. eMontmorillonite K-10 (5 g) was used as reaction medium. fFormic acid (1.5 mmol) was 
used as catalyst.
Scheme 2.17. Paal-Knorr synthesis of bis-2,5-dimethyl-1H-pyrroles 4-7 under microwave irradiation.
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As can be seen from the data gathered in Table 2.2, all syntheses proceeded efficiently in very short reaction 
times, with the exception of entries 3 and 4, when 1,4-diaminobenzene was the nitrogen-containing reactant. In 
fact,  structural  characterisation  of  the  final  product  demonstrated  that  the  desired  1,4-bis(2,5-dimethyl-1H-
pyrrol-1-yl)benzene 5 was  not  formed,  1-aniline-2,5-dimethyl-1H-pyrrole  being  obtained  instead,  even  when 
irradiating at 100 W for 10 minutes, which resulted in temperature values as high as 192 ºC to be reached. Once 
more, when formic acid was employed as catalyst in the neat reagent mixture procedure, the desired bis-pyrrole 
was generated with a 92% isolated yield, after microwave heating at  100 ºC for 3 minutes (entry 10). Direct  
recrystallisation in methanol of the solid residue obtained from drying the diethyl ether solution of the crude  
product mixture with anhydrous sodium sulphate, filtration and evaporation of the solvent was the only work-up 
needed.  Broadening  this  experimental  procedure  to  other  diamine  starting  materials  rendered  1,2-bis(2,5-
dimethyl-1H-pyrrol-1-yl)ethane  4,  1,2-bis(4-(2,5-dimethyl-1H-pyrrol-1-yl)phenyl)ethane  6 and  1,2-bis(2-(2,5-
dimethyl-1H-pyrrol-1-yl)ethoxy)ethane 7 with optimal reaction yields (entries 9, 11 and 12).[67]
Figure 2.5. Structures and isolated  yields of  bis-2,5-dimethyl-1H-pyrroles  4-7 synthesised  via  a  solventless, 
formic acid-catalysed, microwave-assisted, Paal-Knorr method.
D. Multicomponent Synthesis of 3,5-Diaryl-2-Methyl-1H-Pyrroles
A multicomponent reaction (MCR) can be seen as a single chemical process in which three or more reagents,  
usually quite simple and readily available, are combined in such a way that the final product holds significant  
components of all of them. Thus, multicomponent reactions can lead to the connection of three or more starting  
materials  with  high bond-forming efficiency and atom economy,  increasing  structural  complexity  in  an often 
experimentally straightforward way.[68] For this reason, MCRs have been perceived by the pharmaceutical and 
medicinal  chemistry communities  as  a particularly suited approach for compound library synthesis,  aimed at 
performing structure-activity relationship (SAR) studies of drug-like molecules.
As credited earlier, Ranu and co-workers have looked into this type of diversity-oriented methodologies to 
prepare highly substituted pyrrolic structures under microwave irradiation.[47, 48] Nevertheless, and in spite the 
reasonably fair reaction yields accomplished, the vast majority of the pyrrole substituents were linear or branched 
aliphatic groups, phenyl and 4-chlorophenyl being the only aromatic scaffolds reported. It was decided to extend 
this solid-supported strategy in order to prepare novel multisubstituted pyrroles bearing various aromatic groups  
at positions 3 and 5 of the pyrrolic unit. In our first studies, equimolar amounts of (E)-1,3-diphenylprop-2-en-1-
one,  commonly known as  (E)-chalcone,  benzylamine  and a  three-fold molar  excess of  nitroethane  were  pre-
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adsorbed on the surface of several inorganic solids and the resulting reaction mixtures were microwave-heated in 
sealed-vessel conditions; variation of some experimental parameters, such as reaction temperature and time or 
microwave power, was also assessed (Table 2.3, entries 1-9; Scheme 2.18a). The isolation protocol consisted in  
washing the crude product mixture with diethyl ether, followed by filtration of the inorganic solid support, SiO 2 
flash column chromatography and recrystallisation in methanol, rendering 1-benzyl-2-methyl-3,5-diphenyl-1H-
pyrrole 9 as a white solid. Sadly, the best result obtained was a 28% isolated yield, after heating at 100 ºC for 10  
minutes and making use of SiO2 60 (35-70 μm) as the solid support (entry 2). Increasing the reaction time to 20 
minutes (entry 3) or performing the synthetic operation at 150 ºC (entry 4) did not improve the final outcome.  
When a constant microwave power of 100 W was applied (entry 5), temperature and pressure values of 180 ºC  
and 8 bar, respectively, were reached inside the reaction vessel and, besides numerous unidentified secondary  
products, only trace amounts of pyrrole 9 were observed by TLC analysis of the crude product mixture.
Table  2.3. Multicomponent  synthesis  of  1-benzyl-2-methyl-3,5-diphenyl-1H-pyrrole 9 under  microwave 
irradiation.
Entry Reaction Medium Time (min) Yielda (%)
1 SiO2 60 (200-500 μm)b 10 19d
2 SiO2 60 (35-70 μm)b 10 28d
3 SiO2 60 (35-70 μm)b 20 27d
4 SiO2 60 (35-70 μm)b 10 24e
5 SiO2 60 (35-70 μm)b 5 -f, g
6 SiO2 N (2-20 μm)b 10 23d
7 SiO2 60/H2SO4 (35-70 μm)b 10 -d, g
8 Al2O3 (50-150 μm)b 10 25d
9 Montmorillonite K-10b 10 -d, g
10 Solventless 10 -d, h
11 Solventless 20 -d, h
12 AcOHc 10 -d, h
13 AcOHc 20 -d, h
14 EtOH/H2SO4c 10 -d, h
15 EtOH/H2SO4c 20 -d, h
All  reactions  were  carried-out  using  (E)-1,3-diphenylprop-2-en-1-one (5  mmol),  benzylamine  (5  mmol)  and 
nitroethane (15 mmol)  in a  closed vessel. aYields refer  to  the isolated reaction products.  bThe selected solid 
support (8 g) was used as reaction medium. cThe selected solvent (3 ml) was used as reaction medium. dConstant 
temperature of 100 ºC.  eConstant temperature of 150 ºC.  fConstant microwave power of 100 W.  gOnly trace 
amounts  of  pyrrole  9 were  detected  by  TLC  analysis  of  the  crude  product  mixture,  along  with  several  
unidentified by-products. hOnly trace amounts of pyrrole 9 were detected by TLC analysis of the crude product 
mixture, along with the initial reagents.
Although other silicon dioxide supports were tested (entries 1, 6 and 7), as well as aluminium oxide (entry 8) 
and  montmorillonite  K-10  (entry  9),  the  reaction  yields  were  either  lower  or  no  product  was  isolated. 
Simplification of the procedure by eliminating the inorganic solid support, that is, carrying-out the reaction in 
solvent-free  conditions  (Scheme  2.18b),  turned  out  to  be  even  worse,  since  almost  no  pyrrole  was  formed 
(entries  10  and  11).  The  same  phenomenon  was  observed  upon  application  of  a  solvent-based  approach 
(Scheme 2.18c), using glacial acetic acid (entries 12 and 13) or ethanol acidified with a few drops of concentrated 
sulphuric acid (entries 14 and 15).
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Scheme  2.18. Multicomponent  synthesis  of  1-benzyl-2-methyl-3,5-diphenyl-1H-pyrrole 9 under  microwave 
irradiation.
It should be stressed that our best result was less than half the one reported by Ranu for the same compound  
(65%  yield),  utilising  an  unmodified  domestic  microwave  oven  and  silicon  dioxide  HF254  as  the  inorganic  
support,  and quite  similar  to  the one found by  the same author  when conventional  heating  conditions were 
employed, using THF/SiO2 HF254 as the reaction medium (32% yield).[47,  48] We believe that the different 
microwave equipment used was not responsible for the discrepancies concerning the reaction yields achieved. On 
the other hand,  the different characteristics  of  the SiO2 employed as solid support  could have hampered the 
reactivity of our microwave-mediated process, comparing to the one described by Ranu and co-workers.
Moreover, it was determined that there was no advantage in performing this three-component microwave-
assisted methodology in closed reaction vials, given that an identical isolated yield of 28% was attained when 
open-vessel conditions were tested at the same reaction temperature and time. In fact, it became evident that the  
pressure build-up observed inside the sealed vessels during the synthetic process could sometimes be prejudicial,  
since small particles of the solid support were frequently released from the pressurised vial into the microwave  
apparatus,  which  can  be  seriously  damaging  to  the  equipment.  Therefore,  irradiation  of  the  solid-supported 
reaction mixture utilising open glassware at atmospheric pressure averted this harmful situation, without altering 
the reaction yield. Other primary amines and chalcone materials were later employed as reagents, 3,5-diaryl-2-
methyl-1H-pyrroles 8-37 being prepared (Scheme 2.19, Figure 2.6).
Scheme 2.19. Multicomponent synthesis of 3,5-diaryl-2-methyl-1H-pyrroles 8-37 under microwave irradiation.
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Figure  2.6. Structures  and  isolated  yields  of  3,5-diaryl-2-methyl-1H-pyrroles  8-37 synthesised  via  a  solid-
supported, multicomponent, microwave-assisted method.
A possible reaction pathway for the three-component preparation of the pyrrolic compounds depicted above is 
presented in Scheme 2.20, following the rationalisation proposed in the late 1990s by the Yshii research group 
regarding a related synthesis.[69, 70] Formation of an α,β-unsaturated imine XIII by condensation between the 
primary  amine  and  the  chalcone  reagent  is  followed  by  coupling  with  nitroethane,  generating  an  enamine 
intermediate  XIV. Proton transfer leads to a related enamine structure  XV, which in turn renders the pyrrole 
precursor XVI through intramolecular cyclisation. Finally, elimination of water and nitrosyl hydride by the latter  
affords the desired multisubstituted pyrrole.
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Scheme 2.2o. Mechanistic proposal for the multicomponent synthesis of 3,5-diaryl-2-methyl-1H-pyrroles 8-37.
A  few of  these  nitrogen-containing  heterocycles,  compounds  9,  12,  14 and  16,  were  further  investigated 
through a collaboration with the Photochemistry Group of the Coimbra Chemistry Centre of the University of 
Coimbra, some of their spectroscopic and photophysical properties being determined and compared to the ones of  
their  simpler  aromatic  analogues,  benzene,  naphthalene,  anthracene  and  pyrene.[71]  The  room temperature 
absorption  and  fluorescence  emission  spectra  of  the  selected  3,5-diaryl-2-methyl-1H-pyrroles  in 
methylcyclohexane solution, as well as of their aromatic counterparts, is portrayed in Figure 2.7.
Figure 2.7. Normalised absorption (A and C) and fluorescence emission (B and D) spectra of  3,5-diaryl-2-
methyl-1H-pyrroles 9,  12,  14 and  16,  as  well  as  their  aromatic  counterparts,  in  methylcyclohexane  at  room 
temperature (293 K).
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Methylcyclohexane was chosen as medium since it is a 'spectroscopically clean' solvent, i.e. absence of cut-off 
up to around 220 nm, and also exhibits superior glass-type media properties for low-temperature measurements.  
A significant decrease in vibrational structure, along with a very broad wavelength red-shift, particularly in the 
fluorescence emission spectra, was observed for all pyrrolic molecules under study, comparing to their aromatic  
analogues.  The  phosphorescence  emission  spectra  of  the  3,5-diaryl-2-methyl-1H-pyrroles  were  obtained  in 
methylcyclohexane glasses at 77 K (Figure 2.8), with the exception of 3-(anthracen-9-yl)-1-benzyl-2-methyl-5-
phenyl-1H-pyrrole  14, given that the experimental set-up utilised in this work was unable to detect any signal.  
However, phosphorescence has been previously reported for anthracene in ether-pentane-alcohol glasses at the  
same temperature.[72, 73] As somewhat expected, it was ascertained that the phosphorescence emission spectra 
of  compounds  9,  12 and  16 closely  resembled  that  of  benzene,  naphthalene  and  pyrene,  respectively.[73] 
The  relevant spectroscopic data of the investigated multisubstituted pyrroles, including absorption, fluorescence  
and phosphorescence emission and triplet absorption wavelength maxima, singlet and triplet molar extinction 
coefficients, is summed-up in Table 2.4.
Figure 2.8. Normalised phosphorescence emission spectra of 3,5-diaryl-2-methyl-1H-pyrroles  9,  12 and 16 in 
methylcyclohexane at 77 K.
Table  2.4. Relevant  spectroscopic  properties  of  3,5-diaryl-2-methyl-1H-pyrroles 9,  12,  14 and  16  in 
methylcyclohexane at room temperature (293 K).
Entry Compound
λmax εS λmaxF λmaxP λmaxT1-Tn εT
(nm) (M-1 cm-1) (nm) (nm) (nm) (M-1 cm-1)
1 9 239, 284 10990 347 493 370 14800
2 12 291 16480 371 503, 539, 581 360 18700
3 14 290, 348, 366, 385 7000 422, 441 -a 430 10400
4 16 277, 325, 352 23600 393, 415 612, 672 430 12300
aThe experimental set-up used in this study was unable to detect any phosphorescence signal.
A series  of  photophysical  properties  of  the selected 3,5-diaryl-2-methyl-1H-pyrroles,  namely  fluorescence, 
phosphorescence, internal conversion, triplet formation and singlet oxygen formation quantum yields, ФF, ФP, ФIC, 
ФT and  Φ∆, respectively, are presented in Table 2.5. The radiationless phenomena, i.e. internal conversion and  
inter-system crossing (ФIC +  ФT),  constituted the main excited state deactivation pathway for the investigated 
molecules, with the exception of compound 12, where a similar contribution was found between the radiative (ФF) 
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and radiationless (ФIC + ФT) excited state deactivation processes. Singlet oxygen formation quantum yields were 
acquired following photolysis  of aerated methylcyclohexane solutions of the  pyrrolic structures,  the  Φ∆ values 
being in agreement with the ones obtained for ΦT within the experimental error.
Table 2.5. Relevant photophysical  properties of 3,5-diaryl-2-methyl-1H-pyrroles 9,  12,  14 and  16,  as well as 
their aromatic counterparts, in methylcyclohexane at room temperature (293 K) or 77 K.
Entry Compound
ФF ФIC ФP ФT Φ∆
(293 K) (293 K) (77 K) (293 K) (293 K)
1 9 0.29 0.50 0.021 0.21 0.22
2 Benzenea 0.06 0.150 0.25
3 12 0.52 0.15 0.012 0.33 0.32
4 Naphthalenea 0.19 0.033 0.75
5 14 0.34 0.32 -b 0.34 0.20
6 Anthracenea 0.30 0.0003c 0.71
7 16 0.40 0.38 0.0010 0.22 0.24
8 Pyrenea 0.65 0.0021 0.37
aData obtained in non polar solvents.[73] bThe experimental set-up used in this study was unable to detect any 
phosphorescence signal. cData obtained in ether-pentane-alcohol glasses at 77 K.[72, 73]
It  must  be mentioned that,  in  addition to  the spectroscopic  and photophysical  properties  summarised  in 
Tables 2.4 and 2.5, fluorescence decays and transient triplet-triplet absorption spectra of compounds  9,  12,  14 
and  16,  as  well  as  their  fluorescence,  phosphorescence  and  triplet  lifetimes,  were  also  determined  in 
methylcyclohexane. Moreover, related spectral and photophysical  studies in more polar solvents are currently  
being undertaken and the results are to be reported elsewhere in due time.[71]
The chalcone derivatives necessary for the synthesis of the pyrrole library were previously prepared through 
the Claisen-Schmidt procedure described by Kohler and Chadwell.[74] Briefly, a solution containing equimolar  
amounts of the selected aldehyde and the appropriate acetophenone and a slight excess of sodium hydroxide in 
distilled water/ethanol (1:1 v/v) was vigorously stirred, at a temperature between 20 and 30 ºC, until a solid 
precipitated.  It should be emphasised that lower temperatures make the reaction sluggish and unwanted by-
products usually start forming above 30 ºC. After filtration, washing with distilled water and recrystallisation in 
aqueous ethanol, 1,3-diarylprop-2-en-ones 38-55 were effortlessly obtained with very good yields (Scheme 2.21, 
Figure 2.7). In the case of pyrrolyl-chalcone 53, the required pyrrole precursor 56 was synthesised beforehand, by 
reacting  phosphorous  oxychloride,  N,N-dimethylacetamide  and  pyrrole  at  room  temperature,  following  a 
previously  published  procedure.[75]  After  stirring  overnight,  the  crude  product  mixture  was  subjected  to 
neutralisation, liquid/liquid extraction, silica gel flash column chromatography and recrystallisation, the sought 
2-acetyl-1H-pyrrole being obtained as a pale-yellow solid with a 70% isolated yield (Scheme 2.22).
Scheme 2.21. Base-catalysed Claisen-Schmidt synthesis of chalcones 38-55.
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Figure 2.9. Structures and isolated yields of chalcones 38-55 synthesised via a base-catalysed Claisen-Schmidt 
condensation method.
Scheme 2.22. Regioselective Vilsmeier-Haack acetylation of pyrrole.
As expected, only the more stable (E)-isomeric form of the chalcones was formed. This was easily assessed by 
analysis of their 1H NMR spectra, given that the coupling constants of the doublets corresponding to the hydrogen 
atoms of the carbon-carbon double bond were in the 15-16 Hz range, which is typical of the trans arrangement. 
Apart from being excellent starting materials for organic synthesis, as shown here for the preparation of highly  
substituted pyrrolic compounds, chalcone and chalcone-based molecules are widely recognised for their various  
biological  activities,  such as antibacterial,[76,  77]  antifungal,[76,  78]  anti-inflammatory,[76]  antiviral[76]  and 
antitumour,[79-81] and have also been reported to show interesting photophysical properties, being used as light-
emitting diodes and fluorescent dyes and sensors.[82, 83]
IV. Summary
Both 2,5-dimethyl-1H-pyrroles  1-3 and  bis-2,5-dimethyl-1H-pyrroles  4-7 were effortlessly synthesised via a 
solvent-free, microwave-mediated, Paal-Knorr protocol, utilising a small amount of formic acid as catalyst. The  
isolated yields ranged from 90 to 97% while the reaction times did not exceed 3 minutes. A small compound 
library  of  thirty  structurally-diverse  pyrroles  8-37,  incorporating  both  electron-donating  and  electron-
withdrawing  moieties,  was  also  prepared  under  microwave  irradiation  using  a  solid-supported  and 
multicomponent  strategy,  although  with  low  reaction  yields.  Four  of  these  interesting  multisubstituted 
heterocycles, 9, 12, 14 and 16, were selected and further studied, some of their spectroscopic and photophysical  
properties being determined.  The different chalcone precursors required for the synthesis of the 3 ,5-diaryl-2-
methyl-1H-pyrroles, as  well  as  some others that were later employed in the preparation of other heterocyclic  
structures (see Chapter 5), were easily synthesised with very good yields (38-55, 70-90%) through a classical, 
base-catalysed, Claisen-Schmidt condensation reaction.
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Porphyrins & Hydroporphyrins
I. Introduction & Relevance
Tetrapyrrolic macrocycles, as their name suggests, are cyclic conjugated molecules containing four pyrrole-
type  units,  which  can  be  linked  together  directly  or  through different  sorts  of  atoms  and  bonds.  The  most  
important class of these compounds is that of porphyrins. Non-porphyrinic macrocycles can be divided into three 
main groups: contracted, isomeric and expanded.[1] Contracted macrocycles, although arranged in a conjugated 
fashion, display an inferior number of carbon atoms comparing to the skeletal core of porphyrins, corroles being 
one of the most studied examples. Structural variations of porphyrin possessing the same molecular formula are  
titled isomeric macrocycles, e.g. N-inverted porphyrins, porphycenes and corphycenes. Conjugated systems whose 
cycle is built by 24 atoms or more, such as texaphyrins, vinylogous porphyrins, porphocyanines and saphyrins, are 
designated by expanded macrocycles.
In  spite  of  being  a  large  family  of  compounds,  tetrapyrrolic  macrocyclic  structures  found  in  nature  are 
exclusively of the porphyrin, hydroporphyrin and corrole types and are, nearly always, metal complexes. Among 
the naturally-occurring porphyrins one can emphasise: haem B, the iron(II) complex of protoporphyrin IX, which 
constitutes the prosthetic group of haemoglobin and mioglobine, biologically important proteins responsible for  
the  transport  and  storage  of  oxygen  in  many  living  beings;  the  corresponding  iron(III)  complex  present  in  
cytochromes P450 and c, essential enzymes in oxidation/reduction processes involving the transfer of electrons 
and  oxygen  atoms;[2]  the  copper(II)  complex  of  uroporphyrin  III,  produced  through  bio-oxidation  of 
uroporphyrinogen  and  usually  found  in  urine  in  small  amounts;  various  geoporphyrins,  specially  metallic 
complexes of nickel and vanadium, most likely resultant from degradation of haem and chlorophyll and often 
present in crude oil and bituminous sands (Figure 3.1).[3, 4]
Figure 3.1. Representative examples of natural porphyrin compounds.
Hydroporphyrins  that  play  fundamental  roles  concerning  the  development  and  maintenance  of  living 
organisms are also abundant. Some relevant examples of naturally-occurring chlorins are portrayed in Figure 3.2: 
chlorophylls  a and  b,  crucial  photosynthetic  pigments  found  in  plants,  algae  and  cyanobacteria;[5]  factor  I, 
obtained from various vitamin B12-producing bacteria; haem D, the prosthetic group present in cytochrome  d, 
typical of the respiratory chain of several bacterial  systems.[3] Amongst the natural bacteriochlorins, one can 
underline the relevant photosynthetic dyes found in diverse cyanobacteria, bacteriochlorophylls a and b.[5]
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Figure 3.2. Representative examples of natural hydroporphyrin compounds.
The acknowledgement that porphyrin compounds were indispensable in a diversified ensemble of essential 
functionalities in nature triggered an increasing interest in multiple domains of the scientific community, from the  
better comprehension of those functions to the investigation of potential applications based on the very same 
natural  phenomena.  The  role  played  by  chlorophylls  at  the  photosynthetic  centres,  where  solar  energy  is 
converted to chemical energy, gave rise to the study of porphyrin systems in areas such as dye-sensitised solar  
cells,[6] molecular electronics and non-linear optics.[7-10] Mimicking the transport process of molecular oxygen 
and carbon dioxide within living  cells  inspired the use of  this  type of  structures as  sensors of  small  organic 
molecules, e.g. O2,  NO, CO2 and NH3,[11] as well as other targets, like amines, thiols and phosphines[7] and,  
generically, in molecular recognition mechanisms.[12-14] The reduction of molecular oxygen by cytochrome P450 
led to the synthesis  and application of a myriad of compounds as effective catalysts in a variety of oxidation  
reactions.[2, 15-17]
Other extremely relevant utilisations of porphyrins and hydroporphyrins are related to their enormous and  
inherent capabilities as photosensitisers in the activation of reactive oxygen species (ROS). These macrocyclic  
tetrapyrroles  can  be  used  to  generate  singlet  oxygen and  hydroxyl  radicals,  illustrious  intermediaries  in  the  
oxidation  of  several  substrates,  from  the  simplest  olefin  to  complex  biological  polymers,  including  cellular 
components.[18, 19] As molecular oxygen sensitising species, synthetic porphyrin derivatives have already been 
profoundly  studied  in  photo-oxidation  reactions,[18-21]  as  photoherbicides  and  photoinsecticides[22]  and  in 
various fields of medicine. The importance and utility of these compounds as therapeutic agents, for instance, in 
photodynamic therapy of cancer (PDT)[23-26] and photodynamic inactivation of viruses (PDV),[27-30] has also 
been  undoubtedly  demonstrated.  Selected  examples  of  porphyrin  and  hydroporphyrin  sensitisers  for 
photodynamic therapy purposes, either approved or in advanced clinical trials, are summarised in Figure 3.3.
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Figure 3.3. Representative examples of porphyrin and hydroporphyrin compounds relevant in PDT.
II. Classical Synthetic Methods
A. Porphyrins
The tremendous popularity and availability of porphyrin derivatives, particularly β- or meso-substituted ones, 
results from the elegant synthetic strategies that have been developed and improved over the years. Simple one- 
or two-step approaches (starting from suitable and widely accessible aldehydes and pyrrole) and more complex 
multi-step protocols (making use of previously synthesised pyrrolic precursors) can be applied to prepare these 
macrocycles.[31-33]  Historically  significant  examples  are  presented  in  the  following  sections,  methodologies 
devised to synthesise porphyrins substituted at the methylene positions being emphasised.
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1. Rothemund Synthesis
The synthesis of meso-substituted porphyrins was firstly investigated by Rothemund in the mid-1930s.[34-36] 
In this seminal work, pyrrole and one of a few different aldehydes were heated in a closed vial utilising methanol  
as solvent, spectroscopic evidence of the target porphyrins being found. However, only in a small number of cases  
was it possible to obtain extremely poor amounts of porphyrin crystals directly from the crude product mixture. In  
1941, the same author described the reaction between benzaldehyde and pyrrole at 220 ºC, using pyridine as 
solvent  and  again  in  sealed-vessel  conditions.  5,10,15,20-Tetraphenylporphyrin  (TPP)  crystallised  upon  slow 
cooling of the reaction medium, after 48 hours of heating, with isolated yields of up to 9% (Scheme 3.1).[37]
Scheme 3.1. Rothemund synthesis of  5,10,15,20-tetraphenylporphyrin.
2. Adler-Longo Synthesis
 More  than  20  years  later,  the  research  team  of  Adler  and  Longo  continued  this  line  of  investigation, 
conducting several condensation reactions between pyrrole and benzaldehyde and making use of different acidic  
solvent media, various metal salts, high temperatures and aerobic conditions.[38] Although reasonable reaction  
yields  were  achieved employing  acetic  acid  or  acidified  benzene,  30-40%,  the  utilisation of  metallic  salts  as  
additives proved to be detrimental to the synthetic process. Further studies led to the use of equimolar quantities  
of the reagents (50 mM), propionic acid as solvent and a half-hour refluxing time, TPP crystals being collected  
with a 20% isolated yield (Scheme 3.2).[39, 40]
Scheme 3.2. Adler-Longo synthesis of 5,10,15,20-tetraphenylporphyrin.
It should be stressed that albeit the reaction proceeded faster in propionic acid, the yield was around half the 
one obtained when using acetic acid as reaction medium. However, it was established that TPP crystallised more  
promptly from the former solvent and, consequently, originated a final product of higher purity in an effortless  
fashion. Regrettably, contamination of the porphyrin product with up to 10% of the corresponding chlorin, as well 
as with large amounts of tarry side-products, was observed for various aldehyde starting materials, which made  
the purification procedure more troublesome. Moreover, synthesis involving alkyl aldehydes or aryl aldehydes  
bearing  either  acid-sensitive  functionalities  or  bulky  substituents  at  the  ortho  positions  were  not 
successful.[41, 42]
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3. Rocha Gonsalves Two-Step Synthesis
In 1985, Rocha Gonsalves and colleagues described a sequential two-step protocol for the preparation of meso-
tetraalkylporphyrins (Scheme 3.3).[43] A solution of pyrrole and the methyl acetal of a chosen aliphatic aldehyde 
in trifluoroacetic acid-containing carbon tetrachloride was stirred at 60 ºC for 16 hours under  a saturated argon  
atmosphere.  The  resulting  porphyrinogen  was  then  oxidised  to  the  corresponding  porphyrin,  either 
photochemically or employing high oxidation potential quinones, such as 2,3,5,6-tetrachloro-1,4-benzoquinone or 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone,  p-TCQ  or  DDQ,  respectively.  Isolated  yields  of  up  to  18%  were 
accomplished after chromatographic work-up and recrystallisation.
Scheme 3.3. Rocha Gonsalves two-step synthesis of meso-tetraalkylporphyrins.
4. Lindsey Two-Step Synthesis
A rather similar stepwise strategy for the synthesis of meso-tetraarylporphyrins was presented shortly-after by 
Lindsey and co-workers (Scheme 3.4).[44-46] Condensation under a saturated nitrogen atmosphere of equimolar 
quantities of pyrrole and a selected aryl aldehyde (10 mM) in dichloromethane doped with catalytic amounts of 
trifluoroacetic  acid  or  boron  trifluoride  diethyl  etherate  rendered  the  porphyrinogen  after  one  hour.  DDQ-
promoted oxidation under reflux conditions for an additional hour, followed by chromatographic purification, 
afforded the corresponding porphyrin with isolated yields that reached 50% in the case of TPP.
Scheme 3.4. Lindsey two-step synthesis of meso-tetraarylporphyrins.
5. Rocha Gonsalves One-Step Synthesis
In  the  1990s,  the  research  group  of  Rocha  Gonsalves  looked  into  the  possibility  of  preparing  various  
porphyrins, containing both alkyl- and aryl-type functional groups in the methylene positions, via a simple one-
step process.[47, 48] A mixture of an adequate aldehyde and pyrrole was refluxed in aerobic conditions for one 
hour, using either acetic acid or propionic acid, along with nitrobenzene, as the reaction medium (Scheme 3.5).  
Several  porphyrins  were  obtained  directly  from  the  crude  product  mixture,  after  slow  cooling  to  room  
temperature, filtration and washing with methanol, with isolated yields between 10 and 45%, depending on the  
nature of the  meso-substituents. Given that no toxic and expensive quinone oxidants were required and, most 
importantly,  that  no  chlorin  contaminations  were  observed  in  the  final  products,  complex  and  tedious 
chromatographic work-up was avoided.
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Scheme 3.5. Rocha Gonsalves one-step synthesis of meso-tetraalkylporphyrins and meso-tetraarylporphyrins.
6. Other Syntheses
A method for the preparation of porphyrins containing non-equivalent β-substituents was described by Ogoshi 
and co-workers in the 1980s.[49, 50] It was based on the 'head-to-tail' condensation of four molecules of a pyrrole 
derivative under acidic reaction conditions (Scheme 3.6). One of the α-pyrrolic positions must possess a methyl  
group that promotes the generation of a highly electrophilic  azafulvene in acid media,  while the remaining  α 
position should either be unsubstituted or have a group easily eliminated under the same conditions. A serious  
disadvantage was that several steps were necessary to synthesise the multisubstituted pyrrolic precursor.
Scheme 3.6. Synthesis of a β-substituted porphyrin starting from a pyrrole derivative.
Porphyrins  can  also  be  prepared  via  an  acid-catalysed  '2+2'  synthetic  procedure  using  suitable 
dipyrromethanes as reagents. Early work was published by MacDonald in 1960,[51] the key synthetic route being 
depicted in Scheme 3.7. The original strategy involved one dipyrromethane with no  α-substitution and another 
one bearing two formyl groups at the α positions of the pyrrolic structures. The β-positions on the pyrrole rings 
can be diversely substituted and the bridging carbon at  the dipyrromethane units  can also be functionalised. 
Originally,  the  exploration  of  this  useful  experimental  approach  was  highly  dependent  on  the  synthetic  
accessibility of the dipyrromethane starting materials, a problem that was later overcame.
Scheme 3.7. '2+2' Synthesis of multisubstituted porphyrins.
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The '3+1' condensation between a tripyrrane and a diformyl pyrrole affords interesting porphyrin derivatives, 
a methodology also applicable to the preparation of expanded porphyrins and other exotic structures.[52] Both 
simple and unusual porphyrin-type compounds have been prepared using this approach.  Lash and colleagues 
employed a pyrrole dialdehyde and a substituted tripyrrane to synthesise a β-octaalkylporphyrin  with a 60% 
isolated yield.[53] The corresponding porphyrinogen was formed under mild acid catalysis conditions and then 
oxidised using DDQ (Scheme 3.8).
Scheme 3.8. '3+1' Synthesis of a β-substituted porphyrin.
Porphyrins  can also  be  obtained via  cyclisation of  linear  tetrapyrroles.  This  strategy  is  generally  used  to 
prepare unsymmetrical porphyrins bearing various substituent groups at the β-positions. The oxidative cyclisation 
of  appropriately  functionalised  b-bilenes  has  been  described.[54]  However,  the  most  common  tetrapyrrole 
precursors  are  a,c-biladiene  structures.  For  instance,  Dolphin  and  co-workers  demonstrated  that  various 
porphyrins can be synthesised in several steps starting from previously prepared 1-bromo-19-methyl-a,c-biladiene 
intermediates (Scheme 3.9).[55, 56]
Scheme 3.9. Synthesis of β-substituted porphyrins starting from a,c-biladienes.
B. Hydroporphyrins
The preparation of hydroporphyrin derivatives is highly conditioned by their intrinsic thermodynamic stability 
and  also  by  the  kinetic  barriers  associated  with  the  synthetic  processes  that  lead  to  these  macrocyclic  
structures.[57]  These  include  various  reactions  at  the  periphery  of  porphyrins,  such  as  reduction,[58-60] 
oxidation[61-63]  and  cycloaddition,[64-66]  and  the  oxidation  of  porphyrinogens.[67]  The  modification  of 
naturally occurring chlorins and bacteriochlorins[68] and the synthesis of hydroporphyrins starting from suitable 
pyrrole-containing  fragments  via  '2+2'[69]  or  '3+1'[70]  condensation  strategies,  as  well  as  utilising  linear 
tetrapyrroles,[71-74]  have  also  been  reported.  Some  classic  and  important  exemplifications  regarding  the 
synthesis of hydroporphyrin macrocycles are given below.
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1. Reduction of Porphyrins
Whitlock  and  colleagues  studied  the  reduction  of  both  β-  and  meso-substituted  porphyrins  in  the  late 
1960s.[58] The hydrogenation of TPP by di-imide, which was generated  in situ through the reaction between 
excess  p-toluenesulphonyl hydrazide and base in pyridine for several hours, rendered a mixture of 5,10,15,20-
tetraphenylchlorin  (TPC)  and  5,10,15,20-tetraphenylbacteriochlorin  (TPB).  Selective  dehydrogenation  of  the 
bacteriochlorin component, using 3,4,5,6-tetrachloro-1,2-benzoquinone (o-TCQ) at room temperature, followed 
by  digestion,  liquid/liquid  extraction  and  recrystallisation,  provided  TPC  with  a  72%  yield  (Scheme  3.10). 
Increasing the reaction time and the amount of di-imide precursors led to the formation of TPB as the major 
reaction product, which was isolated with a 50% yield after similar work-up.
Scheme  3.10. Di-imide-promoted  reduction  of  porphyrins.  Synthesis  of  5,10,15,20-tetraphenylchlorin  and 
5,10,15,20-tetraphenylbacteriochlorin.
About 20 years later, Bonnett and co-workers employed this procedure to the preparation of a series of meso-
tetrahydroxyphenylchlorins  and bacteriochlorins  with moderate  reaction yields.[59]  One  of  them,  5,10,15,20-
tetrakis(3-hydroxyphenyl)chlorin, also known by the commercial name Foscan (Figure 3.3), is presently used in 
several countries as a sensitiser drug in photodynamic therapy of certain tumours. Pereira and colleagues have 
recently applied a similar reduction methodology under solvent-free and sealed-vessel reaction conditions.[60]
2. Oxidation of Porphyrins
The osmium tetroxide-mediated oxidation of  meso-tetraarylporphyrins  and their metallated analogues was 
described  by  Brückner  and  Dolphin  in  1995,  affording  β,β'-dihydroxylated  meso-tetraarylchlorins  and 
metallochlorins (Scheme 3.11a).[62]
Scheme 3.11. Osmium tetroxide-promoted oxidation of porphyrins. Synthesis of β,β'-dihydroxylated 5,10,15,20-
tetraphenylchlorin (a) and 5,10,15,20-tetraphenylbacteriochlorin (b).
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The reaction was carried-out using a stoichiometric quantity of osmium tetroxide in chloroform doped with 
pyridine, the resulting osmate ester intermediate being quickly reduced with hydrogen sulphide. Although the 
oxidation  was  slow,  up  to  one  week  in  the  case  of  TPP,  isolated  yields  of  up  to  50%  were  achieved  after  
chromatographic work-up. Furthermore, the same authors reacted previously prepared TPC and its zinc complex  
under  similar  reaction  conditions,  obtaining  the  corresponding  β,β'-dihydroxylated  bacteriochlorin  and 
isobacteriochlorin counterparts, respectively (Scheme 3.11b).[63]
3. Cycloaddition of Porphyrins
The synthesis of β-substituted hydroporphyrins via Diels-Alder cycloaddition between A,C-divinylporphyrins 
and  activated  dienophiles  was  studied  by  the  Dolphin  research  team  more  than  two  decades  ago.[64]  The 
reactions were conducted in degassed toluene under reflux conditions for 72 hours, using a 50-fold molar excess  
of  the  appropriate  dienophile.  When  diethyl  acetylenedicarboxylate  (DEAD)  was  employed,  a  stable 
bacteriochlorin-type chromophore was obtained with a 52% isolated yield (Scheme 3.12).
Scheme 3.12. Diels-Alder cycloaddition of porphyrins. Synthesis of a β-substituted bacteriochlorin.
In 1997, Cavaleiro and colleagues revealed that meso-tetraarylporphyrins could also participate in Diels-Alder 
reactions as dienophiles, rendering the corresponding chlorin and bacteriochlorin structures.[65] A few years 
later,  the  same  authors  disclosed  that  the  extremely  electron-withdrawing  5,10,15,20-tetrakis(2,3,4,5,6-
pentafluorophenyl)porphyrin  could act as an effective dipolarophile in 1,3-dipolar cycloaddition processes with 
azomethine ylides, created in situ through the reaction between p-formaldehyde and N-methylglycine in refluxing 
toluene, affording the corresponding chlorin and isobacteriochlorin with moderate yields after chromatographic  
work-up (Scheme 3.13).[66]
Scheme  3.13.  1,3-Dipolar  cycloaddition  of  porphyrins.  Synthesis  of  a  meso-tetraarylchlorin  and 
isobacteriochlorin.
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4. Oxidation of Porphyrinogens
Recently, meso-tetraarylchlorins have been synthesised in acidic media through the selective oxidation of the 
respective porphyrinogens.[67] Serra and Rocha Gonsalves found that the structural characteristics of the latter, 
particularly the nature of the substituents on the meso-phenyl groups, is crucial to the successful outcome of the 
synthetic  process.  For  instance,  oxidation  of  5,10,15,20-tetrakis(2,6-dichlorophenyl)porphyrinogen  using  a 
mixture of propionic acid, acetic anhydride and nitrobenzene as reaction medium, provided the desired chlorin, 
contaminated with merely 8% of the corresponding porphyrin, with an optimised yield of 28% (Scheme 3.14).
Scheme 3.14. Oxidation of porphyrinogens. Synthesis of 5,10,15,20-tetrakis(2,6-dichlorophenyl)chlorin.
5. Other Syntheses
Jacobi and colleagues proposed the synthesis of some chlorin derivatives via a MacDonald-type approach, i.e.  
a '2+2' condensation in acidic media between two proper and previously prepared pyrrole-containing starting 
materials,  as  portrayed  in  Scheme  3.15.[69]  Albeit  the  several  steps  required  to  attain  the  dipyrrolic-type  
precursors and the low-to-moderate overall yields, interesting multisubstituted chlorins may be obtained.
Scheme 3.15. '2+2' Synthesis of multisubstituted chlorins.
The regioselective '3+1'  preparation of a chlorin macrocycle starting from a tripyrrane and a diformylated 
pyrrole was described in 2000 by the Lash research group (Scheme 3.16).[70] Yields as high as the ones achieved  
via  '2+2'  condensation  strategies  were  reported.  Chlorins  can  also  be  synthesised  from  linear  tetrapyrrole 
derivatives,  the  preparation  of  bonellin,  presented  by  Battersby  and  colleagues  in  the  late  1980s,  being  a 
fascinating example.[71, 72]  In general, this methodology is based upon either a photochemical or a thermally 
induced ring closure of appropriately functionalised bilatrienes (Scheme 3.17). The thermal cyclisation process 
requires copper chelation for activation and supplies chlorins with 5 to  10% yield after decomplexation (X=Br). 
The photochemical approach is higher yielding, up to 20%, but requires several days of irradiation of highly dilute 
solutions (X=OMe). A significant improvement to this procedure was developed by Montforts and co-workers,  
employing zinc as a template and performing the cyclisation reaction in alkaline conditions (X=Br, I).[73, 74]
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Scheme 3.16. '3+1' Synthesis of a β-substituted chlorin.
Scheme 3.17. Synthesis of β-substituted chlorins starting from bilatrienes.
III. Microwave-Assisted Synthetic Methods
Although a vast amount of developments has been described over the years, the preparation of porphyrin and 
hydroporphyrin compounds continues to be a hot research topic to the organic synthesis community world-wide. 
Reaction yields are usually not as high as desired, particularly in the case of porphyrins, and effective scale-up 
methodologies  are  yet  to  be  presented  for  both  types  of  tetrapyrrolic  structures.  As  with  other  heterocyclic  
molecules, microwave irradiation has been employed in the synthesis of these nitrogen-containing macrocycles,  
some of the methodologies already published being shortly reviewed in the next pages.
A. Literature Review & Selected Examples
1. Porphyrins
The preparation of porphyrins under microwave activation was firstly described by Loupy and co-workers in  
1992.[75] Irradiation of a mixture of pyrrole and benzaldehyde pre-adsorbed on the surface of silicon dioxide for  
10 minutes, utilising a single-mode reactor and open-vessel conditions, afforded TPP with a 9.5% isolated yield 
(Scheme 3.18). A lower yield of 4% was reported by the same authors when a domestic microwave oven was used.
Scheme 3.18. Solid-supported synthesis of 5,10,15,20-tetraphenylporphyrin.
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About 10 years later, Chauhan and colleagues presented the condensation of equimolar amounts of a series of 
aryl aldehydes and pyrrole in an open Pyrex reaction vial, employing propionic acid as solvent and making use of a  
household microwave equipment.[76] Although the microwave power applied was not disclosed, irradiation for 3 
to 5 minutes, followed by cooling to room temperature, washing with water, extraction with dichloromethane,  
chromatographic purification and recrystallisation, rendered the target  meso-substituted porphyrin compounds 
with poor to reasonable isolated yields (Scheme 3.19).
Scheme 3.19. Synthesis of meso-tetraarylporphyrins in propionic acid.
A solvent-free microwave-promoted synthesis of porphyrins under open-vessel conditions was published in  
2004  by  the  research  group of  Raghavan.[77]  The  reactions  were  carried-out  for  12  minutes  in  a  domestic 
microwave apparatus operating at 1200 W, using HZSM-5 zeolites or Al-MCM-41 mesoporous molecular sieves as  
solid catalysts, the latter exhibiting a better performance (Scheme 3.20). Work-up involved removal of the catalyst  
by filtration and column chromatography of the crude product mixture, good reaction yields being obtained.
Scheme 3.20. Solventless synthesis of meso-tetraarylporphyrins using heterogeneous acid catalysts.
A  simple,  rapid,  solvent-free  and  gram-scale  procedure  for  the  preparation  of  a  couple  of  meso-
tetraarylporphyrins  was  developed by Liu and co-workers in 2004.[78] An open Quartz reaction vial  and an  
unmodified domestic microwave oven were utilised under the reaction conditions summarised in Scheme 3.21.
Scheme 3.21. Solventless synthesis of meso-tetraarylporphyrins.
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The adaptation of the classical Rocha Gonsalves one-step synthesis of meso-tetrarylporphyrins to microwave 
technology was reported by our own research team in 2007.[79] Irradiation of stoichiometric quantities of one of 
13 different aryl aldehydes and pyrrole in a mixture of propionic acid and nitrobenzene for 5 minutes, using a  
domestic  microwave equipment  set  at  640 W,  provided the  corresponding porphyrins  with low to moderate 
isolated yields (Scheme 3.22). As in the original method, chromatographic purification procedures were avoided  
in some cases. 
Scheme 3.22. Synthesis of meso-tetraarylporphyrins using nitrobenzene as oxidant.
An unsymmetrical meso-substituted porphyrin bearing two different aryl groups at the methylene positions in 
a 3:1 proportion (A3B) was prepared under microwave heating by application of solid-supported and open-vessel 
reaction conditions.[80] A 3:1:4 molar ratio of methyl  p-formylbenzoate,  m-hydroxybenzaldehyde and pyrrole, 
pre-adsorbed on the  surface  of  silica  gel,  was  heated for  12 minutes at  450 W, the desired porphyrin  being  
obtained with a 13% isolated yield after column chromatography and preparative TLC (Scheme 3.23).
Scheme 3.23. Solid-supported synthesis of an unsymmetrical meso-tetraarylporphyrin.
Yaseen and colleagues have also presented a solid-supported synthesis  of  a  few  meso-tetraarylporphyrins 
under microwave heating with good yields.[81] Equimolar amounts of the selected aryl aldehyde and pyrrole, pre-
adsorbed on the surface of previously prepared propionic acid-doped silica gel, were irradiated at 100 ºC for 10  
minutes, affording the corresponding porphyrin compounds after chromatographic work-up (Scheme 3.24).
Scheme 3.24. Solid-supported synthesis of meso-tetraarylporphyrins.
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Lucas and co-workers described a microwave-assisted, small-scale, iodine-catalysed and two-step synthesis of 
TPP in  2008.[82] Pyrrole,  benzaldehyde and dichloromethane were claimed to be employed as received,  i.e.  
without  prior  purification  protocols  being  used.  A  maximum  isolated  yield  of  47%  was  achieved  after 
chromatographic work-up, using a 10% molar equivalent of iodine as the catalyst in the first step and p-TCQ as 
the porphyrinogen oxidising agent in the second one (Scheme 3.25). The same authors subsequently employed 
this  microwave-activated  synthetic  approach  to  the  preparation  of  some  A3B  unsymmetrical  meso-
tetraarylporphyrins, low to moderate yields being reported.[83]
Scheme 3.25. Synthesis of 5,10,15,20-tetraphenylporphyrin using iodine as catalyst.
2. Hydroporphyrins
The Diels-Alder cycloaddition of 5,10,15,20-tetrakis(2,3,4,5,6-pentafluorophenyl)porphyrin with a three-fold 
molar excess of pentacene and naphthacene under microwave irradiation was reported by the Cavaleiro research 
group in  2005.[84] Both reactions were conducted in  a single-mode microwave reactor at  high temperature, 
utilising  1,2-dichlorobenzene  (DCB)  as  solvent  and  under  sealed-vessel  conditions,  the  corresponding  meso-
substituted  chlorins  being  obtained  after  chromatographic  work-up,  with  83  and  23%  yield,  respectively 
(Scheme 3.26). It should be noticed that the synthetic process proceeded far worse under conventional heating  
conditions, only 22% isolated yield after 8 hours at 200 ºC and no reaction, respectively. Bacteriochlorin- and 
isobacteriochlorin-type compounds were also observed when pentacene was used as starting material, preparative  
HPLC being required to isolate them in low yields.
Scheme 3.26. Diels-Alder cycloaddition of porphyrins. Synthesis of meso-tetraarylchlorins.
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The microwave-assisted synthesis of novel  meso-tetraarylchlorins through '8π+2π' cycloaddition of a slight 
excess of the respective porphyrins and diazafulvenium methide, rendered in situ via thermal extrusion of sulphur 
dioxide from a suitable  and previously prepared pyrazolo-thiazole,  was  recently described by Pereira and co-
workers (Scheme 3.27a).[85, 86] When 5,15-diarylporphyrins were used as reagents the cycloaddition led to the 
synthesis of the corresponding chlorin compounds in a regioisomeric fashion (Scheme 3.27b).  Both strategies 
were  performed  in  1,2,4-trichlorobenzene  (TCB)  under  closed-vessel  conditions  and  employing  a  dedicated 
microwave  reactor.  Although several  reaction parameters were  tested,  the best  results  were  accomplished by 
heating at 250 ºC for 20 minutes, followed by cooling to room temperature and purification of the crude product  
mixture  by  column  chromatography.  Bacteriochlorin-type  structures  were  also  prepared  through  related 
procedures but, in this case, microwave activation did not improve the synthetic process comparing to classical  
heating conditions.
Scheme 3.27.  '8π+2π' cycloaddition of porphyrins. Synthesis of meso-tetraarylchlorins.
Giving our long-standing interest in the chemistry of tetrapyrrolic macrocycles, particularly of the porphyrin  
and hydroporphyrin types,[33] it was decided to explore the preparation of these compounds using microwave 
technology. The efforts regarding the synthetic methodologies studied and the subsequent results are presented in 
detail within the pursuing sections.
B. Synthesis of meso-Tetraarylporphyrins
As  mentioned  above,  we  have  looked  into  the  Rocha  Gonsalves  one-step  synthesis  of  porphyrins  under 
microwave irradiation using a domestic multi-mode microwave oven.[79] However, albeit the several advantages 
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of  this  adaptation  relatively  to  the  classical  heating  method,[47,  48]  such  as  reduced  reaction  times  and  
minimisation of the amount of solvents employed and, consequently, of the overall cost of the synthetic process,  
the reaction yields were reasonably good but not as high as desired and, therefore, room for further improvements  
remained.  Moreover,  the  possibility  of  broadening the  scope  of  this  procedure  to  a  larger  set  of  porphyrins  
utilising  a  dedicated  single-mode  microwave  equipment  and  closed-vessel  reaction  conditions,  which  allows 
higher reaction temperatures to be reached, appeared promising. Hence, equimolar quantities of benzaldehyde 
and pyrrole (10 mmol) in 5 ml of propionic acid/nitrobenzene (7:3 v/v) were heated at 200 ºC for 5 minutes, with 
an initial power setting of 250 W, under sealed-vessel conditions (Scheme 3.28, R=Ph). Temperature values above 
200 ºC were not easily attained unless a fixed microwave power was applied and a drastic increase of the pressure  
inside the reaction vial was observed, which could lead to its fissure and, consequently, to a dangerous outcome. 
After  cooling  to  room  temperature,  the  crude  product  mixture  was  washed  with  methanol  and  5,10,15,20-
tetraphenylporphyrin  57 was obtained as a dark-purple solid via filtration under reduced pressure with a 46% 
isolated yield and a typical molecular absorption spectrum in the UV-Vis region (Figure 3.4). This is more than  
twice the one achieved in our earlier studies using a household microwave apparatus (20%).[79]
Scheme 3.28. One-step synthesis of meso-tetraarylporphyrins 57-81 under microwave irradiation.
Figure 3.4. UV-Vis absorption spectrum of 5,10,15,20-tetraphenylporphyrin 57 in dichloromethane.
Various other aldehydes, bearing both electron-donating and electron-withdrawing substituents at different 
positions of  the phenyl  ring,  as  well  as  containing  polycyclic  aromatic  hydrocarbons,  were later  employed as 
reagents,  the corresponding  meso-tetraarylporphyrins being obtained either directly by crystallisation or after 
flash column chromatography (Figure 3.5). Higher yields were usually achieved, comparing with the conventional 
heating methodology and also with our previously reported microwave-promoted approach, except in the cases 
where large aromatic groups (58-60) or phenyl rings carrying bulky substituents at the ortho positions (62 and 
63) were present, which can be justified by steric hindrance effects. 
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Figure 3.5. Structures and isolated yields of  meso-tetraarylporphyrins  57-81 synthesised via a solvent-based, 
one-step, microwave-assisted method.
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Regrettably,  when  9-anthracenaldehyde,  4-fluorobenzaldehyde  and  4-nitrobenzaldehyde  were  used  as 
reactants, only trace amounts of the corresponding porphyrins were detected by TLC analysis of the crude product  
mixtures. Furthermore, utilising 4-dimethylaminobenzaldehyde as the starting aryl aldehyde led to an intense and  
dangerous pressure build-up inside the reaction vessel upon microwave irradiation, which may be explained by 
the rapid generation of dimethylamine as a reaction by-product. When 4-acetamidobenzaldehyde was used as 
reagent, several porphyrins were observed by TLC analysis of the crude product mixture. This could be owed to  
the  partial  deacetylation  of  the  acetamido  substituents,  which  are  rather  labile  under  the  acidic  and  high-
temperature  reaction  conditions  employed.  In  fact,  MS studies  of  the  porphyrin  product  after  flash  column 
chromatography subsequently confirmed this assumption.  On the other hand, isolation of porphyrins 67 (55%), 
68 (50%), 71 (50%) and 73 (88%) provided our best results, without the demand of chromatographic work-up.
The same microwave-mediated formulation was also applied to the mixed-aldehyde synthesis of a small series  
of hydroxylated unsymmetrical  meso-tetraarylporphyrins of the A3B type, starting from a 3:1:4 molar ratio of 
3-hydroxybenzaldehyde,  another  selected  aryl  aldehyde  and  pyrrole  (Scheme  3.29).  Although  column 
chromatography  procedures  were  mandatory  to  effectively  provide  the  target  porphyrin  compounds,  yields 
between 6 and 15% were  attained,  which are  quite  reasonable  for  this  kind  of  synthesis  (Figure  3.6).  In  all  
situations, 5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin 66 was also isolated with yields ranging from 9 to 13%.
Scheme 3.29. One-step synthesis of A3B meso-tetraarylporphyrins 82-87 under microwave irradiation.
Figure 3.6. Structures and isolated yields of A3B  meso-tetraarylporphyrins  82-87 synthesised via a solvent-
based, one-step, microwave-assisted method.
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Introduction of microwave activation to the classical two-step synthesis of porphyrins was also investigated,  
porphyrin 57 being used as the model molecule. The equilibrium conditions reported by Lindsey and colleagues 
were  applied  to  prepare  5,10,15,20-tetraphenylporphyrinogen,[45]  which  in  turn  was  oxidised  to  the 
corresponding porphyrin under different reaction conditions. Trying to avert the utilisation of costly and toxic  
quinone oxidants, such as DDQ or p-TCQ, activated manganese dioxide was selected as an alternative oxidising 
agent, given its inexpensiveness, user-friendly character and wide and successful application in various processes,  
such as oxidation of alcohols and hydroxylated compounds, dehydrogenation and oxidative aromatisation.[87-89]  
Thus, heating the porphyrinogen adsorbed in the surface of MnO2-doped silica gel at 100 ºC for 30 minutes, with 
an initial power setting of 200 W and under open-vessel conditions, followed by cooling to room temperature and 
washing the product mixture with an organic solvent, removal of the solid support via filtration through a small  
column of SiO2, evaporation and recrystallisation, provided 5,10,15,20-tetraphenylporphyrin with a 22% isolated 
yield (Scheme 3.30a). Alternatively, a concentrated solution of the porphyrinogen and a 30-fold molar excess of  
activated manganese dioxide in dichloromethane was irradiated at 50 ºC for 10 minutes in a sealed reaction vial,  
applying an initial microwave power setting of 50 W, TPP being obtained with a related isolated yield of 20% after  
similar  work-up (Scheme  3.30b).  Finally,  a  conventional  heating  approach  to  the  oxidation  step was  tested, 
refluxing the previously prepared porphyrinogen with excess MnO2 in dichloromethane overnight (Scheme 3.30c). 
This last mentioned strategy afforded the best outcome, 32% yield of porphyrin 57, although it was clearly not as 
good as the one achieved via the microwave-assisted one-step synthesis in propionic acid and nitrobenzene.
Nevertheless,  we decided to extend this two-step methodology to some of the porphyrins that gave worse  
results in our one-step procedure, namely porphyrins 58 and 60, isolated yields of 20 and 2%, respectively, being 
attained. While the reaction yield was slightly higher in the case of 5,10,15,20-tetrakis(naphthalen-1-yl)porphyrin, 
5,10,15,20-tetrakis(pyren-1-yl)porphyrin was obtained with an even lower isolated yield. Hence, it was verified 
that activated MnO2 can be applied in the oxidation of porphyrinogens to the corresponding porphyrins, under 
both  classical  and  microwave  heating,  although  the  most  efficient  reaction  conditions  were  not  fully 
determined.[90] Even so, this cheap heterogeneous oxidant proved to be a valid option when compared to other  
oxidising compounds commonly used in this synthetic operation, i.e. DDQ and  p-TCQ, particularly taking into 
account  their  inherent  toxicity  and  the  tedious  chromatographic  work-up  required  when  these  quinone 
compounds are  employed.  Albeit  a  large  amount  of  MnO2 is  needed  to  achieve  the  dehydrogenation  of  the 
porphyrinogen in out two-step strategy, its straightforward removal by simple filtration constitutes an enormous 
advantage from both the synthetic and economical standpoints.
Scheme 3.30. Two-step synthesis of 5,10,15,20-tetraphenylporphyrin 57 using activated manganese dioxide as 
oxidant under microwave irradiation and conventional heating.
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C. Synthesis of meso-Tetraarylhydroporphyrins
Aiming  to  synthesise  hydroporphyrins  of  the  chlorin  and  bacteriochlorin  types  starting  from  the 
corresponding porphyrins, we decided to explore the already referenced and broadly utilised di-imide-mediated 
reduction  methodology,  firstly  described  by  Whitlock  and  co-workers  in  1969  (Scheme  3.10),[58]  under  
microwave irradiation. Again, TPP was chosen as the case-study compound. Using our single-mode microwave  
equipment, the best reaction conditions were found when a mixture of 5,10,15,20-tetraphenylporphyrin and a 
100-fold molar excess of both anhydrous potassium carbonate and p-toluenesulphonyl hydrazide in 1,4-dioxane 
was  irradiated  at  120 ºC,  for  a  25-minute period  of  time,  in  sealed-vessel  conditions.  After  cooling to  room 
temperature, the crude product mixture was simply washed with distilled water and neutralised by the addition of 
hydrochloric  acid.  The  solid  that  precipitated  out  of  the  aqueous  solution  was  then filtrated  and thoroughly  
washed with distilled water, in order to remove any water-soluble by-products and excess reagents, 5,10,15,20-
tetraphenylbacteriochlorin  88 being  obtained  as  a  pinkish-brown  solid  with  a  96%  isolated  yield,  although 
contaminated with 25% of the respective chlorin (Table 3.1, entry 1; Scheme 3.31, R=Ph). The UV-Vis molecular  
absorption spectrum of the final product is presented in Figure 3.7. It should be stressed that smaller reaction  
times led to a larger amount of TPC as contaminant and longer ones did not improve the final outcome of the  
synthetic procedure. Also, 1,4-dioxane was selected as the reaction medium because of its versatility, since it can  
solvate different kinds of organic substrates and also many inorganic substances, like the anhydrous base used in 
this method.
Other  meso-substituted  porphyrins  were  later  employed  as  starting  materials,  the  corresponding 
bacteriochlorin derivatives 89-94 being obtained with very high yields, albeit contaminated with 15 to 35% of the 
chlorin  analogues  (entries  2-6)  and,  in  one  case,  also  with  25%  of  the  unreacted  porphyrin  (entry  7).[90] 
Analysing the data collected in Table 3.1, one can infer that the reduction of porphyrins comprising functionalities 
either at the ortho or the meta positions of the meso-phenyl rings (entries 2-4) afforded a more bacteriochlorin-
rich product than that of porphyrins bearing para-substituted aromatic moieties (entries 5 and 6), regardless of 
the nature of the functional groups. Moreover, the reduction of 5,10,15,20-tetrakis(4-t-butylphenyl)porphyrin 67 
proved  to  be  challenging,  given  that  25%  of  the  initial  porphyrin  reactant  was  present  in  the  final  product 
(entry 7). A reasonable explanation for these facts requires further investigation.
Purification of the bacteriochlorin components via SiO2 and Al2O3 column chromatography was tested, but 
failed to provide the desired products in pure form. This was mainly due to the very similar affinities of the chlorin  
and bacteriochlorin compounds regarding the chromatographic stationary phases, which seriously hampered the 
isolation procedure. Furthermore, given that a relatively generous period of time is necessary in order to achieve 
an appropriate separation within the chromatographic column, it is quite possible that the bacteriochlorins start 
to oxidise to the respective chlorins during the purification process.
Table 3.1. Synthesis of meso-tetraarylbacteriochlorins 88-94 under microwave irradiation.
Entry Compound R Yielda (%, Bacteriochlorin/Chlorin Ratio)b
1 88 Ph 96, 75/25
2 89 0-Cl2C6H3 92, 85/15
3 90 m-OMeC6H4 95, 85/15
4 91 m-OHC6H4 93, 80/20
5 92 p-OMeC6H4 95, 65/35
6 93 p-BrC6H4 92, 65/35
7 94 p-t-BuC6H4 90, 45/30/25c
All reactions were carried-out using the selected porphyrin (25 mg), anhydrous potassium carbonate (100 molar 
equivalents),  p-toluenesulphonyl hydrazide (100 molar equivalents) and 1,4-dioxane (2 ml) at 120 ºC for 25 
minutes in a closed vessel.  aYields refer to the isolated reaction products. bAssessed by 1H NMR analysis of the 
isolated reaction products. cBacteriochlorin/Chlorin/Porphyrin ratio.
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Scheme 3.31. Synthesis of meso-tetraarylbacteriochlorins 88-94 under microwave irradiation.
Figure 3.7. UV-Vis absorption spectrum of 5,10,15,20-tetraphenylbacteriochlorin 88 in dichloromethane.
Scheme  3.32. Mechanistic  proposal  for  the  in  situ generation  of  di-imide  (a)  and  the  synthesis  of  meso-
tetraarylbacteriochlorins 88-94 (b).
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A large excess of p-toluenesulphonyl hydrazide and anhydrous potassium carbonate were required to ensure 
that enough di-imide was being formed in situ and, consequently, becoming available to hydrogenate the exocyclic 
double bonds of the porphyrin. A mixture of both (E) and (Z) isomers of di-imide is produced, both of which are 
quite unstable. The (E)-(Z) equilibrium favours the latter structure owing to its consumption upon reaction with  
the unsaturated substrate.[91]  A possible  mechanistic  pathway for the preparation of bacteriochlorins  88-94 
through di-imide-promoted reduction of the corresponding porphyrins is given in Scheme 3.32. Briefly, formation 
of  di-imide  via  base-assisted  cleavage  of  p-TSH  is  followed  by  a  concerted  hydrogen  transfer  to  one  of  the 
exocyclic unsaturated centres of the porphyrin, rendering the respective chlorin. A second hydrogen transfer of di-
imide to the remaining exocyclic double bond affords the target bacteriochlorin. It was observed that the internal 
pressure inside the closed reaction vial raised substantially in the first minutes of the synthetic process and then  
became increasingly steadier. This can be rationalised by the formation of gaseous nitrogen as a by-product of the  
reduction reaction, as  well  as  the result of di-imide disproportionation, which renders both nitrogen gas and  
hydrazine.  In  fact,  it  is  well  known that  this  rapid  decomposition phenomenon is  an important  competitive 
process regarding the hydrogenation of double and triple bonds.[91, 92]
We then  turned our  attention to  the  microwave-assisted  synthesis  of  some  meso-substituted  chlorins  via 
selective  dehydrogenation of  the bacteriochlorin analogues that were previously prepared as described above. 
Activated manganese dioxide was again chosen as the oxidising agent. After a few trials using TPB 88 as the initial 
reagent, in order to study the influence of both the reaction time and temperature and also the stoichiometry of  
the heterogeneous oxidant, it was determined that the most effective reaction conditions were microwave heating 
a mixture of the selected bacteriochlorin and an excess of activated MnO2 in 1,4-dioxane at 90 ºC for 3 minutes. 
Washing the crude product mixture with a suitable organic solvent, followed by filtration through a small column 
of SiO2 and evaporation under reduced pressure,  provided the desired chlorin  compounds  95-101 with high 
yields, although contaminated with the corresponding porphyrins (Table 3.2; Scheme 3.33).[90] As an example, 
the absorption spectra of 5,10,15,20-tetraphenylchlorin in the UV-Vis region is depicted in Figure 3.8.
Table 3.2. Synthesis of meso-tetraarylchlorins 95-101 under microwave irradiation.
Entry Compound R Yielda (%, Chlorin/Porphyrin Ratio)b
1 95 Ph 92, 80/20
2 96 0-Cl2C6H3 85, 75/25
3 97 m-OMeC6H4 93, 90/10
4 98 m-OHC6H4 88, 65/35
5 99 p-OMeC6H4 90, 90/10
6 100 p-BrC6H4 88, 85/15
7 101 p-t-BuC6H4 86, 70/30
All  reactions  were  carried-out  using  the  selected  bacteriochlorin  (23-24  mg),  activated  manganese  dioxide 
(50 molar equivalents) and 1,4-dioxane (2 ml) at 90 ºC for 3 minutes in a closed vessel.  aYields refer to the 
isolated reaction products. bAssessed by 1H NMR analysis of the isolated reaction products.
Scheme 3.33. Synthesis of meso-tetraarylchlorins 95-101 under microwave irradiation.
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Figure 3.8. UV-Vis absorption spectrum of 5,10,15,20-tetraphenylchlorin 95 in dichloromethane.
It  may  be  stated  from  the  data  summarised  in  Table  3.2  that,  in  general,  meso-tetraarylchlorins  were 
efficiently prepared through this microwave-activated and MnO2-promoted process, reaction yields ranging from 
85 to 93% being attained. For instance, methoxylated chlorins 97 and 99 were obtained with superior reaction 
yields, only 10% of the final product being the respective porphyrin contaminants (entries 3 and 5). The selectivity  
in  the  oxidation  of  the  bacteriochlorin  chromophore  can  be  seen  in  the  synthesis  of  chlorin  101 (entry  7). 
Dehydrogenation of a mixture containing a bacteriochlorin/chlorin/porphyrin proportion of 45/30/25, afforded 
the  target  chlorin  contaminated  with  30% of  the  corresponding porphyrin.  Hence,  the  amount  of  porphyrin 
remained nearly unaltered after the reaction took place, demonstrating that all the bacteriochlorin component of 
the starting material was oxidised to the respective chlorin and only a tiny fraction of the pre-existing chlorin was  
oxidised to the porphyrin. Furthermore, the replacement of o-TCQ, the traditionally utilised yet highly toxic and 
expensive  oxidising  agent,  by  the  much  cheaper  activated  manganese  dioxide  proved  to  be  a  beneficial  
modification to the classic Whitlock methodology,  both from the economical and environmental perspectives, 
even considering the demand of using a larger excess of the oxidant in our heterogeneous approach. Additionally,  
simple filtration through a small amount of SiO2 was sufficient to isolate the chlorin compounds, numerous and 
tedious extraction processes and rather complex and lengthy chromatographic separations being averted.
IV. Summary
A series of  meso-tetraarylporphyrins  57-81 was rapidly synthesised through a one-pot methodology under 
microwave irradiation. The isolated yields achieved were usually higher than the ones attained via the related 
conventional heating method or through our previously reported microwave-assisted approach using a domestic  
microwave oven. The same procedure was also successfully applied to the preparation of some unsymmetrical  
meso-tetraarylporphyrins  of  the  A3B  type  82-87.  An  alternative  two-step  synthesis  of  meso-substituted 
porphyrins, in which microwave-heating was applied in the second reaction step and the expensive, toxic and 
conventionally utilised quinone oxidants, i.e.  o-TCQ,  p-TCQ and DDQ, were replaced by the much cheaper and 
user-friendly activated manganese dioxide, was investigated under different reaction conditions, compounds 57, 
58 and  60 being obtained with low to moderately good reaction yields. The broadly known di-imide-mediated  
reduction of porphyrins to their hydroporphyrin analogues was revised and studied under microwave-assisted  
conditions. Bacteriochlorins  89-94 were readily obtained with very high yields (90-96%), albeit contaminated 
with up to 35% of the corresponding chlorins and, in one case, also with 25% of the porphyrin starting material.  
Lastly, the selective MnO2-promoted dehydrogenation of the previously prepared bacteriochlorins was carried-out 
under microwave irradiation. The target chlorin compounds 95-101 were quickly synthesised and easily isolated 
with high yields (85-93%), although contaminated with 10 to 35% of the corresponding porphyrins.
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Hantzsch 1,4-Dihydropyridines
I. Introduction & Relevance
Described over 130 years ago by the German chemist Arthur Rudolph Hantzsch,[1, 2] the synthesis of 1,4-
dihydropyridines (DHPs) has attracted considerable  interest  as  a  multicomponent reaction that  provides six-
membered nitrogen-containing heterocycles of pharmacological significance.[3] It was uncovered in the 1930s 
that the DHP motif was an active part  of the reduced nicotinamide adenine dinucleotide co-enzymes NADH,  
NADPH and their analogues, which are responsible for mediating crucial hydride transfer reactions in biological  
systems (Figure 4.1).[4] Analgesic properties were not reported until the mid-1970s and an enormous amount of  
papers  and  patents  dealing  with  the  chemistry,  biochemistry  and  pharmacology  of  Hantzsch  DHPs  as 
antihypertensive  and  hypoglycaemic  substances  was  presented  after  the  seminal  publication  of  Loev  and 
colleagues.[5] Several commercial DHP derivatives are currently recognised as important therapeutic agents in  
the treatment of cardiovascular diseases, such as angina, hypertension and arrhythmia (Figure 4.2). It has been  
established that their successful application in this field is related to their efficacy to bind to calcium channels and,  
consequently, to decrease the passage of the transmembrane calcium current, associated in smooth muscle with a 
long lasting relaxation and in cardiac muscle with a reduction of contractility throughout the heart.[5-7]
Figure 4.1. Structure of the reduced nicotinamide adenine dinucleotide NADH.
It  is  known that  some  dihydropyridine  scaffolds  play  a  decisive  role  in  brain-targeted  chemical  delivery 
systems.  For  instance,  the  attachment  of  a  dihydropyridyl  unit  to  a  given  pharmacophore  enhances  the 
lipophilicity of the conjugate and, therefore, improves the access to the central nervous system. Once inside, the 
enzyme-promoted oxidation to the corresponding pyridinium salt locks this compound in the inner side of the 
blood-brain barrier and subsequent hydrolysis liberates the active compound.[8] This concept has been applied to 
the transport  of  neuropeptides,[9]  hormone analogues,[10]  antioxidants,[11]  AZT derivatives[12]  and even to 
some Hantzsch 1,4-dihydropyridines.[13] The remarkable affinity of dihydropyridine structures to bioreceptors, 
e.g. α1a-adrenergic,[14] A3-adenosine[15] and neuropeptide YY1 receptors,[16] has also been assessed, resulting in 
novel,  selective  and  potent  antagonists. Moreover,  it  has  been  suggested  that  multidrug resistance  may  be 
surmounted  by  dihydropyridine-containing  molecules  without  severe  side  effects.[17] A  non-competitive 
inhibition of topoisomerase I was observed for dexniguldipine, an antitumour and multidrug resistance reverting 
dihydropyridine.[18] Radioprotection[19] and  modulation  of  cocaine  dependence  in  animals[20] were  also 
described for Hantzsch DHPs. Finasteride, a 4-azasteroid drug employed in the treatment of benign prostatic 
hyperplasia,  was  shown  to  exert  its  inhibition  on  a  NADPH-dependent  enzyme  by  forming  a  covalent 
dihydropyridine adduct with the NADP moiety.[21] Furthermore, new and efficient gene delivery systems based 
on cationic liposomes bearing charged amphiphilic 1,4-dihydropyridines have been described.[22] Several DHP 
derivatives exhibiting anticonvulsant[23] and antitubercular activities[24] have also been reported.
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Figure 4.2. Representative  examples of  Hantzsch 1,4-dihydropyridine compounds relevant in cardiovascular  
diseases as calcium channel antagonists.
On a related matter, the oxidative aromatisation of Hantzsch 1,4-dihydropyridines has been the subject of a 
vast number of studies in the last 25 years or so, since Böcker and  Guengerich demonstrated that the  in vivo 
metabolism of these molecules involved an important oxidative process catalysed by cytochrome P450.[25] The  
resulting pyridines, although devoid of the pharmacological properties of their preceding heterocycles, may be  
further and properly modified,  rendering other biologically interesting molecules.  In fact,  several  commercial 
drugs possessing antiseptic, antihistaminical and antirheumatismal activities display a multisubstituted pyridine 
as the key structural element.[26, 27]
II. Classical Synthetic Methods
As pointed-out above, the first report on the preparation of 1,4-dihydropyridines was produced by Hantzsch in  
the 19th century and it described the one-pot condensation reaction of an aldehyde, a β-ketoester and ammonium 
hydroxide in refluxing ethanol.[1, 2] Apart from Hantzsch, Beyer[28] and Knoevenagel[29] were amongst the first 
researchers to study this synthetic process (Scheme 4.1). It can be visualised as proceeding through a Knoevenagel 
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condensation product, i.e. an arylidene- or alkylidene-type 1,3-dicarbonyl compound II, as a key intermediate (a). 
A second intermediate is an enaminone-like structure III, which is formed by condensation of a second equivalent 
of  the β-ketoester  I with ammonia (b).  Further  condensation between these key fragments  affords the DHP 
derivative VI via cyclisation of an imine IV/enamine V system (c).
Scheme 4.1. Mechanistic proposal for the Hantzsch synthesis of 1,4-dihydropyridines.
Another  possible  mechanistic  pathway  involves  the  reaction  between  enaminone  III and  β-ketoester  I, 
followed by condensation of the resulting intermediate  VII with the aldehyde starting material (Scheme 4.2a). 
Also, a 1,5-diketone structure VIII may be generated through the reaction of the Knoevenagel intermediate II and 
β-ketoester  I.  Further condensation with ammonia provides the target 1,4-dihydropyridine  VI (Scheme 4.2b). 
It should be stressed that the reaction mechanism of the Hantzsch 1,4-dihydropyridine synthesis was exhaustively 
studied by NMR spectroscopy in the 1980s and it was established that the synthetic operation occurs through the  
intermediates depicted in Scheme 4.1.[30, 31]
Generally  speaking,  DHPs  can  be  prepared  via  the  Hantzsch  methodology,  reduction  of  or  addition  to 
appropriate pyridines and several cycloaddition reactions.[32-34] Being a simple and widely tolerable protocol, 
the Hantzsch reaction is still one of the most broadly utilised procedures to access variously substituted DHPs in a 
large number of areas, such as stereoselective synthesis and green chemistry strategies.[35-41] Nevertheless, given 
the  rapid  progress  of  the  chemical  and  pharmaceutical  industries,  some  limitations  of  this  classical  
multicomponent approach have been observed. One of them is that the 1,4-dihydropyridines synthesised are all 
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symmetrical in the heterocyclic moiety, since this unit is built by using two molecules of the same 1,3-dicarbonyl 
reagent. Although two different 1,3-dicarbonyl compounds can be employed, the symmetrical DHPs formed by the  
homocondensation of the starting materials are still produced in large quantities, which lowers the reaction yields 
and  makes  the  purification  process  more  troublesome.  Considering  biological  screening,  one  can  state  that  
obtaining  several  diversified structures of  a given pharmacophore is an efficient strategy for  discovering new 
biologically  active  lead  compounds.[42]  Notwithstanding  many  reported  1,4-dihydropyridines  possessing 
promising biological activities are symmetrical,  this was not a specific requirement of the biological receptors  
studied, but the result of employing the Hantzsch method for the preparation of the majority of the known DHP 
derivatives. Therefore, the synthesis of novel, structurally-diverse and bioactive 1,4-dihydropyridines, including 
some unsymmetrical DHP systems, remains a riveting and continuously growing subject to the organic synthesis,  
chemical biology and medicinal chemistry communities.
Scheme 4.2. Alternative mechanistic proposals for the Hantzsch synthesis of 1,4-dihydropyridines.
A  wide  assortment  of  oxidants  has  been  applied  to  the  oxidative  aromatisation  of  Hantzsch  1,4-
dihydropyridines and subsequent  preparation of  the respective  pyridine heterocycles  IX (Scheme 4.3):  solid-
supported ferric and cupric nitrates,[43] ceric ammonium nitrate (CAN),[44] clay-supported cupric nitrate under 
ultrasounds,[45] MnO2,[46]  DDQ,[46]  nitric  oxide,[47]  bismuth(III)  nitrate,[48]  pyridinium  chlorochromate 
(PCC),[49]  cobalt(II)  tetrakis(pyridine)  dichromate,[50]  nicotinum  dichromate,[51]  S-nitrosoglutathione,[52] 
N2O4/18-crown-6,[53]  3-carboxypyridinium  chlorochromate  (CPCC),[54]  KMnO4,[55]  HNO3,[56]  HNO2,[57] 
t-butyl  hydroperoxide  (TBHP),[58]  phenyliodine(III)  bis(trifluoroacetate),[59]  elemental  sulphur,[59] 
combination  of  inorganic  and  acidic  salts  with  sodium  nitrite  or  sodium  nitrate,[60]  polystyrene-bound 
metalloporphyrin/NaIO4,[61]  metalloporphyrin/n-Bu4NIO4,[62]  triazolinediones,[63]  H2O2/Co(OAc)2,[64] 
Zr(NO3)4,[65]  urea nitrate,[66] cobalt(II) peroxydisulphate,[66] hypervalent iodine reagents,[67]  I2/MeOH,[68] 
SeO2,[69]  heteropolyacid/NaNO2/SiO2,[70]  Mn(OAc)3,[71]  N-hydroxyphthalimide/O2/Co(OAc)2,[72] 
Fe(ClO4)3/AcOH,[73] manganese(III)-salophen/NaIO4,[74] Pd/C in acetic acid,[75] HgO/I2,[76] urea/H2O2,[77] 
vanadium(V) salts,[78] electrochemical[79] and photochemical[80] methods, among others. Even so, many of the 
published oxidation methods require extended periods of time for completion, make use of a large excess of strong 
oxidising agents, afford moderate reaction yields, generate by-products which are difficult to remove and utilise  
highly toxic and expensive oxidants and/or catalysts.
74|
R1
NH2 O
OR2
III
R1
O O
OR2
I
(a)
N
H
R1R1
R2O
O
OR2
O
-H2O
VII
R1
O O
OR2
I
R1
O O
OR2
R3
II
R1R1
R2O
O
OR2
OR3
O O
VIII
NH3
-2H2O
N
H
CO2R
2
R1
R2O2C
R1
R3
VI
(b)
R3CHO
-H2O
                                                                                                                                                  4. Hantzsch 1,4-Dihydropyridines
Scheme 4.3. Oxidative aromatisation of Hantzsch 1,4-dihydropyridines.
III. Microwave-Assisted Synthetic Methods
Several modifications to the classical Hantzsch protocol and recent advances that extend far beyond it have 
been the topic of interesting review papers,[81-83] the successful application of microwave irradiation also being 
addressed in detail.[84-87] Some examples of the microwave-assisted preparation of Hantzsch DHPs, as well as of 
their corresponding pyridine derivatives, are summarised in the following section. 
A. Literature Review & Selected Examples
The ground-breaking report on the employment of microwaves to the preparation of Hantzsch DHPs was 
published in 1992 by Alajarin and co-workers.[88] A small series of 4-aryl derivatives was obtained in only 4 
minutes making use of ethanol as solvent, closed Teflon reaction vessels and a household microwave equipment 
(Scheme 4.4a). Although the yields were poor to moderate and chromatographic purification was mandatory, the  
group claimed that conventional heating procedures required a reflux period of 12 hours in order to afford equal  
structures in similar  yields. A few years later the same authors extended their work to the synthesis of some  
unsymmetrical 1,4-dihydropyridines, starting from suitable arylidene-type 1,3-dicarbonyl compounds and alkyl 3-
aminocrotonates (Scheme 4.4b). Again, chromatographic  work-up was necessary to obtain the pure products.[89]
Scheme 4.4. Synthesis of Hantzsch 1,4-dihydropyridines in ethanol.
Zhang and colleagues presented a solvent-free synthesis of 1,4-dihydropyridines under microwave irradiation 
in 1995.[90] Yields ranging from 59 to 77% were achieved under 10 minutes using a domestic oven, the reaction  
vials being fitted with a condenser containing chilled xylenes (Scheme 4.5). In the same year and utilising identical 
starting materials,  but  in the presence of  an unreported amount of  ethanol  as  solvent,  the research team of  
Khadilkar described the preparation of some Hantzsch DHPs with isolated yields between 32 and 80%.[91]
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Scheme 4.5. Solventless synthesis of Hantzsch 1,4-dihydropyridines.
Khadilkar  and  co-workers  also  explored  the  microwave-promoted synthesis  of  1,4-dihydropyridines  in  an 
aqueous hydrotrope solution, sodium n-butylmonoglycosulphate, to be exact.[92] The experiments were carried-
out  in  a  domestic  apparatus,  using  methyl  3-aminocrotonate,  alkyl  acetoacetates  and  aliphatic  or  aromatic 
aldehydes  as  reagents  (Scheme 4.6).  It  should  be noticed that  these methods were performed by microwave 
heating the reaction mixtures in vessels equipped with a condenser charged with pre-cooled carbon tetrachloride, 
in order to prevent any loss of volatile materials.[91, 92] Furthermore, the same research group later published 
the scale-up preparation of some clinically important Hantzsch DHPs utilising a modified household microwave 
oven and evaluated different aqueous hydrotrope solutions as reaction media, both in batch and in continuous-
flow processes.[93]
Scheme 4.6. Synthesis of Hantzsch 1,4-dihydropyridines in an aqueous hydrotope solution.
A solid-supported and microwave-mediated strategy was presented by Suarez and colleagues in 1996.[94] 
An unsymmetrical 1,4-dihydropyridine was obtained after 6 minutes of irradiation in a domestic oven, followed by  
standard  chromatographic  purification,  with  an  85%  isolated  yield  (Scheme  4.7).  Aiming  to  reach  higher 
temperatures, a small amount of DMF was added to the reaction mixture and used as an energy transfer medium.
Scheme 4.7. Solid-supported synthesis of an unsymmetrical Hantzsch 1,4-dihydropyridine.
Five  years  later  Yadav  and  co-workers  described  the  rapid  microwave-activated  condensation  of  ethyl  
acetoacetate, urea and a series of aryl and alkyl aldehydes on the surface of silica gel.[95] Open-vessel reaction 
conditions  were  employed  in  a  domestic  microwave  equipment  operating  at  650  W,  14  Hantzsch  1,4-
dihydropyridines being obtained with high yields after column chromatography (Scheme 4.8).
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Scheme 4.8. Solid-supported synthesis of Hantzsch 1,4-dihydropyridines.
A single-mode microwave reactor was utilised by Öhberg and Westman to prepare several 4-aryl and 4-alkyl  
Hantzsch DHP derivatives with low to very good yields in 10 to 15 minutes (Scheme 4.9).[96] The syntheses were 
performed in sealed vessels and no solvent was added as reaction medium. Comparing with the same procedure  
under conventional heating and the microwave-mediated process carried-out in a domestic oven, higher yields 
and shorter reaction times were attained after chromatographic purification and/or recrystallisation. However, 
the purity of the compounds varied greatly, ranging from 53 to 99%, as determined by LC-MS.
Scheme 4.9. Synthesis of Hantzsch 1,4-dihydropyridines in aqueous ammonium hydroxide.
The synthesis of various 1,4-dihydropyridines has also been accomplished through the reaction of aldehydes,  
alkyl acetoacetates and ammonium acetate in water, utilising tetra-n-butylammonium bromide (TBAB) as a phase 
transfer agent and catalyst under microwave irradiation (Scheme 4.10).[97] High yields and brief reaction times  
were generally observed using a modified household microwave apparatus.
Scheme 4.10. Synthesis of Hantzsch 1,4-dihydropyridines in water using TBAB as catalyst.
A water soluble Lewis acid complex, Zn(L-proline)2,  was employed in 2006 as catalyst for the microwave-
assisted, multicomponent, Hantzsch 1,4-dihydropyridine synthesis, using aqueous ethanol as reaction medium 
and a domestic microwave oven operating at 200 W (Scheme 4.11).[98] Isolated yields of up to 98% were reported 
without the need of chromatographic work-up. Moreover, the authors claimed that the catalyst could be recycled 
up to five times without loss of activity.
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Scheme 4.11. Synthesis of Hantzsch 1,4-dihydropyridines in aqueous ethanol using Zn(L-proline)2 as catalyst.
A  copper-catalysed  one-pot  preparation  of  diverse  1,4-dihydropyridine  structures  using  a  single-mode 
microwave reactor was described by Pasunooti and co-workers in 2010.[99] Fairly mild reaction conditions and 
low catalytic loading furnished a compound library of 48 DHP analogues for medicinal chemistry applications,  
with exceedingly high yields, after cooling of the crude product mixtures to room temperature,  filtration and  
washing with n-hexane (Scheme 4.12).
Scheme 4.12. Synthesis of Hantzsch 1,4-dihydropyridines in ethanol using Cu(OTf)2 as catalyst.
An aza-Diels-Alder strategy under microwave heating was utilised by Lee and Kim for the synthesis of an  
unsymmetrical  Hantzsch  DHP  motif  with  a  31%  isolated  yield,  after  column  chromatography  followed  by 
recrystallisation (Scheme 4.13).[100] This was further converted to amlodipine after several steps, providing a 
new approach for the preparation of this well known anti-hypertensive drug.
Scheme 4.13. Aza-Diels-Alder synthesis of an unsymmetrical Hantzsch 1,4-dihydropyridine leading to the anti-
hypertensive drug amlodipine.
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Some 1,4-dihydropyridine derivatives have been prepared with excellent yields and within remarkably short  
reaction times by employing a small amount of lanthanum oxide as catalyst in a solvent-free  and microwave-
assisted Hantzsch protocol (Scheme 4.14).[101] Other catalysts were tested but the isolated yields dropped to less 
than half the ones achieved using La2O3. Open-vessel reaction conditions and a domestic microwave equipment 
were applied in all syntheses.
Scheme 4.14. Solventless synthesis of Hantzsch 1,4-dihydropyridines using La2O3 as catalyst.
Quite recently, Bandyopadhyay and colleagues asserted that bismuth(III) nitrate pentahydrate can act as an 
efficient catalyst for the one-pot solvent-free synthesis of Hantzsch DHPs, under microwave activation and sealed-
vessel conditions, starting from diverse primary amines or ammonium acetate, 1,3-dicarbonyl compounds and 
aryl,  heteroaryl  or  alkyl  aldehydes  (Scheme 4.15).[102]  Albeit  the  small  scale  of  this  synthetic  methodology, 
superior results were reported within 1 to 3 minutes of irradiation in a dedicated microwave apparatus, followed 
by washing the crude products with brine, liquid/liquid extraction and chromatographic purification.
Scheme 4.15. Solventless synthesis of Hantzsch 1,4-dihydropyridines using Bi(NO3)3.5H2O as catalyst.
A  small-scale,  multicomponent  and  microwave-assisted  procedure  that  provided  a  rapid  access  to 
functionalised 1,4-dihydropyridines bearing no substituents at positions 2 and 6 of the heterocyclic moiety was 
published by  Al-Awadi  and  co-workers  in  2012.[103] Making  use  of  ammonium acetate  or  primary  amines, 
previously prepared enaminones and aryl aldehydes as reactants, glacial  acetic acid as solvent, a single-mode  
microwave reactor and closed reaction vials, 11 compounds were prepared with high yields in only 2 minutes of  
irradiation (Scheme 4.16).  When chiral primary amines were employed, chiral DHP derivatives were obtained. 
Isolation was simple and usually included washing the crude product mixtures with ice-cold water, followed by  
filtration of the resulting  solid and recrystallisation in an appropriate solvent.
Scheme 4.16. Synthesis of Hantzsch 1,4-dihydropyridines in glacial acetic acid.
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The microwave-assisted oxidation of Hantzsch 1,4-dihydropyridines was firstly described in 1991 by Delgado 
and colleagues.[104, 105] A series of DHP compounds was heated in a domestic microwave oven using a mixture 
of manganese dioxide and bentonite clay as reaction medium in open-vessel conditions. Short reaction times, up 
to  10 minutes,  and fair  to  quantitative  isolated yields,  47 to  100%, were reported.  Interestingly,  when DHPs 
bearing a methyl, ethyl or n-propyl substituent at position 4 of the nitrogen-containing heterocycle were utilised 
as  starting  materials,  mixtures  of  the  corresponding  4-alkylpyridines and  4-unsubstituted  pyridines  were 
obtained.  A  couple  of  years  later,  the  same  research  group  claimed  that  these  4-alkyl-1,4-dihydropyridine  
derivatives did not afford the dealkylated products when subjected to microwave irradiation in the presence of a 
nitric acid-doped  bentonite clay.[56] The oxidative  aromatisation of  1,4-dihydropyridines was also studied by 
Varma and Kumar in the late 1990s.[59] The solvent-free oxidation of several DHPs, using a slight excess of  
elemental  sulphur  as  the  oxidising  agent  in  an  unmodified  household  microwave  apparatus,  provided  the 
dehydrogenated derivatives after column chromatography, irrespective of the nature of the substituent present at  
position 4 of the dihydropyridine unit (Scheme 4.17).
Scheme 4.17. Solventless oxidative aromatisation of Hantzsch 1,4-dihydropyridines using sulphur as oxidant.
Cotterill and co-workers presented the application  of microwave activation in the context of combinatorial 
synthesis  in  1998:  a  multicomponent  domino  Hantzsch  synthesis  of  diversely  substituted  symmetrical  and 
unsymmetrical pyridines in a 96-well microplate.[106] The reactions were carried-out on a NH4NO3/bentonite 
clay support. Ammonium nitrate acted both as the nitrogen source and the oxidising agent, the initially formed 
DHPs being rapidly dehydrogenated to their pyridine analogues (Scheme 4.18). Given that a domestic microwave 
equipment  was  used,  the  reaction temperature  could not be  accurately measured and the microwave  energy 
distribution over the microplate was rather uneven. Nonetheless, the products were obtained with purity levels 
above 70%, determined by HPLC-MS techniques, although no isolated yields were indicated.
Scheme 4.18. Solid-supported domino synthesis of symmetrical and unsymmetrical Hantzsch pyridines.
In another solid-supported methodology, Hantzsch 1,4-dihydropyridines were employed in the reduction of 
olefins, both in a domestic multi-mode oven and in a dedicated single-mode reactor, the pyridine counterparts  
being obtained as side-products.[107] The authors found that the efficiency of the reduction/oxidation reaction  
was highly dependent on steric effects in the DHP derivatives and on electronic effects exhibited by the different  
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olefins. In 2005, Heravi and Ghassemzadeh published the use of a bismuth(III) chloride/HZSM-5 zeolite system 
as a mild and clean oxidant of 1,4-dihydropyridines  under microwaves.[108] No chromatographic purification 
procedures were necessary in order to furnish the pyridine products with generally good yields (Scheme 4.19). The 
same research team also employed a HZSM-5/MnO2 support under similar reaction conditions with very good 
results.[109]
Scheme 4.19. Solid-supported oxidative aromatisation of Hantzsch 1,4-dihydropyridines using BiCl3 as oxidant.
Shortly  after,  Bagley  and  Lubinu  reported  that  4-aryl-  and 4-alkyl-1,4-dihydropyridines  were  readily  and 
effectively oxidised by activated manganese dioxide, in only one minute of microwave irradiation, using sealed-
vessel  conditions  and  a  commercial  microwave  reactor  (Scheme  4.20).[110]  The  authors  also  tested  other 
oxidising agents, such as Pd/C, molecular iodine or  o-iodoxybenzoic acid, under a series of microwave-assisted 
reaction conditions, but with poor results. The reaction proceeded either through oxidative aromatisation, for 4-
aryl or linear 4-alkyl substrates, or via oxidative dealkylation, for branched 4-alkyl or 4-benzyl derivatives. MnO 2 
was easily removed by simple filtration through a small column of Celite.
Scheme 4.20. Oxidative aromatisation of Hantzsch 1,4-dihydropyridines using MnO2 as oxidant.
Another one-pot domino approach for the preparation of Hantzsch pyridines was presented by the research  
group of Török in 2008.[111] The process was based on the employment of microwaves (single-mode reactor) and 
a noble metal-solid acid catalyst  (montmorillonite K-10/Pd/C). The cyclisation occurred on the surface of the 
acidic  solid-support,  followed  by  the  palladium-promoted  dehydrogenation  of  the  1,4-dihydropyridine 
intermediate  to  the corresponding pyridine  product (Scheme 4.21).  Albeit  the catalyst  is  easily removable  by  
filtration of the cooled crude product mixture and, in theory, can be recycled, it must be emphasised that the 
reaction times reported were quite high for a microwave-assisted methodology, up to 2 hours, and the reaction  
yields varied significantly.
Scheme 4.21. Solid-supported domino synthesis of Hantzsch pyridines.
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The oxidative aromatisation of a few Hantzsch DHPs in water and under 10 minutes was also described in  
2008, using  a  typical  nitrating  mixture  composed of  nitric  and sulphuric  acids  as  the oxidising  agent and a 
domestic multi-mode microwave apparatus (Scheme 4.22).[112] No reference of reaction temperature, microwave 
power setting or even isolated yields was made.
Scheme 4.22. Oxidative aromatisation of Hantzsch 1,4-dihydropyridines in water using HNO3/H2SO4 as oxidant.
The  fast  and  effective  dehydrogenation  of  some  1,4-dihydropyridines  with  tetra-n-butylammonium 
peroxymonosulphate (TBAPM) catalysed by manganese(III) Schiff base complexes, under both low-temperature 
activation  utilising  a  closed  vessel  and  dedicated  microwave  equipment  or  mechanical  stirring  at  room 
temperature,  was  published in  2009 by  Nasr-Esfahani  and co-workers (Scheme 4.23).[113]  High  yields were  
reported in all microwave-assisted syntheses after standard chromatographic work-up.
Scheme 4.23. Oxidative aromatisation of Hantzsch 1,4-dihydropyridines using TBAPM as oxidant and Mn(III)-
salophen as catalyst.
The Leadbeater research team utilised tandem UV irradiation and microwave heating for the oxidation of 
some Hantzsch DHPs to the corresponding pyridines.[114] The reactions were performed in closed vessels using 
acetonitrile as solvent, 1000 kPa of molecular oxygen as oxidant and an electrodeless discharge lamp as the UV  
irradiation source (Scheme 4.24).  It  was shown that  both oxygen and ultraviolet  irradiation were key to  the  
success of  this  protocol,  although the need for heating in conjunction with irradiation was not unequivocally 
demonstrated. Still, this strategy was significantly faster than others previously described using photoactivation in 
the presence of molecular oxygen.
Scheme  4.24. Oxidative  aromatisation  of  Hantzsch  1,4-dihydropyridines  using  oxygen  as  oxidant  and  UV 
irradiation.
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The solid-supported oxidative  aromatisation of  a few 1,4-dihydropyridines with glycinium chlorochromate 
(GCC)  was  studied  in  2009,  using  silica  gel  as  reaction  medium  and  open-vessel  conditions  in  a  domestic  
microwave oven.[115] The authors claimed that quantitative yields were obtained in very short reaction times, 
without the requirement of any chromatographic purification procedure (Scheme 4.25).
Scheme 4.25. Solid-supported oxidative aromatisation of Hantzsch 1,4-dihydropyridines using GCC as oxidant.
Various  Hantzsch  DHPs  were  oxidised  to  the  corresponding  pyridine  derivatives  by  Memarian  and  co-
workers,  both at  room temperature and under microwave irradiation conditions,  using DDQ as the oxidising  
compound.[116] It was established that this reaction was greatly influenced by the nature of the substituents 
located at positions 3, 4 and 5 of the dihydropyridine ring, the type of solvent and the presence of an oxygen or  
argon atmosphere.  One  year  later,  the  same authors  reported  that  tetra-n-butylammonium  peroxydisulphate 
(TBAPD), either in combination with basic aluminium oxide in refluxing acetonitrile or under microwave heating 
in the absence or presence of basic alumina, could also produce pyridines via dehydrogenation of the preceding  
1,4-dihydropyridines.[117]
B. Multicomponent Synthesis of Hantzsch 1,4-Dihydropyridines
Following part of the work carried-out by Bagley and Lubinu,[110] and firstly by Öhberg and Westman,[96] we 
decided to synthesise a small compound library of Hantzsch 1,4-dihydropyridines under microwave irradiation  
through a low-budget and solvent-free method. The purpose was not to modify the microwave-assisted procedure 
reported by the above mentioned authors, but to  make use of  its  straightforwardness to prepare some novel  
4-aryl-DHPs  comprising  several  different  substituents  of  both  electron-donating  and  electron-withdrawing 
character and also to further explore these heterocycles as substrates in oxidation reactions under microwave  
activation. Hence, a mixture of the selected aryl aldehyde, a five-fold molar excess of methyl acetoacetate and a  
four-fold molar excess of aqueous ammonium hydroxide was heated at 140 ºC for 10 minutes, with an initial  
power setting of 150 W, under closed-vessel conditions (Scheme 4.26). Contrary to that described in the reports of 
Westman[96] and Bagley,[110] in which chromatographic purification processes were often needed in order to get  
the final product with a high level of purity, the isolation protocol in our approach was significantly easier and  
much more effective.  The yellow solid that  precipitated out of  the cooled crude product mixture was simply  
filtrated under reduced pressure, washed with distilled water and recrystallised in aqueous ethanol, Hantzsch 1,4-
dihydropyridines 102-125 being obtained as yellowish solids with moderate to good isolated yields, ranging from 
30 to 72% (Figure 4.3).
Scheme  4.26.  Multicomponent  synthesis  of  Hantzsch  1,4-dihydropyridines  102-125 under  microwave 
irradiation.
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Figure  4.3. Structures  and  isolated  yields  of  Hantzsch  1,4-dihydropyridines  102-125 synthesised  via  a 
solventless, multicomponent, microwave-assisted method.
It should be emphasised that, as far as we know, compounds 109, 117, 118, 121, 122 and 125 have never been 
reported  in  the  scientific  literature.  Also,  when  9-phenanthrenaldehyde,  9-anthracenaldehyde,  2,6-
dichlorobenzaldehyde  and  mesitylaldehyde  were  used  as  reagents,  only  trace  amounts  of  the  corresponding 
dihydropyridine derivatives were detected by TLC analysis of the crude product mixtures, which can be explained 
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by steric impediment phenomena. Moreover, using 4-dimethylaminobenzaldehyde as the starting aryl aldehyde, a 
strong, fast and unsafe pressure accumulation was detected inside the reaction vessel upon microwave activation,  
which was most likely due to the release of dimethylamine as a secondary product.
C. Oxidation of Hantzsch 1,4-Dihydropyridines
Based in the methodology presented by Bagley and Lubinu,[110] nearly all the previously prepared 4-aryl-
DHP structures depicted in Figure 4.3 were promptly oxidised to the corresponding 4-arylpyridines with isolated  
yields above 90%. Briefly, a mixture of the selected Hantzsch 1,4-dihydropyridine and a 10-fold stoichiometry of 
activated manganese dioxide in dichloromethane was irradiated at 100 ºC for 5 minutes in an appropriate sealed 
vessel. After cooling to room temperature, the excess MnO2 and any oxidation by-products were easily removed by 
simple filtration through a small silica gel column. Evaporation of the filtrate under reduced pressure, followed by 
recrystallisation, afforded the desired Hantzsch pyridine as a white or yellowish solid or oil (Scheme 4.27a).
Scheme 4.27. Synthesis of Hantzsch pyridines 126-146 under microwave irradiation.
Interestingly, the heterogeneous oxidative aromatisation of DHP 118 using activated manganese dioxide was 
entirely unsuccessful, the starting heterocyclic material being recovered unaltered upon work-up. Broadening the 
reaction time to 10 and 20 minutes or changing the reaction medium to a more polar solvent, e.g. ethyl acetate,  
was  also  ineffective.  However,  full  conversion  to  the  respective  dimethyl  4-(4-carboxyphenyl)-2,6-
dimethylpyridine-3,5-dicarboxylate 142 was achieved through a homogeneous oxidative aromatisation strategy, 
utilising  potassium peroxydisulphate  as  oxidant,  an  acetonitrile/distilled  water  mixture  as  solvent  and  equal 
reaction conditions (Scheme 4.27b).  Work-up was extremely simple and involved washing the crude product  
mixture with brine and filtering  the solid that  precipitated out of  the resulting aqueous solution.  It  must be  
pointed-out that the MnO2-promoted oxidation of DHPs  116,  121,  122 and  125 provided the desired pyridine 
derivatives  as  minor  reaction  products,  37,  8,  22  and  7%  conversion,  respectively,  as  verified  by  GC-MS  
examinations  after  isolation.  It  was  established  that,  in  these  cases,  dimethyl  2,6-dimethylpyridine-3,5-
dicarboxylate, rendered via an unforeseen and, to the best of our knowledge, unreported oxidative dearylation  
process, was the major component in the final products, 63 to 93% conversion (Scheme 4.28).
Scheme 4.28. MnO2-promoted oxidative aromatisation/dearylation of Hantzsch 1,4-dihydropyridines 116, 121, 
122 and 125 under microwave irradiation.
Unlike the oxidative dealkylation reaction in some 4-alkyl-DHPs, which has already been determined both 
under  classical  conditions  and  microwave  irradiation,  further  investigation  is  clearly  necessary  in  order  to 
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elucidate  what  drives  this  surprising  oxidative  aromatisation/dearylation  phenomenon.  In  this  regard,  and 
although no studies were performed and no proof was substantiated, we consider that the presence of hydroxyl 
and methoxyl functionalities at the aromatic ring of the 1,4-dihydropyridine motif should be of great influence, 
given that these are the only common substituents present at the compounds in which this process was observed.  
Application of the K2S2O8-mediated homogeneous oxidative aromatisation approach to the supra-cited Hantzsch 
1,4-dihydropyridines,  i.e.  116,  121,  122 and  125,  was  only  successful  in  the  first  situation,  dimethyl  4-(4-
hydroxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate 140 being easily isolated. Unfortunately, the other DHP 
reactants were recovered unchanged upon work-up, even after extended microwave irradiation at 100 ºC for 10 
and 20 minutes. Apparently, the existence of both hydroxyl and methoxyl functional groups at the phenyl ring of 
the 1,4-dihydropyridine skeleton somehow hampered the formation of the hydropyridinoyl radical intermediate, 
which is essential for the oxidation reaction to succeed (Scheme 4.30). This could be related to the balance of 
inductive  and  resonance  effects  caused by  these  particular  substituents.  Nonetheless,  a  series  of  twenty  one 
Hantzsch  pyridines  was  easily  prepared  through the  microwave-assisted  oxidation  of  the  corresponding  and 
previously synthesised 1,4-dihydropyridine analogues, with isolated yields between 83 and 95% (Figure 4.4).
Figure  4.4. Structures  and  isolated  yields  of  Hantzsch  pyridines  126-146 synthesised  via  solvent-based, 
microwave-assisted, oxidative aromatisation methods.
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Activated  manganese  dioxide  is  characterised  by  a  high  standard  oxidation/reduction  potential 
(E0[Mn(IV)/Mn(II)]=1.23 V), acting as a strong oxidising agent in acidic conditions (E0=1.57 V), but only as a mild 
oxidant  in  neutral  media.  On  the  other  hand,  its  oxidation  potential  in  alkaline  conditions  is  negligible  
(E0=0.05 V).[118, 119] MnO2 can perform both as a powerful two-equivalent and also a one-electron oxidant, 
selective oxidation being usually achieved at room temperature. However, its oxidising ability increases greatly 
above 70 ºC, although commonly with loss of selectivity.[120] Nevertheless, many dehydrogenation reactions, as  
well  as  the  complete  aromatisation  of  several  types  of  saturated  ring  systems,  can  be  accomplished  by  the  
utilisation of  this  inexpensive  and user-friendly  inorganic  oxidant.[119]  A  mechanistic  rationalisation for  the 
MnO2-promoted heterogeneous oxidative aromatisation of the Hantzsch 1,4-dihydropyridines studied in this work 
is  portrayed in Scheme 4.29.  DHP adsorption to the surface of  MnO2 X and hydrogen abstraction renders a 
coordination complex XI. The oxidation proceeds through an intramolecular one-electron transfer, generating a 
radical cation intermediate XII, followed by a hydrogen atom transfer XIII, which results in the formation of the 
target pyridine structure, as well as water and MnO as by-products.[118, 119]
Scheme 4.29. Mechanistic proposal for the synthesis of Hantzsch pyridines 126-146 using activated manganese 
dioxide as the oxidising agent under heterogeneous oxidative aromatisation conditions.
The  peroxydisulphate  ion  is  generally  recognised  as  one  of  the  strongest  oxidising  agents  available 
(E0[S2O82-/SO42-]=2.01 V)[121]  and has been widely and successfully employed in various oxidative  processes,  
including the dehydrogenation of Hantzsch 1,4-dihydropyridines.[122]  Regarding our preparation of Hantzsch 
pyridines via the K2S2O8-mediated homogeneous oxidative aromatisation of the corresponding DHPs, a possible 
reaction pathway is represented in Scheme 4.30. Thermal decomposition of the weakest O-O bond in potassium  
peroxydisulphate yields a sulphate radical anion (a), which preferentially abstracts a hydrogen atom from the 
water molecules present within the reaction medium to furnish a hydroxyl radical (b). The oxidation is presumed 
to be initiated through a hydrogen abstraction at position 4 of the heterocyclic structure by the previously formed 
hydroxyl  radical,  affording  a  hydropyridinoyl  radical  intermediate  XIV and  water.  Lastly,  abstraction  of  the 
nitrogen-linked hydrogen atom by another sulphate radical anion generates the desired pyridine compound along 
with potassium bisulphate as a secondary product (c).
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Scheme  4.30. Mechanistic  proposal  for  the  synthesis  of Hantzsch  pyridines  126-146 using  potassium 
peroxydisulphate as the oxidising agent under homogeneous oxidative aromatisation conditions.
IV. Summary
A small compound library of Hantzsch 1,4-dihydropyridines 102-125, including some novel and unreported 
structures,  was  rapidly  and  effortlessly  synthesised  via  a  multicomponent  and  solvent-free  strategy  under 
microwave activation, moderate to good reaction yields being obtained (30-72%) without the requirement of any 
chromatographic isolation procedure. Hantzsch pyridines 126-146 were also efficiently prepared through the fast 
and microwave-assisted oxidative  aromatisation of the corresponding DHP analogues,  isolated yields ranging 
from 83 to  95% being  attained,  either  under  heterogeneous  reaction  conditions  using  the  cheap  and useful  
activated  manganese  dioxide  as  the  oxidising  agent  or  by  means  of  a  homogeneous  methodology  utilising  
potassium peroxydisulphate as the alternative oxidant. An unexpected oxidative dearylation process was observed 
in a few cases when MnO2 was employed as the oxidising species, although further studies are manifestly needed 
in order to clarify the reaction mechanisms involved.
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5
Biginelli 3,4-Dihydropyrimidines
I. Introduction & Relevance
The  preparation  of  3,4-dihydropyrimidines (DHPMs)  was  firstly  described  120  years  ago  by  the  Italian 
chemist  Pietro Biginelli.[1]  This  simple,  one-pot and multicomponent  approach to  partly  reduced pyrimidine  
derivatives, nowadays broadly recognised as the Biginelli synthesis, was mostly neglected in the following decades  
and, consequently, the biological activity of this class of nitrogen-containing heterocycles remained unexplored. 
However, interest in these compounds increased sharply since the early 1980s, in particular among synthetic and 
medicinal chemists.[2] This was largely due to the structural resemblance of DHPMs to the profoundly studied 
calcium channel blockers and α1a-adrenergic receptor antagonists of the Hantzsch 1,4-dihydropyridine type. In 
fact, it was soon corroborated that several Biginelli 3,4-dihydropyrimidines exhibited improved pharmacological  
profiles,  comparing  to  some  widely  known  DHP  pharmacophores  employed  against  common  cardiovascular  
diseases, an incredible progress in this area being observed in the 1990s.[2-6] As an example, two orally active and 
long-lasting antihypertensive DHPM agents are depicted in Figure 5.1.
Figure 5.1. Representative examples of Biginelli 3,4-dihydropyrimidine compounds relevant in cardiovascular 
diseases as calcium channel antagonists.
3,4-Dihydropyrimidines represent much more than just aza-analogues of Hantzsch DHPs. The evolution of 
combinatorial chemistry technology allowed the rapid generation of several DHPM compound libraries, which 
were then subjected to high-throughput screening techniques; hence, other interesting biological properties have 
been observed over the last 20 years and have been reviewed extensively.[7-12] Batzelladine A and B, which are 
obtained from marine natural sources and  contain dihydropyrimidine  moieties, have demonstrated promising 
anti-human immunodeficiency virus (HIV) activity (Figure 5.2). These low molecular weight alkaloids block the 
binding of HIV gp120 glycoproteins to CD4 receptors and, therefore, are reasoned as potential leads for acquired 
immunodeficiency syndrome (AIDS) therapy.[13] It should also be mentioned that batzelladines C, D and E were 
found  to be cytotoxic[13] and batzelladines F and G might be helpful for the treatment of several autoimmune  
disorders.[14] The discovery  of  monastrol  is  currently  seen as  a  ground-breaking  development  regarding  the 
pharmacology of Biginelli DHPM derivatives. In their pioneering work, Mayer and associates reported that this  
compound specifically suppressed the motor activity of human mitotic kinesin Eg5 as the first cell-permeable 
small molecule.[15] Given that Eg5 plays a pivotal role in the assembly of bipolar mitotic spindle, inhibition of this  
protein causes cell cycle arrest during the mitosis stage and, thus, it is considered a valid and effective strategy for 
cancer chemotherapy.[16, 17] Moreover, enzymatic experiments and in vivo assays indicated that (S)-monastrol 
presented a much higher activity than the corresponding (R)-enantiomer.[18] Also, both steady-state ATPase and 
cell-based assessments revealed that the inhibition potency of several monastrol-like compounds was even greater  
(Figure 5.3).
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Figure 5.2. Representative examples of natural dihydropyrimidine-containing bioactive compounds.
Phenobarbital  is  the  oldest  and  most  widely  used  anticonvulsant  drug  world-wide,[19]  targeting 
γ-aminobutyric acid (GABA) receptors in the central nervous system and is also known for possessing  sedative 
and  hypnotic  properties.  Due  to  structural  similarities  to  this  barbiturate  molecule,  some  Biginelli  3,4-
dihydropyrimidines  have  been  analysed  and  were  found  to  be  auspicious  anti-epileptic  agents.[20]  Various 
DHPM-amide derivatives, such as JAB 75, DMT 3024 and MAL 3-39, have been investigated as a new kind of heat  
shock  protein  Hsp70  modulators,  quenching the  replication  of  the  malaria-causing  parasite  Plasmodium 
falciparum  in  human  red  blood  cells.[21]  It  was  also  uncovered  that  SNAP  6201  and  SNAP  7941,  two  
multifunctionalised  DHPMs,  were powerful  and selective  antagonists  of  α 1a-adrenergic  receptors and,  thence, 
good  lead  compounds  for  the  treatment  of  benign  prostatic  hyperplasia  (BPH),  presenting  a  good  
pharmacokynetic profile and no adverse cardiovascular effects (Figure 5.3).[6, 22]
A  few  heteroaryl-dihydropyrimidine  structures,  namely  HAP1,  Bay41-4109  and  Bay39-5493,  which  were 
designed and synthesised at Bayer pharmaceutical company, have proven to efficiently bind to the protein shell  
that protects the nucleus of the hepatitis B virus (HBV) and, consequently, disrupt the replication mechanism of  
the  latter.[23-25]  A  series  of  pyrazolyl-dihydropyrimidines  were  evaluated  in  vitro for  their  antitubercular 
properties against a Mycobacterium tuberculosis H37Rv strain,[26] a couple of compounds demonstrating to be 
more potent than isoniazid,  the  first-line medication in prevention and handling of  tuberculosis (Figure 5.3). 
Furthermore,  some  Biginelli  DHPM  scaffolds  bearing  isoxazole  substituents  have  shown  an  assortment  of 
biological activities, such as  antimicrobial, antibacterial, antifungal and antimalarial.[27] Also, significant anti-
inflammatory properties have been reported in several 3,4-dihydropyrimidine-propionic acid derivatives.[28-30]
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Figure 5.3. Representative examples of synthetic dihydropyrimidine-containing bioactive compounds.
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II. Classical Synthetic Methods
As credited above, the first paper on the synthesis of 3,4-dihydropyrimidines was authored by Biginelli in the  
late 19th century.[1] It discussed the three-component condensation of benzaldehyde, ethyl acetoacetate and urea 
in refluxing ethanol doped with a small amount of hydrochloric acid as catalyst, followed by filtration of the solid 
that  precipitated  upon slow  cooling  to  room temperature  and  recrystallisation  in  ethanol.  Seminal  research 
concerning the mechanism of this reaction was produced by Folkers and Johnson in the early 1930s[31, 32] and is  
summarised in Scheme 5.1. The open-chain ureide-type scaffold  III, either derived from intermediate  I or  II, 
which are the result of a preceding bimolecular condensation process, Scheme 5.1a and 5.1b, respectively,  was 
suggested as the key chemical structure.
Scheme 5.1. Folkers and Johnson mechanistic proposal for the Biginelli synthesis of 3,4-dihydropyrimidines.
Four decades later, Sweet and Fissekis  reinvestigated the Biginelli  condensation and proposed a different  
mechanistic  pathway  involving  a  preliminary  acid-catalysed  aldol  condensation  between  the  aldehyde  and 
β-ketoester reagents, followed by reaction of urea/thiourea with the carbenium ion intermediate  VII,  rendered 
either  from  the  aldol  structure  V or  from  the  α,β-unsaturated  ketone  VI,  this  being  generated  through 
dehydration  of  the  same  aldol  condensation  product (Scheme  5.2).[33]  Sixteen  years  ago  Kappe  employed 
trapping experiments and both 1H and 13C NMR spectroscopic techniques in order to study this synthetic process, 
establishing that the crucial step in the preparation of Biginelli DHPMs concerned the acid-catalysed creation of  
an  N-acyliminium  ion  intermediate  X via  protonation  of  the  previously  formed  condensation  product  IX 
(Scheme 5.3).[34] Interception of this species by the  β-ketoester starting material, presumably through its enol 
tautomer, affords the open-chain ureide VIII, which later undergoes cyclisation and water elimination leading to 
the target 3,4-dihydropyrimidine compound IV.
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Scheme 5.2. Sweet and Fissekis mechanistic proposal for the Biginelli synthesis of 3,4-dihydropyrimidines.
In short, the Kappe mechanism can be seen as an  α-ureidoalkylation;[35] the carbenium ion intermediate 
approach disclosed by Sweet and Fissekis and depicted in Scheme 5.2 is not a prevailing synthetic route. Withal,  
minute quantities of α,β-unsaturated ketone VI were occasionally detected as a by-product. Albeit the extremely 
reactive  N-acyliminium  structure  X was not  isolated  or  experimentally  observed,  further  indication  for  this 
mechanistic  rationalisation  was  later  found  using  β-ketoester reactants  bearing  bulky[36]  or  electron-
deficient[37] substituents. More recently, ESI-MS assessments and DFT calculations carried-out by de Souza and 
colleagues have demonstrated that the  N-acyliminium ion mechanism is the thermodynamically and kinetically 
favoured pathway in the one-pot three-component Biginelli synthesis.[38] However, new information reported by 
Kolosov and co-workers reintroduced the discussion, arguing that the mechanism suggested by Kappe is only 
credible for reactions occurring in highly acidic media, when Brønsted acids are used, and no longer reasonable in 
the case of Lewis acid- or non-catalysed reactions and of non-acidic reaction conditions.[39]
Scheme 5.3. Kappe mechanistic proposal for the Biginelli synthesis of 3,4-dihydropyrimidines.
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An alternative strategy for the preparation of Biginelli DHPMs was presented by the research group of Atwal in 
the  late  1980s.[40-42]  This  two-step  methodology  involves  the  base-catalysed  condensation  of  a  previously 
synthesised alkylidene- or arylidene-type 1,3-dicarbonyl compound VI with urea or thiourea derivatives, ureide 
adduct XI being the proposed reaction intermediate. Cyclisation and water elimination of the latter to structure 
XII,  followed by  simple deprotection of  the  nitrogen atom ultimately  furnishes  the 3,4-dihydropyrimidinone 
(X=O) or its thione equivalent (X=S) IV (Scheme 5.4). Moreover, it was disclosed that piperidine can act as both 
solvent  and  base  in  the  multicomponent  Biginelli  condensation  process,  the  corresponding  Hantzsch 1,4-
dihydropyridine analogues also being isolated as secondary products, which are assumed to be formed due to 
decomposition of urea and subsequent generation of ammonia within the reaction medium.[43]
Regardless of whether the Biginelli  synthesis is  performed under acid or alkaline catalysis  conditions,  the 
generally accepted mechanistic routes that have been presented over the years clearly display common features 
and evidence strongly  supports  that  open-chain  ureides,  such as  VIII  or  XI,  although of  different  synthetic 
origins, are important intermediates preceding the ring-closing step. On the other hand, experimental studies on 
the reaction mechanisms of non-catalysed approaches to Biginelli DHPMs are scarce and, consequently, some 
controversy continues in the academic community.
Scheme 5.4. Atwal mechanistic proposal for the alternative Biginelli synthesis of 3,4-dihydropyrimidines.
Unlike Hantzsch 1,4-dihydropyridines, in which oxidative aromatisation is typically an easy procedure, the  
oxidation of Biginelli 3,4-dihydropyrimidines, portrayed in a generic fashion in Scheme 5.5, is rather difficult and 
no efficient, practical and broad method has been disclosed so far. In fact, it was pointed-out 20 years ago that the 
resistance of DHPMs to oxidative processes may explain the extended duration of cardioprotective activity as 
compared to DHP-type calcium channel modulator drugs.[4, 5] Biginelli DHPMs have proven to be quite stable  
towards powerful oxidising agents, such as sodium nitrite in acetic acid, PCC, clay-supported KMnO 4, activated 
manganese  dioxide,  p-TCQ  and  DDQ,[44]  as  well  as  some  common  oxidants  successfully  utilised  in  the 
dehydrogenation of Hantzsch DHPs, e.g. Br2,[45] elemental sulphur,[46] FeCl3,[47, 48] bismuth(III) nitrate,[48] 
o-iodoxybenzoic acid[48] and ceric ammonium nitrate in acetic acid.[49] It was discovered that Pd/C-promoted 
oxidation  at  high  temperature  only  worked  for  3,4-dihydropyrimidines  that  did  not  incorporate  sensitive 
functional  groups[50] and oxidants such as selenium dioxide[51] and Co(NO3)2.6H2O/K2S2O8[52] often led to 
unwanted  oxidation  by-products.  However,  formation  of  a  few  pyrimidine  products  could  be  accomplished 
through an electrochemical methodology on a carbon electrode.[53] Nitric acid was also described as a selective  
reagent  for  the  dehydrogenation  of  some  DHPMs.[54]  Furthermore,  a  mixture  of  a  slight  excess  of  t-butyl 
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hydroperoxide and catalytic amounts of potassium carbonate and a copper salt demonstrated to be satisfactory for  
the oxidation of 3,4-dihydropyrimidine derivatives.[55] More recently,  CAN was reinvestigated under alkaline 
reaction  conditions  and  it  was  reported  that  conversion  of  several  DHPMs  into  the  corresponding  oxidised 
structures was attained.[56] Additionally, potassium peroxydisulphate[57] and UV irradiation[58] also proved to 
be effective in the dehydrogenation of various 3,4-dihydropyrimidinones. Notwithstanding, it must be emphasised  
that, to the best of our knowledge, a study dealing with the successful oxidation of Biginelli DHPMs of the thione  
kind (Scheme 5.5, X=S) has never been published.
Scheme 5.5. Oxidation of Biginelli 3,4-dihydropyrimidines.
III. Microwave-Assisted Synthetic Methods
Various  review  papers focussing on  the  tremendous  amount  of  different  alterations  to  the  centennial 
multicomponent Biginelli reaction, including the thriving usage of microwave activation, have appeared in the 
scientific  literature.[2,  10,  59-61]  Novel  developments  regarding  the  reactivity  and  functionalisation  of  3,4-
dihydropyrimidine  compounds  have  also  been  addressed  in  detail[2,  10,  61,  62]  and  even  an  interesting 
biographical  survey on  Pietro  Biginelli  has  been  issued.[63]  Selected  illustrations  on the  microwave-assisted 
organic synthesis of Biginelli DHPM derivatives, as well as some of their related oxidised analogues,  are shortly 
presented in the following pages.
A. Literature Review & Selected Examples
Early work on the application of microwaves to the synthesis of Biginelli DHPMs was published in the late  
1990s[64-70]  and  was  mainly  centred  on  the  employment  of  household  microwave  ovens  under  solventless 
reaction conditions,[64-66] briefer reaction times comparing to conventional heating approaches and moderate to 
high yields being reported. A series of  3,4-dihydropyrimidines was prepared by Kappe and co-workers in 1999 
utilising a solvent-free methodology and polyphosphate ester (PPE) as the reaction promoter (Scheme 5.6).[64] 
Heating the multicomponent reaction mixture for only 90 seconds in a domestic microwave apparatus, followed  
by simple precipitation in water and filtration, afforded the desired DHPMs with isolated yields up to 95%, 1 to 
50 mmol scale protocols being successfully performed. However, PPE had to be prepared beforehand, since it was  
not commercially available.
Scheme 5.6. Solventless synthesis of Biginelli 3,4-dihydropyrimidines using PPE as catalyst.
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The  application  of  other  acidic  catalysts  under  solvent-free  and  microwave  heating  conditions,  such  as  
aluminium(III)  chloride  hexahydrate,[71]  aluminium  hydrogen  phosphate,[72]  alumina-sulfuric  acid[73]  and 
oxalic acid[74] to the Biginelli condensation was reported more recently. The automated synthesis of a DHPM 
compound library, starting  from several combinations of carbonyl compounds, aldehydes and urea or thiourea 
derivatives, was accomplished in a single-mode microwave reactor by Stadler and Kappe in 2001.[75] The use of  
ytterbium(III)  triflate as  Lewis acid catalyst in an acetic acid/ethanol solvent mixture at  120  ºC for  10 to 20 
minutes, following precipitation of the product upon cooling or crystallisation in water, rendered the Biginelli  
structures (Scheme 5.7). Forty eight DHPMs were prepared within 12 hours with a 52% average isolated yield and 
a 90% minimum purity using this sequential process. Dallinger and Kappe later revisited this strategy and found  
that  the  thione  derivatives  were  generally  obtained  with  improved  yields  when  acetonitrile  was  utilised  as 
solvent.[76]
Scheme 5.7. Synthesis of Biginelli 3,4-dihydropyrimidines using Yt(OTf)3 as catalyst.
A microwave-mediated and solid-supported Biginelli-like method was published by Kidwai and colleagues in  
2003,[77]  six  thiobarbituric  acid  derivatives  being  synthesised  with  good  yields  in  a  short  time-span,  after  
washing-off the products from the acidic alumina support with ethanol, evaporation of the solvent under reduced  
pressure and recrystallisation in methanol (Scheme 5.8).
Scheme 5.8. Solid-supported synthesis of Biginelli-type 3,4-dihydropyrimidines using Al2O3.
The solvent-free synthesis of some DHPMs was carried-out by Xia and Wang using a polyethylene glycol-
linked  reagent.[78]  A  mixture  comprising  previously  prepared  PEG-4000-bound  acetoacetate, urea,  aryl 
aldehydes and polyphosphoric acid (PPA) as catalyst was heated in an unmodified household microwave oven 
operating at  400 W, furnishing  the expected polymer-bound 3,4-dihydropyrimidinones  in very brief  reaction 
times. Subsequent cleavage from the polymeric material with sodium methoxide in methanol at room temperature 
and appropriate work-up rendered the target Biginelli structures with good isolated yields (Scheme 5.9).
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Scheme 5.9. Solventless synthesis of Biginelli 3,4-dihydropyrimidines using PPA as catalyst.
Glasnov and associates developed a microwave-assisted continuous-flow (CF) Biginelli protocol in 2006.[79] 
A freshly prepared solution of benzaldehyde, ethyl acetoacetate and urea in acetic acid/ethanol doped with a 10% 
molar equivalent of hydrochloric acid (1.3 M) was introduced through a HPLC pump in an appropriate flow cell at  
a 2 ml min-1 flow rate and heated at 120 ºC, the desired DHPM being obtained with a 52% yield after 13 minutes of 
total processing time (5 minutes of residence time inside the flow cell), allowing the synthesis of the product on a 
25 g h-1 scale (Scheme 5.10).
Scheme 5.10. Continuous-flow synthesis of a Biginelli 3,4-dihydropyrimidine using HCl as catalyst.
The microwave-activated preparation of  some Biginelli  3,4-dihydropyrimidines  using polystyrenesulphonic 
acid (PSSA) as catalyst was presented by Polshettiwar and Varma in 2007.[80] The reaction proceeded efficiently  
in a single-mode reactor, under closed-vessel conditions, using water as reaction medium. Simple filtration of the  
precipitated products after cooling to room temperature, followed by recrystallisation in an appropriate organic  
solvent, was the only work-up needed in order to achieve isolated yields of up to 92% (Scheme 5.11).
Scheme 5.11. Synthesis of Biginelli 3,4-dihydropyrimidines in water using PSSA as catalyst.
Trichloroisocyanuric acid (TCCA), a known industrial disinfectant for swimming pools and dyestuffs and also 
a  bleaching  agent used  in  the  textile  industry,  was  employed  as  catalyst  in  the  microwave-assisted  Biginelli  
reaction  by  Bigdeli  and  colleagues.[81]  Both  ethanol  and DMF  were  found to  be  suitable  solvents,  fourteen 
DHPMs  being  obtained  with  generally  high  yields  in  short  reaction  times  after  irradiation  in  a  domestic 
microwave  equipment  operating  at  600  W,  no  chromatographic  isolation  procedures  being  required 
(Scheme 5.12).
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Scheme 5.12. Synthesis of Biginelli 3,4-dihydropyrimidines using TCCA as catalyst.
The solventless synthesis  of some Biginelli  bis-DHPM compounds using chlorotrimethylsilane (TMSCl) as 
catalyst was reported in 2010 by the research team of Miri.[82] Condensation between terephthalaldehyde, 1,3-
dicarbonyl compounds and urea, thiourea or guanidine was carried-out in a multi-mode microwave reactor at 
100 ºC for 4 to 6 minutes, the target 3,4-dihydropyrimidine derivatives being prepared with very high yields 
(Scheme 5.13). Mirza and associates have recently explored a rather similar strategy for the preparation of this  
type  of  heterocycles,  replacing  chlorotrimethylsilane  by  a  heterogeneous  nanosilica  catalyst  (50  nm  average  
particle size and 200 m2 g-1 specific surface area), fourteen bis-3,4-dihydropyrimidines being synthesised in 3 to 4 
minutes  with  isolated  yields  ranging  from  81  to  93%.[83]  Nonetheless,  no  data  regarding  the  commercial  
availability or synthetic process of the catalyst was provided, albeit the authors asserted that it was inexpensive 
and could be recycled several times.
Scheme 5.13. Solventless synthesis of Biginelli bis-3,4-dihydropyrimidines using TMSCl as catalyst.
A simple and effective methodology for the synthesis of heterobicyclic 3,4-dihydropyrimidine scaffolds using a  
dedicated  microwave  equipment was  presented  by  Rahman  and  colleagues  in  2010.[84]  The  one-pot 
condensation of aryl aldehydes, cyclopentanone and urea or thiourea in the presence of a previously prepared 
Brønsted  acidic  ionic  liquid,  namely  butane-1-sulfonic  acid-3-methylimidazolium  tosylate  ([bsmim]OTs), 
furnished sixteen DHPM compounds with moderately good to high yields (Scheme 5.14). The authors claimed that 
the ionic liquid could be reutilised six times without any noticeable decrease in its activity.
Scheme 5.14. Synthesis of Biginelli-type 3,4-dihydropyrimidines in ionic liquids.
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An efficient and eco-friendly method to generate 3,4-dihydropyrimidines via a microwave-activated Biginelli 
condensation was  described by  Pasunooti  and associates.[85] Utilising  a  single-mode microwave reactor  and 
catalytic quantities of copper(II) triflate in ethanol, thirty one DHPMs were synthesised under relatively mild 
conditions (Scheme 5.15). Although the reaction times were reduced comparing to classical heating procedures, 
the authors  needed to  heat  the  reaction mixtures  at  100 ºC for  one  hour,  which is  much longer  than other  
microwave-assisted Biginelli or Biginelli-like protocols that have been reported.
Scheme 5.15. Synthesis of Biginelli 3,4-dihydropyrimidines using Cu(OTf)2 as catalyst.
Montmorillonite  K-10-supported zirconium(IV) oxychloride octahydrate was  able  to  promote the  Biginelli 
reaction under microwave irradiation and in the absence of any organic solvent.[86] A microwave power setting of 
150 W, a reaction temperature of 80 ºC and a 40% molar equivalent of ZrOCl2.8H2O were found to be the best 
reaction conditions, some 3,4-dihydropyrimidines being prepared with low to good isolated yields after work-up 
(Scheme 5.16). It was claimed that the  montmorillonite K-10/ZrOCl2.8H2O system, which had to be prepared 
beforehand and properly activated, could be regenerated and reused without significant loss in its activity.
Scheme  5.16. Solid-supported  synthesis  of  Biginelli  3,4-dihydropyrimidines  using  montmorillonite  K-10/ 
ZrOCl2.8H2O.
A series of tricyclic 3,4-dihydropyrimidine derivatives was synthesised under microwave-activation by Gijsen 
and colleagues in 2012,[87] starting from various aryl aldehydes, thiourea and 1,3-indandione as reagents and  
using hydrochloric acid as catalyst. No information about the type of microwave apparatus employed or even the 
microwave power applied was given. All products were obtained with low isolated yields (Scheme 5.17).
Scheme 5.17. Synthesis of Biginelli-type 3,4-dihydropyrimidines using HCl as catalyst.
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Starting from suitable and previously synthesised chalcones and urea or thiourea as reagents and employing 
neutral  aluminium  oxide  as  solid  support,  the  Kidwai  research  group  prepared  four  Biginelli-type  3,4-
dihydropyrimidines with good reaction yields utilising a domestic microwave equipment (Scheme 5.18a).[88] The 
authors also tested a microwave-assisted procedure in ethanol, making use of sodium ethoxide as catalyst, the  
same compounds being  obtained with  similar  isolated  yields  under  6  minutes  (Scheme 5.18b).  However,  no 
information concerning the reaction temperature or even the microwave power applied was given.
Scheme 5.18. Solid-supported (a) and solvent-based (b) synthesis of Biginelli-type 3,4-dihydropyrimidines.
Lin and co-workers studied the microwave-assisted three-component reaction of aryl aldehydes, substituted 
acetophenones and urea in N,N-dimethylformamide, a few Biginelli-like 3,4-dihydropyrimidines being prepared 
with good to high yields, after only 3 minutes of irradiation using a domestic microwave oven, cooling to room  
temperature,  washing  with  distilled  water,  filtration  and  recrystallisation  in  ethanol  (Scheme  5.19a).[89] 
Furthermore, it was claimed that performing the same protocol in the presence of chlorotrimethylsilane afforded 
the corresponding dehydrogenated pyrimidinone derivatives with satisfactory isolated yields (Scheme 5.19b).
Scheme 5.19. Synthesis of Biginelli-type 3,4-dihydropyrimidines (a) and pyrimidinones (b).
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Liang  and  co-workers  described  the  three-component  and  one-pot  Biginelli-type  condensation  of  aryl 
aldehydes, acetophenone and urea, under solvent-free and microwave heating conditions, utilising zinc iodide as  
catalyst.[90] The corresponding Bigineli-like  3,4-dihydropyrimidines  were produced with good isolated yields 
after 8 minutes of irradiation in an unmodified household apparatus and an easy work-up protocol (Scheme 5.20).
Scheme 5.20. Solventless synthesis of Biginelli-type 3,4-dihydropyrimidines using ZnI2 as catalyst.
Fang and Lam developed a fast and convenient strategy for the preparation of a series of 5-unsubstituted  
Biginelli-type structures in 2011,[91] involving the one-pot reaction between selected aryl aldehydes, oxalacetic 
acid and urea or thiourea derivatives, under single-mode microwave heating and sealed-vessel conditions, the 
desired DHPM structures being obtained with good yields after a simple isolation procedure (Scheme 5.21).
Scheme 5.21. Synthesis of Biginelli-type 3,4-dihydropyrimidines using TFA as catalyst.
A  simple  and  cost-effective  methodology  for  the  dehydrogenation  of  Biginelli  DHPMs  under  microwave 
heating conditions was presented by Memarian and colleagues in 2009,[92] potassium peroxydisulphate being 
employed as oxidising agent and water as solvent (Scheme 5.22). Although high isolated yields were reported 
under 8 minutes of irradiation using an unmodified domestic equipment,  the reactions were carried-out in a  
rather  small  scale  (0.23  mmol  of  the  reactants)  and the  oxidation  process  of  the  thione  analogues  was  not 
investigated. It should also be stressed that the reaction mixtures were irradiated in 30-second time intervals in 
order to  avert uncontrollable super-heating  phenomena and, due to  evaporation upon microwave irradiation,  
water had to be constantly added in order to maintain an invariable concentration of the reaction mixtures.
Scheme 5.22. Oxidation of Biginelli 3,4-dihydropyrimidines in water using K2S2O8 as oxidant.
|105
N
H
N
R2OC
O
R1
H2O, K2S2O8
MW (900 W, 1-8 min)
22 examples
87-95% yield
N
H
NH
R2OC
O
R1
NHR2H2N
X
HO2C
O O
OH
N
NH
HO2C X
R1CHO
R1
THF, TFA
MW (95 ºC, 15 min)
23 examples
71-94% yield
R2
X=O (12), S (11)
NH2H2N
O
N
H
NH
Ph O
PhCOMe
R
ZnI2
MW (750 W, 8 min)
16 examples
71-96% yield
RCHO
5. Biginelli 3,4-Dihydropyrimidines                                                                                                                                               
B. Multicomponent Synthesis of Biginelli 3,4-Dihydropyrimidines
 Aiming to  prepare a  medium-sized  compound library  of  structurally-diverse  Biginelli  DHPMs through a 
simple, inexpensive and both environment- and user-friendly strategy under microwave activation, we decided to 
synthesise methyl 6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate 147 in order to optimise the 
reaction conditions and, particularly, select a suitable reaction medium (Scheme 5.23).  In our first studies,  a 
three-component mixture of benzaldehyde, a 1.5 molar equivalent of methyl acetoacetate and a two-fold molar 
excess of urea was microwave-heated at 120 ºC for 10 minutes, under sealed-vessel conditions, with an initial  
power setting of 100 W (Scheme 5.23a). After cooling to room temperature, a small amount of a yellowish solid  
precipitated out of the crude product mixture. This was filtered, washed with distilled water and recrystallised in  
aqueous ethanol, the desired 3,4-dihydropyrimidine being obtained as a pale-yellow solid with a slim 24% yield  
(Table 5.1, entry 1). Given that this solvent- and catalyst-free approach proved to be ineffective, a water-based 
protocol  was  tested  under  equal  reaction conditions;  however,  an even worse  result  was  achieved (entry  2).  
Furthermore, the addition of catalytic amounts of acids, namely concentrated sulphuric acid, p-toluenesulphonic 
acid (TSA) and trifluoroacetic acid (TFA), did not significantly alter the final outcome (entries 3-5).
Ethanol was then chosen as the reaction solvent, a 27% isolated yield being attained after similar work-up 
(entry 6). Unlike before, the acidification of the reaction medium demonstrated to be slenderly advantageous, 
yields between 50 and 53% being accomplished (entries 7-9). When glacial  acetic acid was employed as both  
solvent and acidic catalyst,  the yield after  isolation increased sharply to 83%, after 10 minutes of microwave  
heating at 120 ºC (entry 10). Nevertheless, changing the reaction time to 20 minutes was not beneficial to the  
synthetic process (entry 11). In terms of the reaction yield, this result is very similar to the one found by Yu and co-
workers,[93]  which  described  the  preparation  of  the  related  ethyl  6-methyl-4-phenyl-3,4-dihydropyrimidin-
2(1H)-one-5-carboxylate derivative with an 80% isolated yield, after carrying-out the reaction under conventional 
heating conditions for 3 hours at 90 ºC using a 10% molar equivalent of acetic acid as catalyst.
Table  5.1.  Multicomponent  synthesis  of  methyl  6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one-5-
carboxylate 147 under microwave irradiation.
Entry Reaction Medium Time (min) Yielda (%)
1 Solventless 10 24
2 H2Ob 10 20
3 H2O/H2SO4b 10 25
4 H2O/TSAb 10 22
5 H2O/TFAb 10 25
6 EtOHb 10 27
7 EtOH/H2SO4b 10 53
8 EtOH/TSAb 10 50
9 EtOH/TFAb 10 53
10 AcOHb 10 83
11 AcOHb 20 80
12 SiO2 60 (35-70 μm)c 10 20
13 SiO2 60/H2SO4 (35-70 μm)c 10 75
14 Montmorillonite K-10c 10 57
All  reactions  were  carried-out  using benzaldehyde (10  mmol),  methyl  acetoacetate  (15  mmol)  and  urea 
(20 mmol) at 120 ºC. aYields refer to the isolated reaction products. bThe selected solvent (2.5 ml) was used as 
reaction medium in closed-vessel conditions, an initial microwave power of 100 W being applied. cThe selected 
solid support (10 g) was used as reaction medium in open-vessel conditions,  an initial  microwave power of 
200 W being applied.
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Scheme  5.23. Multicomponent  synthesis  of  methyl  6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one-5-
carboxylate 147 under microwave irradiation.
Apart from the solvent-based methodologies (Scheme 5.23b), a few inorganic solid supports were also tested  
as reaction medium (Table 5.1, entries 12-14; Scheme 5.23c), sulphuric acid-doped silica gel being the one that  
produced better results, since methyl 6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate 147 was 
obtained with a 75% isolated yield, after heating at 120 ºC for 10 minutes under open-vessel conditions and using  
an initial microwave power setting of 200 W. The isolation protocol was facile and consisted in washing the crude  
product mixture with ethyl acetate, followed by removal of the solid support through filtration, evaporation of the 
solvent  under  reduced pressure and recrystallisation of  the resulting  yellow residue in  aqueous ethanol.  The 
application of  unmodified silicon dioxide (entry  12)  or  montmorillonite  K-10 (entry  14)  as  the solid  support 
rendered much lower isolated yields of the target Biginelli product, 20 and 57%, respectively.
We  then  turned  our  attention  to  the  preparation  of  the  thione  analogue,  methyl  6-methyl-4-phenyl-3,4-
dihydropyrimidine-2(1H)-thione-5-carboxylate  175,  by replacing urea for thiourea and making use of the best 
reaction conditions found in our previous studies: microwave heating at 120 ºC for 10 minutes in an appropriate 
sealed vessel utilising 2.5 ml of glacial  acetic acid as both solvent and acid catalyst; withal, the yield dropped  
drastically to 29%. Increasing the reaction time to 20 minutes doubled the amount of DHPM 175, a 57% isolated 
yield being attained. Sadly, irradiation for longer periods of time (up to 30 minutes) did not further improve the 
reaction yield. The application of the second best set of reaction parameters, i.e. heating for 10 minutes at 120 ºC  
under microwave-assisted and open-vessel conditions using 10 g of SiO2 60/H2SO4 as solid support, was entirely 
impossible, given that the synthetic process had to be aborted due to fast and severe decomposition of thiourea 
upon microwave irradiation.
It should be noted that significant formation of by-products occurred when performing the synthesis of both 
compounds  147 and  175 at  higher  reaction  temperatures,  as  shown  by  TLC  analysis  of  the  crude  product  
mixtures, owing to decomposition phenomena of urea and thiourea. This has also been reported by various other 
research groups. Moreover, it became evident that our AcOH-based Biginelli reaction was slower and furnished a 
lower yield when utilising thiourea. This might be explained by the possible delocalisation of the lone electron  
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pairs of the nitrogen atoms in the thiourea molecule to the sulphur atom d-orbitals, which can cause a decrease of 
the  nucleophilic  character  of  the  nitrogen  atoms  towards  the  aldehyde  carbonyl  group.  Several  other  aryl  
aldehydes,  bearing  both  electron-withdrawing  and  electron-donating  substituents,  as  well  as  some polycyclic 
aromatic moieties, were later employed as reactants, fifty five Biginelli DHPMs being prepared in short reaction 
times,  using  a  small  amount  of  glacial  acetic  acid  as  solvent  and  acid  catalyst  under  microwave  activation 
(Scheme 5.24). The isolated yields were generally very good, ranging from 35 to 90% for 3,4-dihydropyrimidin-
2(1H)-ones  147-174 (Figure 5.4) and between 28 and 78% in the case of 3,4-dihydropyrimidine-2(1H)-thiones 
175-201 (Figure 5.5). The single-crystal X-ray diffraction structure obtained for  methyl  6-methyl-4-phenyl-3,4-
dihydropyrimidine-2(1H)-thione-5-carboxylate 175 is presented in Figure 5.6.
Scheme  5.24. Multicomponent  synthesis  of  Biginelli  3,4-dihydropyrimidines  147-201 under  microwave 
irradiation.
In general, 3,4-dihydropyrimidin-2(1H)-ones were obtained with better yields comparing to the related 3,4-
dihydropyrimidine-2(1H)-thiones.  Nevertheless,  the  use  of  3,4-  or  3,5-dimethoxybenzaldehyde  and  3,4,5-
trimethoxybenzaldehyde as the starting aryl aldehyde provided good and similar isolated yields for both types of 
Biginelli DHPMs; apparently, in these cases and under the reaction conditions tested, the lower reactivity of the  
thiourea reagent did not affect the final outcome of the procedure. Also, the worse results found when utilising  
bulky aryl aldehydes as reagents, such as 9-anthracenaldehyde, 2,6-dichlorobenzaldehyde or mesitylaldehyde, can 
easily be explained by steric impediment factors. Lastly, it must be mentioned that when 4-nitrobenzaldehyde and 
thiourea  were  employed,  only  trace  amounts  of  the  corresponding  3,4-dihydropyrimidine-2(1H)-thione  were 
noticed by TLC analysis of the crude product mixture, along with some other reaction by-products. It is known 
that  4-nitrobenzaldehyde,  as  well  as  other  nitrobenzene  derivatives,  possesses  a  relatively  high  oxidation  
potential. Therefore, it seems possible that competition between the multicomponent Biginelli condensation and  
some-sort of oxidative process, most likely involving the thiourea component, is responsible for the failure of our  
microwave-assisted approach in this particular instance.
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Figure 5.4. Structures and isolated yields of Biginelli 3,4-dihydropyrimidin-2(1H)-ones 147-174 synthesised via 
a solvent-based, multicomponent, microwave-assisted method.
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Figure 5.5. Structures and isolated yields of Biginelli 3,4-dihydropyrimidine-2(1H)-thiones 175-201 synthesised 
via a solvent-based, multicomponent, microwave-assisted method.
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Figure  5.6. Single-crystal  X-ray  diffraction  structure  of  methyl  6-methyl-4-phenyl-3,4-dihydropyrimidine-
2(1H)-thione-5-carboxylate 175.
C. Multicomponent Synthesis of Biginelli Bis-3,4-Dihydropyrimidines
The synthesis of a small series of Biginelli bis-3,4-dihydropyrimidines was later achieved by application of the 
microwave-promoted  methodology  discussed  in  the  preceding  section.  Briefly,  a  mixture  comprised  of  
terephthalaldehyde (5 mmol), the selected 1,3-dicarbonyl compound (15 mmol) and urea or thiourea (20 mmol) in  
2.5 ml of glacial acetic acid was heated at 120 ºC for 10 or 20 minutes, with an initial microwave power setting of  
100 W (Scheme 5.25). After cooling to room temperature a yellow solid precipitated from the crude product 
mixture. This was filtered, washed with distilled water and recrystallised in aqueous ethanol, rendering the target 
DHPM  derivatives  202-209 with  low  to  good  isolated  yields  (Figure  5.7).  As  somewhat  expected,  bis-3,4-
dihydropyrimidin-2(1H)-ones  202-205 were prepared with higher yields comparing to the equivalent bis-3,4-
dihydropyrimidine-2(1H)-thiones  206-209, except in the case of structures  205 and 209, when acetylacetone 
was utilised as starting material, quite resembling and good reaction yields being obtained. On the other hand, the  
worse results were found when benzyl acetoacetate was used as reactant, which clearly demonstrates that this  
β-ketoester is far less reactive when compared to methyl or ethyl acetoacetate in the reaction conditions tested. 
As referenced in section 5.III.A, some of these interesting and less studied Biginelli structures have recently and  
efficiently been prepared under solvent-free and microwave heating conditions, although in a smaller 1 mmol 
scale.[82, 83] Cytotoxicity evaluations on a few human cancer cell lines revealed that these bis-DHPM derivatives,  
specially compound 209, may be viewed as helpful candidates for future design and drug discovery.[82]
Scheme 5.25. Multicomponent synthesis of  Biginelli  bis-3,4-dihydropyrimidines  202-209 under microwave 
irradiation.
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Figure 5.7. Structures and isolated yields of Biginelli  bis-3,4-dihydropyrimidines  202-209 synthesised via a 
solvent-based, multicomponent, microwave-assisted method.
D. Synthesis of Biginelli-Type 3,4-Dihydropyrimidine-2(1H)-Thiones
Although an extensive work on the synthesis of Biginelli-like 3,4-dihydropyrimidin-2(1H)-ones can be found 
in the scientific literature, particularly dealing with Lewis acid-catalysed condensation reactions,[90, 94-99] the  
number of reports on the development of a Biginelli-type process under basic conditions is quite small and studies 
focusing on the thione analogues are even scarcer.[100-102] Hence, our recent efforts regarding the preparation 
of some novel Biginelli-type 3,4-dihydropyrimidine-2(1H)-thiones are presented and discussed in the following 
pages. The first approach for the synthesis of these DHPM derivatives was based on the application of common  
Lewis acids, such as zinc iodide and iron(III) chloride hexahydrate, which were previously described as successful 
catalysts  for  the  preparation  of  4,6-diaryl-3,4-dihydropyrimidin-2(1H)-ones,[90,  94]  and  a  one-pot,  three-
component, microwave-assisted strategy, starting from equimolar amounts of benzaldehyde and acetophenone 
and a 1.5 molar equivalent of thiourea (Table 5.2, entries 1-6; Schemes 5.26a and 5.26b). However, none of these 
endeavours led to the formation of the desired 4,6-diphenyl-3,4-dihydropyrimidine-2(1H)-thione 210. Pursuing 
the studies of Shen and colleagues,[101] which synthesised various 4,5,6-triaryl-3,4-dihydropyrimidin-2(1H)-ones 
and their corresponding thiones under alkaline and classical heating conditions, we decided to utilise a small  
amount  of  ethanol  as  solvent  and  an  equimolar  quantity  of  sodium  hydroxide  as  reaction  promoter 
(Scheme  5.26c).  Heating  the  multicomponent  reaction  mixture  at  70  ºC  for  20  minutes  under  microwave 
irradiation,  followed  by  cooling  to  room  temperature,  pouring  the  crude  product  mixture  over  crushed-ice, 
filtration of the yellow solid that precipitated and recrystallisation in aqueous ethanol,  provided compound 210 
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with a 45% isolated yield (entry 7). Interestingly, increasing the reaction temperature to 100 ºC did not alter the 
final outcome of the synthetic process (entry 8), while a longer reaction time negatively affected the yield obtained 
(entry 9). Also, it must be stressed that performing the reaction at 70 ºC for 18 hours, under conventional heating  
conditions,  using a 1:1:2:1 stoichiometric ratio of benzaldehyde, acetophenone, urea and sodium hydroxide in 
25 ml of ethanol, furnished the target DHPM with a lower isolated yield of 38% after similar work-up. Moreover, 
replacing the starting aryl aldehyde by 4-bromobenzaldehyde, 4-chlorobenzaldehyde or 4-methoxybenzaldehyde 
and carrying-out the reaction using the parameters of entry 8 in Table 5.2, proved that the electron-donating or  
electron-withdrawing nature of the substituents present at the para position of the phenyl ring in the aldehyde 
reagent did not change the overall  yield of the respective 4-aryl-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione 
(32-33%).
Table  5.2.  Multicomponent  synthesis  of  4,6-diphenyl-3,4-dihydropyrimidine-2(1H)-thione  210 under 
microwave irradiation.
Entry Reaction Medium Catalyst Time (min) Yielda (%)
1 Solventless ZnI2c 10 -f, h
2 Solventless ZnI2c 20 -f, h
3 Solventless ZnI2c 30 -f, h
4 CH3CNb FeCl3.6H2Od 10 -f, h
5 CH3CNb FeCl3.6H2Od 20 -f, h
6 CH3CNb FeCl3.6H2Od 30 -f, h
7 EtOHb NaOHe 20 45g
8 EtOHb NaOHe 20 45f
9 EtOHb NaOHe 30 36f
All reactions were carried-out using benzaldehyde (5 mmol), acetophenone (5 mmol) and thiourea (7.5 mmol) in 
a closed vessel. aYields refer to the isolated reaction products. bThe selected solvent (3 ml) was used as reaction 
medium, an initial microwave power of 100 W being applied. cZnI2 (1 mmol), dFeCl3.6H2O (1 mmol) and eNaOH 
(5 mmol) were used as catalysts. fConstant temperature of 100 ºC. gConstant temperature of 70 ºC. hOnly trace 
amounts of  DHPM 210 were detected by TLC analysis  of the crude product mixture,  along with the initial 
reagents. 
Scheme  5.26. Multicomponent  synthesis  of  4,6-diphenyl-3,4-dihydropyrimidine-2(1H)-thione  210 under 
microwave irradiation.
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In the already cited work authored by Shen and associates concerning the base-catalysed three-component  
synthesis of 4,5,6-triaryl-3,4-dihydropyrimidine-2(1H)-thiones,[101] the formation of a 1,2,3-triarylprop-2-en-1-
one reaction intermediate was suggested. In addition, we have found a few reports dealing with the base-mediated 
preparation of 4,6-diaryl-3,4-dihydropyrimidine-2(1H)-thiones, starting from the corresponding 1,3-diarylprop-
2-en-1-ones, ordinarily known as chalcones, and thiourea. In 1999, Kidway and Misra synthesised two 4,6-diaryl-
3,4-dihydropyrimidine-2(1H)-thiones, using a domestic microwave equipment and either neutral alumina or an 
ethanolic  solution of  sodium ethoxide as reaction medium, with yields of  up to  85%.[88] Mahmoud and El-
Shahawi  prepared  6-p-tolyl-4-(3,4,5-trimethoxyphenyl)-3,4-dihydropyrimidine-2(1H)-thione  with  a  quite 
moderate  isolated  yield  of  44%  by  heating  a  mixture  of  the  corresponding  chalcone,  thiourea  and  sodium 
hydroxide  in  ethanol  under  classic  heating  conditions,[100]  mentioning  an  experimental  protocol  published 
earlier by the same research team. Al-Abdullah described the related preparation of two 4,6-diarylpyrimidine-
2(1H)-thiones in 2011, refluxing the chalcone and thiourea reagents in an aqueous ethanol solution of potassium 
hydroxide for 24 hours, both compounds being obtained with yields that did not exceed 28%.[102]
In order to examine the low efficiency of our multicomponent approach, we attempted the synthesis of  4,6-
diphenyl-3,4-dihydropyrimidine-2(1H)-thione 210 via  a  two-step  one-pot  method  (Scheme  5.27).  Thus, 
equimolar amounts of benzaldehyde, acetophenone and sodium hydroxide in ethanol were microwave-heated in a 
sealed  vessel  at  100  ºC for  20 minutes,  followed by  the  addition  of  a  1.5  molar  equivalent  of  thiourea  and  
microwave irradiation for another 20 minutes at the same temperature, the desired product being prepared with a  
15%  isolated  yield.  It  should  be  highlighted  that  diminishing  the  temperature  to  70  ºC in  both  microwave-
activated steps provided only trace quantities of the Biginelli-type DHPM and that GC-MS analysis of the crude  
product mixtures prior to the addition of thiourea demonstrated that less than 40% of the expected chalcone was 
present,  the  remaining  unidentified  components  exhibiting  higher  molecular  weights.  Furthermore,  neither 
modifying the reaction time nor the reactants concentration afforded larger amounts of the chalcone intermediate. 
Interestingly,  subtracting  the  thiourea  starting  material  from the  process,  i.e.  microwave  heating  an  alkaline 
ethanolic solution of previously prepared (E)-1,3-diphenylprop-2-en-1-one  38 at 70 or 100 ºC for 20 minutes, 
supplied a closely resembling result. Hence, our overall low reaction yields, attained either via a three-component 
strategy or following a two-step methodology, are apparently related to the ineffective  in situ generation of the 
chalcone intermediate  and also to  some-sort of degradation mechanism that occurs with it  under microwave 
irradiation.
Scheme  5.27. One-pot  two-step synthesis  of  4,6-diphenyl-3,4-dihydropyrimidine-2(1H)-thione  210 under 
microwave irradiation.
Since both our multicomponent (Scheme 5.26) and one-pot two-step (Scheme 5.27) methods either failed or 
furnished only moderate results, a two-pot two-step formulation was employed in order to improve the reaction  
yield of 4,6-diphenyl-3,4-dihydropyrimidine-2(1H)-thione  210 (Scheme 5.28). (E)-1,3-diphenylprop-2-en-1-one 
38, which was synthesised with an 85% isolated yield through a base-promoted Claisen-Schmidt procedure,[103] 
served as starting material, along with a slight molar excess of thiourea, in a microwave-activated second step. The  
reaction conditions tested in this final synthetic stage are summarised in Table 5.3. Contrary to what Kidwai and 
Misra described,[88] microwave heating using alumina as solid support yielded only residual amounts of the  
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target Biginelli-type DHPM (entries 1 and 2). Replacing aluminium oxide by silica gel provided very low yields 
that did not surpass 11% (entries 3 and 4). Delightfully, compound 210 was prepared with an 86% isolated yield 
by performing the reaction at 100 ºC for 20 minutes in a small volume of ethanol and making use of sodium 
hydroxide as base (entry 5).  Work-up was  very  straightforward and involved forcing the precipitation of  the  
product  in  crushed-ice,  followed  by  filtration,  washing  with  distilled  water  and  recrystallisation  in  aqueous  
ethanol. TLC analysis of the crude product mixture resulting of shorter time periods under microwave irradiation  
revealed that the reaction was far from completion, while longer reaction times did not further improve the final  
outcome of the synthetic process (entry 6).
Table  5.3. Two-pot  two-step  synthesis  of  4,6-diphenyl-3,4-dihydropyrimidine-2(1H)-thione  210 under 
microwave irradiation.
Entry Reaction Medium Catalyst Time (min) Yielda (%)
1 Al2O3 (50-150 μm)b - 10 -e
2 Al2O3 (50-150 μm)b - 20 -e
3 SiO2 60 (35-70 μm)b - 10 5
4 SiO2 60 (35-70 μm)b - 20 11
5 EtOHc NaOHd 20 86
6 EtOHc NaOHd 30 83
All reactions were carried-out using chalcone 38 (5 mmol) and thiourea (7.5 mmol) at 100 ºC. aYields refer to the 
isolated  reaction  products.  bThe  selected  solid  support  (5  g)  was  used  as  reaction  medium  in  open-vessel  
conditions, an initial microwave power of 200 W being applied. cEtOH (3 ml) was used as reaction medium in 
closed-vessel conditions, an initial  microwave power of 100 W being applied.  dNaOH (5 mmol) was used as 
reaction catalyst.  eOnly  trace  amounts  of  DHPM 210 were  detected  by  TLC  analysis  of  the  crude  product 
mixture, along with the initial reagents.
Scheme  5.28. Two-pot  two-step synthesis  of  4,6-diphenyl-3,4-dihydropyrimidine-2(1H)-thione  210 under 
microwave irradiation.
Several  other  previously  prepared  chalcones  were  later  employed  as  reagents  (see  Chapter  2  for  details 
concerning  their  syntheses  and  structures), some  of  the  corresponding  and  novel  4,6-diaryl-3,4-
dihydropyrimidine-2(1H)-thiones  210-220 being  synthesised  with  high  reaction  yields  and  great  purity 
(Scheme 5.29; Figure 5.8).[104] As an example, the X-ray diffraction structure of  4-(naphthalen-1-yl)-6-phenyl-
3,4-dihydropyrimidine-2(1H)-thione  211, obtained from a single crystal, is depicted in Figure 5.9. It should be 
referenced that  no  reaction occurred  when  (E)-3-(4-nitrophenyl)-1-phenylprop-2-en-1-one  46 was  utilised  as 
starting material, this being recovered unchanged after work-up. Also, when pyrrolyl-chalcones 49 and 53 were 
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used, solely trace quantities of the respective Biginelli-like DHPMs were detected in the crude product mixtures, 
which  consisted  of  several  unknown  side-products.  Lastly,  carrying-out  the  reaction  with  the  fluorinated 
chalcones  45 and  52 provided the expected 3,4-dihydropyrimidine-2(1H)-thione compounds,  although heavily 
contaminated with what seems to be their isomeric adducts, a similar phenomenon being already reported by 
Wang and colleagues.[94] All the same, further work is required to undoubtedly identify these by-products.
Scheme  5.29. Two-pot  two-step synthesis  of  Biginelli-type 3,4-dihydropyrimidine-2(1H)-thiones  210-220 
under microwave irradiation.
Figure  5.8. Structures  and  isolated  yields  of  Biginelli-type  3,4-dihydropyrimidine-2(1H)-thiones  210-220 
synthesised via a solvent-based microwave-assisted method.
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Figure 5.9. Single-crystal  X-ray diffraction structure  of  4-(naphthalen-1-yl)-6-phenyl-3,4-dihydropyrimidine-
2(1H)-thione 211.
A possible reaction pathway for the two-pot two-step preparation of the Biginelli-like structures portrayed in 
Figure 5.8 is presented in Scheme 5.30 and supported by the one suggested by Shen and co-workers.[101] A base-
mediated  aldol  condensation between  an  aryl  aldehyde  and  a  suitable  acetophenone  renders  chalcone  XIV. 
Subsequent aza-Michael addition of thiourea to the latter in alkaline conditions leads to the open-chain ureide  
XV,  which  undergoes  a  1,2  addition  of  the  amino  functionality  to  the  carbonyl  group,  followed  by  water  
elimination, the target 4,6-diaryl-3,4-dihydropyrimidine-2(1H)-thione being obtained.
Scheme 5.30. Mechanistic proposal for the two-pot two-step synthesis of Biginelli-type 3,4-dihydropyrimidine-
2(1H)-thiones 210-220.
The cytotoxicity of 4,6-diaryl-3,4-dihydroprimidine-2(1H)-thiones 215-220 was assessed in vitro against four 
cancer cell lines, A375 human malignant melanoma, WiDr human colon adenocarcinoma, HCC1806 and MCF7 
human breast carcinomas, through a collaboration with the Centre of Investigation in Environment, Genetics and 
Oncobiology (CIMAGO) and the Institute for Biomedical Imaging and Life Sciences (IBILI) of the University of 
Coimbra.[104] It was found that the selected compounds exhibited a concentration-dependent inhibition of cell 
proliferation and, considering the  half maximal inhibitory concentration (IC50) values presented in Table 5.4, it 
can be inferred that they were generally more active against MCF7 human breast cancer cells; the brominated  
Biginelli-type DHPMs  215 and  219 were the most active compounds, IC50 values of 24.2 and 22.2 μM being 
determined,  respectively.  The related Biginelli  compound monastrol  is known for suppressing human mitotic 
kinesin  Eg5.[15]  Compared  with  the  traditional  chemotherapeutic  agents,  kinesin  inhibitors  do  not  lead  to 
neuropathic  side  effects  and,  thus,  kinesin  spindle  protein  has  become  an  attractive  anticancer  target.[105] 
Inhibition of human mitotic kinesin Eg5 using monastrol has prevented the growth of oestrogen-treated MCF7 
cells, an IC50 value of 29.7 μM being reported, while simultaneous suppression of the oestrogen receptor function 
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with the selective down-regulator fulvestrant increased the IC50 value to 112.7 μM.[106] Biginelli-type structures 
215 and 219 were found to be effective against MCF7 cell lines, without the addition of any oestrogen receptor 
inhibitor. Also, these compounds were 3.7 and 3.2 times more active against MCF7 human breast carcinoma cells  
than against HCC1806 triple-negative human breast cancer cells, respectively. 
Table 5.4. IC50 and CI95 values for  Biginelli-type 3,4-dihydropyrimidine-2(1H)-thiones 215-220 against MCF7, 
HCC1806, WiDr and A375 human cancer cell lines.
Entry Compound
Human Cancer Cell Line
MCF7 HCC1806 WiDr A375
IC50 (μM) CI95 (μM) IC50 (μM) CI95 (μM) IC50 (μM) CI95 (μM) IC50 (μM) CI95 (μM)
1 215 24.2 21.9; 26.7 89.2 73.1; 108.8 45.7 42.9; 48.6 42.8 40.4; 45.2
2 216 67.4 62.2; 73.1 72.6 68.7; 76.8 68.2 62.8; 74 >100 -
3 217 60.2 57.6; 62.9 >100 - 85.2 83.4; 87.1 >100 -
4 218 78.4 75.2; 81.7 64.4 59.1; 70.2 >100 - >100 -
5 219 22.2 19.5; 25.3 70.8 63; 79.6 69.9 67.6; 71.6 56.3 53.1; 59.6
6 220 63.2 59.7; 66.9 75.4 64.7; 87.8 >100 - 73.6 69.7; 77.6
It must be mentioned that, apart from the cytotoxicity results shown in Table 5.4, flow cytometry, cell viability, 
cell cycle and Bax/Bcl-2 ratio analyses were also performed using some of these compounds.[104] Furthermore,  
the  employment  of  selected  Biginelli-type  4,6-diaryl-3,4-dihydropyrimidine-2(1H)-thiones  to  the  synthesis  of 
some of their corresponding transition metal complexes is presently being addressed through a collaboration with 
the  Inorganic  Chemistry  Department  of  the  University  of  Vigo.  Their  full  structural  characterisation  and 
evaluation of anticancer properties is currently being tackled and will be reported elsewhere in a near future.
E. Oxidation of Biginelli 3,4-Dihydropyrimidines
It is broadly recognised that  Biginelli 3,4-dihydropyrimidines, particularly the thione-containing structures, 
are not easily dehydrogenated. In fact, after carefully reviewing the available scientific literature, we can confirm  
that no general and efficient method for the oxidation of 3,4-dihydropyrimidine-2(1H)-thiones has been reported 
so  far.  Hence,  we  decided  to  employ  some  common,  inexpensive  and  widely  utilised  oxidising  agents  and  
microwave irradiation in order to establish weather or not a synergistic effect could be achieved in this oxidative  
process.  The  previously  synthesised  methyl  6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate 
147 was selected as the model DHPM compound for the oxidation studies, both under solvent-based and solid-
supported  reaction conditions.  Activated  manganese  dioxide,  potassium permanganate,  a  mixture  of  the  two 
prepared  beforehand  following  the  available  literature[107]  and  potassium  peroxydisulphate  were  used  as 
oxidants, the results being summarised in Table 5.5 and Scheme 5.31. Remarkably, apart from entries 5 and 6, i.e. 
application of 10 molar equivalents of MnO2 in sulphuric acid-doped dichloromethane, which furnished methyl 6-
methyl-4-phenylpyrimidin-2(1H)-one-5-carboxylate 221 with only 6 and 15% conversion, after heating at 100 ºC 
in an appropriate sealed vessel for 10 and 20 minutes, respectively, all attempts to dehydrogenate the starting 
DHPM using heterogeneous oxidising agents failed completely. However, full conversion to the expected partially 
oxidised  derivative  221 was  accomplished  using  a  slight  molar  excess  of  potassium  peroxydisulphate  in  an 
acetonitrile/distilled  water  mixture  at  100  ºC  for  10  minutes  (entry  13),  shorter  reaction  times  providing  
incomplete outcomes. Work-up was quite simple and involved washing the crude product mixture with brine,  
followed by liquid/liquid extraction with ethyl acetate, collection of the organic layer and drying with anhydrous 
sodium sulphate, filtration, evaporation under reduced pressure and, lastly, recrystallisation in diethyl ether or 
ethyl acetate/n-hexane.
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Table  5.5. Synthesis  of methyl  6-methyl-4-phenylpyrimidin-2(1H)-one-5-carboxylate 221 under  microwave 
irradiation.
Entry Reaction Medium Oxidant Time (min) Conversiona (%)
1 CH2Cl2b MnO2e 5 0i
2 CH2Cl2b MnO2e 10 0i
3 CH2Cl2b MnO2e 20 0i
4 CH2Cl2/H2SO4b MnO2e 5 0i
5 CH2Cl2/H2SO4b MnO2e 10 6
6 CH2Cl2/H2SO4b MnO2e 20 15
7 CO(CH3)2b KMnO4f 10 0i
8 CO(CH3)2b KMnO4f 20 0i
9 CH2Cl2b KMnO4/MnO2g 10 0i
10 CH2Cl2b KMnO4/MnO2g 20 0i
11 CH2Cl2/H2SO4b KMnO4/MnO2g 10 0i
12 CH2Cl2/H2SO4b KMnO4/MnO2g 20 0i
13 CH3CN/H2Oc K2S2O8h 10 100j
14 SiO2 60 (35-70 μm)d MnO2e 10 0i
15 SiO2 60 (35-70 μm)d MnO2e 20 0i
16 SiO2 60/H2SO4 (35-70 μm)d MnO2e 10 0i
17 SiO2 60/H2SO4 (35-70 μm)d MnO2e 20 0i
18 Montmorillonite K-10d MnO2e 10 0i
19 Montmorillonite K-10d MnO2e 20 0i
20 Montmorillonite K-10d KMnO4f 10 0i
21 Montmorillonite K-10d KMnO4f 20 0i
All reactions were carried-out using DHPM 147 (1 mmol) and the selected oxidant at 100 ºC. aConversion was 
assessed by GC-MS analysis of the isolated reaction products. bThe selected solvent (3 ml) was used as reaction 
medium in closed-vessel conditions, an initial microwave power of 100 W being applied. cCH3CN/H2O (3:2 v/v, 
5 ml) was  used as reaction medium in closed-vessel conditions,  an initial  microwave power of  80 W being 
applied.  dThe selected solid support (5 g) was used as reaction medium in open-vessel conditions, an initial 
microwave power of 200 W being applied.  eMnO2 (10 mmol),  fKMnO4 (2.5 mmol),  gKMnO4/MnO2 (2 g) and 
hK2S2O8 (1.2 mmol) were used as oxidants. iNo reaction occurred, the starting DHPM 147 being recovered upon 
work-up. jAn 85% isolated yield was obtained.
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Scheme 5.31. Synthesis of methyl 6-methyl-4-phenylpyrimidin-2(1H)-one-5-carboxylate 221 under microwave 
irradiation.
Various  other  3,4-dihydropyrimidin-2(1H)-ones  were  later  employed  as  the  initial  reactant  under  equal 
microwave-assisted, closed-vessel and oxidative reaction conditions (Scheme 5.32), the corresponding pyrimidin-
2(1H)-ones  221-238 being  isolated  with  very  good  yields  (Figure  5.10).  Nevertheless,  the  oxidations  of 
anthracenyl-DHPM  150 and hydroxylated 3,4-dihydropyrimidines  157 and  165 were totally unsuccessful,  the 
starting  heterocyclic  scaffolds  being  recovered  unchanged  upon  work-up,  even  after  prolonged  microwave 
irradiation at 100 ºC for 20 and 30 minutes. Moreover, when DHPMs 169 and 173 were employed as reagents, 
several  unidentified  by-products  were  detected,  along with the  unreacted  methyl  4-(3,4-dimethoxyphenyl)-6-
methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate  and  methyl  6-methyl-4-(3,4,5-trimethoxyphenyl)-3,4-
dihydropyrimidin-2(1H)-one-5-carboxylate, respectively. This data was assessed via NMR and GC-MS studies of 
the reaction products after isolation. Contrary to the work published by Memarian and co-workers,[92] in which  
related  3,4-dihydropyrimidin-2(1H)-ones  were  successfully  oxidised  utilising  a  similar  microwave-activated 
procedure, albeit with a 4-times smaller stoichiometry, we could not use simply water as solvent, given that our  
DHPMs were completely insoluble in this medium, even after microwave heating. Moreover, since the authors  
employed an open-vessel strategy using an unmodified domestic oven, the reaction temperature could not be  
monitored or controlled and, consequently, water had to be constantly added to the reaction mixtures in order to 
compensate the one that evaporated upon microwave irradiation. This was avoided in our methodology due to the 
use of focused microwave irradiation, built-in IR temperature monitoring and sealed-vessel reaction conditions.
Scheme 5.32. Synthesis of Biginelli pyrimidin-2(1H)-ones 221-238 under microwave irradiation.
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Figure 5.10. Structures and isolated yields of Biginelli pyrimidin-2(1H)-ones 221-238 synthesised via a solvent-
based microwave-assisted method.
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In  recent  years,  the  Memarian  research  group  has  thoroughly  investigated  this  oxidative  process  under  
thermal,[57]  sonochemical,[108,  109]  photochemical[58]  and voltammetric[110]  conditions,  analogous  results 
regarding product selectivity and isolated yields being found comparing to the ones obtained under microwave 
heating. Therefore, it is our opinion that the observed rate enhancements in this oxidation reaction, including the 
ones verified in our own work,  are not due to any specific  microwave effect,  as postulated by Memarian and 
colleagues,[92]  but are  instead  the  consequence  of  the  reaction  temperature  being  quickly  reached  under 
microwave  irradiation,  i.e.  a  strictly  thermal/kinetic  phenomenon.  The  reaction mechanism is  thought  to  be 
closely related to the K2S2O8-promoted dehydrogenation of Hantzsch 1,4-dihydropyridines described before (see 
Chapter 4) and is depicted below in Scheme 5.33. Thermal decomposition of the weakest O-O bond in potassium 
peroxydisulphate renders a sulphate radical anion (a), which in turn abstracts a hydrogen atom from the water  
present  in  the  reaction  medium affording  a  hydroxyl  radical  (b).  Hydrogen  abstraction  at  position  4  of  the  
heterocyclic  moiety  by  the  previously  generated  hydroxyl  species  furnishes  a  hydropyrimidinoyl  radical 
intermediate XVI and water. Finally, abstraction of the neighbouring hydrogen atom by another sulphate radical 
anion yields the desired Biginelli pyrimidin-2(1H)-one, along with potassium bisulphate as by-product (c).
It must be mentioned that the removal of the CH-4 hydrogen atom and subsequent generation of intermediate 
XVI is believed to be the rate-determining step, since this is a quite stable radical species with both allylic and  
benzylic characteristics which, accordingly, should lower the activation energy of its formation. However, the fact 
that the oxidation of DHPMs 157, 165, 169 and 173 either totally failed or afforded poor results may be justified 
by the possible destabilisation of the corresponding hydropyrimidinoyl structures, which can be reasoned by the 
balance of electronic effects (resonance and induction) caused by the hydroxyl or methoxyl substituents present at 
the phenyl ring in those cases, a similar phenomenon being already observed in the K2S2O8-mediated oxidative 
aromatisation of some closely related Hantzsch DHPs (see Chapter 4). In the case of 3,4-dihydropyrimidin-2(1H)-
one  150,  the  large  anthracene  moiety  should  be  nearly  perpendicular  to  the  radical  centre  at  C-4  and,  
consequently, a strong stabilisation phenomenon through conjugation with the polycyclic aromatic ring would be 
expected,  thus facilitating  the  dehydrogenation process.   However,  it  was  noted during  our studies  that  this  
particular DHPM was poorly soluble in the acetonitrile/distilled water mixture used as solvent, which can explain 
why the oxidation reaction was unsuccessful.
Scheme  5.33. Mechanistic  proposal  for  the  synthesis  of Biginelli  pyrimidin-2(1H)-ones  221-238 using 
potassium peroxydisulphate as the oxidising agent.
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Regarding  the  structural  identification of  the  dehydrogenation products,  it  should be  noticed  that  due  to 
tautomerisation phenomena in solution, specifically of NH-1 to N-3 and NH-1 or NH-3 to the carbonyl group at 
position  2  of  the  heterocyclic  skeleton,  three  different  arrangements  are  possible  and  must  be  reasoned 
(Scheme 5.5,  XIIIa-c).  Although X-ray diffraction studies have undoubtedly  confirmed that  the oxidation of  
Biginelli 3,4-dihydropyrimidin-2(1H)-ones renders products of type XIIIa in the solid state, i.e. with a CONH-1 
amide group,[49, 52] Yamamoto and colleagues reported the preparation of several pyrimidine structures of type 
XIIIc via oxidation of the corresponding DHPMs[55] and the NH-1 to  N-3 interconversion (and subsequent  
formation of  XIIIb-type scaffolds) in solution has also been described in the scientific literature.[49, 54] The 
absence of the NH-3 and CH-4 resonances in the 1H NMR spectra of compounds 221-238 clearly demonstrates 
that our microwave-assisted oxidation method was successful and pointed towards the formation of pyrimidin-
2(1H)-one compounds. Nonetheless, the expected and typically broad and low-field NH-1 signal was also absent in 
many instances, namely in compounds 221-223,  226-228,  230,  231,  235 and 238, indicating that the above 
mentioned tautomerisations were occurring in many of our synthesised compounds in solution. Further evidence  
of  these  rapid  interconversion  processes  was  uncovered through  13C NMR analysis;  the  C-4  and C-6  carbon 
resonances in the entire  series of  oxidation products  221-238,  along with the signals  of  the directly bonded 
carbon atoms of their substituent moieties, aryl and methyl,  respectively, were quite difficult to locate, if  not  
impossible, due to their extremely low intensity. Extending the acquisition time of the spectra and/or increasing 
the temperature at which they were recorded did not improve the signal-to-noise ratio. Similar observations have  
also been described earlier.[49, 52, 54]
Attempting to oxidise Biginelli 3,4-dihydropyrimidine-2(1H)-thiones to the corresponding pyrimidine-2(1H)-
thiones, a synthetic endeavour that, as far as we know, as never been effectively accomplished, it was decided to  
employ  the  previously  prepared  methyl  6-methyl-4-phenyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate 
175 as the model compound and make use of the oxidising reaction conditions that proved to be highly successful  
in  the  dehydrogenation  of  most  of  its  related  3,4-dihydropyrimidin-2(1H)-ones,  i.e.  microwave  heating  the 
selected  3,4-dihydropyrimidine  175 and  a  slight  molar  excess  of  potassium  peroxydisulphate  in  an 
acetonitrile/distilled water mixture for 10 minutes at 100 ºC under closed-vessel conditions (Table 5.6, entry 1;  
Scheme 5.34a). Since absolutely no reaction occurred, the starting heterocyclic reagent being retrieved after work-
up, the irradiation time was increased to 20 minutes, methyl  6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-
one-5-carboxylate 147 being formed with a 10% conversion (entry 2). This interesting but unexpected oxidative 
desulphurisation reaction, that is,  the loss of the sulphur atom of the thione reactant and replacement by an 
oxygen, was also observed, and in a much greater extent, when K2S2O8 was replaced by Oxone (Scheme 5.34b), a 
versatile  potassium  triple  salt  of  molecular  formula  2KHSO5.KHSO4.K2SO4 and  strong  oxidising  agent 
(E0[HSO5-/HSO4-]=1.85 V), often utilised in chemical reactions and abundantly used as a swimming pool shock 
oxidant, odour control agent in waste-water treatment and bleach component in denture cleansers and laundry 
formulations, among other applications.[111] In fact, a 57 and 67% conversion of DHPM 175 to its analogue 147 
was  attained  after  10  and  20  minutes  of  microwave  irradiation,  respectively  (entries  3  and  4),  a  plausible  
mechanistic  rationalisation being  depicted  in  Scheme 5.35  following  the  work of  Kim and colleagues,  which 
reported a similar phenomenon a few years ago.[112] Presumably, the thione group of DHPM 175 is transformed 
in the cyclic sulphate intermediate XVII, which is subsequently oxidised to sulphite structure XVIII, DHPM 147 
being finally rendered via elimination of sulphur dioxide.  We then turned our attention to another powerful,  
inexpensive and environmentally-benign oxidant, aqueous hydrogen peroxide (E0[H2O2/H2O]=1.78 V), which is 
widely employed in dilute  form as a domestic disinfectant for small  skin wounds,  as  well  as  in research and 
development  in  organic  synthesis  and several  industrial  applications,  particularly  pulp  and paper  bleaching. 
However,  no  reaction  was  observed  when  a  20-fold  molar  excess  of  aqueous  H 2O2 (35%  m/v)  was  used  in 
acetonitrile at 100 ºC (entries 5-7; Scheme 5.34c). Altering the reaction medium to glacial acetic acid and heating 
the  reaction  mixture  at  the  same  temperature  for  10 or  20  minutes  under  microwave  activation  afforded  a  
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complex mixture of several unidentified products (entries 8 and 9). It is noteworthy to emphasise that neither the 
starting DHPM 175 nor the desired and corresponding dehydrogenated compound 239 were obtained. Also, the 
oxidative  desulphurisation  process  that  characterised  the  application  of  Oxone  and  led  to  the  formation  of  
Biginelli 3,4-dihydropyrimidin-2(1H)-one 147, was absent when using H2O2 under the reaction conditions tested.
Table 5.6. Synthesis of methyl 6-methyl-4-phenylpyrimidine-2(1H)-thione-5-carboxylate 239 under microwave 
irradiation.
Entry Reaction Medium Oxidant Time (min) Conversiona (%)
1 CH3CN/H2Ob K2S2O8d 10 0h
2 CH3CN/H2Ob K2S2O8d 20 10i
3 CH3CN/H2Ob Oxonee 10 57i
4 CH3CN/H2Ob Oxonee 20 67i
5 CH3CNc H2O2f 10 0h
6 CH3CNc H2O2f 20 0h
7 CH3CNc H2O2f 30 0h
8 AcOHc H2O2f 10 -j
9 AcOHc H2O2f 20 -j
10 CH2Cl2c DDQg 20 78k
11 CH2Cl2c DDQg 30 22l
All reactions were carried-out using DHPM 175 (1 mmol) and the selected oxidant at 100 ºC in a closed vessel.  
aConversion was assessed by GC-MS analysis of the isolated reaction products. bCH3CN/H2O (3:2 v/v, 5 ml) was 
used as reaction medium, an initial microwave power of 80 W being applied.  cThe selected solvent (3 ml) was 
used as reaction medium, an initial  microwave power of  100 W being applied.  dK2S2O8 (1.2 mmol),  eOxone 
(1.2 mmol), fH2O2 (35% m/v, 20 mmol) and gDDQ (1.2 mmol) were used as oxidants. hNo reaction occurred, the 
starting DHPM  175 being recovered upon work-up.  iDHPM  147 was obtained via oxidative desulphurisation, 
along with the initial DHPM 175.  jSeveral unidentified products were observed.  kPyrimidine-2(1H)-thione 239 
was obtained, along with secondary oxidation product 240. lPyrimidine-2(1H)-thione 239 was obtained, along 
with secondary oxidation products 240 and 241.
Scheme  5.34. Synthesis  of methyl  6-methyl-4-phenylpyrimidine-2(1H)-thione-5-carboxylate 239 under 
microwave irradiation.
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Scheme  5.35. Mechanistic  proposal  for  the  oxidative  desulphurisation  of  methyl  6-methyl-4-phenyl-3,4-
dihydropyrimidine-2(1H)-thione-5-carboxylate 175 using Oxone as the oxidising agent.
Lastly, DDQ was employed as oxidant and dichloromethane as solvent (Scheme 5.34d), pyrimidine-2(1H)-
thione  239 being prepared with a 78% conversion, along with compound  240 as by-product, after heating at 
100 ºC for 20 minutes under microwave irradiation, followed by chromatographic purification through a small  
silica gel column (using dichloromethane and dichloromethane/ethyl acetate, 9:1 and 7:3 v/v, as eluents) and  
recrystallisation in diethyl ether or ethyl acetate/n-hexane (Table 5.6, entry 10). Extending the reaction time to 30 
minutes did not improve the synthetic process, given that oxidation product 239 was obtained with a much lower 
conversion (22%), heterocycles  240 and  241 being the major reaction products, with 32 and 46% conversion, 
respectively (entry 11). A non-microwave-assisted, room temperature and slow (up to 48 hours) approach using 
DDQ was also tested, but a closely related outcome was determined, given that the same oxidation products were  
formed.  While  compound  239 was  synthesised  through  microwave-activated  and  DDQ-promoted 
dehydrogenation of DHPM  175 (a possible reaction mechanism being initiated by a hydride transfer from the 
starting Biginelli 3,4-dihydropyrimidine-2(1H)-thione to DDQ, leading to the formation of hydropyrimidinium 
structure  XIX and  derivative  HDDQ-,  followed  by  a  HDDQ--mediated  proton  abstraction  from  the 
aforementioned carbocation intermediate and subsequent generation of the target pyrimidine-2(1H)-thione and 
secondary  product  H2DDQ),  the  unwanted  compounds  240 and  241 were  most  likely  formed  via  oxidative 
demethylation and dehydroxylation reactions occurring at a second stage on product 239 (Scheme 5.36).
It must be mentioned that after GC-MS analysis of the yellowish solid obtained through application of the  
reaction conditions summarised in entry 10 of Table 5.6, our first impression was that the contaminant species 
was simply unreacted DHPM 175 (m/z=262). However, a closer look showed that both the fragmentation pattern 
in the mass spectrum and, particularly, the retention time in the chromatogram were somewhat different, tR (175) 
and tR (240) being 13.20 and 12.87 minutes, respectively, which pointed towards the synthesis of oxidation by-
product  240 instead of contamination with the starting material. Moreover, it did not make any sense that by  
increasing the reaction time (entry 11), the amount of unreacted DHPM present in the final product was higher.  
Finally, the preparation of compound  240 with a higher conversion and the formation of secondary oxidation 
product 241 (m/z=246; tR=11.84 min) after 30 minutes of microwave heating supports our rationalisation. Thus, 
although  our  synthetic  efforts  either  failed,  furnished  unforeseen  results  like  the  oxidative  desulphurisation 
process  or  did  not  efficaciously  provide  the  desired  dehydrogenation  product  239 with  high  purity,  a  re-
evaluation of DDQ as oxidant (e.g. changing the reaction medium, temperature and/or time) and the use of other 
quinone-type oxidising agents,  o-TCQ or  p-TCQ,  might  be interesting and,  hopefully,  advantageous in  future 
oxidation studies of Biginelli 3,4-dihydropyrimidine-2(1H)-thiones under microwave irradiation.
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Scheme 5.36. Mechanistic proposal for the synthesis of Biginelli pyrimidine-2(1H)-thione 239 and by-products 
240 and 241 using DDQ as the oxidising agent.
IV. Summary
Making use of glacial acetic acid as both solvent and acid catalyst and microwave heating under sealed-vessel 
conditions, a medium-sized compound library of fifty five Biginelli DHPMs was effortlessly synthesised with high 
purity and without the requirement of any chromatographic purification protocol. Broadly speaking, the isolated 
yields were quite good, 35-90% for 3,4-dihydropyrimidin-2(1H)-ones  147-174 and 28-78% in the case of 3,4-
dihydropyrimidine-2(1H)-thiones  175-201.  The  same  synthetic  approach  was  also  effectively  applied  to  the 
multicomponent preparation of some Biginelli bis-DHPMs, bis-3,4-dihydropyrimidin-2(1H)-ones 202-205 being 
generally obtained with higher yields comparing to the equivalent bis-3,4-dihydropyrimidine-2(1H)-thiones 206-
209.  A two-pot two-step strategy, in which microwave irradiation was used at the second stage of the reaction, 
proved to be the best course of action for the efficient synthesis of a series of 4,6-diaryl-3,4-dihydropyrimidine-
2(1H)-thiones 210-220. Again, no chromatographic separation technique was necessary for the isolation of the 
target products with high yields (80-86%). Six of these Biginelli-type DHPMs, 215-220, were later selected and 
their in vitro cytotoxic activity examined against four human cancer cell lines. In general, all compounds studied 
were more active against MCF7 breast cancer cells, the brominated derivatives 215 and 219 being the most active 
Biginelli-type  molecules.  Eighteen  pyrimidin-2(1H)-ones  221-238,  bearing  both  electron-withdrawing  and 
electron-donating functionalities, were rapidly prepared through the microwave-assisted dehydrogenation of the 
related  3,4-dihydropyrimidin-2(1H)-ones.  Among the  several  oxidants  employed,  potassium peroxydisulphate 
was established as the only effective one under the reaction conditions tested. Withal, application of this oxidising  
agent to the dehydrogenation of 3,4-dihydropyrimidine-2(1H)-thione 175 was disappointing. Oxone and hydrogen 
peroxide were also studied as oxidants, but either failed or rendered unexpected or unidentified by-products. The  
best result was attained using DDQ, a 78% conversion to the desired pyrimidine-2(1H)-thione being determined. 
Further efforts are undoubtedly needed in order to accomplish this exceedingly difficult synthetic endeavour.
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Experimental
I. Instrumentation
A. Microwaves
Microwave-assisted reactions were performed in  a CEM Discover S-Class single-mode microwave reactor,  
featuring continuous temperature, pressure and microwave power monitoring.
B. Melting Points
Uncorrected  melting  points  were  determined  in  an  Ernst  Leitz  799  heated-plate  microscope,  using  an 
AmaDigit ad1700th digital thermometer.
C. Elemental Analysis
Quantitative  determination  of  carbon,  hydrogen  and  nitrogen  elements  was  accomplished  in  a Fisons 
Instruments EA-1108 CHNS-O analyser.
D. Ultraviolet-Visible Absorption Spectroscopy
UV-Vis absorption spectra were obtained in a Hitachi U-2001, Shimadzu UV-2100 or Ocean Optics USB 4000 
spectrometer.
E. Nuclear Magnetic Resonance Spectroscopy
1H NMR spectra were registered at room temperature in a Bruker AMX or Bruker Avance III spectrometer, 
operating at 300 and 400 MHz, respectively. 13C NMR spectra were recorded at ambient temperature in a Bruker 
Avance III spectrometer, operating at 100 MHz. TMS was the internal standard used. Chemical shifts (δ) and 
coupling constants (J) are indicated in ppm and Hz, respectively.
F. Gas Chromatography-Mass Spectrometry
GC-MS spectra were obtained in a Hewlett-Packard 5973 MSD spectrometer, using EI (70 eV), coupled to a  
Hewlett-Packard Agilent 6890 chromatograph, equipped with a HP-5 MS column (30 m x 0.25 mm x 0.25 μm).
G. Mass Spectrometry
MS spectra were recorded in a Thermo Finnigan LCQ Advantage or Bruker Daltonics Autoflex III Smartbeam 
spectrometer, using ESI and MALDI, respectively. HR-MS were registered in a Waters Micromass VG Autospec M 
or Thermo Scientific Q Exactive spectrometer, using ESI.
H. X-Ray Diffraction
XRD studies were performed at 293 K in  a  Bruker-Nonius Kappa Apex II diffractometer, equipped with a 
4KCCD detector,  using graphite-monochromated MoKα radiation (λ=0.71073 Å).  The structures were solved by 
direct methods (SHELXS-97) and refined by full-matrix least-squares methods (SHELXL-97). All non-hydrogen 
atoms were refined anisotropically.
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II. Materials
A. Reagents
All  commercially  acquired  reagents  were  high-grade  chemicals  and  were  utilised  without  any  additional 
purification, with the following exceptions: aniline (Riedel-de Haën, 99.5%), distillation under reduced pressure, 
1,4-diaminobenzene (Aldrich,  99%),  recrystallisation in ethanol  and pyrrole  (Aldrich,  98%),  distillation under 
reduced pressure or filtration through a small column of Al2O3, type 507C neutral, Brockmann Grade I, 50-150 μm 
(Fluka).
B. Solvents
All commercially acquired solvents were purified according to literature procedures prior to their usage,[1] 
with  the  following  exceptions:  acetonitrile  (Fisher  Scientific,  99.9%),  carbon  tetrachloride  (Panreac,  99.9%), 
deuterated chloroform (Aldrich, 99.9% D, 0.03% v/v TMS; Euriso-Top, 99.8% D, 0.03% v/v TMS), deuterated  
dimethylsulphoxide (Aldrich, 99.9% D; Euriso-Top, 99.8% D, 0.03% v/v TMS), N,N-dimethylformamide (Merck, 
99.8%), dimethylsulphoxide (Fisher Scientific, 99.9%), 1,4-dioxane (Panreac, 99.5%), glacial acetic acid (Panreac, 
99.7%), methylcyclohexane (Aldrich, 99%), nitrobenzene (Merck, 99%) and propionic acid (Panreac, 99%).
C. Others
Solid-supported reactions using SiO2 60, 200-500 μm (Fluka) and 35-70 μm (Acros Organics), SiO2 60/H2SO4, 
35-70  μm  (Acros Organics), SiO2 N, 2-20  μm (Macherey-Nagel), montmorillonite K-10, 220-270 m2  g-1 surface 
area (Aldrich) and Al2O3, type 507C neutral, Brockmann Grade I, 50-150 μm (Fluka), were preceded by drying the 
solid support  in an oven at  120 ºC for 24 hours. In the reactions employing heterogeneous oxidising agents, 
activated manganese dioxide (Aldrich, 85%) and potassium permanganate (Riedel-de Haën, 99%), these were also 
previously dried in an oven at 120 ºC for 24 hours. TLC-monitoring of the reactions was performed utilising SiO2 
60 F254-coated aluminium plates (Merck).  Flash  column chromatography purification of the reaction products 
was carried-out using SiO2 60, 35-70 μm (Acros Organics) or 35-63 μm (Panreac).
III. Methods
A. Pyrroles
1. Paal-Knorr Synthesis of 2,5-Dimethyl-1H-Pyrroles
A mixture of the selected amine (10 mmol), 2,5-hexanedione (10 mmol, 1.21 ml) and formic acid (1.5 mmol, 
60 μl) was thoroughly mixed in an appropriate 10 ml thick-walled glass vial. This was tightly sealed with a Teflon 
cap and the reaction mixture was stirred and heated at 100 ºC for 1 minute, under microwave irradiation, with an 
initial power setting of 100 W. After cooling to room temperature, the reaction product was washed with diethyl 
ether (50 ml) and the resulting solution was dried over anhydrous sodium sulphate, filtered and evaporated under 
reduced pressure. The yellow solid obtained was recrystallised in methanol, yielding the desired 2,5-dimethyl-1H-
pyrrole as a pale-yellow solid (1 and 2). Regarding pyrrole 3, the isolation process afforded a yellow oil that was 
purified  through  SiO2 flash  column  chromatography  (8x2  cm),  using  diethyl  ether  as  eluent.  The  pyrrole-
containing fraction was collected and evaporated under reduced pressure, yielding the desired 2,5-dimethyl-1H-
pyrrole as a pale-yellow oil.
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2,5-Dimethyl-1-phenyl-1H-pyrrole, 1. Yield: 96%, 1.650 g (pale-yellow solid); mp (ºC): 50-51 (Lit. 51-52);[2] 
C12H13N: calculated (%) = C 84.17, H 7.65, N 8.18; found (%) = C 84.38, H 7.72, N 8.18;  1H NMR (400 MHz, 
CDCl3): δ, ppm = 7.450 (2H, t, J = 7.2, Ph), 7.382 (1H, t, J = 7.2, Ph), 7.207 (2H, d, J = 7.2, Ph), 5.903 (2H, s, CH),  
2.029 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm =138.954, 129.029, 128.783, 128.225, 127.612, 105.590, 
13.007; GC-MS (EI): m/z (tR, min) = 171 (9.45) (M+).
1-Benzyl-2,5-dimethyl-1H-pyrrole, 2. Yield: 97%, 1.800 g (pale-yellow solid); mp (ºC): 44-45 (Lit. 46-48);[2] 
C13H15N: calculated (%) = C 84.28, H 8.16, N 7.56; found (%) = C 83.92, H 8.57, N 7.75;  1H NMR (400 MHz, 
CDCl3): δ, ppm = 7.268 (2H, t, J = 7.2, Ph), 7.198 (1H, t, J = 7.2, Ph), 6.867 (2H, d, J = 7.2, Ph), 5.853 (2 H, s, CH), 
4.984 (2H, s, CH2), 2.123 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 138.504, 128.669, 127.992, 126.957, 
125.588, 105.372, 46.648, 12.412; GC-MS (EI): m/z (tR, min) = 185 (10.21) (M+).
1-n-Butyl-2,5-dimethyl-1H-pyrrole, 3.  Yield: 94%, 1.420 g (pale-yellow oil);  1H NMR (400 MHz, CDCl3): δ, 
ppm = 5.756 (2H, s, CH), 3.710 (2H, t, J = 7.6, NCH2CH2CH2CH3), 2.214 (6H, s, CH3), 1.593 (2H, quin, J = 7.6, 
NCH2CH2CH2CH3), 1.364 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.950 (3H, t, J = 7.6, NCH2CH2CH2CH3); 13C NMR 
(100 MHz,  CDCl3):  δ,  ppm = 127.333,  104.870, 43.414,  33.137,  20.183,  13.853,  12.484; GC-MS (EI):  m/z (tR, 
min) = 151 (8.46) (M+).
2. Paal-Knorr Synthesis of Bis-2,5-Dimethyl-1H-Pyrroles
A mixture of the selected diamine (10 mmol), 2,5-hexanedione (30 mmol, 3.63 ml) and formic acid (1.5 mmol, 
60 μl) was thoroughly mixed in an appropriate 10 ml thick-walled glass vial. This was tightly sealed with a Teflon 
cap and the reaction mixture was stirred and heated at 100 ºC for 3 minutes, under microwave irradiation, with 
an initial  power setting of 100 W. After cooling to room temperature, the reaction product was washed with  
diethyl  ether  (50  ml)  and  the  resulting  solution  was  dried  over  anhydrous  sodium  sulphate,  filtered  and  
evaporated under reduced pressure. The yellow solid obtained was recrystallised in methanol, yielding the desired 
bis-2,5-dimethyl-1H-pyrrole as a pale-yellow solid (4-6). Regarding bis-pyrrole 7, the isolation process afforded a 
yellow oil that was purified through SiO2 flash column chromatography (8x2 cm), using diethyl ether as eluent. 
The bis-pyrrole-containing fraction was collected and evaporated under reduced pressure, yielding the desired 
bis-2,5-dimethyl-1H-pyrrole as a pale-yellow oil.
1,2-Bis(2,5-dimethyl-1H-pyrrol-1-yl)ethane, 4.  Yield: 95%, 2.050 g (pale-yellow solid); mp (ºC): 130-132 
(Lit. 134);[3] C14H20N2: calculated (%) = C 77.73, H 9.32, N 12.95; found (%) = C 77.54, H 9.53, N 12.77; 1H NMR 
(400 MHz, CDCl3):  δ, ppm = 5.746 (4H, s, CH), 3.921 (4H, s, CH2), 2.006 (12H, s, CH3);  13C NMR (100 MHz, 
CDCl3): δ, ppm = 127.462, 105.540, 43.712, 11.742; GC-MS (EI): m/z (tR, min) = 216 (11.33) (M+).
1,4-Bis(2,5-dimethyl-1H-pyrrol-1-yl)benzene, 5. Yield: 92%, 2.420 g (pale-yellow solid); mp (ºC): 238-240; 
C18H20N2: calculated (%) = C 81.78, H 7.63, N 10.60; found (%) = C 81.58, H 7.57, N 10.52; 1H NMR (400 MHz, 
CDCl3): δ, ppm = 7.293 (4H, s, Ph), 5.934 (4H, s, CH), 2.085 (12H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 
138.478, 128.972, 128.924, 106.211, 13.190; GC-MS (EI): m/z (tR, min) = 264 (12.67) (M+).
1,2-Bis(4-(2,5-dimethyl-1H-pyrrol-1-yl)phenyl)ethane,  6.  Yield:  96%,  3.520  g  (pale-yellow  solid); 
mp (ºC): 151-153; C26H28N2:  calculated (%) = C 84.74, H 7.66, N 7.60; found (%) = C 84.45, H 7.59, N 7.45; 
1H NMR (400 MHz, CDCl3): δ, ppm = 7.224 (4H, d, J = 8.4, Ph), 7.103 (4H, d, J = 8.4, Ph), 5.891 (4H, s, CH), 
3.026 (4H, s, CH2), 2.016 (12H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 140.838, 136.947, 129.102, 128.761, 
128.081, 105.535, 37.336, 12.958; GC-MS (EI): m/z (tR, min) = 368 (21.92) (M+).
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1,2-Bis(2-(2,5-dimethyl-1H-pyrrol-1-yl)ethoxy)ethane, 7.  Yield: 90%, 2.740 g (pale-yellow oil);  1H NMR 
(400 MHz, CDCl3): δ, ppm = 5.738 (4H, s, CH), 3.917 (4H, t, J = 6.4, NCH2CH2OCH2), 3.570 (4H, t, J = 6.4, 
NCH2CH2OCH2),  3.484 (4H,  s,  NCH2CH2OCH2),  2.213  (12H,  s,  CH3);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 
127.683, 105.261, 70.764, 70.579, 43.313, 12.515; GC-MS (EI): m/z (tR, min) = 304 (13.96) (M+).
3. Multicomponent Synthesis of 3,5-Diaryl-2-Methyl-1H-Pyrroles
A mixture of the selected amine (5 mmol), the adequate chalcone* (5 mmol), nitroethane (15 mmol, 1.12 ml) 
and SiO2 (8 g) in diethyl ether (50 ml) was stirred at room temperature for 5 minutes in a 100 ml round-bottomed  
flask, followed by evaporation under reduced pressure. The reaction mixture was heated at 100 ºC for 10 minutes, 
under microwave irradiation,  with an initial  power setting of 200 W. After cooling to room temperature, the  
reaction product was washed with diethyl ether (50 ml) and the resulting suspension was filtered and evaporated  
under reduced pressure, in order to remove the solid support. The yellow oil obtained was purified through SiO2 
flash column chromatography (8x2 cm), using n-hexane/diethyl ether (9:1 v/v) as eluent. The pyrrole-containing 
fraction was collected and evaporated under reduced pressure and the yellow solid obtained was recrystallised in  
methanol, yielding the desired 3,5-diaryl-2-methyl-1H-pyrrole as a white or yellowish solid (8-37).
*The  chalcones  needed  for  the  synthesis  of  3,5-diaryl-2-methyl-1H-pyrroles  8-37 were  previously  prepared 
through a procedure described by Kohler and Chadwell (see section 6.III.A.4., pages 139-141).[4]
2-Methyl-1,3,5-triphenyl-1H-pyrrole,  8.  Yield:  23%,  350  mg  (white  solid);  mp  (ºC):  161-163;  1H  NMR 
(400 MHz, CDCl3): δ, ppm = 7.513 (2H, d, J = 7.6, Ph), 7.425-7.337 (5H, m, Ph), 7.255-7.214 (3H, m, Ph), 7.147-
7.095 (5H, m, Ph), 6.564 (1H, s, CH), 2.248 (3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 139.264, 136.927, 
133.891,  133.216,  129.018,  128.681,  128.395,  128.060,  127.977,  127.948,  127.894,  127.561,  125.883,  125.452, 
122.766, 109.313, 12.420; GC-MS (EI): m/z (tR, min) = 309 (16.34) (M+).
1-Benzyl-2-methyl-3,5-diphenyl-1H-pyrrole,  9.  Yield:  28%,  460  mg  (white  solid);  mp  (ºC):  115-116; 
C24H21N: calculated (%) = C 89.12, H 6.54, N 4.33; found (%) = C 89.47, H 6.78, N 4.11;  1H NMR (400 MHz, 
CDCl3): δ, ppm = 7.466 (2H, d, J = 7.6, Ph), 7.386 (2H, d, J = 7.2, Ph), 7.377-7.279 (6H, m, Ph), 7.256-7.192 (3H, 
m, Ph), 6.993 (2H, d, J = 7.2, Ph), 6.449 (1H, s, CH), 5.183 (2H, s, CH2), 2.262 (3H, s, CH3); 13C NMR (100 MHz, 
CDCl3):  δ,  ppm = 138.810,  137.146,  134.346,  133.396,  128.783,  128.734,  128.422,  128.342,  128.054,  127.049,  
126.896, 126.668, 125.658, 125.266, 122.478, 108.611, 47.971, 11.374; GC-MS (EI): m/z (t R, min) = 323 (16.61) 
(M+).
1-n-Butyl-2-methyl-3,5-diphenyl-1H-pyrrole,  10.  Yield:  25%,  360  mg  (white  solid);  mp  (ºC):  88-90; 
1H NMR (400 MHz, CDCl3): δ, ppm = 7.447-7.353 (8H, m, Ph), 7.326-7.294 (1H, m, Ph), 7.204 (1H, t, J = 7.2, Ph),  
6.295  (1H,  s,  CH),  3.909  (2H,  t,  J  =  7.6,  NCH2CH2CH2CH3),  2.437  (3H,  s,  CH3),  1.611  (2H,  quin,  J  =  7.6, 
NCH2CH2CH2CH3), 1.225 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.883 (3H, t, J = 7.6, NCH2CH2CH2CH3); 13C NMR 
(100 MHz, CDCl3):  δ, ppm = 137.327, 134.069, 133.634, 129.132, 128.353, 128.288, 128.103, 126.809, 125.934, 
125.118, 122.039, 108.438, 44.214, 33.277, 19.913, 13.632, 11.444; GC-MS (EI): m/z (tR, min) = 289 (14.34) (M+).
2-Methyl-3-(naphthalen-1-yl)-1,5-diphenyl-1H-pyrrole, 11.  Yield: 14%, 250 mg (yellow solid); mp (ºC): 
106-108; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.208 (1H, d, J = 7.2, Ph), 7.898 (1H, d, J = 7.2, Ph), 7.826-7.804 
(1H, m, Ph), 7.551-7.478 (4H, m, Ph), 7.433-7.340 (3H, m, Ph), 7.301 (2H, d, J = 7.2, Ph), 7.168-7.085 (5H, m,  
Ph), 6.591 (1H, s, CH), 2.042 (3H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 139.529, 134.905, 133.921, 
133.330,  133.237,  132.644,  129.365,  129.029,  128.629,  128.202,  128.011,  127.745,  127.714,  127.481,  126.853, 
126.687, 125.747, 125.586, 125.537, 125.454, 120.878, 111.585, 12.202; MS (MALDI): m/z = 359 (M+).
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1-Benzyl-2-methyl-3-(naphthalen-1-yl)-5-phenyl-1H-pyrrole,  12.  Yield:  19%,  350  mg  (yellow  solid); 
mp (ºC): 101-103; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.126 (1H, d, J = 7.6, Ph), 7.863 (1H, d, J = 7.6, Ph), 7.776 
(1H, d, J = 7.2, Ph), 7.507-7.435 (4H, m, Ph), 7.392 (2H, d, J = 7.2, Ph), 7.350-7.282 (4H, m, Ph), 7.261-7.211 (2H, 
m, Ph), 7.038 (2H, d, J = 7.6, Ph), 6.470 (1H, s, CH), 5.240 (2H, s, CH2), 2.028 (3H, s, CH3); 13C NMR (100 MHz, 
CDCl3):  δ,  ppm = 139.036,  135.151,  133.953,  133.943,  133.503,  132.755,  128.808,  128.666,  128.450,  128.165,  
127.740, 127.056, 126.811, 126.780, 126.581, 125.642, 125.528, 125.462, 125.402, 120.724, 110.915, 48.052, 11.194;  
HR-MS (ESI): m/z = 374.18940 ([M+H]+, C28H24N: required = 374.19033).
1-n-Butyl-2-methyl-3-(naphthalen-1-yl)-5-phenyl-1H-pyrrole,  13.  Yield:  18%,  310  mg  (yellow  solid); 
mp (ºC): 61-63; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.101 (1H, d, J = 7.6, Ph), 7.870 (1H, d, J = 7.6, Ph), 7.777 
(1H, d, J = 8, Ph), 7.513-7393 (8H, m, Ph), 7.305 (1H, t, J = 7.6, Ph), 6.321 (1H, s, CH), 3.978 (2H, t, J = 7.2,  
NCH2CH2CH2CH3),  2.214 (3H, s,  CH3),  1.665 (2H, quin,  J = 7.2,  NCH2CH2CH2CH3),  1.262 (2H,  sex,  J  = 7.2, 
NCH2CH2CH2CH3),  0.863 (3H, t,  J = 7.2,  NCH2CH2CH2CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 135.349, 
134.136,  133.890,  133.145,  132.732,  128.951,  128.380,  128.113,  127.677,  127.428,  126.933,  126.628,  126.392, 
125.423, 120.096, 110.683, 44.364, 33.316, 19.935, 13.706, 11.359; MS (MALDI): m/z = 339 (M+).
3-(Anthracen-9-yl)-1-benzyl-2-methyl-5-phenyl-1H-pyrrole, 14.  Yield: 19%, 400 mg  (yellow solid); mp 
(ºC): 161-163; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.426 (1H, s, Ph), 8.074 (2H, d, J = 8.4, Ph), 8.016 (2H, d, J = 
8.4, Ph), 7.456 (2H, d, J = 7.6, Ph), 7.423-7.211 (10H, m, Ph), 7.107 (2H, d, J = 7.6, Ph), 6.483 (1H, s, CH), 5.326  
(2H, s,  CH2),  1.795 (3H,  s,  CH3);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 139.189,  134.274,  133.582,  132.549, 
131.615,  131.255,  129.529,  128.844,  128.626,  128.504,  128.374,  127.547,  127.109,  126.735,  125.844,  125.655, 
124.960,  117.939,  112.109,  48.115,  11.119;  HR-MS  (ESI):  m/z  =  424.20548  ([M+H]+,  C32H26N:  required  = 
424.20598).
3-(Anthracen-9-yl)-1-n-butyl-2-methyl-5-phenyl-1H-pyrrole, 15.  Yield: 14%, 280 mg (yellow solid); mp 
(ºC): 134-136; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.421 (1H, s, Ph), 8.022 (4H, d, J = 8.4, Ph), 7.530 (2H, d,  
J = 7.2,  Ph),  7.458-7.361 (6H, m,  Ph),  7.309 (1H, t,  J  = 7.2,  Ph),  6.324 (1H, s,  CH),  4.068 (2H,  t,  J = 7.6,  
NCH2CH2CH2CH3),  1.973 (3H,  s,  CH3),  1.696 (2H,  quin,  J  = 7.6,  NCH2CH2CH2CH3),  1.293 (2H, sex,  J = 7.6, 
NCH2CH2CH2CH3),  0.889 (3H, t,  J = 7.6,  NCH2CH2CH2CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 134.347, 
133.422,  132.997,  131.633,  131.303,  128.861,  128.811,  128.548,  128.319,  127.711,  126.524,  125.651,  124.941,  
124.846, 117.333, 111.988, 44.420, 33.394, 19.911, 13.765, 11.269; MS (MALDI): m/z = 389 (M+).
1-Benzyl-2-methyl-5-phenyl-3-(pyren-1-yl)-1H-pyrrole, 16.  Yield:  11%, 235 mg (yellow solid);  mp (ºC): 
167-169; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.331 (1H, d, J = 8.8, Ph), 8.196 (1H, d, J = 7.6, Ph), 8.149 (2H, t,  
J = 6.4, Ph), 8.092-7.998 (4H, m, Ph), 7.979 (1H, t, J = 7.6, Ph), 7.450 (2H, d, J = 7.6, Ph), 7.405-7.239 (6H, m, 
Ph), 7.105 (2H, t, J = 7.6, Ph), 6.597 (1H, s, CH), 5.308 (2H, s, CH2), 2.090 (3H, s, CH3);  13C NMR (100 MHz, 
CDCl3):  δ,  ppm  =  138.997,  134.275,  133.452,  132.995,  131.517,  131.162,  129.845,  129.295,  128.870,  128.718, 
128.505,  127.497,  127.124,  126.876,  126.828,  126.786,  126.334,  125.782,  125.692,  125.109,  125.036,  124.672, 
124.527, 124.488, 121.324, 111.151, 48.143, 11.379; HR-MS (ESI): m/z = 448.20583 ([M+H]+, C34H26N: required = 
448.20598).
3-(4-Bromophenyl)-2-methyl-1,5-diphenyl-1H-pyrrole,  17.  Yield:  18%,  350  mg  (pale-yellow  solid); 
mp (ºC): 163-165; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.518 (2H, d, J = 8.4, Ph), 7.404-7.346 (5H, m, Ph), 7.206 
(2H, d, J = 6.8, Ph), 7.168-7.081 (5H, m, Ph), 6.520 (1H, s, CH), 2.219 (3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, 
ppm = 139.006, 135.847, 134.114, 132.958, 131.458, 129.542, 129.072, 128.592, 128.011, 127.894, 127.691, 126.043, 
121.602, 119.178, 108.940, 12.414; GC-MS (EI): m/z (tR, min) = 387 (22.19) (M+).
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1-Benzyl-3-(4-bromophenyl)-2-methyl-5-phenyl-1H-pyrrole, 18. Yield: 22%, 435 mg (pale-yellow solid); 
mp (ºC): 130-131; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.477 (2H, d, J = 8, Ph), 7.322-7.210 (10H, m, Ph), 6.977 
(2H, d, J = 8, Ph), 6.394 (1H, s, CH), 5.161 (2H, s, CH2), 2.223 (3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 
138.592,  136.110,  134.598,  133.185,  131.381,  129.578,  128.810,  128.754,  128.452,  127.119,  127.053,  126.751,  
125.635, 121.345, 118.981, 108.332, 47.991, 11.358; GC-MS (EI): m/z (tR, min) = 401 (24.03) (M+).
3-(4-Bromophenyl)-1-n-butyl-2-methyl-5-phenyl-1H-pyrrole, 19. Yield: 20%, 370 mg (pale-yellow solid); 
mp (ºC): 90-91; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.478 (2H, d, J = 8.4, Ph), 7.406-7.396 (4H, m, Ph), 7.348-
7.316 (1H, m, Ph), 7.292 (2H, d, J = 8.4, Ph), 6.250 (1H, s, CH), 3.896 (2H, t, J = 7.6, NCH2CH2CH2CH3), 2.405 
(3H, s, CH3), 1.594 (2H, quin, J = 7.6, NCH2CH2CH2CH3), 1.216 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.826 (3H, t, 
J = 7.6, NCH2CH2CH2CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 136.238, 133.858, 133.791, 131.334, 129.587, 
129.128, 128.388, 126.970, 126.019, 120.850, 118.815, 108.113, 44.211, 33.222,  19.881,  13.620, 11.428; GC-MS 
(EI): m/z (tR, min) = 367 (18.11) (M+).
3-(4-Chlorophenyl)-2-methyl-1,5-diphenyl-1H-pyrrole,  20.  Yield:  19%,  330  mg  (pale-yellow  solid); 
mp (ºC): 167-169; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.432 (2H, d, J = 8.4, Ph), 7.391-7.357 (5H, m, Ph), 7.210 
(2H, d, J = 6.8, Ph), 7.152-7.083 (5H, m, Ph), 6.522 (1H, s, CH), 2.224 (3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, 
ppm = 139.026, 135.374, 134.078, 132.977, 131.125, 129.170, 129.071, 128.600, 128.521, 128.011, 127.894, 127.683, 
126.033, 121.601, 108.997, 12.408; GC-MS (EI): m/z (tR, min) = 343 (19.92) (M+).
1-Benzyl-3-(4-chlorophenyl)-2-methyl-5-phenyl-1H-pyrrole, 21. Yield: 23%, 410 mg (pale-yellow solid); 
mp (ºC): 103-104; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.376 (2H, d, J = 8, Ph), 7.339-7.224 (10H, m, Ph), 6.982 
(2H, d, J = 8, Ph), 6.397 (1H, s, CH), 5.169 (2H, s, CH2), 2.230 (3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 
138.631,  135.656,  134.577,  133.219,  130.956,  129.214,  128.820,  128.768,  128.456,  127.126,  127.053,  126.748,  
125.651, 121.365, 108.395, 48.002, 11.360; GC-MS (EI): m/z (tR, min) = 357 (21.05) (M+).
1-n-Butyl-3-(4-chlorophenyl)-2-methyl-5-phenyl-1H-pyrrole,  22.  Yield:  20%,  320  mg  (pale-yellow 
solid); mp (ºC): 97-98; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.409-7.398 (4H, m, Ph), 7.365-7.319 (5H, m, Ph), 
6.251  (1H,  s,  CH),  3.899  (2H,  t,  J  =  7.6,  NCH2CH2CH2CH3),  2.409  (3H,  s,  CH3),  1.597  (2H,  quin,  J  =  7.6, 
NCH2CH2CH2CH3), 1.219 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.829 (3H, t, J = 7.6, NCH2CH2CH2CH3); 13C NMR 
(100 MHz, CDCl3):  δ, ppm = 135.767, 133.817, 130.767, 129.206, 129.129, 128.392, 126.959, 126.006, 120.855,  
108.164, 44.214, 33.233, 19.887, 13.625, 11.426; GC-MS (EI): m/z (tR, min) = 323 (16.76) (M+).
3-(4-Fluorophenyl)-2-methyl-1,5-diphenyl-1H-pyrrole, 23.  Yield: 22%, 360 mg  (white solid); mp (ºC): 
149-151; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.450 (2H, dd, J = 8.4, 5.6, Ph), 7.407-7.328 (3H, m, Ph), 7.215 
(2H, d, J = 7.2, Ph), 7.170-7.076 (7H, m, Ph), 6.511 (1H, s, CH), 2.216 (3H, s, CH 3); 13C NMR (100 MHz, CDCl3): δ, 
ppm = 161.163 (C, d, J = 242.7), 139.150, 133.903, 133.071, 132.916 (C, d, J = 3.3), 129.420 (2xCH, d, J = 7.5),  
129.050, 128.626, 127.999, 127.881, 127.739, 127.623, 125.964, 121.811, 115.200 (2xCH, d, J = 21), 109.164, 12.307; 
GC-MS (EI): m/z (tR, min) = 327 (16.95) (M+).
1-Benzyl-3-(4-fluorophenyl)-2-methyl-5-phenyl-1H-pyrrole,  24.  Yield:  25%,  430  mg  (white  solid); 
mp (ºC): 130-132; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.391 (2H, dd, J = 8.4, 5.6, Ph), 7.337-7.271 (6H, m, Ph), 
7.250-7.195 (2H, m, Ph), 7.054 (2H, t, J = 8.4, Ph), 6.981 (2H, d, J = 7.2, Ph), 6.389 (1H, s, CH), 5.164 (2H, s,  
CH2),  2.217 (3H, s,  CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 161.054 (C, d, J = 242.4), 138.723, 134.383, 
133.284, 133.174 (C, d, J = 2.9), 129.429 (2xCH, d, J = 7.5), 128.801, 128.728, 128.449, 127.090, 126.977, 126.457,  
125.644, 121.555, 115.118 (2xCH, d, J = 21), 108.507, 47.977, 11.252; GC-MS (EI): m/z (tR, min) = 341 (17.68) (M+).
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1-n-Butyl-3-(4-fluorophenyl)-2-methyl-5-phenyl-1H-pyrrole, 25.  Yield: 23%, 350 mg (white solid); mp 
(ºC): 110-112; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.409-7.350 (6H, m, Ph), 7.334-7.292 (1H, m, Ph), 7.057 (2H, 
t, J = 8.4, Ph), 6.240 (1H, s, CH), 3.900 (2H, t, J = 7.6, NCH2CH2CH2CH3), 2.399 (3H, s, CH3), 1.600 (2H, quin, 
J = 7.6, NCH2CH2CH2CH3), 1.219 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.829 (3H, t, J = 7.6, NCH2CH2CH2CH3); 
13C NMR (100 MHz, CDCl3): δ, ppm = 160.972 (C, d, J = 242.2), 133.904, 133.646, 133.298 (C, d, J = 3.1), 129.423  
(2xCH, d,  J  = 7.6),  129.110,  128.374,  126.885,  125.728,  121.067,  115.061 (2xCH,  d,  J  = 21),  108.288, 44.215,  
33.256, 19.893, 13.631, 11.335; GC-MS (EI): m/z (tR, min) = 307 (14.58) (M+).
2-Methyl-3-(4-nitrophenyl)-1,5-diphenyl-1H-pyrrole,  26. Yield:  20%,  350 mg  (yellow solid);  mp (ºC): 
190-193; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.268 (2H, d, J = 8.8, Ph), 7.638 (2H, d, J = 8.8, Ph), 7.449-7.380 
(3H, m, Ph), 7.214 (2H, d, J = 6.8, Ph), 7.175-7.093 (5H, m, Ph), 6.605 (1H, s, CH), 2.291 (3H, s, CH 3); 13C NMR 
(100 MHz, CDCl3):  δ, ppm = 145.233, 144.002, 138.586, 134.952, 132.572, 129.580, 129.222, 128.545, 128.112, 
128.053, 128.005, 127.740, 126.443, 123.987, 120.914, 108.834, 12.825; MS (MALDI): m/z = 353 ([M-H]+).
1-Benzyl-2-methyl-3-(4-nitrophenyl)-5-phenyl-1H-pyrrole,  27.  Yield:  24%,  440 mg  (yellow solid);  mp 
(ºC): 93-94; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.235 (2H, d, J = 8.8, Ph), 7.582 (2H, d, J = 8.8, Ph), 7.329-
7.266 (8H, m, Ph), 6.990 (2H, d, J = 7.6, Ph), 6.484 (1H, s, CH), 5.197 (2H, s, CH2), 2.311 (3H, s, CH3); 13C NMR 
(100 MHz, CDCl3):  δ, ppm = 145.139, 144.257,  138.155, 135.443, 132.789, 128.934, 128.911, 128.574, 128.373,  
127.783,  127.477,  127.330,  125.628,  123.932,  120.668,  108.387,  48.103,  11.800; MS  (MALDI):  m/z  =  367 
([M-H]+).
1-n-Butyl-2-methyl-3-(4-nitrophenyl)-5-phenyl-1H-pyrrole,  28.  Yield:  21%, 350 mg (yellow solid);  mp 
(ºC): 94-96; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.228 (2H, d, J = 8.4, Ph), 7.552 (2H, d, J = 8.4, Ph), 7.448-
7.337 (5H, m, Ph), 6.338 (1H, s, CH), 3.920 (2H, t, J = 7.6, NCH2CH2CH2CH3), 2.481 (3H, s, CH3), 1.596 (2H, quin, 
J = 7.6, NCH2CH2CH2CH3), 1.222 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.830 (3H, t, J = 7.6, NCH2CH2CH2CH3); 
13C NMR (100 MHz, CDCl3):  δ, ppm 144.970, 144.422,  134.690, 133.384, 129.244,  128.494, 127.680, 127.627, 
127.377, 123.911, 120.187, 108.215, 44.274, 33.137, 19.856, 13.595, 11.846; MS (MALDI): m/z = 333 ([M-H]+).
3-(4-Methoxyphenyl)-2-methyl-1,5-diphenyl-1H-pyrrole,  29. Yield:  20%,  340  mg  (pale-yellow  solid); 
mp (ºC): 117-119; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.431 (2H, d, J = 8.4, Ph), 7.400-7.336 (3H, m, Ph), 7.219 
(2H, d, J = 7.2, Ph), 7.164-7.088 (5H, m, Ph), 6.967 (2H, d, J = 8.4, Ph), 6.517 (1H, s, CH), 3.848 (3H, s, OCH 3), 
2.223 (3H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 157.668, 139.310, 133.672, 133.246, 129.481, 129.114, 
128.992, 128.655, 127.959, 127.853, 127.480, 125.806, 122.359, 113.880, 109.275, 55.306, 12.345; GC-MS (EI): 
m/z (tR, min) = 339 (21.01) (M+).
1-Benzyl-3-(4-methoxyphenyl)-2-methyl-5-phenyl-1H-pyrrole,  30. Yield:  25%,  440  mg  (pale-yellow 
solid); mp (ºC): 82-84; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.382 (2H, d, J = 8.4, Ph), 7.342-7.222 (8H, m, Ph), 
6.993 (2H, d, J = 7.2, Ph), 6.936 (2H, d, J = 8.4, Ph), 6.396 (1H, s, CH), 5.172 (2H, s, CH 2), 3.820 (3H, s, OCH3), 
2.230 (3H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 157.549, 138.901, 134.160, 133.461, 129.770, 129.112, 
128.768, 128.696, 128.409, 127.021, 126.820, 126.185, 125.674, 122.094, 113.839, 108.555, 55.289, 47.970, 11.295; 
GC-MS (EI): m/z (tR, min) = 353 (22.35) (M+).
1-n-Butyl-3-(4-methoxyphenyl)-2-methyl-5-phenyl-1H-pyrrole,  31.  Yield:  21%,  330  mg  (pale-yellow 
solid); mp (ºC): 53-55; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.409-7.394 (4H, m, Ph), 7.353 (2H, d, J = 8.4, Ph),  
7.317-7.286 (1H, m, Ph), 6.931 (2H, d, J = 8.4, Ph), 6.246 (1H, s, CH), 3.898 (2H, t, J = 7.6, NCH2CH2CH2CH3), 
3.828 (3H, s, OCH3), 2.405 (3H, s, CH3), 1.608 (2H, quin, J = 7.6, NCH2CH2CH2CH3), 1.223 (2H, sex, J = 7.6, 
NCH2CH2CH2CH3),  0.832 (3H, t,  J = 7.6,  NCH2CH2CH2CH3);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 157.415, 
134.076, 133.423, 129.901, 129.139, 129.072, 128.332, 126.724, 125.471, 121.610, 113.759, 108.333, 55.271, 44.207, 
33.291, 19.912, 13.643, 11.363; GC-MS (EI): m/z (tR, min) = 319 (17.05) (M+).
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1-Benzyl-5-(4-bromophenyl)-2-methyl-3-phenyl-1H-pyrrole, 32. Yield: 19%, 380 mg (pale-yellow solid); 
mp (ºC): 135-136; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.461-7.364 (6H, m, Ph), 7.341-7.304 (2H, m, Ph), 7.271-
7.224 (2H, m, Ph), 7.184 (2H, d, J = 8.4, Ph), 6.976 (2H, d, J = 7.2, Ph), 6.433 (1H, s, CH), 5.156 (2H, s, CH2), 
2.266 (3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 138.526, 136.938, 133.052, 132.311, 131.904, 131.585, 
130.173, 128.898, 128.389, 128.080, 127.214, 125.557, 125.431, 122.736, 120.959, 109.012, 47.970, 11.343; GC-MS 
(EI): m/z (tR, min) = 401 (23.62) (M+).
5-(4-Bromophenyl)-1-n-butyl-2-methyl-3-phenyl-1H-pyrrole,  33.  Yield:  20%,  360  mg  (pale-yellow 
solid); mp (ºC): 87-88; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.523 (2H, d, J = 8.4, Ph), 7.423-7.349 (4H, m, Ph), 
7.278 (2H, d, J = 8.4, Ph), 7.207 (1H, t, J = 7.2, Ph), 6.278 (1H, s, CH), 3.884 (2H, t, J = 7.6, NCH2CH2CH2CH3), 
2.419 (3H, s, CH3), 1.587 (2H, quin, J = 7.6, NCH2CH2CH2CH3), 1.225 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.847 
(3H, t, J = 7.6, NCH2CH2CH2CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 137.091, 132.989, 132.302, 131.543, 
130.509, 128.325, 128.102, 126.507, 125.272, 122.322, 120.818, 108.884, 44.263, 33.275, 19.914, 13.656, 11.420; 
GC-MS (EI): m/z (tR, min) = 367 (20.69) (M+).
1-Benzyl-5-(4-chlorophenyl)-2-methyl-3-phenyl-1H-pyrrole, 34. Yield: 20%, 360 mg (pale-yellow solid); 
mp (ºC): 99-101; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.456 (2H, d, J = 7.6, Ph), 7.387 (2H, t, J = 7.6, Ph), 7.326 
(2H, t, J = 7.6, Ph), 7.274-7.208 (6H, m, Ph), 6.980 (2H, d, J = 7.6, Ph), 6.433 (1H, s, CH), 5.156 (2H, s, CH 2), 
2.268 (3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 138.501, 136.902, 133.018, 132.803, 131.791, 129.842, 
128.881, 128.620, 128.382, 128.048, 127.191, 127.109, 125.528, 125.404, 122.619, 108.922, 47.929, 11.335; GC-MS 
(EI): m/z (tR, min) = 357 (21.66) (M+).
1-n-Butyl-5-(4-chlorophenyl)-2-methyl-3-phenyl-1H-pyrrole, 35.  Yield: 19%, 300 mg; mp (ºC): 79-80; 
1H NMR (400 MHz, CDCl3): δ, ppm = 7.416 (2H, d, J = 7.2, Ph), 7.386-7.325 (6H, m, Ph), 7.207 (1H, t, J = 7.2,  
Ph), 6.274 (1H, s, CH), 3.883 (2H, t, J = 7.6, NCH2CH2CH2CH3), 2.422 (3H, s, CH3), 1.587 (2H, quin, J = 7.6, 
NCH2CH2CH2CH3), 1.224 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.844 (3H, t, J = 7.6, NCH2CH2CH2CH3); 13C NMR 
(100 MHz, CDCl3):  δ, ppm = 137.118, 132.728, 132.540, 132.300, 130.229, 128.591, 128.325, 128.102, 126.414, 
125.260, 122.268, 108.856, 44.250, 33.273, 19.914, 13.651, 11.420; GC-MS (EI): m/z (tR, min) = 323 (18.97) (M+).
1-Benzyl-5-(4-fluorophenyl)-2-methyl-3-phenyl-1H-pyrrole,  36.  Yield:  18%,  310  mg  (white  solid); 
mp (ºC): 95-97; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.462 (2H, d, J = 7.6, Ph), 7.388 (2H, t, J = 7.6, Ph), 7.341-
7.206 (6H, m, Ph), 7.015-6.971 (4H, m, Ph), 6.404 (1H, s, CH), 5.143 (2H, s, CH2), 2.271 (3H, s, CH3); 13C NMR 
(100 MHz, CDCl3):  δ, ppm = 162.015 (C, d, J = 245.2), 138.619, 137.003, 133.167, 130.461 (2xCH, d, J = 7.9),  
129.469 (C, d, J = 3.2), 128.844, 128.370, 128.036, 127.145, 126.561, 125.559, 125.334, 122.373, 115.342 (2xCH, d,  
J = 21.3), 108.606, 47.857, 11.348; GC-MS (EI): m/z (tR, min) = 341 (17.93) (M+).
1-n-Butyl-5-(4-fluorophenyl)-2-methyl-3-phenyl-1H-pyrrole, 37.  Yield: 20%, 300 mg (white solid); mp 
(ºC): 59-60; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.422 (2H, d, J = 7.2, Ph), 7.387-7.351 (4H, m, Ph), 7.204 (1H, 
t, J = 7.2, Ph), 7.094 (2H, t, J = 8.2, Ph), 6.249 (1H, s, CH), 3.863 (2H, t, J = 7.6, N CH2CH2CH2CH3), 2.424 (3H, s, 
CH3), 1.577 (2H, quin, J = 7.6, NCH2CH2CH2CH3), 1.216 (2H, sex, J = 7.6, NCH2CH2CH2CH3), 0.831 (3H, t, J = 7.6, 
NCH2CH2CH2CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 162.011 (C, d, J = 244.6), 137.219, 132.449, 130.849 
(2xCH, d, J = 7.9), 130.179 (C, d, J = 3.2), 128.310, 128.088, 125.843, 125.185, 121.993, 115.287 (2xCH, d, J =  
21.2), 108.504, 44.140, 33.262, 19.904, 13.626, 11.414; GC-MS (EI): m/z (tR, min) = 307 (16.51) (M+).
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4. Base-Catalysed Claisen-Schmidt Synthesis of Chalcones
A solution of sodium hydroxide (63 mmol, 2.486 g) in distilled water/ethanol (1:1 v/v, 50 ml) was stirred at 
room  temperature  in  a  100  ml  round-bottomed  flask.  This  was  placed  in  a  water  bath  and  the  selected 
acetophenone or 2-acetyl-1H-pyrrole* (50 mmol) was added, followed by the adequate aldehyde or 2-formyl-1H-
pyrrole (50 mmol). The reaction mixture was left stirring at 20-30 ºC until a thick yellow solid precipitated. This  
was filtered under reduced pressure, thoroughly washed with distilled water and recrystallised in aqueous ethanol, 
yielding the desired chalcone as a yellowish solid (38-47 and 49-55). Chalcone 48 did not easily precipitate from 
the alkaline reaction medium. Hence, the synthetic process was followed over time by TLC and, once completed,  
the  reaction  product  was  washed  with  distilled  water  (50  ml)  and  neutralised  by  the  addition  of  aqueous 
hydrochloric  acid  (37%  m/v)  until  a  yellow  solid  precipitated.  This  was  filtered  under  reduced  pressure, 
thoroughly washed with distilled water and recrystallised in aqueous ethanol, yielding the desired chalcone as a 
pale-yellow solid. Chalcones  41 and  42 were prepared via a 10 mmol stoichiometry of acetophenone and the 
adequate  aldehyde.  Chalcones  54 an  55 were  synthesised  through  a  5  mmol  stoichiometry  of  the  selected 
acetophenone and pyren-1-carbaldehyde.
*The 2-acetyl-1H-pyrrole needed for the synthesis of chalcone 49 was previously prepared through a procedure 
described by Alonso-Garrido and co-workers (see section 6.III.A.5., page 142).[5]
(E)-1,3-Diphenylprop-2-en-1-one, 38. Yield: 85%, 8.850 g (pale-yellow solid); mp (ºC): 53-55 (Lit. 55-57);[6] 
C15H12O: calculated (%) = C 86.51, H 5.81; found (%) = C 86.25, H 5.55; 1H NMR (400 MHz, CDCl3):  δ, ppm = 
8.020 (2H, d, J = 7.6, Ph), 7.811 (1H, d, J = 16, CH-3), 7.643-7.626 (2H, m, Ph), 7.582 (1H, d, J = 7.2, Ph), 7.531 
(1H, d, J = 16, CH-2), 7.482 (2H, d, J = 7.2, Ph), 7.410-7.396 (3H, m, Ph); 13C NMR (100 MHz, CDCl3): δ, ppm = 
190.490, 144.814, 138.152, 134.826, 132.787, 130.543, 128.943, 128.612, 128.486, 128.441, 122.001; GC-MS (EI): 
m/z (tR, min) = 208 (11.69) (M+).
(E)-3-(Naphthalen-1-yl)-1-phenylprop-2-en-1-one, 39. Yield: 81%, 10.400 g (yellow solid); mp (ºC): 79-81; 
1H NMR (400 MHz, CDCl3): δ, ppm = 8.654 (1H, d, J = 15.6, CH-3), 8.219 (1H, d, J = 8.4, Ph), 8.060 (2H, d, J = 
7.6, Ph), 7.889-7.837 (3H, m, Ph), 7.596 (1H, d, J = 15.6, CH-2), 7.558 (2H, d, J = 7.6, Ph), 7.548-7.458 (4H, m, 
Ph); 13C NMR (100 MHz, CDCl3): δ, ppm = 190.292, 141.731, 138.196, 133.771, 132.962, 132.358, 131.805, 130.898, 
128.828, 128.745, 128.652, 127.035, 126.361, 125.507, 125.149, 124.616, 123.521; GC-MS (EI): m/z (tR, min) = 258 
(15.57) (M+).
(E)-3-(Phenanthren-9-yl)-1-phenylprop-2-en-1-one, 40. Yield: 80%, 2.475 g (yellow solid); mp (ºC): 121-
123; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.722 (1H, d, J = 8, Ph), 8.645 (1H, d, J = 15.6, CH-3), 8.638 (1H, d, J = 
8, Ph), 8.252 (1H, d, J = 7.6, Ph), 8.116-8.094 (3H, m, Ph), 7.927 (1H, d, J = 8, Ph), 7.685 (1H, d, J = 15.6, CH-2), 
7.718-7.647 (3H, m, Ph), 7.611 (2H, t, J = 7.6, Ph), 7.533 (2H, t, J = 7.6, Ph); 13C NMR (100 MHz, CDCl3): δ, ppm = 
190.245,  142.464,  138.133,  132.930,  131.558,  131.245,  131.154,  130.471,  130.276,  129.247,  128.707,  128.641,  
127.754, 127.141, 127.062, 127.011, 126.587, 125.201, 124.456, 123.208, 122.670; GC-MS (EI): m/z (t R, min) = 308 
(24.49) (M+).
(E)-3-(Anthracen-9-yl)-1-phenylprop-2-en-1-one, 41. Yield: 83%, 12.850 g (bright-yellow solid); mp (ºC): 
118-120; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.785 (1H, d, J = 16, CH-3), 8.442 (1H, s, Ph), 8.289 (2H, d, J = 
8.4, Ph), 8.078 (2H, d,  J = 7.2, Ph), 8.010 (2H, d,  J = 7.2, Ph), 7.613-7.576 (2H, m, Ph), 7.543 (1H, d,  J = 16, 
CH-2),  7.506-7.467 (5H,  m, Ph);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 189.648, 141.892,  137.834,  133.091, 
131.256, 130.963, 130.107, 129.585, 128.896, 128.744, 128.704, 128.424, 126.416, 125.405, 125.262; GC-MS (EI):  
m/z (tR, min) = 308 (24.11) (M+).
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(E)-1-Phenyl-3-(pyren-1-yl)prop-2-en-1-one, 42.  Yield: 85%, 2.825 g (bright-yellow solid); mp (ºC): 157-
158; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.973 (1H, d, J = 15.6, CH-3), 8.524 (1H, d, J = 8, Ph), 8.396 (1H, d, J = 
8, Ph), 8.210 (2H, d, J = 7.2, Ph), 8.180-8.101 (5H, m, Ph), 8.061-8.001 (2H, m, Ph), 7.800 (1H, d, J = 15.6, CH-2), 
7.622 (1H, t,  J = 7.2, Ph), 7.551 (2H, t,  J = 7.2, Ph);  13C NMR (100 MHz, CDCl3):  δ, ppm = 190.234, 141.465, 
138.427,  132.943,  132.834,  131.300,  130.715,  130.350,  128.708,  128.599,  127.320,  126.315,  126.065,  125.921, 
125.032, 124.975, 124.597, 124.186, 123.960, 122.578; MS (MALDI): m/z = 332 (M+).
(E)-3-(4-Bromophenyl)-1-phenylprop-2-en-1-one, 43.  Yield: 87%, 12.500 g (pale-yellow solid); mp (ºC): 
117-119; C15H11OBr: calculated (%) = C 62.74, H 3.86; found (%) = C 62.62, H 3.90; 1H NMR (400 MHz, CDCl3): δ, 
ppm = 8.014 (2H, d, J = 7.2, Ph), 7.737 (1H, d, J = 15.6, CH-3), 7.613-7.574 (3H, m, Ph), 7.546 (2H, d, J = 8, Ph), 
7.506 (1H, d, J = 15.6, CH-2), 7.496 (2H, d, J = 8, Ph); 13C NMR (100 MHz, CDCl3): δ, ppm = 190.179, 143.350, 
137.957, 133.756, 132.950, 132.187, 129.787, 128.669, 128.488, 124.792, 122.476; GC-MS (EI): m/z (tR, min) = 286 
(13.86) (M+).
(E)-3-(4-Chlorophenyl)-1-phenylprop-2-en-1-one, 44.  Yield: 78%, 9.500 g (pale-yellow solid); mp (ºC): 
110-111 (Lit.  113-117);[7] C15H11OCl: calculated (%) = C 74.23, H 4.57; found (%) = C 74.18, H 4.34;  1H NMR 
(400 MHz, CDCl3): δ, ppm = 8.019 (2H, d, J = 7.2, Ph), 7.742 (1H, d, J = 16, CH-3), 7.618-7.590 (1H, m, Ph), 7.580 
(2H, d,  J = 8.4, Ph), 7.530-7.494 (2H, m, Ph), 7.511 (1H, d, J = 16, CH-2), 7.396 (2H, d, J = 8.4, Ph);  13C NMR 
(100 MHz, CDCl3):  δ, ppm = 190.236, 143.321, 138.001, 136.431, 133.351, 132.949, 129.595, 129.248, 128.680,  
128.499, 122.417; GC-MS (EI): m/z (tR, min) = 242 (13.24) (M+).
(E)-3-(4-Fluorophenyl)-1-phenylprop-2-en-1-one, 45.  Yield: 70%, 7.880 g (pale-yellow solid); mp (ºC): 
85-86 (Lit.  84-88);[8]  C15H11OF:  calculated  (%)  =  C  79.63,  H 4.90;  found  (%)  =  C  79.33,  H 5.31;  1H NMR 
(400 MHz, CDCl3): δ, ppm = 8.016 (2H, d, J = 7.8, Ph), 7.773 (1H, d, J = 15.8, CH-3), 7.628 (2H, dd, J = 8.4, 5.6, 
Ph), 7.576 (1H, d, J = 7.8, CH-2), 7.509 (2H, d, J = 7.8, Ph), 7.462 (1H, d, J = 15.8, CH-2), 7.101 (2H, t, J = 8.4, 
Ph); 13C NMR (100 MHz, CDCl3): δ, ppm = 190.284, 164.041 (C, d, J = 250.2), 143.501, 138.086, 132.868, 131.112 
(C, d, J = 3.2), 130.359 (2xCH, d, J = 9.2), 128.654, 128.478, 121.694, 116.126 (2xCH, d, J = 21.8); GC-MS (EI): 
m/z (tR, min) = 226 (12.22) (M+).
(E)-3-(4-Nitrophenyl)-1-phenylprop-2-en-1-one, 46.  Yield: 75%, 9.500 g (bright-yellow solid); mp (ºC): 
155-158 (Lit. 158-160);[9] 1H NMR (400 MHz, CDCl3): δ, ppm = 8.289 (2H, d, J = 8.8, Ph), 8.046 (2H, d, J = 7.2, 
Ph), 7.831 (1H, d, J = 16, CH-3), 7.799 (2H, d, J = 8.8, Ph), 7.656 (1H, d, J = 16, CH-2), 7.638 (1H, t, J = 7.2, Ph), 
7.542 (2H, t,  J = 7.2, Ph);  13C NMR (100 MHz, CDCl3):  δ, ppm = 189.659, 148.549, 141.535, 141.038, 137.517, 
133.400, 128.954, 128.841, 128.607, 125.684, 124.241; GC-MS (EI): m/z (tR, min) = 253 (14.71) (M+).
(E)-3-(4-Methoxyphenyl)-1-phenylprop-2-en-1-one, 47. Yield: 75%, 8.950 g (pale-yellow solid); mp (ºC): 
71-72  (Lit.  73-76);[10]  C16H14O2:  calculated  (%)  =  C  80.65,  H 5.92;  found (%)  =  C  80.76,  H 5.69;  1H NMR 
(400 MHz, CDCl3): δ, ppm = 8.006 (2H, dd, J = 7.2, 1.2, Ph), 7.801 (1H, d, J = 15.6, CH-3), 7.584 (2H, dd, J = 8.8, 
2, Ph), 7.562-7.534 (1H, m, Ph), 7.503-7.458 (2H, m, Ph), 7.410 (1H, d, J = 15.6, CH-2), 6.602 (2H, dd, J = 8.8, 2, 
Ph), 3.820 (3H, s, OCH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 190.584, 161.742, 144.761, 138.540, 132.651, 
130.324, 128.641, 128.487, 127.633, 119.753, 114.480, 55.458; GC-MS (EI): m/z (tR, min) = 238 (13.79) (M+).
(E)-3-(3-Hydroxyphenyl)-1-phenylprop-2-en-1-one, 48. Yield: 70%, 7.850 g (pale-yellow solid); mp (ºC): 
156-158; 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.661 (1H, bs, OH), 8.145 (2H, d, J = 7.6, Ph), 7.839 (1H, d, J = 
15.6, CH-3), 7.698-7.644 (1H, m, Ph), 7.679 (1H, d, J = 15.6, CH-2), 7.566 (2H, t, J = 7.6, Ph), 7.321 (1H, d, J = 7.6, 
Ph),  7.287-7.257 (2H, m, Ph), 6.905 (1H, d,  J = 7.6, Ph);  13C NMR (100 MHz, (CD3)2SO):  δ,  ppm = 189.214, 
157.737,  144.266,  137.584,  135.910,  133.047,  129.863,  128.742,  128.464,  121.889,  119.840,  117.834,  115.265; 
GC-MS (EI): m/z (tR, min) = 224 (13.84) (M+).
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(E)-1-Phenyl-3-(1H-pyrrol-2-yl)prop-2-en-1-one, 49. Yield: 88%, 8.500 g (yellow solid); mp (ºC): 127-129; 
1H NMR (400 MHz, CDCl3): δ, ppm = 9.297 (1H, bs, NH), 7.975 (2H, d, J = 7.6, Ph), 7.769 (1H, d, J = 15.6, CH-3), 
7.546 (1H, t, J = 7.6, Ph), 7.461 (2H, t, J = 7.6, Ph), 7.191 (1H, d, J = 15.6, CH-2), 6.991 (1H, s, CH-5-pyrrole), 6.714 
(1H, s,  CH-3-pyrrole),  6.327 (1H, d, J = 2.4,  CH-4-pyrrole);  13C NMR (100 MHz, CDCl3):  δ,  ppm = 190.770, 
138.703, 134.942, 132.399, 129.342, 128.559, 128.293, 123.353, 115.792, 115.348, 111.516; GC-MS (EI): m/z (t R, 
min) = 197 (10.94) (M+).
(E)-1-(4-Bromophenyl)-3-phenylprop-2-en-1-one, 50.  Yield: 80%, 11.420 g (pale-yellow solid); mp (ºC): 
99-100 (Lit. 103-105);[11] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.877 (2H, d, J = 8.4, Ph), 7.807 (1H, d, J = 15.6, 
CH-3), 7.629 (4H, d, J = 8.8, Ph), 7.485 (1H, d, J = 15.6, CH-2), 7.421-7.406 (3H, m, Ph);  13C NMR (100 MHz, 
CDCl3):  δ,  ppm = 189.304,  145.368,  136.921,  134.688,  131.914,  130.737,  130.012,  128.994,  128.506,  127.875,  
121.475; GC-MS (EI): m/z (tR, min) = 286 (13.60) (M+).
(E)-1-(4-Chlorophenyl)-3-phenylprop-2-en-1-one,  51.  Yield:  77%,  9.350 g  (pale-yellow solid);  mp (ºC): 
94-95 (Lit. 97-101);[12] 1H NMR (400 MHz, CDCl3):  δ, ppm = 7.960 (2H, d,  J = 8.4, Ph), 7.810 (1H, d,  J = 16, 
CH-3), 7.637-7.624 (2H, m, Ph), 7.478 (1H, d, J = 16, CH-2), 7.469 (2H, d, J = 8.4, Ph), 7.425-7.411 (3H, m, Ph); 
13C NMR (100 MHz, CDCl3):  δ, ppm = 189.085, 145.294, 139.188, 136.499, 134.699, 130.717, 129.899, 128.988, 
128.923, 128.501, 121.489; GC-MS (EI): m/z (tR, min) = 242 (13.03) (M+).
(E)-1-(4-Fluorophenyl)-3-phenylprop-2-en-1-one, 52.  Yield:  72%, 7.870 g (pale-yellow solid);  mp (ºC): 
134-136; 1H NMR (400 MHz, CDCl3):  δ, ppm = 8.050 (2H, dd,  J = 8.6, 5.6, Ph), 7.807 (1H, d,  J = 15.6, CH-3), 
7.640-7.619 (2H, m, Ph),  7.496 (1H, d,  J = 15.6, CH-2),  7.416-7.401 (3H, m, Ph), 7.160 (2H, t,  J = 8.4, Ph); 
13C NMR (100 MHz, CDCl3): δ, ppm = 188.776, 165.603 (C, d, J = 253), 145.024, 134.775, 134.542 (C, d, J = 2.8), 
131.093 (2xCH, d, J = 9.2), 130.651, 128.990, 128.475, 121.583, 115.736 (2xCH, d, J = 21.7); GC-MS (EI): m/z (tR, 
min) = 226 (12.02) (M+).
(E)-3-Phenyl-1-(1H-pyrrol-2-yl)prop-2-en-1-one, 53. Yield: 90%, 8.900 g (yellow solid); mp (ºC): 134-136; 
1H NMR (400 MHz, CDCl3): δ, ppm = 10.186 (1H, bs, NH), 7.834 (1H, d, J = 15.6, CH-3), 7.639 (2H, d, J = 7.6, 
Ph), 7.414-7.397 (3H, m, Ph), 7.352 (1H, s, CH-5-pyrrole), 7.116 (1H, d, J = 15.6, 1H, CH-2), 7.096 (1H, s, CH-3-
pyrrole), 6.353 (1H, d, J = 3.2, CH-4-pyrrole); 13C NMR (100 MHz, CDCl3): δ, ppm = 178.967, 142.299, 135.074, 
133.198, 130.224, 128.921, 128.343, 125.669, 122.076, 116.561, 110.984; GC-MS (EI): m/z (tR, min) = 197 (12.03) 
(M+).
(E)-3-(Pyren-1-yl)-1-(2-(trifluoromethyl)phenyl)prop-2-en-1-one, 54. Yield: 83%, 1.660 g (bright-yellow 
solid); mp (ºC): 135-136; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.506 (1H, d, J = 16, CH-3), 8.301 (1H, d, J = 8.4, 
Ph), 8.215-8.182 (3H, m, Ph), 8.132-8.082 (3H, m, Ph), 8.035-7.993 (2H, m, Ph), 7.847 (1H, d, J = 7.6, Ph), 7.733-
7.611 (3H, m, Ph), 7.318 (1H, d, J = 16, CH-2); 13C NMR (100 MHz, CDCl3): δ, ppm = 194.720, 144.046, 139.357, 
133.266,  131.811,  131.253,  130.565,  130.228,  130.022,  129.002,  128.920,  128.272,  127.745,  127.324,  126.876, 
126.830, 126.378, 126.294, 126.069, 125.128, 124.867, 124.487, 124.342, 121.989; MS (MALDI): m/z = 400 (M+).
(E)-1-(2-Fluoro-6-(trifluoromethyl)phenyl)-3-(pyren-1-yl)prop-2-en-1-one,  55. Yield:  85%,  1.780  g 
(bright-yellow solid); mp (ºC): 193-194;  1H NMR (400 MHz, CDCl3):  δ, ppm = 8.485 (1H, d, J = 15.8, CH-3), 
8.308 (1H, d, J = 8.4, Ph), 8.229-8.095 (6H, m, Ph), 8.047-8.004 (2H, m, Ph), 7.652-7.609 (2H, m, Ph), 7.475-
7.435 (1H, m, Ph), 7.295 (1H, d, J = 15.8, CH-2); 13C NMR (100 MHz, CDCl3): δ, ppm = 190.442, 160.515, 158.043, 
144.167,  133.389,  131.332,  131.257,  130.564,  130.238,  129.086,  129.009,  127.597,  127.339,  126.398,  126.357, 
126.116, 125.139, 124.870, 124.548, 124.489, 122.491, 121.917, 119.902, 119.682; MS (MALDI): m/z = 418 (M+).
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5. Vilsmeier-Haack Acetylation of Pyrrole
A solution of N,N-dimethylacetamide (100 mmol, 9.36 ml) in toluene (50 ml) was stirred at room temperature 
in a 250 ml round-bottomed flask. This was placed in a water/ice bath and a solution of phosphorous oxychloride 
(100 mmol, 9.25 ml) in toluene (50 ml) was added drop-wise during 30 minutes. The reaction mixture was stirred  
at room temperature for 30 minutes, placed again in a water/ice bath and a solution of pyrrole (100 mmol, 7.14 
ml) in toluene (20 ml) was added drop-wise during 30 minutes. The reaction mixture was left stirring at room 
temperature overnight (16-18 hours) under moisture exclusion conditions (calcium chloride tower). After cooling 
in an ice bath, the reaction product was washed with distilled water (100 ml), neutralised by addition of solid 
sodium bicarbonate, alkalised to pH=12 by addition of aqueous sodium hydroxide (40% m/v) and stirred at room 
temperature for 1 hour. The aqueous phase was separated and extracted with dichloromethane (3x100 ml), the  
organic extracts being collected and pooled with the initial toluene phase. The resulting solution was dried over  
anhydrous sodium sulphate,  filtered and evaporated under reduced pressure and the yellow oil  obtained was  
purified through  SiO2 flash column chromatography (12x3 cm), using dichloromethane as eluent.  The pyrrole-
containing  fraction was  collected  and  evaporated  under  reduced pressure  and  the  yellow solid  obtained was 
recrystallised in ethyl acetate/n-hexane, yielding the desired 2-acetyl-1H-pyrrole as a pale-yellow solid (56).
2-Acetyl-1H-pyrrole,  56.  Yield:  70%, 6.450 g (pale-yellow solid); mp (ºC): 86-87 (Lit.  88-89);[5] 1H NMR 
(400 MHz, CDCl3): δ, ppm = 10.326 (1H, bs, NH), 7.061 (1H, s, CH-5), 6.928 (1H, s, CH-3), 6.262 (1H, s, CH-4),  
2.444 (3H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 188.320, 132.197, 125.240, 117.240, 110.545, 25.450; 
GC-MS (EI): m/z (tR, min) = 109 (6.92) (M+).
B. Porphyrins
1. Synthesis of meso-Tetraarylporphyrins
i. One-Step Methodology
A mixture of the selected aldehyde (10 mmol) and pyrrole (10 mmol, 0.72 ml) in propionic acid/nitrobenzene 
(7:3 v/v, 5 ml) was thoroughly mixed in an appropriate 10 ml thick-walled glass vial. This was tightly sealed with a 
Teflon cap and the reaction mixture was stirred and heated at 200 ºC for 5 minutes, under microwave irradiation,  
with an initial  power setting of 250 W. After cooling to room temperature, the reaction product was purified 
through SiO2 flash column chromatography (12x3 cm), using dichloromethane/n-hexane (5:1 v/v, 58-60, 62-64, 
69 and 70), dichloromethane/ethyl acetate (9:1 v/v,  65,  74,  75,  79 and 80; 1:1 v/v,  66,  72,  76-78 and 81) or 
dichloromethane/methanol  (95:5  v/v,  61)  as  eluents.  The  porphyrin-containing  fraction  was  collected  and 
evaporated  under  reduced  pressure  and  the  reddish-brown  solid  obtained  was  recrystallised  in 
dichloromethane/methanol (58-60, 62-65,  69,  70,  74, 75,  79 and 80) or ethyl acetate/n-hexane (61,  66,  72, 
76-78 and 81), yielding the desired porphyrin as a dark-purple solid. Porphyrins 57,  67,  68 and 71 were easily 
crystallised from the reaction product by addition of methanol  (100 ml). The dark-purple solid obtained was  
filtered under reduced pressure and thoroughly washed with methanol. Porphyrin 73 was easily crystallised from 
the reaction product by addition of acetone (100 ml). The dark-purple solid obtained was filtered under reduced 
pressure and thoroughly washed with acetone.
5,10,15,20-Tetraphenylporphyrin, 57.  Yield: 46%, 710 mg (dark-purple solid); mp (ºC) > 300; C44H30N4: 
calculated (%) = C 85.97, H 4.92, N 9.11; found (%) = C 86.13, H 5.02, N 8.85; UV-Vis (CH 2Cl2): λmax, nm (relative 
absorbance, %) = 416 (100), 513.5 (6.7), 548 (3.6), 588.5 (2.9), 645.5 (2.8); 1H NMR (300 MHz, CDCl3): δ, ppm = 
8.847 (8H, s, CH), 8.236-8.305 (8H, m, Ph), 7.792-7.731 (12H, m, Ph), -2.787 (2H, bs, NH); MS (ESI): m/z = 615  
([M+H]+).
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5,10,15,20-Tetrakis(naphthalen-1-yl)porphyrin, 58.  Yield: 15%, 315 mg  (dark-purple solid); mp (ºC) > 
300; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 277 (8.2), 423 (100), 515 (6.3), 547 (2.7), 589 (3), 648 
(2.1); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.474 (8H, s, CH), 8.295-8.208 (8H, m, Ph), 8.102 (4H, d, J = 7.6, 
Ph), 7.820 (4H, t, J = 7.6, Ph), 7.463 (4H, t, J = 7.6, Ph), 7.232-7.107 (8H, m, Ph), -2.241 (2H, bs, NH); MS (ESI):  
m/z = 815 ([M+H]+).
5,10,15,20-Tetrakis(phenanthren-9-yl)porphyrin, 59.  Yield: 9%, 225 mg (dark-purple solid); mp (ºC) > 
300; UV-Vis (CH2Cl2):  λmax, nm (relative absorbance, %) = 253 (56.5), 292 (14.2), 426 (100), 516 (7.8), 548 (3), 
589 (3.3), 650 (2.2); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.953 (8H, t, J = 7.6, Ph), 8.609 (8H, s, CH), 8.574-
8.506 (4H, m, Ph), 8.030 (4H, d, J = 7.6, Ph), 7.843 (4H, t, J = 7.6, Ph), 7.766-7.731 (4H, m Ph), 7.620 (4H, t, J = 
7.6, Ph), 7.347-7.194 (8H, m, Ph), -2.092 (2H, bs, NH); MS (ESI): m/z = 1015 ([M+H]+).
5,10,15,20-Tetrakis(pyren-1-yl)porphyrin,  60.  Yield:  4%,  100 mg (dark-purple  solid);  mp (ºC)  >  300; 
UV-Vis (CH2Cl2):  λmax, nm (relative absorbance, %) = 241 (86), 274 (50), 324 (31.1), 337 (35.2), 371 (19.3), 431 
(100), 519 (10.1), 555 (5.2), 591 (4.3), 648 (2.9); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.857-8.750 (4H, m, Ph), 
8.459-8.411 (4H, m, Ph), 8.425 (8H, s, CH), 8.337-8.242 (12H, m, Ph), 8.092-8.001 (8H, m, Ph), 7.752-7.697 (4H,  
m, Ph), 7.643-7.603 (1H, m, Ph), 7.554 (1H, d, J = 9.2, Ph), 7.489 (2H, d, J = 9.2, Ph), -1.945 (2H, bs, NH); MS  
(ESI): m/z = 1111 ([M+H]+).
5,10,15,20-Tetrakis(pyridin-4-yl)porphyrin, 61.  Yield: 18%, 275 mg (dark-purple solid); mp (ºC) > 300; 
UV-Vis (CH2Cl2):  λmax, nm (relative absorbance, %) = 415 (100), 510.5 (7.7), 544 (3.7), 585.5 (3.9), 641.5 (2.7); 
1H NMR (400 MHz, CDCl3): δ, ppm = 9.067 (8H, d, J = 4.2, Ph), 8.872 (8H, s, CH), 8.163 (8H, d, J = 4.2, Ph),  
-2.917 (2H, bs, NH); MS (ESI): m/z = 619 ([M+H]+).
5,10,15,20-Tetrakis(2,6-dichlorophenyl)porphyrin, 62. Yield: 5%, 110 mg (dark-purple solid); mp (ºC) > 
300; C44H22N4Cl8: calculated (%) = C 59.36, H 2.49, N 6.29; found (%) = C 59.56, H 2.73, N 6.35; UV-Vis (CH 2Cl2): 
λmax, nm (relative absorbance, %) = 416.5 (100), 511.5 (8.1), 541 (3.2), 587 (4.1), 655.5 (2.4); 1H NMR (300 MHz, 
CDCl3): δ, ppm = 8.677 (8H, s, CH), 7.851-7.653 (12H, m, Ph), -2.530 (2H, bs, NH-pyrrole); MS (ESI): m/z = 890  
([M+H]+).
5,10,15,20-Tetramesitylporphyrin,  63.  Yield:  2%,  30  mg  (dark-purple  solid);  mp  (ºC)  >  300;  UV-Vis 
(CH2Cl2): λmax, nm (relative absorbance, %) = 417 (100), 513.5 (6.7), 546 (3.2), 589.5 (3.1), 646 (2.3); 1H NMR (300 
MHz, CDCl3): δ, ppm = 8.614 (8H, s, CH), 7.255 (8H, s, Ph), 2.619 (12H, s, CH3), 1.848 (24H, s, CH3), -2.512 (2H, 
bs, NH); MS (ESI): m/z = 783 ([M+H]+).
5,10,15,20-Tetrakis(3-nitrophenyl)porphyrin, 64. Yield: 22%, 435 mg (dark-purple solid); mp (ºC) > 300; 
C44H26N8O8: calculated (%) = C 66.50, H 3.30, N 14.10; found (%) = C 66.69, H 3.54, N 13.98; UV-Vis (CH2Cl2): 
λmax, nm (relative absorbance, %) = 420 (100), 512.5 (10.1), 547 (5.9), 586.5 (6.1), 644.5 (5.1); 1H NMR (300 MHz, 
CDCl3): δ, ppm = 9.092 (4H, s, Ph), 8.820 (8H, s, CH), 8.721 (4H, d, J = 7.8, Ph), 8.565 (4H, d, J = 7.8, Ph), 7.999 
(4H, t, J = 7.8, Ph), -2.828 (2H, bs, NH); MS (ESI): m/z = 795 ([M+H]+).
5,10,15,20-Tetrakis(3-methoxyphenyl)porphyrin, 65. Yield: 30%, 550 mg (dark-purple solid); mp (ºC) > 
300; C48H38N4O4: calculated (%) = C 78.45, H 5.21, N 7.62; found (%) = C 78.12, H 5.02, N 7.43; UV-Vis (CH 2Cl2): 
λmax, nm (relative absorbance, %) 417.5 (100), 513.5 (5.7), 548.5 (2.9), 588 (2.7), 644.5 (2.3); 1H NMR (300 MHz, 
CDCl3): δ, ppm = 8.886 (8H, s, CH), 7.812-7.794 (8H, m, Ph), 7.637 (4H, t, J = 8.4, Ph), 7.328 (4H, dd, J = 8.4, 
2.5, Ph), 3.978 (12H, s, OCH3), -2.807 (2H, bs, NH); MS (ESI): m/z = 735 ([M+H]+).
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5,10,15,20-Tetrakis(3-hydroxyphenyl)porphyrin, 66. Yield: 36%, 615 mg (dark-purple solid); mp (ºC) > 
300; C44H30N4O4: calculated (%) = C 77.86, H 4.46, N 8.25; found (%) = C 77.62, H 4.32, N 8.12; UV-Vis (CH 3OH): 
λmax, nm (relative absorbance, %) = 413 (100), 510.5 (7.1), 545.5 (4.1), 586 (3.5), 643 (3.1);  1H NMR (400 MHz, 
(CD3)2SO): δ, ppm = 9.889 (4H, bs, OH), 8.894 (8H, s, CH), 7.600-7.578 (12H, m, Ph), 7.266 (4H, d, J = 8.4, Ph), 
-2.968 (2H, bs, NH); MS (ESI): m/z = 679 ([M+H]+).
5,10,15,20-Tetrakis(4-t-butylphenyl)porphyrin, 67.  Yield:  55%, 1.150 g (dark-purple  solid);  mp (ºC) > 
300; UV-Vis (CH2Cl2):  λmax, nm (relative absorbance, %) = 416 (100), 513.5 (6.7), 548 (3.6), 588.5 (2.9), 645.5 
(2.8); 1H NMR (300 MHz, CDCl3): δ, ppm = 8.871 (8H, s, CH), 8.143 (8H, d, J = 8.2, Ph), 8.03 (8H, d, J = 8.2, 
Ph), 1.607 (36H, s, CH3), -2.751 (2H, bs, NH); MS (ESI): m/z = 839 ([M+H]+).
5,10,15,20-Tetra-p-tolylporphyrin, 68.  Yield:  50%, 830 mg  (dark-purple  solid);  mp (ºC) > 300; UV-Vis 
(CH2Cl2):  λmax,  nm (relative  absorbance,  %)  =  419 (100),  515  (6),  551  (3.9),  589.5  (2.9),  647 (2.8);  1H NMR 
(400 MHz, CDCl3): δ, ppm = 8.848 (8H, s, CH), 8.092 (8H, d, J = 7.6, Ph), 7.547 (8H, d, J = 7.6, Ph), 2.699 (12H,  
s, CH3), -2.769 (2H, bs, NH); MS (ESI): m/z = 671 ([M+H]+).
5,10,15,20-Tetrakis(4-bromophenyl)porphyrin, 69.  Yield: 30%, 715 mg  (dark-purple solid); mp (ºC) > 
300; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 418 (100), 513.5 (6.6), 548 (4.1), 588.5 (3.5), 645 (2.9);  
1H NMR (300 MHz, CDCl3): δ, ppm = 8.841 (8H, s, CH), 8.069 (8H, d, J = 8.3, Ph), 7.903 (8H, d, J = 8.3, Ph),  
-2.880 (2H, bs, NH); MS (ESI): m/z = 931 ([M+H]+).
5,10,15,20-Tetrakis(4-chlorophenyl)porphyrin, 70.  Yield:  33%, 615 mg  (dark-purple  solid);  mp (ºC) > 
300; C44H26N4Cl4: calculated (%) = C 70.23, H 3.48, N 7.45; found (%) = C 70.45, H 3.70, N 7.22; (CH2Cl2): λmax, 
nm (relative absorbance, %) =  417.5 (100), 513.5 (6.3), 548.5 (3.8), 587.5 (3.2), 645 (2.6); 1H NMR (300 MHz, 
CDCl3): δ, ppm = 8.841 (8H, s, CH), 8.133 (8H, d, J = 8.4, Ph), 7.750 (8H, d, J = 8.4, Ph), -2.868 (2H, bs, NH); 
MS (ESI): m/z = 753 ([M+H]+).
5,10,15,20-Tetrakis(4-methoxyphenyl)porphyrin, 71. Yield: 50%, 920 mg (dark-purple solid); mp (ºC) > 
300; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 420 (100), 517 (7.3), 554 (5.8), 592.5 (4.3), 649.5 (4.4);  
1H NMR (300 MHz, CDCl3): δ, ppm = 8.864 (8H, s, CH), 8.244 (8H, d, J = 8.4, Ph), 7.290 (8H, d, J = 8.4, Ph),  
4.102 (12H, s, OCH3), -2.758 (2H, bs, NH); MS (ESI): m/z = 735 ([M+H]+).
5,10,15,20-Tetrakis(4-hydroxyphenyl)porphyrin, 72.  Yield: 35%, 590 mg (dark-purple solid); mp (ºC) > 
300; UV-Vis (CH3OH): λmax, nm (relative absorbance, %) = 417.5 (100), 516 (5.5), 553.5 (4.5), 589.5 (2.8), 649.5 
(3); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 10.009 (4H, bs, OH), 8.862 (8H, s, CH), 7.993 (8H, d, J = 8, Ph), 
7.209 (8H, d, J = 8, Ph), -2.884 (2H, bs, NH); MS (ESI): m/z = 679 ([M+H]+).
5,10,15,20-Tetrakis(4-carboxyphenyl)porphyrin, 73.  Yield: 88%, 1.750 g  (dark-purple solid); mp (ºC) > 
300; UV-Vis (CH3OH):  λmax, nm (relative absorbance, %) = 414.5 (100), 511.5 (7.3), 545.5 (4.9), 587 (4.1), 644 
(3.6); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 8.863 (8H, s, CH), 8.393 (8H, d, J = 8, Ph), 8.349 (8H, d, J = 8,  
Ph), -2.938 (2H, bs, NH); MS (ESI): m/z = 791 ([M+H]+).
5,10,15,20-Tetrakis(3-chloro-4-methoxyphenyl)porphyrin, 74. Yield: 25%, 540 mg (dark-purple solid); 
mp (ºC) > 300; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 421.5 (100), 516 (7.2), 552.5 (4.9), 589 (3.7), 
647.5 (3.3); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.873 (8H, s, CH), 8.243 (4H, s, Ph), 8.052 (4H, d, J = 8, Ph), 
7.313 (4H, d, J = 8, Ph), 4.201 (12H, s, OCH3), -2.848 (2H, bs, NH); MS (ESI): m/z = 873 ([M+H]+).
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5,10,15,20-Tetrakis(3,4-dimethoxyphenyl)porphyrin,  75.  Yield:  30%,  650  mg  (dark-purple  solid); 
mp (ºC) > 300; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 424.5 (100), 518 (6.3), 556 (4.4), 591 (3), 649  
(3.2); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.930 (8H, s, CH), 7.406-7.390 (8H, m, Ph), 6.898 (4H, s, Ph), 3.958 
(24H, s, OCH3), -2.826 (2H, bs, NH); MS (MALDI): m/z = 855 ([M+H]+).
5,10,15,20-Tetrakis(4-hydroxy-3-methoxyphenyl)porphyrin,  76.  Yield:  23%,  450  mg  (dark-purple 
solid); mp (ºC) > 300; UV-Vis (CH3OH):  λmax, nm (relative absorbance, %) = 421 (100), 516 (6.7), 553.5 (5.2), 
592.5 (3.3), 650 (3.5); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.507 (4H, bs, OH), 8.914 (8H, s, CH), 7.778 (4H, 
s, Ph), 7.587 (4H, d, J = 8, Ph), 7.217 (4H, d, J = 8, Ph), 3.904 (12H, s, OCH 3), -2.859 (2H, bs, NH); MS (ESI): 
m/z = 799 ([M+H]+).
5,10,15,20-Tetrakis(3-hydroxy-4-methoxyphenyl)porphyrin,  77.  Yield:  25%,  500  mg  (dark-purple 
solid); mp (ºC) > 300;  UV-Vis (CH3OH):  λmax, nm (relative absorbance, %) = 420 (100), 515.5 (6.7), 552.5 (5), 
590.5 (3.6), 648 (3.4);  1H NMR (400 MHz,  (CD3)2SO):  δ, ppm = 9.453 (4H, bs, OH), 8.886 (8H, s, CH), 7.630 
(4H, s, Ph), 7.573 (4H, d, J = 8, Ph), 7.340 (4H, d, J = 8, Ph), 4.059 (12H, s, OCH 3), -2.932 (4H, bs, NH); MS 
(ESI): m/z = 799 ([M+H]+).
5,10,15,20-Tetrakis(3,4-dihydroxyphenyl)porphyrin,  78.  Yield:  33%,  620 mg  (dark-purple  solid);  mp 
(ºC) > 300; UV-Vis (CH3OH):  λmax, nm (relative absorbance, %) = 421 (100), 517 (6.2), 556 (4.9), 590.5 (3.3), 
649.5 (3.3); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.406 (4H, bs, OH), 9.361 (4H, bs, OH), 8.902 (8H, s, CH), 
7.591 (4H, s, Ph), 7.452 (4H, d, J = 7.6, Ph), 7.167 (4H, d, J = 7.6, Ph), -2.905 (2H, bs, NH); MS (ESI): m/z = 743  
([M+H]+).
5,10,15,20-Tetrakis(3,5-dimethoxyphenyl)porphyrin, 79.  Yield:  28%,  590 mg  (dark-purple  solid);  mp 
(ºC) > 300; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 420 (100), 513.5 (6.8), 548 (3.1), 587 (3.1), 643.5 
(2.2); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.930 (8H, s, CH), 7.398 (8H, s, Ph), 6.898 (4H, s, Ph), 3.958 (24H, s, 
OCH3), -2.826 (2H, bs, NH); MS (ESI): m/z = 855 ([M+H]+).
5,10,15,20-Tetrakis(3,4,5-trimethoxyphenyl)porphyrin,  80.  Yield:  39%,  950  mg  (dark-purple  solid); 
mp (ºC) > 300; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 422.5 (100), 515.5 (7.4), 552 (3.9), 589 (3.2),  
646.5 (2.7); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.961 (8H, s, CH), 7.472 (8H, s, Ph), 4.185 (12H, s, OCH3), 3.971 
(24H, s, OCH3), -2.775 (2H, bs, NH); MS (ESI): m/z = 975 ([M+H]+).
5,10,15,20-Tetrakis(4-hydroxy-3,5-dimethoxyphenyl)porphyrin, 81.  Yield: 35%, 800 mg (dark-purple 
solid); mp (ºC) > 300; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 424 (100), 518 (7.8), 555 (5), 590.5 
(3.9), 648.5 (3.5); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 8.937 (8H, s, CH), 7.471 (8H, s, Ph), 5.888 (4H, bs, 
OH), 4.007 (24H, s, OCH3), -2.753 (2H, bs, NH); MS (ESI): m/z = 919 ([M+H]+).
A mixture  of  the  selected  aldehyde  (2.5  mmol),  3-hydroxybenzaldehyde  (7.5  mmol,  945  mg)  and  pyrrole 
(10 mmol, 0.72 ml) in propionic acid/nitrobenzene (7:3 v/v, 5 ml) was thoroughly mixed in an appropriate 10 ml 
thick-walled glass vial. This was tightly sealed with a Teflon cap and the reaction mixture was stirred and heated  
at 200 ºC for 5 minutes, under microwave irradiation, with an initial power setting of 250 W. After cooling to  
room temperature, the reaction product was purified through SiO2 flash column chromatography (12x3 cm), using 
dichloromethane/ethyl acetate (1:1 v/v) as eluent. A broad fraction containing a mixture of porphyrins and other  
by-products was collected and evaporated under reduced pressure and the reddish-brown oil obtained was further 
purified through SiO2 flash column chromatography (12x4 cm), using dichloromethane and dichloromethane/ 
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ethyl acetate (firstly 9:1 v/v, followed by 7:3 v/v and, finally, 1:1 v/v) as eluents. The porphyrin-containing fraction  
was collected and evaporated under reduced pressure and the reddish-brown solid obtained was recrystallised in 
ethyl acetate/n-hexane, yielding the desired porphyrin as a dark-purple solid (82-87). 
5,10,15-Tris(3-hydroxyphenyl)-20-(naphthalen-1-yl)porphyrin,  82.  Yield:  10%,  170  mg  (dark-purple 
solid); mp (ºC) > 300; UV-Vis (CH3OH): λmax, nm (relative absorbance, %) = 276 (8.9), 415 (100), 512 (7.8), 545 
(3.7), 587 (3.4), 643 (2.6); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.866 (3H, bs, OH), 8.904 (4H, s, CH), 8.797 
(2H, d, J = 4.4, CH), 8.512 (2H, d, J = 4.4, CH), 8.425 (1H, d, J = 8.4, Ph), 8.322 (1H, d, J = 7.6, Ph), 8.261 (1H, d,  
J = 8.4, Ph), 7.969 (1H, t, J = 7.6, Ph), 7.613-7.528 (11H, m, Ph), 7.301-7.248 (2H, m, Ph), 7.221 (2H, d, J = 8.4,  
Ph), -2.976 (2H, bs, NH); MS (ESI): m/z = 713 ([M+H]+).
5,10,15-Tris(3-hydroxyphenyl)-20-(phenanthren-9-yl)porphyrin, 83.  Yield:  8%, 160 mg  (dark-purple 
solid); mp (ºC) > 300; UV-Vis (CH3OH): λmax, nm (relative absorbance, %) = 251 (20.4), 416 (100), 512 (6.9), 546 
(3.5), 587 (3.3), 645 (2.7); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.884 (3H, bs, OH), 9.170 (2H, d, J = 8.4, Ph), 
8.915 (4H, s, CH), 8.794 (2H, d, J = 4.4, CH), 8.687 (1H, s, Ph), 8.665 (2H, d, J = 4.4, CH), 8.229 (1H, d, J = 7.6,  
Ph), 7.946 (1H, t, J = 7.6, Ph), 7.855 (1H, t, J = 7.6, Ph), 7.729-7.553 (11H, m, Ph), 7.303-7.257 (2H, m, Ph), 7.219  
(2H, d, J = 8.4, Ph), -2.757 (2H, bs, NH); MS (ESI): m/z = 763 ([M+H]+).
5,10,15-Tris(3-hydroxyphenyl)-20-(pyren-1-yl)porphyrin, 84. Yield: 9%, 180 mg (dark-purple solid); mp 
(ºC) > 300; UV-Vis (CH3OH): λmax, nm (relative absorbance, %) = 240 (23.6), 260 (26.2), 272 (14), 321 (10.5), 335 
(11.9), 416 (100), 512 (7.6), 547 (4.1), 587 (3.7), 644 (3.1); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.875 (3H, bs, 
OH), 8.930 (4H, s, CH), 8.850 (1H, d, J = 7.6, Ph), 8.781 (2H, d, J = 4.6, CH), 8.674 (1H, d, J = 7.6, Ph), 8.521 (1H, 
d, J = 8.4, Ph), 8.457 (1H, d, J = 8.4, Ph), 8.445 (2H, d, J = 4.6, CH), 8.210-8.188 (1H, m, Ph), 8.126 (1H, t, J =  
7.6, Ph), 7.807-7.795 (1H, m, Ph), 7.641-7.534 (10H, m, Ph), 7.302-7.264 (2H, m, Ph), 7.210 (2H, d, J = 7.6, Ph), 
-2.718 (2H, bs, NH); MS (ESI): m/z = 787 ([M+H]+).
5,10,15-Tris(3-hydroxyphenyl)-20-(2,6-dichlorophenyl)porphyrin, 85. Yield: 6%, 105 mg (dark-purple 
solid); mp (ºC) > 300; UV-Vis (CH3OH): λmax, nm (relative absorbance, %) = 415.5 (100), 511.5 (7.4), 545 (3.6), 
586.5 (3.6), 643.5 (2.7); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.892 (3H, bs, OH), 8.911-8.879 (6H, m, CH), 
8.695 (2H, d, J = 4.4, CH), 8.016 (2H, d, J = 8, Ph), 7.926 (1H, t, J = 8, Ph), 7.638-7.577 (9H, m, Ph), 7.244 (3H, d,  
J = 7.6, Ph), -2.891 (2H, bs, NH); MS (ESI): m/z = 731 ([M+H]+).
5,10,15-Tris(3-hydroxyphenyl)-20-(3,5-dichlorophenyl)porphyrin, 86. Yield: 11%, 195 mg (dark-purple 
solid); mp (ºC) > 300; UV-Vis (CH3OH):  λmax, nm (relative absorbance, %) = 415.5 (100), 511 (6.7), 545 (3.3), 
586.5 (3), 643 (2.3);  1H NMR (400 MHz,  (CD3)2SO):  δ, ppm = 9.906 (3H, bs, OH), 8.910-8.884 (8H, m, CH), 
8.330 (2H, s, Ph), 8.116 (1H, s, Ph), 7.616-7.579 (9H, m, Ph), 7.252 (3H, d, J = 7.6, Ph), -2.987 (2H, bs, NH); MS  
(ESI): m/z = 731 ([M+H]+).
5,10,15-Tris(3-hydroxyphenyl)-20-(2,3,4,5,6-pentafluorophenyl)porphyrin,  87.  Yield:  15%,  290 mg 
(dark-purple solid); mp (ºC) > 300; UV-Vis (CH3OH): λmax, nm (relative absorbance, %) = 412.5 (100), 509 (6.5), 
542 (3.3), 584.5 (3.4), 643 (2.7); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.914 (3H, bs, OH), 9.168 (2H, d, J = 
4.4, CH), 8.965 (2H, d, J = 4.4, CH), 8.916 (4H, s, CH), 7.642-7.590 (8H, m, Ph), 7.258 (4H, d, J = 7.6, Ph), -2.976 
(2H, bs, NH); MS (MALDI): m/z = 753 ([M+H]+).
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ii. Two-Step Methodology
A solution  of  the  selected  aldehyde  (5  mmol)  and boron  trifluoride  etherate  (50  μl)  in  dichloromethane 
(500 ml) was stirred at room temperature for 10 minutes in a 1 l round-bottomed flask and de-oxygenated with a 
continuous flow of gaseous nitrogen, followed by the addition of pyrrole (5 mmol, 0.36 ml). The reaction mixture  
was left stirring at room temperature overnight (16 hours), under a gaseous nitrogen atmosphere and ambient-
light exclusion conditions. Triethylamine (125 μl) was added, in order to neutralise the acid catalyst, complete the 
first  reaction  step  and  obtain  the  porphyrinogen,  followed  by  activated  manganese  dioxide 
(30 molar equivalents/porphyrinogen, 37.5 mmol, 3.836 g) and the reaction mixture was  left stirring at 40 ºC 
overnight (16 hours). After cooling to room temperature, the reaction product was filtered through a small column 
of SiO2,  in order to remove the excess oxidising agent and oxidation by-products.  The resulting solution was 
evaporated  under  reduced  pressure  and  the  reddish-brown  solid  obtained  was  recrystallised  in 
dichloromethane/methanol, yielding the desired porphyrin as a dark-purple solid (57, 58 and 60).
5,10,15,20-Tetraphenylporphyrin, 57.  Yield: 32%, 245 mg (dark-purple solid); elemental analysis and UV-
Vis, 1H NMR and MS spectroscopic information identical to the one described in page 142.
5,10,15,20-Tetrakis(naphthalen-1-yl)porphyrin,  58.  Yield:  20%,  210  mg  (dark-purple  solid);  UV-Vis, 
1H NMR and MS spectroscopic information identical to the one described in page 143.
5,10,15,20-Tetrakis(pyren-1-yl)porphyrin, 60. Yield: 2%, 25 mg (dark-purple solid); UV-Vis, 1H NMR and 
MS spectroscopic information identical to the one described in page 143.
C. Hydroporphyrins
1. Synthesis of meso-Tetraarylbacteriochlorins
A mixture of the selected porphyrin (25 mg), anhydrous potassium carbonate (100 molar equivalents) and  
p-toluenesulphonyl  hydrazide  (100  molar  equivalents)  in  1,4-dioxane  (2  ml)  was  thoroughly  mixed  in  an 
appropriate 10 ml thick-walled glass vial. This was tightly sealed with a Teflon cap and the reaction mixture was  
stirred and heated at 120 ºC for 25 minutes, under microwave irradiation, with an initial power setting of 100 W. 
After cooling to room temperature, the reaction product was washed with distilled water (50 ml) and neutralised 
by the addition of aqueous hydrochloric acid  (37% m/v). The reddish-brown solid obtained was filtered under 
reduced pressure and thoroughly washed with distilled water, yielding the desired bacteriochlorin (major product) 
and the corresponding chlorin (minor product) as a pinkish-brown solid (88-94).
5,10,15,20-Tetraphenylbacteriochlorin,  88.  Yield:  96%,  24  mg  (pinkish-brown  solid, 
bacteriochlorin/chlorin ratio = 75/25); mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 354 
(83.8), 376 (100), 490 (8.5), 520 (40.6), 677 (6.3), 740 (75.2); 1H NMR (400 MHz, CDCl3): δ, ppm = 7.919 (4H, s, 
CH), 7.803 (8H, d, J = 6, Ph), 7.684-7.604 (12H, m, Ph), 3.965 (8H, s, CH), -1.318 (2H, bs, NH); MS (ESI): m/z = 
619 ([M+H]+).
5,10,15,20-Tetrakis(2,6-dichlorophenyl)bacteriochlorin, 89.  Yield:  92%, 23 mg (pinkish-brown solid, 
bacteriochlorin/chlorin ratio = 85/15); mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 351 
(100), 363 (79.4), 377 (96.6), 484 (10.6), 515 (39.6), 681 (5.3), 746 (66.9); 1H NMR (400 MHz, CDCl3): δ, ppm = 
7.884 (4H, s,  CH),  7.549-7.433 (12H, m, Ph), 3.931 (8H, s,  CH), -1.254 (2H, bs, NH); MS (ESI): m/z = 894 
([M+H]+).
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5,10,15,20-Tetrakis(3-methoxyphenyl)bacteriochlorin,  90.  Yield:  95%,  24  mg  (pinkish-brown  solid, 
bacteriochlorin/chlorin ratio = 85/15); mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 355 
(83.1), 377 (100), 489.5 (7), 520 (40.9), 677 (5.9), 740 (79.6); 1H NMR (400 MHz, CDCl3): δ, ppm = 7.988 (4H, s, 
CH), 7.532 (4H, t, J = 8, Ph), 7.398-7.362 (8H, m, Ph), 7.151 (4H, dd, J = 8, 1.6, Ph), 4.007 (8H, s, CH), 3.900  
(12H, s, OCH3), -1.372 (2H, bs, NH); MS (ESI): m/z = 739 ([M+H]+).
5,10,15,20-Tetrakis(3-hydroxyphenyl)bacteriochlorin,  91.  Yield:  93%,  23  mg  (pinkish-brown  solid, 
bacteriochlorin/chlorin ratio = 80/20); mp (ºC) > 250; UV-Vis (CH3OH): λmax, nm (relative absorbance, %) = 351 
(89.8), 371 (100), 485 (11.5), 516 (45.5), 671 (6.2), 734 (77.9); 1H NMR (400 MHz, CD3OD): δ, ppm = 7.965 (4H, s, 
CH), 7.484-7.379 (8H, m, Ph), 7.211-7.179 (8H, m, Ph), 3.951 (8H, s, CH); MS (ESI): m/z = 683 ([M+H]+).
5,10,15,20-Tetrakis(4-methoxyphenyl)bacteriochlorin,  92.  Yield:  95%,  24  mg  (pinkish-brown  solid, 
bacteriochlorin/chlorin ratio = 65/35); mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 357 
(80.6), 378 (100), 495 (7.7), 525 (36.8), 678 (6.1), 741 (78.7); 1H NMR (400 MHz, CDCl3): δ, ppm = 7.940 (4H, s, 
CH), 7.702 (8H, d, J = 8.4, Ph), 7.152 (8H, d, J = 8.4, Ph), 3.994 (12H, s, OCH3), 3.969 (8H, s, CH), -1.340 (2H, bs, 
NH); MS (ESI): m/z = 739 ([M+H]+).
5,10,15,20-Tetrakis(4-bromophenyl)bacteriochlorin,  93.  Yield:  92%,  23  mg  (pinkish-brown  solid, 
bacteriochlorin/chlorin ratio = 65/35); mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 356 
(88.6), 378 (100), 490 (8.8), 521 (41.6), 679 (5.6), 743 (75.8); 1H NMR (400 MHz, CDCl3): δ, ppm = 7.925 (4H, s, 
CH), 7.761 (8H, d, J = 8, Ph), 7.655 (8H, d, J = 8, Ph), 3.949 (8H, s, CH), -1.420 (2H, bs, NH); MS (ESI): m/z =  
934 ([M+H]+).
5,10,15,20-Tetrakis(4-t-butylphenyl)bacteriochlorin,  94.  Yield:  90%,  23  mg (pinkish-brown  solid, 
bacteriochlorin/chlorin/porphyrin  ratio  =  45/30/25);  mp  (ºC)  >  250;  UV-Vis  (CH2Cl2):  λmax,  nm  (relative 
absorbance, %) = 356 (85.4), 376 (100), 493 (9.4), 522 (39.7), 676 (6.1), 739 (70.2); 1H NMR (400 MHz, CDCl3): δ, 
ppm = 7.918 (4H, s, CH), 7.711 (8H, d, J = 8, Ph), 7.607 (8H, d, J = 8, Ph), 3.967 (8H, s, CH), 1.505 (36H, s, CH 3), 
-1.304 (2H, bs, NH); MS (ESI): m/z = 843 ([M+H]+).
2. Synthesis of meso-Tetraarylchlorins
A mixture of the selected bacteriochlorin (23-24 mg) and activated manganese dioxide (50 molar equivalents) 
in 1,4-dioxane (2 ml) was thoroughly mixed in an appropriate 10 ml thick-walled glass vial. This was tightly sealed 
with a Teflon cap and the reaction mixture was stirred and heated at 90 ºC for 3 minutes, under microwave  
irradiation, with an initial power setting of 100 W. After cooling to room temperature, the reaction product was  
washed with dichloromethane or ethyl acetate (50 ml) and filtered through a small column of  SiO2, in order to 
remove  the  excess  oxidising  agent  and  oxidation  by-products.  The  resulting  solution  was  evaporated  under 
reduced pressure, yielding the desired chlorin (major product) and the corresponding porphyrin (minor product) 
as a dark-purple solid (95-101).
5,10,15,20-Tetraphenylchlorin, 95. Yield: 92%, 23 mg (dark-purple solid, chlorin/porphyrin ratio = 80/20); 
mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 417.5 (100), 517.5 (8.6), 545.5 (6), 596 (4.2),  
651 (13.6); 1H NMR (300 MHz, CDCl3): δ, ppm = 8.564 (2H, d, J = 4.9, CH), 8.416 (2H, s, CH), 8.172 (2H, d, J = 
4.9, CH), 8.104 (4H, dd, J = 7.2, 2.4, Ph ), 7.887-7.856 (4H, m, Ph), 7.714-7.643 (12H, m, Ph), 4.156 (4H, s, CH), 
-1.446 (2H, bs, NH); MS (ESI): m/z = 617 ([M+H]+).
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5,10,15,20-Tetrakis(2,6-dichlorophenyl)chlorin,  96.  Yield:  85%,  21  mg  (dark-purple  solid, 
chlorin/porphyrin ratio = 75/25); mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 418 (100), 
513.5 (10.2), 540 (3.8), 601 (3.9), 657.5 (16.4); 1H NMR (300 MHz, CDCl3): δ, ppm = 8.459 (2H, d, J = 4.8, CH), 
8.268 (2H, s, CH), 8.085 (2H, d, J = 4.8, CH), 7.799-7.544 (12, m, Ph), 4.094 (4H, s, CH), -1.314 (2H, bs, NH); MS  
(ESI): m/z = 892 ([M+H]+).
5,10,15,20-Tetrakis(3-methoxyphenyl)chlorin,  97.  Yield:  93%,  23  mg  (dark-purple  solid, 
chlorin/porphyrin ratio = 90/10); mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) 417.5 (100), 
516.5 (10.1), 543.5 (6.8), 596 (4.7), 650 (18.2); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.615 (2H, d, J = 4.6, CH), 
8.460 (2H, s, CH), 8.227 (2H, d, J = 4.6, CH), 7.715-7.674 (4H, m, Ph), 7.594-7.555 (4H, m, Ph), 7.460-7.420 (4H, 
m, Ph), 7.275-7.200 (4H, m, Ph), 4.193 (4H, s, CH), 3.939 (12H, s, OCH3), -1.494 (2H, bs, NH); MS (ESI): m/z = 
737 ([M+H]+).
5,10,15,20-Tetrakis(3-hydroxyphenyl)chlorin,  98.  Yield:  88%,  22  mg  (dark-purple  solid, 
chlorin/porphyrin ratio = 65/35); mp (ºC) > 250; UV-Vis (CH3OH):  λmax, nm (relative absorbance, %) = 414.5 
(100), 514 (10.9), 542.5 (7), 592.5 (5.1), 649 (11.1); 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 8.632 (2H, d, J = 4.8, 
CH), 8.368 (2H, s, CH), 8.239 (2H, d, J = 4.8, CH), 7.540-7.468 (6H, m, Ph), 7.295-7.235 (10H, m, Ph), 4.159 (4H, 
s, CH), -1.650 (2H, bs, NH); MS (ESI): m/z = 681 ([M+H]+).
5,10,15,20-Tetrakis(4-methoxyphenyl)chlorin,  99.  Yield:  90%,  22  mg  (dark-purple  solid, 
chlorin/porphyrin ratio = 90/10); mp (ºC) > 250; UV-Vis (CH2Cl2):  λmax, nm (relative absorbance, %) = 420.5 
(100), 521 (9.1), 550 (7.1), 597.5 (4.2), 650.5 (14.3); 1H NMR (300 MHz, CDCl3): δ, ppm = 8.582 (2H, d, J = 4.8, 
CH), 8.438 (2H, s, CH), 8.185 (2H, d, J = 4.8, CH), 8.009 (4H, d, J = 8.5, Ph), 7.755 (4H, d, J = 8.5, Ph), 7.211  
(4H, d, J = 8.3, Ph), 7.191 (4H, d, J = 8.3, Ph), 4.143 (4H, s, CH), 4.050 (12H, s, OCH3), -1.429 (2H, bs, NH); MS 
(ESI): m/z = 737 ([M+H]+).
5,10,15,20-Tetrakis(4-bromophenyl)chlorin,  100.  Yield:  88%,  22  mg  (dark-purple  solid, 
chlorin/porphyrin ratio = 85/15); mp (ºC) > 250; (CH2Cl2):  λmax, nm (relative absorbance, %) = 418 (100), 518 
(11.6), 544.5 (6.6), 597 (4.5), 651 (15.5); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.553 (2H, d, J = 4.8, CH), 8.389 
(2H, s, CH), 8.179 (2H, d, J = 4.8, CH), 7.938 (4H, d, J = 8, Ph), 7.814 (8H, d, J = 8, Ph), 7.721 (4H, d, J = 8, Ph),  
4.138 (4H, s, CH), -1.525 (2H, bs, NH); MS (ESI): m/z = 933 ([M+H]+).
5,10,15,20-Tetrakis(4-t-butylphenyl)chlorin, 101. Yield: 86%, 21 mg (dark-purple solid, chlorin/porphyrin 
ratio = 70/30); mp (ºC) > 250; UV-Vis (CH2Cl2): λmax, nm (relative absorbance, %) = 419.5 (100), 520.5 (10.4), 548 
(7.5), 596 (4.9), 650 (12.3); 1H NMR (400 MHz, CDCl3): δ, ppm = 8.587 (2H, d, J = 4.8, CH), 8.434 (2H, s, CH), 
8.167 (2H, d, J = 4.8, CH), 7.764 (8H, d, J = 8.4, Ph), 7.672 (8H, d, J = 8.4, Ph), 4.148 (4H, s, CH), 1.562 (18H, s, 
CH3), 1.536 (18H, s, CH3), -1.406 (2H, bs, NH); MS (ESI): m/z = 841 ([M+H]+).
D. Hantzsch 1,4-Dihydropyridines
1. Multicomponent Synthesis of Hantzsch 1,4-Dihydropyridines
A  mixture  of  the  selected  aldehyde  (10  mmol),  methyl  acetoacetate  (50  mmol,  5.45  ml)  and  aqueous 
ammonium hydroxide (25% m/v, 40 mmol, 6.23 ml) was thoroughly mixed in an appropriate 35 ml thick-walled 
glass vial. This was tightly sealed with a Teflon cap and the reaction mixture was stirred and heated at 140 ºC for 
10  minutes,  under  microwave  irradiation,  with  an  initial  power  setting  of  150  W.  After  cooling  to  room  
temperature  a yellow  solid  precipitated.  This  was  filtered  under  reduced  pressure,  thoroughly  washed  with 
distilled  water  and  recrystallised  in  aqueous  ethanol,  yielding  the  desired  Hantzsch  1,4-dihydropyridine  as  a 
yellowish solid (102-125).
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Dimethyl  2,6-dimethyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate,  102.  Yield:  58%,  1.750  g 
(pale-yellow solid); mp (ºC): 199-200 (Lit. 198-199);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.257 (2H, d, J = 
7.2, Ph), 7.207 (2H, t, J = 7.2, Ph), 7.124 (1H, t, J = 7.2, Ph), 5.832 (1H, bs, NH), 5.006 (1H, s, CH), 3.639 (6H, s, 
OCH3), 2.319 (6H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 168.091, 147.423, 144.292, 128.039, 127.622, 
126.210, 103.862, 50.987, 39.302, 19.529; GC-MS (EI): m/z (tR, min) = 301 (13.55) (M+).
Dimethyl 2,6-dimethyl-4-(naphthalen-1-yl)-1,4-dihydropyridine-3,5-dicarboxylate, 103. Yield: 30%, 
1.050 g (pale-yellow solid); mp (ºC): 219-221; C21H21NO4: calculated (%) = C 71.78, H 6.02, N 3.99; found (%) = 
C 72.05, H 6.26, N 4.08; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.568 (1H, d, J = 8, Ph), 7.755 (1H, d, J = 8, Ph), 
7.637 (1H, d, J = 8, Ph), 7.525-7.484 (2H, m, Ph), 7.425-7.332 (2H, m, Ph), 5.811 (1H, s, CH), 5.761 (1H, bs, NH),  
3.400 (6H,  s,  OCH3),  2.321  (6H,  s,  CH3);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 168.273,  146.763,  143.496, 
133.360, 130.929, 128.088, 127.180, 127.031, 125.850, 125.274, 125.197, 125.115, 105.630, 50.744, 34.559, 19.542;  
GC-MS (EI): m/z (tR, min) = 351 (17.65) (M+).
Dimethyl 4-(2-bromophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 104.  Yield: 46%, 
1.750 g (pale-yellow solid); mp (ºC): 167-168 (Lit. 163-165);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.429 (1H, 
d, J = 7.6, Ph), 7.377 (1H, dd, J = 7.6, 1.2, Ph), 7.173 (1H, t, J = 7.6, Ph), 6.949 (1H, t, J = 7.6, Ph), 5.693 (1H, bs,  
NH), 5.354 (1H, s, CH), 3.626 (6H, s, OCH3), 2.312 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 168.009, 
147.880, 143.929, 132.649, 131.229, 127.708, 127.574, 122.659, 104.328, 50.810, 39.385, 19.444; GC-MS (EI): m/z  
(tR, min) = 379 (13.76) (M+).
Dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 105.  Yield: 44%, 
1.480 g (pale-yellow solid); mp (ºC): 190-191 (Lit. 192-193);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.366 (1H, 
dd, J = 7.6, 1.2, Ph), 7.235 (1H, d, J = 7.6, Ph), 7.127 (1H, t, J = 7.6, Ph), 7.036 (1H, t, J = 7.6, Ph), 5.622 (1H, bs,  
NH), 5.402 (1H, s, CH), 3.609 (6H, s, OCH3), 2.317 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 167.958, 
145.878, 143.980, 132.420, 131.206, 129.277, 127.309, 126.910, 103.993, 50.812, 37.219, 19.437; GC-MS (EI): m/z 
(tR, min) = 335 (13.21) (M+).
Dimethyl  2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate,  106.  Yield:  66%, 
2.270 g (yellow solid); mp (ºC): 206-208 (Lit. 210-211);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 8.096 (1H, s, 
Ph), 8.002 (1H, d, J = 8, Ph), 7.629 (1H, d, J = 8, Ph), 7.376 (1H, t, J = 8, Ph), 5.810 (1H, bs, NH), 5.107 (1H, s,  
CH), 3.650 (6H, s, OCH3), 2.369 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 167.506, 149.550, 148.416, 
144.910, 134.200, 128.733, 122.755, 121.433, 103.203, 51.158, 39.662, 19.671; GC-MS (EI): m/z (tR, min) = 346 
(15.22) (M+).
Dimethyl  4-(3-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  107.  Yield: 
60%, 2.000 g (pale-yellow solid); mp (ºC): 172-173 (Lit. 175-176);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.137 
(1H, t, J = 8, Ph), 6.866 (1H, d, J = 8, Ph), 6.826 (1H, s, Ph), 6.687 (1H, dd, J = 8, 2, Ph), 5.644 (1H, bs, NH), 5.001  
(1H, s, CH), 3.765 (3H, s, OCH3), 3.654 (6H, s, OCH3), 2.332 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 
167.989, 159.375, 148.950, 144.260, 128.897, 120.146, 113.931, 110.930, 103.750, 55.076, 51.004, 39.208, 19.604;  
GC-MS (EI): m/z (tR, min) = 331 (13.78) (M+).
Dimethyl  4-(3-hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  108.  Yield: 
48%, 1.530 g (yellow solid); mp (ºC): 223-225 (Lit. 227-229);[13] 1H NMR (400 MHz, CDCl3/(CD3)2SO): δ, ppm = 
8.701 (1H, bs, OH), 8.504 (1H, bs, NH), 6.904 (1H, t, J = 8, Ph), 6.550 (2H, d, J =8, Ph), 6.448 (1H, d, J = 8, Ph),  
4.801 (1H, s,  CH), 3.596 (6H, s, OCH3), 2.268 (6H, s, CH3);  13C NMR (100 MHz,  CDCl3/(CD3)2SO):  δ, ppm = 
166.852,  156.714, 148.700, 144.851,  127.956, 117.314, 113.821, 112.455, 101.511, 49.861, 37.901, 17.918; GC-MS  
(EI): m/z (tR, min) = 317 (14.17) (M+).
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Dimethyl 4-(4-t-butylphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 109.  Yield: 70%, 
2.500 g (pale-yellow solid); mp (ºC): 215-217; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.213 (2H, d, J = 8.4, Ph), 
7.157 (2H, d, J = 8.4, Ph), 5.612 (1H, bs, NH), 4.987 (1H, s, CH), 3.655 (6H, s, OCH 3), 2.335 (6H, s, CH3), 1.271 
(9H, s, C(CH3)3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 168.132, 148.675, 144.199, 144.050, 127.077, 124.923, 
104.042, 50.989, 38.567, 34.305, 31.380, 19.621; GC-MS (EI): m/z (tR, min) = 357 (13.68) (M+).
Dimethyl  2,6-dimethyl-4-p-tolyl-1,4-dihydropyridine-3,5-dicarboxylate,  110.  Yield:  66%,  2.080  g 
(pale-yellow solid); mp (ºC): 175-177 (Lit. 174-175);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.149 (2H, d, J = 8, 
Ph), 7.018 (2H, d, J = 8, Ph), 5.744 (1H, bs, NH), 4.965 (1H, s, CH), 3.640 (6H, s, OCH3), 2.320 (6H, s, CH3), 2.272 
(3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 168.090, 144.545, 144.143, 135.651, 128.775, 127.485, 104.005, 
50.975, 38.801, 21.052, 19.575; GC-MS (EI): m/z (tR, min) = 315 (14.09) (M+).
Dimethyl  4-(4-bromophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  111.  Yield:  65%, 
2.450 g (pale-yellow solid); mp (ºC): 195-197 (Lit. 192);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.325 (2H, d, 
J = 8.4, Ph), 7.136 (2H, d, J = 8.4, Ph), 5.732 (1H, bs, NH), 4.958 (1H, s, CH), 3.639 (6H, s, OCH 3), 2.322 (6H, s, 
CH3);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 167.833,  146.508, 144.364,  131.093,  129.505,  120.001,  103.573, 
51.044, 39.052, 19.574; GC-MS (EI): m/z (tR, min) = 379 (15.88) (M+).
Dimethyl  4-(4-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  112.  Yield:  71%, 
2.380 g (pale-yellow solid); mp (ºC): 191-193 (Lit. 194-196);[13] C17H18NO4Cl: calculated (%) = C 60.81, H 5.40, 
N 4.17; found (%) = C 60.52, H 4.99, N 3.93;  1H NMR (400 MHz, CDCl3):  δ, ppm = 7.195 (2H, d, J = 8.8, Ph), 
7.167 (2H, d, J = 8.8, Ph), 5.772 (1H, bs, NH), 4.970 (1H, s, CH), 3.639 (6H, s, OCH3), 2.325 (6H, s, CH3); 13C NMR 
(100 MHz,  CDCl3):  δ,  ppm = 167.851,  146.006,  144.332,  131.830, 129.091,  128.144,  103.660,  51.038, 38.972,  
19.578; GC-MS (EI): m/z (tR, min) = 335 (14.91) (M+).
Dimethyl  4-(4-fluorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  113. Yield:  65%, 
2.080 g (pale-yellow solid); mp (ºC): 174-175 (Lit. 171);[13] C17H18NO4F: calculated (%) = C 63.94, H 5.68, N 4.39; 
found (%) = C 63.78, H 5.37, N 4.17; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.213 (2H, dd, J = 8.4, 5.2, Ph), 6.881 
(2H, t, J = 8.4, Ph), 5.903 (1H, bs, NH), 4.979 (1H, s, CH), 3.641 (6H, s, OCH3), 2.318 (6H, s, CH3);  13C NMR 
(100 MHz, CDCl3): δ, ppm = 168.004, 161.417 (C, d, J = 242.3), 144.293, 143.370 (C, d, J = 3), 129.114 (2xCH, d, 
J = 7.8) 114.712 (2xCH, d, J = 20.9), 103.857, 51.018, 38.756, 19.510; GC-MS (EI): m/z (t R, min) = 319 (13.53) 
(M+).
Dimethyl  2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate,  114. Yield:  65%, 
2.270 g (yellow solid); mp (ºC): 200-202 (Lit. 198-199);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 8.083 (2H, d, 
J = 8.8, Ph), 7.429 (2H, d, J = 8.8, Ph), 5.712 (1H, bs, NH), 5.105 (1H, s, CH), 3.644 (6H, s, OCH 3), 2.361 (6H, s, 
CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 167.450, 154.713, 146.472, 144.828, 128.617, 123.477, 103.104, 51.166, 
39.881, 19.700; GC-MS (EI): m/z (tR, min) = 346 (17.75) (M+).
Dimethyl  4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  115.  Yield: 
63%, 2.100 g (pale-yellow solid); mp (ºC): 183-185 (Lit. 186-188);[14] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.175 
(2H, d, J = 8.6, Ph), 6.752 (2H, d, J = 8.6, Ph), 5.657 (1H, bs, NH), 4.942 (1H, s, CH), 3.750 (3H, s, OCH 3), 3.644 
(6H, s, OCH3), 2.326 (6H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 168.185, 158.065, 143.978, 140.028, 
128.702, 113.501, 104.264, 55.231, 51.066, 38.526, 19.686; GC-MS (EI): m/z (tR, min) = 331 (15.01) (M+).
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Dimethyl 4-(4-hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 116. Yield: 57%, 
1.800 g (yellow solid); mp (ºC): 232-235 (Lit.  230-232);[15] 1H NMR (400 MHz, CDCl3/(CD3)2SO):  δ, ppm = 
8.612 (1H, bs, OH), 8.397 (1H, bs, NH), 6.897 (1H, d, J = 8.4, Ph), 6.529 (2H, d, J = 8.4, Ph), 4.723 (1H, s, CH),  
3.573  (6H,  s,  OCH3),  2.249  (6H,  s,  CH3);  13C NMR (100 MHz,  CDCl3/(CD3)2SO):  δ,  ppm = 166.971,  155.141, 
144.499, 138.288, 127.541, 114.249, 102.067, 49.860, 37.261, 17.914; GC-MS (EI): m/z (tR,  min) = 317 (14.02) 
(M+).
Dimethyl  4-(4-acetamidophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  117.  Yield: 
58%, 2.060 g (pale-yellow solid); mp (ºC): 259-261; 1H NMR (400 MHz, CDCl3/(CD3)2SO): δ, ppm = 9.673 (1H, 
bs, NH), 8.640 (1H, bs, NHCOCH3 ), 7.363 (2H, d, J = 8.4, Ph), 7.054 (2H, d, J = 8.4, Ph), 4.831 (1H, s, CH), 3.563 
(6H, s, OCH3), 2.267 (6H, s, CH3), 2.015 (3H, s, CH3); 13C NMR (100 MHz, CDCl3/(CD3)2SO): δ, ppm = 167.964, 
167.496, 145.366, 142.947, 137.086, 127.250, 119.026, 101.876, 50.420, 38.084, 23.844, 18.269; GC-MS (EI): m/z 
(tR, min) = 358 (21.32) (M+).
Dimethyl 4-(4-carboxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 118. Yield: 72%, 
2.475 g (pale-yellow solid); mp (ºC): 238-240;  1H NMR (400 MHz, CDCl3/(CD3)2SO):  δ, ppm = 8.702 (1H, bs, 
NH), 7.805 (2H, d, J = 8, Ph), 7.267 (2H, d, J = 8, Ph), 4.961 (1H, s, CH), 3.575 (6H, s, OCH3), 2.294 (6H, s, CH3); 
13C NMR (100 MHz, CDCl3/(CD3)2SO): δ, ppm = 167.496, 167.335, 152.819, 146.026, 137.086, 129.168, 128.509, 
127.234, 101.390, 50.500, 39.052, 18.348; MS (MALDI): m/z = 344 ([M-H]+).
Dimethyl  4-(2,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  119.  Yield: 
53%, 1.950 g (pale-yellow solid); mp (ºC): 191-193 (Lit. 188-189);[13] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.295 
(1H, d, J = 8.4, Ph), 7.254 (1H, s, Ph), 7.108 (1H, dd, J = 8.4, 1.6, Ph), 5.627 (1H, bs, NH), 5.352 (1H, s, CH), 3.608  
(6H, s,  OCH3),  2.315 (6H, s,  CH3);  13C NMR (100 MHz, CDCl3):  δ,  ppm = 167.727,  144.561,  144.189, 133.165, 
132.129, 132.109, 128.914, 127.235, 103.638, 50.867, 37.051, 19.473; GC-MS (EI): m/z (tR,  min) = 369 (14.31) 
(M+).
Dimethyl 4-(3,4-dimethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 120. Yield: 
62%, 2.250 g (pale-yellow solid); mp (ºC): 157-159; 1H NMR (400 MHz, CDCl3): δ, ppm = 6.870 (1H, s, Ph), 6.772 
(1H, d, J = 8.4, Ph), 6.723 (1H, d, J = 8.4, Ph), 5.741 (1H, bs, NH), 4.961 (1H, s, CH), 3.834 (3H, s, OCH 3), 3.816 
(3H, s, OCH3), 3.660 (6H, s, OCH3), 2.333 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 168.103, 148.365, 
147.444, 143.978, 140.301, 119.452, 111.485, 110.955, 103.966, 55.786, 50.987, 38.764, 19.570; GC-MS (EI): m/z 
(tR, min) = 361 (14.46) (M+).
Dimethyl  4-(4-hydroxy-3-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 
121. Yield: 47%, 1.640 g (yellow solid); mp (ºC): 219-220; 1H NMR (400 MHz, CDCl3/(CD3)2SO): δ, ppm = 8.554 
(1H, bs, OH), 8.405 (1H, bs, NH), 6.725 (1H, s, Ph), 6.612 (1H, d, J = 8, Ph), 6.539 (1H, dd, J = 8, 1.2, Ph), 4.801 
(1H, s, CH), 3.746 (3H, s, OCH3), 3.587 (6H, s, OCH3), 2.268 (6H, s, CH3); 13C NMR (100 MHz, CDCl3/(CD3)2SO): 
δ, ppm = 167.677, 146.762, 145.129, 144.621, 139.405, 119.405, 115.007, 111.405, 102.143, 55.466, 50.384, 38.029, 
18.289; GC-MS (EI): m/z (tR, min) = 347 (16.22) (M+).
Dimethyl  4-(3-hydroxy-4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 
122. Yield: 47%, 1.630 g (yellow solid); mp (ºC): 178-180; 1H NMR (400 MHz, CDCl3/(CD3)2SO): δ, ppm = 8.670 
(1H, bs, OH), 8.575 (1H, bs, NH), 6.683 (1H, d, J = 8, Ph), 6.619 (1H, s, Ph), 6.531 (1H, dd, J = 8, 1.4, Ph), 4.780  
(1H, s, CH), 3.716 (3H, s, OCH3), 3.570 (6H, s, OCH3), 2.255 (6H, s, CH3); 13C NMR (100 MHz, CDCl3/(CD3)2SO): 
δ, ppm = 167.550, 145.918, 145.787, 145.105, 140.783, 117.545, 114.697, 111.647, 101.858, 55.564, 50.424, 37.628,  
18.219; GC-MS (EI): m/z (tR, min) = 347 (16.68) (M+).
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Dimethyl 4-(3,5-dimethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 123. Yield: 
63%, 2.280 g (pale-yellow solid); mp (ºC): 147-149; 1H NMR (400 MHz, CDCl3): δ, ppm = 6.453 (2H, s, Ph), 6.268 
(1H, s, Ph), 5.823 (1H, bs, NH), 4.986 (1H, s, CH), 3.746 (6H, s, OCH3), 3.664 (6H, s, OCH3), 2.315 (6H, s, CH3); 
13C NMR (100 MHz, CDCl3):  δ,  ppm = 168.014, 160.434,  149.714,  144.430, 106.032, 103.510, 97.689, 55.168, 
51.011, 39.338, 19.551; GC-MS (EI): m/z (tR, min) = 361 (16.10) (M+).
Dimethyl  4-(3,4,5-trimethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate,  124. 
Yield: 48%, 1.860 g (pale-yellow solid); mp (ºC): 178-180; 1H NMR (400 MHz, CDCl3): δ, ppm = 6.498 (2H, s, Ph), 
5.811 (1H, bs, NH), 4.989 (1H, s, CH), 3.796 (9H, s, OCH3), 3.680 (6H, s, OCH3), 2.342 (6H, s, CH3);  13C NMR 
(100 MHz,  CDCl3):  δ,  ppm = 168.074,  152.792,  144.200,  142.979,  136.571,  104.794,  103.696, 60.736,  56.016, 
51.029, 39.394, 19.539; GC-MS (EI): m/z (tR, min) = 391 (16.85) (M+).
Dimethyl  4-(4-hydroxy-3,5-dimethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-
dicarboxylate,  125.  Yield:  42%,  1.600  g  (yellow  solid);  mp  (ºC):  222-223;  1H  NMR  (400  MHz,  CDCl3/
(CD3)2SO): δ, ppm = 8.708 (1H, bs, OH), 7.972 (1H, bs, NH), 6.370 (2H, s, Ph), 4.805 (1H, s, CH), 3.694 (6H, s,  
OCH3),  3.583 (6H,  s,  OCH3),  2.266 (6H,  s,  CH3);  13C NMR (100 MHz,  CDCl3/(CD3)2SO):  δ,  ppm = 167.504, 
147.482,  145.190,  138.203,  134.058,  104.583,  101.767,  55.821,  50.422,  38.230,  18.142;  GC-MS  (EI):  m/z  (tR, 
min) = 377 (18.03) (M+).
2. Oxidation of Hantzsch 1,4-Dihydropyridines
i. Heterogeneous Oxidative Aromatisation
A mixture of the selected Hantzsch 1,4-dihydropyridine (1 mmol) and activated manganese dioxide (10 mmol,  
1.023 g) in dichloromethane (3 ml) was thoroughly mixed in an appropriate 10 ml thick-walled glass vial. This was 
tightly sealed with a Teflon cap and the reaction mixture was stirred and heated at 100 ºC for 5 minutes, under  
microwave irradiation, with an initial power setting of 100 W. After cooling to room temperature, the reaction 
product was washed with ethyl acetate and filtered through a small column of SiO 2, in order to remove the excess 
oxidising agent and oxidation by-products. The resulting solution was evaporated under reduced pressure and the 
yellow solid obtained was recrystallised in diethyl ether or ethyl acetate/n-hexane, yielding the desired Hantzsch 
pyridine as a white or yellowish solid (126, 127, 130-139, 141 and 144-146). Regarding pyridines 128, 129 and 
143, the isolation process afforded a pale-yellow oil.
ii. Homogeneous Oxidative Aromatisation
A mixture of the selected Hantzsch 1,4-dihydropyridine (1 mmol) and potassium peroxydisulphate (1.2 mmol, 
324 mg) in acetonitrile/distilled water (3:2 v/v, 5 ml) was thoroughly mixed in an appropriate 10 ml thick-walled 
glass vial. This was tightly sealed with a Teflon cap and the reaction mixture was stirred and heated at 100 ºC for  
5 minutes, under microwave irradiation, with an initial power setting of 80 W. After cooling to room temperature,  
the reaction product was washed with brine  (50 ml) and a yellow solid precipitated.  This  was filtered under 
reduced pressure and thoroughly washed with distilled water,  yielding the desired Hantzsch pyridine as a pale-
yellow solid (140 and 142).
Dimethyl  2,6-dimethyl-4-phenylpyridine-3,5-dicarboxylate,  126.  Yield:  95%,  285  mg  (white  solid); 
mp (ºC): 137-138 (Lit. 135-136);[16] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.375-7.363 (3H, m, Ph), 7.247-7.229 
(2H, m, Ph), 3.521 (6H, s, OCH3), 2.595 (6H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 168.406, 155.575, 
146.221, 136.466, 128.531, 128.220, 127.782, 126.769, 52.164, 22.969; GC-MS (EI): m/z (tR, min) = 299 (12.18) 
(M+).
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Dimethyl 2,6-dimethyl-4-(naphthalen-1-yl)pyridine-3,5-dicarboxylate, 127. Yield: 92%, 320 mg (pale-
yellow solid); mp (ºC): 106-107;  1H NMR (400 MHz, CDCl3): δ, ppm = 7.848 (2H, d, J = 8, Ph), 7.491-7.402 (4H, 
m, Ph), 7.273 (1H, d, J = 6.8, Ph), 3.215 (6H, s, OCH3), 2.656 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 
167.989,  156.004,  145.572,  133.776,  133.025,  130.887,  128.837,  127.983,  127.591,  126.298,  126.249,  126.089, 
125.754, 124.711, 51.923, 23.242; GC-MS (EI): m/z (tR, min) = 349 (14.09) (M+).
Dimethyl 4-(2-bromophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate, 128. Yield: 90%, 340 mg (pale-
yellow oil); 1H NMR (400 MHz, CDCl3): δ, ppm = 7.593 (1H, d, J = 7.6, Ph), 7.322 (1H, t, J = 7.6, Ph), 7.213 (1H, t,  
J = 7.6, Ph), 7.166 (1H, d, J = 7.6, Ph), 3.520 (6H, s, OCH3), 2.640 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, 
ppm = 167.347, 156.497, 146.043, 137.435, 132.234, 130.036, 129.733, 126.629, 126.183, 122.193, 52.013, 23.366; 
GC-MS (EI): m/z (tR, min) = 377 (11.98) (M+).
Dimethyl 4-(2-chlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate, 129. Yield: 90%, 300 mg (pale-
yellow oil); 1H NMR (400 MHz, CDCl3): δ, ppm = 7.413 (1H, d, J = 7.6, Ph), 7.322-7.255 (2H, m, Ph), 7.166 (1H, d, 
J = 7.6, Ph), 3.524 (6H, s, OCH3), 2.642 (6H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 167.520, 156.560, 
144.675, 135.467, 132.617,  130.032, 129.744,  129.130, 126.746, 126.196, 52.099, 23.398; GC-MS (EI): m/z (tR, 
min) = 333 (11.67) (M+).
Dimethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate, 130.  Yield: 91%, 315 mg (yellow 
solid); mp (ºC): 112-113; 1H NMR (400 MHz, CDCl3): δ, ppm = 8.273-8.245 (1H, m, Ph), 8.162 (1H, s, Ph), 7.589 
(2H, d, J = 4.8, Ph), 3.589 (6H, s, OCH3), 2.625 (6H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 167.726, 
156.330, 147.951, 143.708, 138.048, 134.096, 129.310, 126.396, 123.518, 123.088, 52.417, 23.194; GC-MS (EI): 
m/z (tR, min) = 344 (12.75) (M+).
Dimethyl  4-(3-methoxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate,  131.  Yield:  92%,  300  mg 
(white solid); mp (ºC): 64-65; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.282 (1H, t, J = 7.6, Ph), 6.907 (1H, dd, J = 
7.6, 1.8, Ph), 6.818 (1H, d, J = 7.6, Ph), 6.790 (1H, s, Ph), 3.792 (3H, s, OCH3), 3.567 (6H, s, OCH3), 2.589 (6H, s, 
CH3);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 168.460,  159.357,  155.568,  145.973,  137.712,  129.398,  126.699, 
120.258, 114.703, 113.032, 55.288, 52.257, 22.962; GC-MS (EI): m/z (tR, min) = 329 (11.97) (M+).
Dimethyl  4-(3-hydroxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate,  132.  Yield:  90%,  285  mg 
(pale-yellow solid); mp (ºC): 179-181;  1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.526 (1H, bs, OH), 7.364 
(1H, t, J = 7.6, Ph), 6.974 (1H, d, J = 7.6, Ph), 6.814 (1H, s, Ph), 6.772 (1H, d, J = 7.6, Ph), 3.759 (6H, s, OCH 3), 
2.730 (6H, s, CH3);  13C NMR (100 MHz,  CCl4/(CD3)2SO): δ, ppm = 167.199, 156.972, 154.253, 145.129, 136.899, 
128.457, 125.891, 117.674, 115.160, 114.187, 51.344, 22.093; GC-MS (EI): m/z (tR, min) = 315 (15.35) (M+).
Dimethyl 4-(4-t-butylphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate, 133. Yield: 92%, 325 mg (white 
solid); mp (ºC): 127-128; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.382 (2H, d, J = 8.4, Ph), 7.160 (2H, d, J = 8.4, 
Ph),  3.518 (6H, s,  OCH3),  2.584 (6H, s,  CH3),  1.322 (9H, s,  C(CH3)3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 
168.605, 155.449, 151.532, 146.317, 133.421, 127.535, 126.901, 125.101, 52.102, 34.669, 31.235, 22.934; GC-MS 
(EI): m/z (tR, min) = 355 (12.38) (M+).
Dimethyl  2,6-dimethyl-4-p-tolylpyridine-3,5-dicarboxylate,  134.  Yield:  95%,  295  mg  (white  solid); 
mp (ºC): 89-90 (Lit. 90-91);[16] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.178 (2H, d, J = 8, Ph), 7.125 (2H, d, J = 8, 
Ph), 3.563 (6H, s, OCH3), 2.582 (6H, s, CH3), 2.367 (3H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 168.588, 
155.393,  146.228,  138.398,  133.375,  129.002,  127.631,  126.879,  52.219,  22.961,  21.312;  GC-MS (EI):  m/z  (t R, 
min) = 313 (12.54) (M+).
154|
                                                                                                                                                                                   6. Experimental
Dimethyl 4-(4-bromophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate, 135. Yield: 95%, 355 mg (white 
solid); mp (ºC): 160-161; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.517 (2H, d, J = 8, Ph), 7.115 (2H, d, J = 8, Ph), 
3.573  (6H,  s,  OCH3),  2.590 (6H,  s,  CH3);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 168.162,  155.804,  144.940, 
135.306, 131.467, 129.544, 126.539, 123.027, 52.346, 23.022; GC-MS (EI): m/z (tR, min) = 377 (13.25) (M+).
Dimethyl 4-(4-chlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate, 136. Yield: 93%, 310 mg (white 
solid); mp (ºC): 136-137 (Lit. 137-139);[17] 1H NMR (400 MHz, CDCl3): δ, ppm = 7.364 (2H, d, J = 8.4, Ph), 7.180 
(2H, d, J = 8.4, Ph), 3.574 (6H, s, OCH3), 2.592 (6H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 168.193, 
155.770, 144.929, 134.793, 129.243, 129.097, 128.536, 126.603, 52.365, 23.020; GC-MS (EI): m/z (tR, min) = 333 
(12.79) (M+).
Dimethyl 4-(4-fluorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate, 137. Yield: 93%, 295 mg (white 
solid); mp (ºC): 114-115; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.227 (2H, dd, J = 8.4, 5.2, Ph), 7.018 (2H, t, J = 
8.4, Ph), 3.566 (6H, s, OCH3), 2.591 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 168.298, 162.759 (C, d, 
J = 247), 155.662, 145.093, 132.297 (C, d, J = 3.4), 129.770 (2xCH, d, J = 8.3), 126.806, 115.388 (2xCH, d, J =  
21.6), 52.310, 23.001; GC-MS (EI): m/z (tR, min) = 317 (12.10) (M+).
Dimethyl 2,6-dimethyl-4-(4-nitrophenyl)pyridine-3,5-dicarboxylate, 138. Yield: 90%, 310 mg (yellow 
solid); mp (ºC): 150-151 (Lit. 148);[17] 1H NMR (400 MHz, CDCl3): δ, ppm = 8.265 (2H, d, J = 8.4, Ph), 7.427 (2H, 
d, J = 8.4, Ph), 3.562 (6H, s, OCH3), 2.626 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 167.676, 156.376, 
147.831, 144.120, 143.205, 129.097, 126.037, 123.380, 52.463, 23.198; GC-MS (EI): m/z (tR, min) = 344 (13.98) 
(M+).
Dimethyl  4-(4-methoxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate,  139.  Yield:  93%,  305  mg 
(white solid); mp (ºC): 117-118 (Lit. 115);[17] 1H NMR (400 MHz, CDCl3):  δ, ppm = 7.177 (2H, d, J = 8.8, Ph), 
6.903 (2H, d, J = 8.8, Ph), 3.830 (3H, s, OCH3), 3.581 (6H, s, OCH3), 2.577 (6H, s, CH3);  13C NMR (100 MHz, 
CDCl3): δ, ppm = 168.669, 159.709, 155.358, 145.804, 129.133, 128.529, 126.984, 113.731, 55.212, 52.282, 22.949; 
GC-MS (EI): m/z (tR, min) = 329 (13.21) (M+).
Dimethyl  4-(4-hydroxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate,  140.  Yield:  83%,  260  mg 
(pale-yellow solid); mp (ºC): 175-176;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.715 (1H, bs, OH), 7.050 
(2H, d, J = 8.4, Ph), 6.847 (2H, d, J = 8.4, Ph), 3.625 (6H, s, OCH3), 2.572 (6H, s, CH3); 13C NMR (100 MHz, CCl4/
(CD3)2SO):  δ,  ppm = 167.491,  157.566,  154.100,  145.168,  128.359,  126.261,  126.123,  114.748,  51.320,  22.086; 
GC-MS (EI): m/z (tR, min) = 315 (12.47) (M+).
Dimethyl  4-(4-acetamidophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate,  141.  Yield:  94%,  335  mg 
(white solid); mp (ºC): 183-185; 1H NMR (400 MHz, CDCl3): δ, ppm = 7.534 (2H, d, J = 8.4, Ph), 7.397 (1H, bs,  
NH), 7.193 (2H, d, J = 8.4, Ph), 3.581 (6H, s, OCH3), 2.582 (6H, s, CH3), 2.173 (3H, s, CH3); 13C NMR (100 MHz, 
CDCl3): δ, ppm = 168.544, 168.346, 155.519, 145.527, 138.424, 131.486, 128.580, 126.830, 118.994, 52.366, 24.714,  
22.965; GC-MS (EI): m/z (tR, min) = 356 (16.30) (M+).
Dimethyl  4-(4-carboxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate,  142.  Yield:  88%,  300  mg 
(pale-yellow solid); mp (ºC): 270-272;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 7.995 (2H, d, J = 8, Ph), 
7.249 (2H, d, J = 8, Ph), 3.505 (6H, s, OCH3), 2.521 (6H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 
167.020, 166.465, 154.940, 144.453, 139.983, 130.956, 129.030, 127.400, 125.836, 51.885, 22.390; HR-MS (ESI): 
m/z = 344.1130 ([M+H]+, C18H18NO6: required = 344.1134).
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Dimethyl  4-(2,4-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate,  143. Yield:  91%,  335  mg 
(pale-yellow oil); 1H NMR (400 MHz, CDCl3): δ, ppm = 7.447 (1H, d, J = 1.6, Ph), 7.279 (1H, dd, J = 8, 1.6, Ph),  
7.114 (1H, d, J = 8, Ph), 3.584 (6H, s, OCH3), 2.641 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 167.336, 
156.794, 143.640, 135.035, 134.062, 133.590, 130.858, 129.071, 126.635, 126.300, 52.255, 23.483; GC-MS (EI): 
m/z (tR, min) = 367 (12.18) (M+).
Dimethyl 4-(3,4-dimethoxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate, 144. Yield: 90%, 320 mg 
(pale-yellow solid); mp (ºC): 123-124; 1H NMR (400 MHz, CDCl3): δ, ppm = 6.872 (1H, d, J = 8.2, Ph), 6.826 (1H, 
s, Ph), 6.815 (1H, d, J = 8.2, Ph), 3.906 (3H, s, OCH3), 3.852 (3H, s, OCH3), 3.600 (6H, s, OCH3), 2.577 (6H, s, 
CH3);  13C NMR (100 MHz,  CDCl3):  δ,  ppm = 168.742,  155.405,  149.212,  148.670,  145.684,  128.815,  126.942, 
120.565, 111.192, 110.843, 55.908, 55.823, 52.364, 22.913; GC-MS (EI): m/z (tR, min) = 359 (12.74) (M+).
Dimethyl 4-(3,5-dimethoxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate, 145. Yield: 92%, 330 mg 
(pale-yellow solid); mp (ºC): 125-127; 1H NMR (400 MHz, CDCl3): δ, ppm = 6.453 (1H, d, J = 2, Ph), 6.403 (2H, d, 
J = 2, Ph), 3.769 (6H, s, OCH3), 3.613 (6H, s, OCH3), 2.584 (6H, s, CH3); 13C NMR (100 MHz, CDCl3): δ, ppm = 
168.502, 160.599, 155.547, 145.919, 138.264, 126.598, 105.904, 101.093, 55.419, 52.360, 22.951; GC-MS (EI): m/z 
(tR, min) = 359 (13.67) (M+).
Dimethyl  4-(3,4,5-trimethoxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate,  146.  Yield:  93%, 
360 mg (pale-yellow solid); mp (ºC): 125-126; 1H NMR (400 MHz, CDCl3): δ, ppm = 6.497 (2H, s, Ph), 3.879 (3H, 
s, OCH3), 3.827 (6H, s, OCH3), 3.622 (6H, s, OCH3), 2.583 (6H, s, CH3);  13C NMR (100 MHz, CDCl3):  δ, ppm = 
168.670, 155.525, 153.070, 145.698, 138.068, 131.755, 126.688, 105.264, 60.941, 56.145, 52.439, 22.911; GC-MS  
(EI): m/z (tR, min) = 389 (14.30) (M+).
E. Biginelli 3,4-Dihydropyrimidines
1. Multicomponent Synthesis of Biginelli 3,4-Dihydropyrimidines
A mixture of the selected aldehyde (10 mmol), methyl acetoacetate (15 mmol, 1.64 ml) and urea or thiourea 
(20 mmol, 1.213 or 1.538 g) in glacial acetic acid (2.5 ml)  was thoroughly mixed in an appropriate 10 ml thick-
walled glass vial. This was tightly sealed with a Teflon cap and the reaction mixture was stirred and heated at  
120 ºC for 10 or 20 minutes, under microwave irradiation, with an initial power setting of 100 W. After cooling to 
room temperature a yellow solid precipitated. This was filtered under reduced pressure, thoroughly washed with 
distilled water and recrystallised in  aqueous ethanol, yielding the desired Biginelli 3,4-dihydropyrimidine as a 
yellowish solid (147-202).
Methyl 6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate, 147.  Yield: 83%, 2.050 g 
(pale-yellow solid); mp (ºC): 210-211 (Lit. 209-212);[18] 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.091 (1H, 
bs, NH-1), 7.610 (1H, bs, NH-3), 7.303-7.187 (5H, m, Ph), 5.156 (1H, d, J = 2.8, CH), 3.549 (3H, s, OCH 3), 2.263 
(3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 165.317, 151.861, 148.246, 144.580, 127.842, 126.667, 
125.954, 98.741, 53.647, 50.177, 17.577; GC-MS (EI): m/z (tR, min) = 246 (12.22) (M+).
Methyl  6-methyl-4-(naphthalen-1-yl)-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  148.  Yield: 
77%, 2.275 g (yellow solid); mp (ºC): 233-235 (Lit. 234-236);[19] 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 
9.202 (1H, bs, NH-1), 8.298 (1H, d, J = 8, Ph), 7.903 (1H, d, J = 8, Ph), 7.802 (1H, d, J = 8, Ph), 7.653 (1H, bs,  
NH-3), 7.585-7.498 (2H, m, Ph), 7.448 (1H, t, J = 8, Ph), 7.390 (1H, d, J = 8, Ph), 6.045 (1H, d, J = 2.8, CH),  
3.388 (3H, s, OCH3), 2.383 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 165.371, 151.526, 148.900, 
139.710, 133.363, 129.921, 128.157, 127.620, 125.690, 125.298, 125.202, 123.642, 123.433, 98.482, 50.281, 49.475, 
17.636; GC-MS (EI): m/z (tR, min) = 296 (15.42) (M+).
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Methyl 6-methyl-4-(phenanthren-9-yl)-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  149.  Yield: 
65%, 2.240 g (yellow solid);  mp (ºC): 263-265;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.259 (1H, bs, 
NH-1), 8.837-8.815 (1H, m, Ph), 8.732 (1H, d, J = 8, Ph), 8.385-8.363 (1H, m, Ph), 7.912 (1H, d, J = 8, Ph), 7.718-
7.699 (2H, m, Ph), 7.699 (1H, bs, NH-3), 7.645 (1H, t, J = 8, Ph), 7.599 (1H, s, Ph), 7.575 (1H, d, J = 8, Ph), 6.086  
(1H, d, J = 2.8, CH), 3.418 (3H, s, OCH3), 2.478 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
165.363,  151.645,  149.448,  137.134,  130.826,  130.328,  129.508,  129.131,  128.502,  126.467,  126.419,  126.323,  
126.073, 124.157, 124.080, 122.939, 122.218, 97.898, 50.327, 49.834, 17.718; GC-MS (EI): m/z (tR, min) = 346 
(25.27) (M+).
Methyl  4-(anthracen-9-yl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  150.  Yield: 
35%, 1.200 g (yellow solid); mp (ºC): 252-254 (Lit. 250-253);[19] 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 
9.346 (1H, bs, NH-1), 8.451-8.483 (3H, m, Ph), 8.027 (2H, d, J = 8, Ph), 7.494-7.436 (4H, m, Ph), 7.453 (1H, bs,  
NH-3), 6.990 (1H, s, CH), 2.993 (3H, s, OCH3), 2.272 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 
165.431, 150.497, 146.022, 134.962, 127.831, 125.341, 124.337, 124.152, 99.324, 50.153, 49.670, 17.563; GC-MS 
(EI): m/z (tR, min) = 346 (24.25) (M+).
Methyl  4-(2-bromophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  151.  Yield: 
70%, 2.270 g (pale-yellow solid);  mp (ºC): 222-223 (Lit. 220-222);[20]  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, 
ppm = 9.224 (1H, bs, NH-1), 7.525 (1H, d, J = 7.6, Ph), 7.468 (1H, bs, NH-3), 7.349-7.299 (2H, m, Ph), 7.156 (1H,  
t, J = 7.6, Ph), 5.606 (1H, d, J = 2.4, CH), 3.473 (3H, s, OCH3), 2.312 (3H, s, CH3);  13C NMR (100 MHz, CCl4/
(CD3)2SO):  δ, ppm = 165.002, 151.048, 149.090, 143.134, 132.304, 128.822, 128.383, 127.921, 122.026, 97.855,  
53.681, 50.222, 17.456; GC-MS (EI): m/z (tR, min) = 324 (13.26) (M+).
Methyl  4-(2-chlorophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  152.  Yield: 
66%, 1.860 g (pale-yellow solid);  mp (ºC): 223-225 (Lit. 226-229);[21] 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, 
ppm = 9.205 (1H, bs, NH-1), 7.435 (1H, bs, NH-3), 7.341 (1H, d, J = 7.6, Ph), 7.310-7.204 (3H, m, Ph), 5.637 (1H, 
d, J = 2.4, CH), 3.477 (3H, s, OCH3), 2.315 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 164.949, 
151.158, 149.138, 141.394,  131.659, 129.017,  128.398, 128.268, 127.095, 97.456, 51.157, 50.163,  17.464; GC-MS 
(EI): m/z (tR, min) = 280 (12.83) (M+).
Methyl  4-(2,6-dichlorophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  153. 
Yield: 55%, 1.730 g (pale-yellow solid); mp (ºC): > 300; 1H NMR (400 MHz, CDCl3/TFA): δ, ppm = 8.658 (1H, bs, 
NH-1), 7.362 (2H, d, J = 8, Ph), 7.220 (1H, t, J = 8, Ph), 6.801 (1H, bs, NH-3), 6.529 (1H, s, CH), 3.614 (3H, s, 
OCH3),  2.350  (3H,  s,  CH3);  13C NMR (100 MHz,  CDCl3/TFA):  δ,  ppm = 167.011,  154.945,  147.864,  135.829, 
134.449, 130.181, 129.715, 98.379, 52.656, 52.123, 18.541; GC-MS (EI): m/z (tR, min) = 314 (13.81) (M+).
Methyl 4-mesityl-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate, 154.  Yield: 40%, 1.150 g 
(pale-yellow solid); mp (ºC): 269-271; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 8.988 (1H, bs, NH-1), 7.171 
(1H, bs, NH-3), 6.722 (2H, s, Ph), 5.784 (1H, s, CH), 3.373 (3H, s, OCH3), 2.317 (6H, s, CH3), 2.200 (3H, s, CH3), 
2.136 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 165.571, 150.575, 146.177, 136.750, 136.345, 
135.083, 129.587, 96.511, 50.695, 49.802, 20.222, 19.061, 17.323; GC-MS (EI): m/z (tR, min) = 288 (13.21) (M+).
Methyl 6-methyl-4-(3-nitrophenyl)-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate, 155. Yield: 87%, 
2.520 g (yellow solid); mp (ºC): 274-276 (Lit. 273-275);[22] 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.298 
(1H, bs, NH-1), 8.104-8.087 (2H, m, Ph), 7.831 (1H, bs, NH-3), 7.670 (1H, d, J = 7.6, Ph), 7.597 (1H, t, J = 7.6, Ph),  
5.295 (1H, d, J = 3.2, CH), 3.571 (3H, s, OCH3), 2.290 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 
165.138, 151.572, 149.386, 147.617, 146.640, 132.459, 129.518, 121.816, 120.845, 97.830, 53.145, 50.424, 17.703;  
GC-MS (EI): m/z (tR, min) = 291 (14.60) (M+).
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Methyl  4-(3-methoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  156.  Yield: 
73%, 2.005 g (pale-yellow solid);  mp (ºC): 193-195 (Lit. 192-195);[23]  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, 
ppm = 9.099 (1H, bs, NH-1), 7.613 (1H, bs, NH-3), 7.188 (1H, t, J = 7.8, Ph), 6.810 (1H, d, J = 7.8, Ph), 6.782 (1H,  
s, Ph), 6.754 (1H, d, J = 7.8, Ph), 5.135 (1H, d, J = 2.8, CH), 3.754 (3H, s, OCH3), 3.563 (3H, s, OCH3), 2.264 (3H, 
s,  CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 165.377,  158.986, 151.998, 148.255, 145.976, 128.946, 
117.926, 112.067, 111.790, 98.643, 54.506, 53.495, 50.249, 17.593; GC-MS (EI): m/z (tR, min) = 276 (13.20) (M+).
Methyl  4-(3-hydroxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  157.  Yield: 
62%, 1.620 g (pale-yellow solid); mp (ºC): 190-192; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.128 (1H, bs, 
NH-1), 9.062 (1H, bs, OH), 7.558 (1H, bs, NH-3), 7.041 (1H, t, J = 8, Ph), 6.670-6.657 (2H, m, Ph), 6.588 (1H, d,  
J = 8,  Ph),  5.079 (1H, d, J  = 2.8,  CH),  3.565 (3H, s,  OCH3),  2.255 (3H, s,  CH3);  13C NMR (100 MHz, CCl4/
(CD3)2SO):  δ,  ppm = 165.447,  157.191,  152.101,  147.997,  145.849,  128.757,  116.529,  113.922,  112.962,  99.040,  
53.599, 50.267, 17.631; GC-MS (EI): m/z (tR, min) = 262 (13.80) (M+).
Methyl  4-(4-t-butylphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  158.  Yield: 
85%, 2.570 g (pale-yellow solid); mp (ºC): 161-162; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.095 (1H, bs, 
NH-1), 7.575 (1H, bs, NH-3), 7.289 (2H, d, J = 8, Ph), 7.163 (2H, d, J = 8, Ph), 5.130 (1H, d, J = 2.8, CH), 3.564 
(3H, s, OCH3), 2.259 (3H, s, CH3), 1.290 (9H, s, C(CH3)3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 165.399, 
152.084, 149.025, 148.138, 141.617,  125.625, 124.664, 98.946, 53.161, 50.243,  33.894, 30.950, 17.594; GC-MS 
(EI): m/z (tR, min) = 302 (13.68) (M+).
Methyl  6-methyl-4-p-tolyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  159.  Yield:  82%,  2.130 g 
(pale-yellow solid);  mp (ºC): 203-205 (Lit. 204-206);[24] 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.045 
(1H, bs, NH-1), 7.532 (1H, bs, NH-3), 7.120 (2H, d, J = 8, Ph), 7.065 (2H, d, J = 8, Ph), 5.116 (1H, d, J = 2.8, CH), 
3.540 (3H, s,  OCH3),  2.302 (3H, s, CH3),  2.256 (3H, s,  CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
165.293, 151.872, 148.020, 141.649, 135.701, 128.399, 125.875, 98.853, 53.356, 50.090, 20.506, 17.540; GC-MS  
(EI): m/z (tR, min) = 260 (12.72) (M+).
Methyl  4-(4-bromophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  160.  Yield: 
85%, 2.760 g (pale-yellow solid);  mp (ºC): 213-215 (Lit. 210-212);[20]  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, 
ppm = 9.155 (1H, bs, NH-1), 7.663 (1H, bs, NH-3), 7.428 (2H, d, J = 8, Ph), 7.186 (2H, d, J = 8, Ph), 5.135 (1H, d,  
J = 2.8, CH), 3.549 (3H, s, OCH3), 2.260 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 165.182, 
151.678,  148.639,  143.765,  130.802,  128.106,  120.060,  98.248,  53.138,  50.243,  17.604;  GC-MS (EI):  m/z (tR, 
min) = 324 (13.88) (M+).
Methyl  4-(4-chlorophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  161.  Yield: 
90%, 2.520 g (pale-yellow solid);  mp (ºC): 205-207 (Lit. 204-207);[18] 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, 
ppm = 9.149 (1H, bs, NH-1), 7.658 (1H, bs, NH-3), 7.288 (2H, d, J = 8.4, Ph), 7.238 (2H, d, J = 8.4, Ph), 5.147 (1H,  
d, J = 3.2, CH), 3.548 (3H, s, OCH3), 2.259 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 165.207, 
151.683, 148.622, 143.312, 131.702, 127.885, 127.725, 98.325, 53.074, 50.253, 17.605; GC-MS (EI): m/z (tR, min) = 
280 (13.32) (M+).
Methyl  4-(4-fluorophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  162.  Yield: 
83%, 2.200 g (pale-yellow solid);  mp (ºC): 190-191 (Lit. 188-190);[25] 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, 
ppm = 9.129 (1H, bs, NH-1), 7.637 (1H, bs, NH-3), 7.258 (2H, dd, J = 8, 5.6, Ph), 7.033 (2H, t, J = 8, Ph), 5.150 
(1H, d, J = 2.8, CH), 3.547 (3H, s, OCH3), 2.260 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
165.465, 160.183 (C, d, J = 217.2), 151.913, 148.619, 140.860, 128.027 (2xCH, d, J = 8), 114.783 (2xCH, d, J = 21.1),  
98.832, 53.202, 50.447, 17.798; GC-MS (EI): m/z (tR, min) = 264 (12.17) (M+).
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Methyl 6-methyl-4-(4-nitrophenyl)-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate, 163. Yield: 90%, 
2.615 g (yellow solid); mp (ºC): 234-236 (Lit. 235-237);[18] 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.280 
(1H, bs, NH-1), 8.163 (2H, d, J = 8.8, Ph), 7.811 (1H, bs, NH-3), 7.503 (2H, d, J = 8.8, Ph), 5.279 (1H, d, J = 2.8,  
CH), 3.559 (3H, s, OCH3), 2.276 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 165.075, 151.642, 
151.515,  149.322,  146.411,  127.213,  123.267,  97.681,  53.289, 50.364,  17.672; GC-MS (EI):  m/z (t R,  min) = 291 
(15.12) (M+).
Methyl 4-(4-methoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  164.  Yield: 
91%, 2.510 g (pale-yellow solid);  mp (ºC): 193-195 (Lit.  192-194);[18] 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, 
ppm = 9.060 (1H, bs, NH-1), 7.544 (1H, bs, NH-3), 7.147 (2H, d, J = 8.4, Ph), 6.805 (2H, d, J = 8.4, Ph), 5.101 (1H, 
d, J = 2.8, CH), 3.741 (3H, s, OCH3), 3.541 (3H, s, OCH3), 2.253 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): 
δ, ppm = 165.380, 158.132, 151.901, 147.916, 136.734, 127.065, 113.219, 99.057, 54.595, 53.049, 50.184, 17.560; 
GC-MS (EI): m/z (tR, min) = 276 (13.52) (M+).
Methyl  4-(4-hydroxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  165.  Yield: 
90%, 2.350 g (pale-yellow solid);  mp (ºC): 235-236 (Lit. 232-234);[20] 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, 
ppm = 9.121 (1H, bs, NH-1), 9.032 (1H, bs, OH), 7.512 (1H, bs, NH-3), 7.014 (2H, d, J = 8.4, Ph), 6.651 (2H, d, J = 
8.4, Ph), 5.045 (1H, d, J = 2.8, CH), 3.537 (3H, s, OCH3), 2.241 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): 
δ, ppm = 165.533, 158.358, 151.996, 147.698, 135.037, 127.031, 114.710, 99.329, 53.154, 50.275, 17.595; GC-MS 
(EI): m/z (tR, min) = 262 (13.96) (M+).
Methyl  4-(4-acetamidophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  166. 
Yield: 81%, 2.460 g (pale-yellow solid); mp (ºC): 295-297; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.742 
(1H, bs, NH-1), 9.075 (1H, bs, NH-3), 7.573 (1H, bs, NHCOCH3), 7.476 (2H, d, J = 8.4, Ph), 7.131 (2H, d, J = 8.4, 
Ph), 5.108 (1H, d, J = 2.8, CH), 3.543 (3H, s, OCH3), 2.257 (3H, s, CH3), 2.012 (3H, s, CH3); 13C NMR (100 MHz, 
CCl4/(CD3)2SO): δ, ppm = 167.552, 165.445, 152.026, 148.016, 139.101, 138.217, 126.192, 118.776, 99.034, 53.337, 
50.269, 23.648, 17.635; HR-MS (ESI): m/z = 304.1291 ([M+H]+, C15H18N3O4: required = 304.1297).
Methyl  4-(4-carboxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  167.  Yield: 
82%, 2.370 g (pale-yellow solid); mp (ºC): 285-287; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.159 (1H, bs, 
NH-1), 7.882 (2H, d, J = 8.4, Ph), 7.690 (1H, bs, NH-3), 7.338 (2H, d, J = 8.4, Ph), 5.217 (1H, d, J = 2.8, CH),  
3.550 (3H, s, OCH3), 2.269 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 166.704, 165.200, 151.756, 
149.040,  148.709,  129.607,  129.257,  125.955,  98.268, 53.560, 50.232,  17.636;  HR-MS (ESI):  m/z  = 291.0975 
([M+H]+, C14H15N2O5: required = 291.0981).
Methyl  4-(2,4-dichlorophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  168. 
Yield: 62%, 1.950 g (pale-yellow solid); mp (ºC): 252-253 (Lit. 254-255);[26] 1H NMR (400 MHz, CCl4/(CD3)2SO): 
δ, ppm = 9.332 (1H, bs, NH-1), 7.746 (1H, bs, NH-3), 7.554 (1H, d, J = 2, Ph), 7.404 (1H, dd, J = 8.4, 2, Ph), 7.311  
(1H, d, J = 8.4, Ph), 5.581 (1H, d, J = 3.2, CH), 3.454 (3H, s, OCH 3), 2.290 (3H, s, CH3); 13C NMR (100 MHz, CCl4/
(CD3)2SO):  δ,  ppm = 165.284,  151.153,  149.615,  140.716,  132.575,  132.539,  130.116,  128.728,  127.902,  97.293, 
51.060, 50.680, 17.694; GC-MS (EI): m/z (tR, min) = 314 (13.85) (M+).
Methyl  4-(3,4-dimethoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  169. 
Yield: 78%, 2.380 g (pale-yellow solid); mp (ºC): 104-105; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.082 
(1H, bs, NH-1), 7.580 (1H, bs, NH-3), 6.843 (1H, d, J = 2, Ph), 6.808 (1H, d, J = 8, Ph), 6.712 (1H, dd, J = 8, 2,  
Ph), 5.107 (1H, d, J = 3.6, CH), 3.755 (3H, s, OCH3), 3.739 (3H, s, OCH3), 3.557 (3H, s, OCH3), 2.261 (3H, s, CH3); 
13C NMR (100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 165.510,  152.051,  148.449, 148.121,  147.899, 137.040,  117.613, 
111.409, 110.419, 98.867, 55.259, 55.149, 53.202, 50.301, 17.587; GC-MS (EI): m/z (tR, min) = 306 (14.32) (M+).
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Methyl  4-(4-hydroxy-3-methoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate, 
170.  Yield: 66%, 1.930 g (pale-yellow solid);  mp (ºC): 250-252 (Lit.  253-254);[22] 1H NMR (400 MHz, CCl4/
(CD3)2SO):  δ, ppm = 9.032 (1H, bs, NH-1), 8.640 (1H, bs, OH), 7.519 (1H, bs, NH-3), 6.790 (1H, d, J = 2, Ph), 
6.660 (1H, d, J = 8, Ph), 6.596 (1H, dd, J = 8, 2, Ph), 5.063 (1H, d, J = 3.2, CH), 3.765 (3H, s, OCH 3), 3.553 (3H, s, 
OCH3), 2.249 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 165.543, 152.034, 147.850, 147.002, 
145.647, 135.456, 117.988, 114.919, 110.671, 99.063, 55.296, 53.273, 50.266, 17.577; GC-MS (EI): m/z (tR, min) = 
292 (14.12) (M+).
Methyl  4-(3-hydroxy-4-methoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate, 
171.  Yield: 73%, 2.150 g (pale-yellow solid);  mp (ºC): 217-219;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 
9.040 (1H, bs, NH-1), 8.674 (1H, bs, OH), 7.510 (1H, bs, NH-3), 6.757 (1H, d, J = 8, Ph), 6.685 (1H, d, J = 1.6, Ph), 
6.607 (1H, dd, J = 8, 1.6, Ph), 5.029 (1H, d, J = 3.2, CH), 3.753 (3H, s, OCH 3), 3.556 (3H, s, OCH3), 2.248 (3H, s, 
CH3);  13C  NMR (100 MHz,  CCl4/(CD3)2SO):  δ,  ppm  =  165.482,  151.999,  147.728,  146.544,  146.238,  137.382, 
116.501, 113.475, 111.679, 99.187, 55.390, 53.136, 50.237, 17.574; GC-MS (EI): m/z (tR, min) = 292 (14.60) (M+).
Methyl  4-(3,5-dimethoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  172. 
Yield: 75%, 2.300 g (pale-yellow solid);  mp (ºC): 185-187;  1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.100 
(1H, bs, NH-1), 7.608 (1H, bs, NH-3), 6.366 (2H, d, J = 2, Ph), 6.320 (1H, t, J = 2, Ph), 5.091 (1H, d, J = 3.6, CH),  
3.729 (6H, s, OCH3), 3.574 (3H, s, OCH3), 2.258 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
165.412,  160.177, 151.998, 148.447, 146.541,  104.064, 98.446, 98.067,  54.647, 53.394, 50.308, 17.559; GC-MS 
(EI): m/z (tR, min) = 306 (14.39) (M+).
Methyl  4-(3,4,5-trimethoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate,  173. 
Yield: 75%, 2.500 g (pale-yellow solid);  mp (ºC): 201-203; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.110 
(1H, bs, NH-1), 7.602 (1H, bs, NH-3), 6.500 (2H, s, Ph), 5.118 (1H, d, J = 3.2, CH), 3.762 (6H, s, OCH 3), 3.661 (3H, 
s,  OCH3),  3.587 (3H,  s,  OCH3),  2.269 (3H,  s,  CH3);  13C NMR (100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 165.475, 
152.528, 152.030, 148.385, 139.924,  136.639,  103.178, 98.543, 59.581,  55.543, 53.528, 50.341, 17.590; GC-MS 
(EI): m/z (tR, min) = 336 (15.09) (M+).
Methyl  4-(4-hydroxy-3,5-dimethoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-
carboxylate,  174.  Yield:  63%,  2.020  g  (pale-yellow  solid);  mp  (ºC):  215-217;  1H  NMR  (400  MHz,  CCl4/
(CD3)2SO): δ, ppm = 9.035 (1H, bs, NH-1), 7.963 (1H, bs, OH), 7.510 (1H, bs, NH-3), 6.465 (2H, s, Ph), 5.087 (1H,  
d, J = 3.2, CH), 3.759 (6H, s, OCH3), 3.574 (3H, s, OCH3), 2.266 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): 
δ, ppm = 165.475, 152.029, 147.880, 147.428, 134.967, 134.479, 103.737, 98.877, 55.679, 53.503, 50.181, 17.535; 
GC-MS (EI): m/z (tR, min) = 322 (16.19) (M+).
Methyl  6-methyl-4-phenyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  175.  Yield:  57%, 
1.500 g (pale-yellow solid); mp (ºC): 220-221 (Lit. 222);[27] 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.173 
(1H, bs, NH-1), 9.515 (1H, bs, NH-3), 7.322-7.212 (5H, m, Ph), 5.195 (1H, d, J = 3.6, CH), 3.583 (3H, s, OCH3), 
2.314 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 174.044, 165.062, 144.886, 143.274, 127.914, 
126.974, 126.111, 100.243, 53.792, 50.370, 16.941; GC-MS (EI): m/z (tR, min) = 262 (13.17) (M+).
Methyl  6-methyl-4-(naphthalen-1-yl)-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  176. 
Yield: 62%, 1.940 g (yellow solid); mp (ºC): 254-255; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.211 (1H, 
bs, NH-1), 9.448 (1H, bs, NH-3), 8.391 (1H, d, J = 8, Ph), 7.860 (1H, d, J = 8, Ph), 7.784 (1H, d, J = 8, Ph), 7.569  
(1H, t, J = 8, Ph), 7.516-7.441 (2H, m, Ph), 7.401 (1H, d, J = 8, Ph), 6.095 (1H, d, J = 2.8, CH), 3.421 (3H, s, OCH 3), 
2.445 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 173.697, 164.949, 145.422, 138.896, 133.269, 
129.928, 127.959, 127.889, 125.600, 125.250, 125.115, 124.467, 123.637, 100.226, 50.296, 49.600, 16.986; GC-MS 
(EI): m/z (tR, min) = 312 (17.84) (M+).
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Methyl  6-methyl-4-(phenanthren-9-yl)-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  177. 
Yield: 72%, 2.600 g (yellow solid); mp (ºC): 250-252; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.306 (1H, 
bs, NH-1), 9.531 (1H, bs, NH-3), 8.798-7.775 (1H, m, Ph), 8.691 (1H, d, J = 8, Ph), 8.502-8.479 (1H, m, Ph), 7.910  
(1H, d, J = 8, Ph), 7.718-7.695 (2H, m, Ph), 7.633 (1H, t, J = 8, Ph), 7.585 (1H, s, Ph), 7.554 (1H, d, J = 8, Ph),  
6.128 (1H, d, J = 3.6, CH), 3.451 (3H, s, OCH3), 2.529 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 
173.844,  164.981,  146.006,  136.165,  130.745,  130.253,  129.650,  128.969,  128.620,  126.467,  126.265,  126.135,  
126.003, 125.042, 124.307, 122.681, 122.030, 99.566, 50.406, 49.866, 17.035; GC-MS (EI): m/z (tR, min) = 362 
(16.54) (M+).
Methyl 4-(anthracen-9-yl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate, 178. Yield: 
28%, 1.010 g (yellow solid);  mp (ºC): 225-227;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 10.315 (1H, bs, 
NH-1), 9.324 (1H, bs, NH-3), 8.477-8.411 (3H, m, Ph), 8.024 (2H, d, J = 8, Ph), 7.539-7.441 (4H, m, Ph), 6.984 
(1H, s, CH), 3.026 (3H, s, OCH3), 2.310 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 172.863, 
164.886, 142.530, 133.729, 128.055, 125.290, 124.106, 123.865, 100.803, 50.163, 49.552, 16.614; GC-MS (EI): m/z 
(tR, min) = 362 (13.47) (M+).
Methyl  4-(2-bromophenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  179. 
Yield: 43%, 1.470 g (pale-yellow solid); mp (ºC): 167-168; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.277 
(1H, bs, NH-1), 9.370 (1H, bs, NH-3), 7.531 (1H, d, J = 7.6, Ph), 7.372-7.295 (2H, m, Ph), 7.174 (1H, t, J = 7.6, Ph), 
5.602 (1H, d, J = 2.8, CH), 3.504 (3H, s, OCH3), 2.344 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 
173.649.164.700, 145.328, 142.270, 132.318, 129.024, 128.935, 127.917, 121.994, 99.666, 53.751, 50.327, 16.740;  
GC-MS (EI): m/z (tR, min) = 340 (14.54) (M+).
Methyl  4-(2-chlorophenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  180. 
Yield: 53%, 1.575 g (pale-yellow solid); mp (ºC): 174-175; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.256 
(1H, bs, NH-1), 9.356 (1H, bs, NH-3), 7.350 (1H, d, J = 7.6, Ph), 7.297-7.228 (3H, m, Ph), 5.651 (1H, d, J = 2.8,  
CH), 3.500 (3H, s, OCH3), 2.339 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 173.804, 164.798, 
145.486, 140.493, 131.764, 129.139, 128.913, 128.818, 127.227, 99.360, 51.361, 50.425, 16.837; GC-MS (EI): m/z  
(tR, min) = 296 (13.94) (M+).
Methyl  4-(2,6-dichlorophenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  181. 
Yield: 39%, 1.280 g (pale-yellow solid); mp (ºC): 247-248; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.173 
(1H, bs, NH-1), 9.306 (1H, bs, NH-3), 7.357 (2H, d, J = 7.6, Ph), 7.254 (1H, t, J = 7.6, Ph), 6.164 (1H, s, CH), 3.416  
(3H, s,  OCH3),  2.212 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 173.607, 164.783, 145.836, 
136.288, 135.499, 129.008, 128.734, 95.776, 51.955, 49.992, 16.807; GC-MS (EI): m/z (tR,  min) = 330 (15.46) 
(M+).
Methyl  4-mesityl-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  182.  Yield:  48%, 
1.455 g (pale-yellow solid);  mp (ºC):  230-232;  1H NMR (400 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 9.961 (1H, bs, 
NH-1), 9.047 (1H, bs, NH-3), 6.735 (2H, s, Ph), 5.755 (1H, s, CH), 3.404 (3H, s, OCH3), 2.312 (6H, s, CH3), 2.202 
(3H,  s,  CH3),  2.164  (3H,  s,  CH3);  13C  NMR (100 MHz,  CCl4/(CD3)2SO):  δ,  ppm  =  172.761,  165.424,  143.011, 
137.000, 135.827, 135.735, 129.659, 98.315, 50.916, 50.091, 20.309, 19.132, 16.692; GC-MS (EI): m/z (t R, min) = 
304 (14.62) (M+).
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Methyl 6-methyl-4-(3-nitrophenyl)-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate, 183.  Yield: 
59%, 1.800 g (yellow solid);  mp (ºC): 237-239 (Lit.  239);[27]  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 
10.362 (1H, bs, NH-1), 9.659 (1H, bs, NH-3), 8.101-8.006 (2H, m, Ph), 7.646-7.571 (2H, m, Ph), 5.330 (1H, d, J =  
3.6,  CH),  3.588 (3H,  s,  OCH3),  2.324 (3H,  s,  CH3);  13C NMR (100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 174.537, 
165.099, 147.839, 146.161, 145.325, 132.623, 129.747, 122.275, 121.237, 99.531, 53.334, 50.829, 17.251; GC-MS  
(EI): m/z (tR, min) = 307 (16.45) (M+).
Methyl  4-(3-methoxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  184. 
Yield: 58%, 1.710 g (pale-yellow solid); mp (ºC): 205-207; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.161 
(1H, bs, NH-1), 9.494 (1H, bs, NH-3), 7.199 (1H, t, J = 8, Ph), 6.806-6.753 (3H, m, Ph), 5.174 (1H, d, J = 3.6, CH), 
3.764 (3H, s, OCH3), 3.597 (3H, s, OCH3), 2.309 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
174.146, 165.095, 159.006, 144.995, 144.616, 128.987, 118.016, 112.169, 112.093, 100.119, 54.433, 53.614, 50.413, 
16.955; GC-MS (EI): m/z (tR, min) = 292 (14.42) (M+).
Methyl  4-(3-hydroxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  185. 
Yield: 58%, 1.630 g (pale-yellow solid); mp (ºC): 217-219; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.178 
(1H, bs, NH-1), 9.507 (1H, bs, OH), 9.231 (1H, bs, NH-3), 7.074 (1H, t, J = 8, Ph), 6.654-6.615 (3H, m, Ph), 5.099  
(1H, d, J = 3.6, CH), 3.588 (3H, s, OCH3), 2.298 (3H, s, CH3);  13C NMR  (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
173.999, 165.308, 157.275, 144.793, 144.439, 128.972, 116.643, 114.336, 113.085, 100.356, 53.693, 50.620, 17.012; 
GC-MS (EI): m/z (tR, min) = 278 (15.23) (M+).
Methyl  4-(4-t-butylphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  186. 
Yield: 56%, 1.780 g (pale-yellow solid); mp (ºC): 203-204; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.161 
(1H, bs, NH-1), 9.480 (1H, bs, NH-3), 7.306 (2H, d, J = 8, Ph), 7.152 (2H, d, J = 8, Ph), 5.160 (1H, d, J = 2.8, CH),  
3.596 (3H, s, OCH3), 2.304 (3H, s, CH3), 1.292 (9H, s, C(CH3)3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 
174.056, 165.121, 149.360, 144.793, 140.359, 125.771, 124.745, 100.379, 53.324, 50.430, 33.907, 30.892, 16.951;  
GC-MS (EI): m/z (tR, min) = 318 (15.24) (M+).
Methyl  6-methyl-4-p-tolyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  187.  Yield:  55%, 
1.525 g (pale-yellow solid);  mp (ºC): 162-164;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 10.109 (1H, bs, 
NH-1), 9.443 (1H, bs, NH-3), 7.119 (2H, d, J = 8, Ph), 7.080 (2H, d, J = 8, Ph), 5.152 (1H, d, J = 3.6, CH), 3.571  
(3H, s, OCH3), 2.310 (3H, s, CH3), 2.256 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 173.905, 
165.054, 144.741, 140.385, 136.127, 128.523, 126.089, 100.347, 53.562, 50.303, 20.561, 16.936; GC-MS (EI): m/z 
(tR, min) = 276 (13.79) (M+).
Methyl  4-(4-bromophenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  188. 
Yield: 55%, 1.870 g (pale-yellow solid); mp (ºC): 123-125; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.243 
(1H, bs, NH-1), 9.543 (1H, bs, NH-3), 7.443 (2H, d, J = 8.4, Ph), 7.171 (2H, d, J = 8.4, Ph), 5.165 (1H, d, J = 3.6,  
CH), 3.578 (3H, s, OCH3), 2.306 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 174.075, 164.980, 
145.311, 142.391, 130.962, 128.226, 120.566, 99.767, 53.238, 50.508, 16.994; GC-MS (EI): m/z (tR, min) = 340 
(15.55) (M+).
Methyl  4-(4-chlorophenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  189. 
Yield: 57%, 1.690g (pale-yellow solid); mp (ºC): 135-137 (Lit. 136-138);[20] 1H NMR (400 MHz, CCl4/(CD3)2SO): 
δ, ppm = 10.206 (1H, bs, NH-1), 9.511 (1H, bs, NH-3), 7.280 (2H, d, J = 8.4, Ph), 7.221 (2H, d, J = 8.4, Ph), 5.180 
(1H, d, J = 3.2, CH), 3.567 (3H, s, OCH3), 2.301 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
174.175, 165.099, 145.371, 142.017, 132.348, 128.125, 127.963, 99.992, 53.320, 50.589, 17.114; GC-MS (EI): m/z 
(tR, min) = 296 (14.57) (M+).
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Methyl  4-(4-fluorophenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  190. 
Yield: 59%, 1.650 g (pale-yellow solid); mp (ºC): 180-181; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.260 
(1H, bs, NH-1), 9.563 (1H, bs, NH-3), 7.249 (2H, dd, J = 8.4, 5.8, Ph), 7.072 (2H, t, J = 8.4, Ph), 5.181 (1H, d, J =  
3.2,  CH),  3.570 (3H, s,  OCH3),  2.305 (3H, s,  CH3);  13C NMR (100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 174.040, 
165.184, 161.379 (C, d, J = 243), 145.169, 139.363, 128.121 (2xCH, d, J = 8.2), 114.911 (2xCH, d, J = 21.1), 100.195,  
53.137, 50.664, 17.043; GC-MS (EI): m/z (tR, min) = 280 (13.09) (M+).
Methyl  4-(4-methoxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  191. 
Yield: 60%, 1.740 g (pale-yellow solid); mp (ºC): 171-172 (Lit. 172-174);[20] 1H NMR (400 MHz, CCl4/(CD3)2SO): 
δ, ppm = 10.164 (1H, bs, NH-1), 9.487 (1H, bs, NH-3), 7.138 (2H, d, J = 8.4, Ph), 6.830 (2H, d, J = 8.4, Ph), 5.124  
(1H, d, J = 3.2, CH), 3.746 (3H, s, OCH3), 3.570 (3H, s, OCH3), 2.301 (3H, s, CH3);  13C NMR (100 MHz, CCl4/
(CD3)2SO):  δ,  ppm  =  173.795,  165.191,  158.415,  144.653,  135.402,  127.287,  113.378,  100.487,  54.625,  53.181,  
50.483, 16.941; GC-MS (EI): m/z (tR, min) = 292 (14.87) (M+).
Methyl  4-(4-hydroxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  192. 
Yield: 55%, 1.520 g (pale-yellow solid); mp (ºC): 223-225 (Lit. 225-227);[20] 1H NMR (400 MHz, CCl4/(CD3)2SO): 
δ, ppm = 10.102 (1H, bs, NH-1), 9.430 (1H, bs, OH), 9.136 (1H, bs, NH-3), 7.005 (2H, d, J = 8.4, Ph), 6.670 (2H, 
d, J = 8.4, Ph), 5.071 (1H, d, J = 3.2, CH), 3.567 (3H, s, OCH 3), 2.292 (3H, s, CH3);  13C NMR (100 MHz, CCl4/
(CD3)2SO):  δ, ppm = 173.665, 165.255,  156.682, 144.385, 133.704, 127.226,  114.803, 100.708, 53.322,  50.444, 
16.939; GC-MS (EI): m/z (tR, min) = 278 (15.49) (M+).
Methyl  4-(4-acetamidophenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  193. 
Yield: 57%, 1.820 g (pale-yellow solid); mp (ºC): 252-254; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.161 
(1H, bs, NH-1), 9.780 (1H, bs, NH-3), 9.492 (1H, bs, NHCOCH3), 7.504 (2H, d, J = 8.4, Ph), 7.115 (2H, d, J = 8.4, 
Ph), 5.125 (1H, d, J = 2.8, CH), 3.569 (3H, s, OCH3), 3.175 (3H, s, CH3), 2.014 (3H, s, CH3); 13C NMR (100 MHz, 
CCl4/(CD3)2SO):  δ,  ppm  =  173.866,  167.580,  165.247,  144.745,  138.568,  137.704,  126.382,  118.784,  100.420, 
53.438, 50.552, 23.653, 17.003; HR-MS (ESI): m/z = 320.1065 ([M+H]+, C15H18N3O3S: required = 320.1069).
Methyl 4-(4-carboxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-one-5-carboxylate, 194.  Yield: 
56%, 1.700 g (pale-yellow solid); mp (ºC): 239-241; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.256 (1H, bs, 
NH-1), 9.579 (1H, bs, NH-3), 7.904 (2H, d, J = 8, Ph), 7.324 (2H, d, J = 8, Ph), 5.249 (1H, d, J = 3.2, CH), 3.579  
(3H, s,  OCH3),  2.312 (3H, s,  CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 174.250, 166.677, 165.064, 
147.593,  145.389,  130.016,  129.418,  126.139,  99.845,  53.666,  50.577,  17.057;  HR-MS (ESI):  m/z  = 307.0748 
([M+H]+, C14H15N2O4S: required = 307.0753).
Methyl  4-(2,4-dichlorophenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate,  195. 
Yield: 50%, 1.650 g (pale-yellow solid); mp (ºC): 201-203; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 10.292 
(1H, bs, NH-1), 9.396 (1H, bs, NH-3), 7.387 (1H, s, Ph), 7.320-7.266 (2H, m, Ph), 5.611 (1H, d, J = 2.8, CH), 3.510  
(3H, s,  OCH3),  2.336 (3H, s,  CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ,  ppm = 173.741,  164.545, 145.687, 
139.457,  132.853,  132.628,  130.199,  128.503,  127.368,  98.910,  50.957,  50.343,  16.785;  GC-MS  (EI):  m/z  (t R, 
min) = 330 (15.15) (M+).
Methyl  4-(3,4-dimethoxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate, 
196.  Yield: 78%, 2.515 g (pale-yellow solid);  mp (ºC): 192-193;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 
10.127 (1H, bs, NH-1), 9.451 (1H, bs, NH-3), 6.835 (1H, s, Ph), 6.803 (1H, d, J = 8, Ph), 6.708 (1H, d, J = 8, Ph),  
5.139 (1H, d, J = 3.2, CH), 3.7776 (3H, s, OCH3), 3.752 (3H, s, OCH3), 3.591 (3H, s, OCH3), 2.308 (3H, s, CH3); 
13C NMR  (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 173.937, 165.180, 148.484, 148.114, 144.736, 135.740, 117.840, 
111.375, 110.447, 100.305, 55.133, 55.041, 53.342, 50.397, 16.928; GC-MS (EI): m/z (tR, min) = 322 (16.05) (M+).
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Methyl  4-(4-hydroxy-3-methoxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-
carboxylate,  197.  Yield:  58%,  1.800  g  (pale-yellow  solid);  mp  (ºC):  252-253;  1H  NMR (400  MHz,  CCl4/
(CD3)2SO): δ, ppm = 10.069 (1H, bs, NH-1), 9.401 (1H, bs, NH-3), 8.602 (1H, bs, OH), 6.782 (1H, s, Ph), 6.679  
(1H, d, J = 7.8, Ph), 6.590 (1H, d, J = 7.8, Ph), 5.097 (1H, d, J = 2.4, CH), 3.787 (3H, s, OCH3), 3.584 (3H, s, 
OCH3), 2.298 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 173.834, 165.326, 147.059, 146.013, 
144.537, 134.172, 118.314, 115.049, 110.749, 100.587, 55.285, 53.509, 50.484, 16.988; GC-MS (EI): m/z (tR, min) = 
308 (15.05) (M+).
Methyl  4-(3-hydroxy-4-methoxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-
carboxylate,  198.Yield:  53%,  1.640  g  (pale-yellow  solid);  mp  (ºC):  221-222;  1H  NMR (400  MHz,  CCl4/
(CD3)2SO): δ, ppm = 10.085 (1H, bs, NH-1), 9.412 (1H, bs, NH-3), 8.706 (1H, bs, OH), 6.763 (1H, d, J = 8, Ph), 
6.664 (1H, s, Ph), 6.602 (1H, d, J = 8, Ph), 5.060 (1H, d, J = 3.2, CH), 3.748 (3H, s, OCH3), 3.570 (3H, s, OCH3), 
2.295 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 173.872, 165.432, 147.008, 146.432, 144.647, 
136.080, 116.941, 113.756, 111.765, 100.724, 55.475, 53.486, 50.642, 17.109; GC-MS (EI): m/z (tR,  min) = 308 
(16.70) (M+).
Methyl  4-(3,5-dimethoxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate, 
199. Yield: 73%, 2.350 g (pale-yellow solid);  mp (ºC): 208-209; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 
10.204 (1H, bs, NH-1), 9.509 (1H, bs, NH-3), 6.354 (2H, d, J = 1.6, Ph), 6.339 (1H, t, J = 1.6, Ph), 5.135 (1H, d, J =  
3.2, CH), 3.735 (6H, s, OCH3), 3.609 (3H, s, OCH3), 2.301 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, 
ppm = 174.256, 165.211, 160.259, 145.150, 145.090, 104.145, 100.000, 98.406, 54.643, 53.495, 50.567, 16.956;  
GC-MS (EI): m/z (tR, min) = 322 (16.05) (M+).
Methyl  4-(3,4,5-trimethoxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate, 
200.  Yield: 77%, 2.730 g (pale-yellow solid);  mp (ºC): 214-216;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 
10.177 (1H, bs, NH-1), 9.464 (1H, bs, NH-3), 6.485 (2H, s, Ph), 5.157 (1H, d, J = 3.2, CH), 3.775 (6H, s, OCH3), 
3.670 (3H, s, OCH3), 3.625 (3H, s, OCH3), 2.307 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
174.311, 165.248, 152.616, 144.972, 138.592, 136.897, 103.236, 100.207, 59.522, 55.376, 53.637, 50.526, 17.000; 
GC-MS (EI): m/z (tR, min) = 352 (17.03) (M+).
Methyl  4-(4-hydroxy-3,5-dimethoxyphenyl)-6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-
carboxylate,  201.  Yield:  56%,  1.900  g  (pale-yellow  solid);  mp  (ºC):  211-213;  1H  NMR  (400  MHz,  CCl4/
(CD3)2SO): δ, ppm = 10.068 (1H, bs, NH-1), 9.390 (1H, bs, NH-3), 7.960 (1H, bs, OH), 6.441 (2H, s, Ph), 5.113 (1H, 
d,  J  =  3.2,  CH),  3.748 (6H,  s,  OCH3),  3.586 (3H,  s,  OCH3),  2.292 (3H,  s,  CH3);  13C NMR (100 MHz,  CCl4/
(CD3)2SO):  δ, ppm = 174.088, 165.457, 147.604, 144.679, 135.322, 133.365, 103.888, 100.674, 55.806, 53.841,  
50.626, 17.115; GC-MS (EI): m/z (tR, min) = 338 (18.03) (M+).
2. Multicomponent Synthesis of Biginelli Bis-3,4-Dihydropyrimidines
A mixture of terephthalaldehyde (5 mmol, 677 mg), the selected alkyl acetoacetate or acetylacetone (15 mmol) 
and urea or thiourea (20 mmol, 1.213 or  1.538 g)  in glacial  acetic  acid (2.5 ml)  was thoroughly mixed  in an 
appropriate 10 ml thick-walled glass vial. This was tightly sealed with a Teflon cap and the reaction mixture was  
stirred and heated at 120 ºC for 10 or 20 minutes, under microwave irradiation, with an initial power setting of 
100 W. After cooling to room temperature a yellow solid precipitated. This was filtered under reduced pressure, 
thoroughly washed with distilled water and recrystallised in  aqueous ethanol, yielding the desired Biginelli bis-
3,4-dihydropyrimidine as a yellowish solid (202-209).
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Dimethyl  4,4'-(1,4-phenylene)bis(6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate),  202. 
Yield: 80%, 1.660 g (pale-yellow solid); mp (ºC) > 300; 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.196 (2H, bs, 
NH-1/1'), 7.706 (2H, bs, NH-3/3'), 7.183 (4H, s, Ph), 5.112 (2H, d, J = 2.4, CH), 3.537 (6H, s, OCH3), 2.244 (6H, s, 
CH3);  13C NMR  (100 MHz, (CD3)2SO):  δ, ppm = 165.789, 152.137, 148.678, 148.627, 143.735, 126.276, 98.901, 
53.477, 50.814, 17.794; HR-MS (ESI): m/z = 415.1612 ([M+H]+, C20H23N4O6: required = 415.1618).
Diethyl  4,4'-(1,4-phenylene)bis(6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate),  203. 
Yield: 75%, 1.650 g (pale-yellow solid); mp (ºC) > 300; 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 9.127 (2H, bs, 
NH-1/1'), 7.676 (2H, bs, NH-3/3'), 7.174 (4H, s, Ph), 5.118 (2H, s, CH), 3.969 (4H, q, J = 6, O CH2CH3), 2.228 (6H, 
s, CH3), 1.079 (6H, t,  J = 6, OCH2CH3);  13C NMR (100 MHz, (CD3)2SO):  δ, ppm = 165.373, 152.174, 148.284, 
143.781, 126.264, 99.279, 59.296, 53.556, 17.707, 13.982; HR-MS (ESI): m/z = 443.1926 ([M+H] +, C22H27N4O6: 
required = 443.1931).
Dibenzyl  4,4'-(1,4-phenylene)bis(6-methyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate),  204. 
Yield:  55%, 1.550 g (yellow solid)  mp (ºC):  > 300;  1H NMR (400 MHz, (CD3)2SO):  δ, ppm = 9.266 (2H, bs, 
NH-1/1'), 7.722 (2H, bs, NH-3/3'), 7.298-7.260 (7H, m, Ph), 7.152-7.113 (m, 3H, Ph), 7.128 (4H, s, Ph), 5.159 (2H, 
d, J = 2.8, CH), 5.066 (2H, d, J = 12.8, CH2), 5.009 (2H, d, J = 12.8, CH2), 2.277 (6H, s, CH3); 13C NMR (100 MHz, 
(CD3)2SO):  δ, ppm = 165.014, 151.984, 149.245, 143.760, 136.455, 128.248, 127.689, 127.543, 126.328, 98.699, 
64.798, 53.560, 17.839; HR-MS (ESI): m/z = 567.2233 ([M+H]+, C32H31N4O6: required = 567.2244).
4,4'-(1,4-phenylene)bis(5-acetyl-6-methyl-3,4-dihydropyrimidin-2(1H)-one),  205.  Yield:  78%, 
1.490 g (pale-yellow solid);  mp (ºC) > 300;  1H NMR (400 MHz, (CD3)2SO):  δ, ppm = 9.158 (2H, bs, NH-1/1'), 
7.768 (2H, bs, NH-3/3'), 7.192 (4H, s, Ph), 5.222 (2H, s, CH), 2.277 (6H, s, CH3), 2.110 (6H, s, COCH3); 13C NMR 
(100 MHz, (CD3)2SO):  δ, ppm = 194.131, 152.087, 148.050, 143.390, 126.534, 109.683, 53.498, 53.445, 30.366, 
18.874; HR-MS (ESI): m/z = 383.1715 ([M+H]+, C20H23N4O4: required = 383.1719).
Dimethyl  4,4'-(1,4-phenylene)bis(6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate), 
206. Yield: 53%, 1.175 g (pale-yellow solid); mp (ºC) > 300; 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 10.344 (2H, 
bs, NH-1/1'), 9.630 (2H, bs, NH-3/3'), 7.192 (4H, s, Ph), 5.148 (2H, s, CH), 3.568 (6H, s, OCH3), 2.288 (6H, s, 
CH3);  13C NMR (100 MHz, (CD3)2SO):  δ, ppm = 174.258, 165.576, 145.343, 142.809, 126.617, 126.584, 100.304, 
53.610, 53.566, 51.144, 17.193; HR-MS (ESI): m/z = 447.1156 ([M+H]+, C20H23N4O4S2: required = 447.1161).
Diethyl  4,4'-(1,4-phenylene)bis(6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate), 
207. Yield: 50%, 1.175 g (pale-yellow solid); mp (ºC) > 300; 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 10.311 (2H, 
bs, NH-1/1'), 9.606 (2H, bs, NH-3/3'), 7.188 (4H, s, Ph), 5.147 (2H, s, CH), 4.010 (4H, q, J = 6.8, OCH2CH3), 
2.282 (6H, s, CH3), 1.103 (6H, t, J = 6.8, OCH2CH3); 13C NMR (100 MHz, (CD3)2SO): δ, ppm = 174.198, 165.067, 
145.031,  144.995,  142.976,  126.579,  100.618,  100.568,  59.594,  53.737,  17.134,  13.969;  HR-MS  (ESI):  m/z  = 
475.1470 ([M+H]+, C22H27N4O4S2: required = 475.1474).
Dibenzyl  4,4'-(1,4-phenylene)bis(6-methyl-3,4-dihydropyrimidine-2(1H)-thione-5-carboxylate), 
208. Yield: 25%, 760 mg (yellow solid); mp (ºC) > 300; 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 10.217 (2H, bs, 
NH-1/1'), 9.514 (2H, bs, NH-3/3'), 7.254-7.159 (10H, m, Ph), 7.117 (4H, s, Ph), 5.214 (2H, s, CH), 5.093 (2H, d, J = 
12, CH2), 4.980 (2H, d, J = 12, CH2), 2.341 (6H, s, CH3); 13C NMR (100 MHz, (CD3)2SO): δ, ppm = 174.115, 164.656, 
145.571,  142.867,  135.974,  128.047,  127.617,  127.514,  126.657,  100.188,  65.018,  53.935,  17.311;  HR-MS (ESI):  
m/z = 599.1780 ([M+H]+, C32H31N4O4S2: required = 599.1787).
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4,4'-(1,4-phenylene)bis(5-acetyl-6-methyl-3,4-dihydropyrimidine-2(1H)-thione),  209.  Yield:  75%, 
1.550 g (pale-yellow solid); mp (ºC) > 300; 1H NMR (400 MHz, (CD3)2SO): δ, ppm = 10.264 (2H, bs, NH-1/1'), 
9.704 (2H, bs, NH-3/3'), 7.191 (4H, s, Ph), 5.259 (2H, s, CH), 2.324 (6H, s, CH3), 2.174 (6H, s, COCH3); 13C NMR 
(100 MHz, (CD3)2SO): δ, ppm = 194.629, 174.137, 174.086, 144.544, 142.521, 142.453, 126.798, 126.741, 110.609, 
53.472, 53.366, 30.524, 18.249; HR-MS (ESI): m/z = 415.1256 ([M+H]+, C20H23N4O2S2: required = 415.1262).
3. Synthesis of Biginelli-Type 3,4-Dihydropyrimidine-2(1H)-Thiones
A mixture of the selected chalcone* (5 mmol), thiourea (7.5 mmol, 578 mg) and sodium hydroxide (5 mmol,  
202 mg) in ethanol (3 ml) was thoroughly mixed in an appropriate 10 ml thick-walled glass vial. This was tightly 
sealed with  a Teflon cap and the reaction mixture was  stirred  and heated  at  100 ºC for  20 minutes,  under 
microwave irradiation, with an initial power setting of 100 W. After cooling to room temperature, the reaction 
product was poured over crushed-ice and a yellow solid precipitated. This was filtered under reduced pressure, 
thoroughly washed with distilled water and recrystallised in aqueous ethanol, yielding the desired Biginelli-type 
3,4-dihydropyrimidine-2(1H)-thione  as  a  white  or  yellowish  solid  (210-217,  219 and  220).  3,4-
Dihydropyrimidine-2(1H)-thione  218 did not easily precipitate from the alkaline reaction medium poured over 
crushed-ice. Hence, the reaction product was washed with distilled water (50 ml) and neutralised by the addition  
of  aqueous  hydrochloric  acid  (37%  m/v)  until  a  yellow  solid  precipitated.  This  was  filtered  under  reduced 
pressure,  thoroughly  washed  with  distilled  water  and recrystallised in  aqueous  ethanol,  yielding  the  desired 
Biginelli-type 3,4-dihydropyrimidine-2(1H)-thione as a white solid.
*The  chalcones needed for  the  synthesis  of  Biginelli-type  3,4-dihydropyrimidine-2(1H)-thiones 211-221 were 
previously  prepared  through  a  procedure  described  by  Kohler  and  Chadwell  (see  section  6.III.A.4.,  pages  
139-141).[4]
4,6-Diphenyl-3,4-dihydropyrimidine-2(1H)-thione, 210. Yield: 86%, 1.140 g (white solid);  mp (ºC): 171-
173; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.271 (1H, bs, NH-1), 8.906 (1H, bs, NH-3), 7.512 (2H, m, Ph), 
7.372-7.321 (7H, m, Ph), 7.279-7.264 (1H, m, Ph),  5.201 (1H, s,  CH-4),  5.156 (1H, d,  J = 2,  CH-5);  13C NMR 
(100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 174.671,  143.802,  134.213,  133.388,  128.253,  128.176,  127.871,  127.113, 
126.388, 125.531, 100.279, 55.197; HR-MS (ESI): m/z = 267.0951 ([M+H]+, C16H15N2S: required = 267.0956).
4-(Naphthalen-1-yl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione,  211.  Yield:  86%,  1.355  g  (pale-
yellow solid); mp (ºC): 221-223; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.705 (1H, bs, NH-1), 9.000 (1H, 
bs, NH-3), 8.198 (1H, d, J = 8.2, Ph), 7.927 (1H, d, J = 8.2, Ph), 7.834 (1H, d, J = 7.2, Ph), 7.598-7.510 (4H, m, 
Ph), 7.451-7.437 (2H, m, Ph), 7.308-7.294 (3H, m, Ph), 5.955 (1H, s, CH-5), 5.401 (1H, d, J = 4, CH-4); 13C NMR 
(100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 175.703,  139.227,  134.210,  133.417,  133.269,  129.146,  128.476,  127.996, 
127.642, 126.210, 125.624, 125.475, 123.850, 122.209, 100.640, 52.014; HR-MS (ESI): m/z = 317.1109 ([M+H]+, 
C20H17N2S: required = 317.1112).
4-(Phenanthren-9-yl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione, 212.  Yield: 85%, 1.560 g (white 
solid);  mp (ºC): 223-224; 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.642 (1H, bs, NH-1), 9.048 (1H, bs, 
NH-3), 8.817-8.794 (1H, m, Ph), 8.707 (1H, d, J = 8, Ph), 8.248-8.225 (1H, m, Ph), 7.951 (1H, d, J = 7.2, Ph), 7.751 
(1H, s, Ph), 7.705-7.685 (2H, m, Ph), 7.664-7.577 (2H, m, Ph), 7.471-7.453 (2H, m, Ph), 7.290-7.276 (3H, m, Ph),  
5.979 (1H, s, CH-5), 5.462 (1H, d, J = 3.2, CH-4); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 175.899, 137.026, 
134.479,  133.269,  130.922,  130.339,  129.342,  128.345,  128.192,  127.745,  126.548,  126.343,  126.330,  126.065, 
125.536, 124.406, 123.468, 123.039, 122.114, 100.100, 52.296; HR-MS (ESI): m/z = 367.1266 ([M+H]+, C24H19N2S: 
required = 367.1269).
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4-(Anthracen-9-yl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione,  213.  Yield:  80%,  1.460  g  (yellow 
solid);  mp (ºC): 175-177;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.630 (1H, bs, NH-1), 8.945 (1H, bs, 
NH-3), 8.536 (3H, bs, Ph), 8.064 (2H, d, J = 7.6, Ph), 7.536-7.479 (4H, m, Ph), 7.489 (2H, d, J = 7.6, 2H, Ph), 
7.316 (3H, bs,  Ph), 6.928 (1H, s,  CH-5), 5.197 (1H, s,  CH-4);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ,  ppm = 
175.083,  133.950,  133.229,  132.419,  131.046,  129.607,  128.816,  128.229,  128.144,  127.860,  125.607,  125.415, 
124.399, 101.157, 50.710; HR-MS (ESI): m/z = 367.1266 ([M+H]+, C24H19N2S: required = 367.1269).
6-Phenyl-4-(pyren-1-yl)-3,4-dihydropyrimidine-2(1H)-thione, 214.  Yield: 83%, 1.620 g (yellow solid); 
mp (ºC): 225-227; 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.757 (1H, bs, NH-1), 9.188 (1H, bs, NH-3), 
8.460 (1H, d, J = 9.2, Ph), 8.295 (1H, d, J = 8, Ph), 8.250-8.206 (3H, m, Ph), 8.103 (3H, bs, Ph), 8.030 (1H, t, J = 
7.6,  Ph),  7.469-7.462  (2H,  m,  Ph),  7.291  (3H,  bs,  Ph),  6.295  (1H,  s,  CH-5),  5.444  (1H,  s,  CH-4);  13C  NMR 
(100 MHz, CCl4/(CD3)2SO):  δ, ppm = 175.612,  137.239,  134.091,  133.296, 130.786, 130.154, 130.109, 128.469, 
128.002,  127.756,  127.143,  127.013,  126.256,  125.873,  125.647,  125.165,  125.095,  124.803,  124.421,  124.203, 
124.125, 122.241, 100.867, 52.190; HR-MS (ESI): m/z = 391.1263 ([M+H]+, C26H19N2S: required = 391.1269).
4-(4-Bromophenyl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione,  215.  Yield:  81%,  1.400  g  (white 
solid);  mp (ºC): 199-200;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.477 (1H, bs, NH-1), 8.987 (1H, bs, 
NH-3), 7.501-7.487 (4H, m, Ph), 7.322-7.287 (5H, m, Ph), 5.204 (1H, s, CH-4), 5.127 (1H, s, CH-5);  13C NMR 
(100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 174.739,  142.918,  134.568,  133.170,  131.057,  128.261,  127.770,  125.558, 
120.583, 99.683, 54.263; HR-MS (ESI): m/z = 345.00484 ([M+H]+, C16H14N2SBr: required = 345.00556).
4-(4-Chlorophenyl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione,  216.  Yield:  83%,  1.250  g  (white 
solid);  mp (ºC): 167-168; 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.524 (1H, bs, NH-1), 8.995 (1H, bs, 
NH-3), 7.503-7.493 (2H, m, Ph), 7.352-7.328 (7H, m, Ph), 5.218 (1H, s, CH-4), 5.141 (1H, s, CH-5);  13C NMR 
(100 MHz, CCl4/(CD3)2SO):  δ, ppm = 174.762, 142.488, 134.557, 133.180, 132.279, 128.329, 128.170, 1297.935,  
127.829, 125.595, 99.858, 54.177; HR-MS (ESI): m/z = 301.05562 ([M+H]+, C16H14N2SCl: required = 301.05607).
4-(4-Methoxyphenyl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione, 217.  Yield: 82%, 1.220 g (white 
solid);  mp (ºC): 178-180;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.392 (1H, bs, NH-1), 8.879 (1H, bs, 
NH-3), 7.515-7.501 (2H, m, Ph), 7.344-7.329 (3H, m, Ph), 7.265 (2H, d, J = 8.4, Ph), 6.878 (2H, d, J = 8.4, Ph), 
5.203 (1H, d,  J = 3.6, CH-5), 5.073 (1H, s, CH-4), 3.769 (s, 3H, OCH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, 
ppm = 174.363, 158.594, 135.894, 134.088, 133.370, 128.246, 127.869, 127.570, 125.529, 113.542, 100.576, 54.677, 
54.372; HR-MS (ESI): m/z = 297.10663 ([M+H]+, C17H17N2OS: required = 297.10561).
4-(3-Hydroxyphenyl)-6-phenyl-3,4-dihydropyrimidine-2(1H)-thione, 218.  Yield: 80%, 1.125 g (white 
solid); mp (ºC): 204-205; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 9.470 (1H, bs, NH-1), 9.255 (1H, bs, OH), 
8.910 (1H, bs, NH-3), 7.515-7.501 (2H, m, Ph), 7.345-7.331 (3H, m, Ph), 7.129 (1H, t, J = 7.6, Ph), 6.762 (2H, bs, 
Ph), 6.663 (1H, d, J = 7.6, Ph), 5.224 (1H, s, CH-4), 5.028 (1H, s, CH-5); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, 
ppm = 174.663, 157.582, 145.158, 134.012, 133.346, 129.154, 128.370, 127.973, 125.614, 116.737, 114.394, 113.221, 
100.716, 54.902; HR-MS (ESI): m/z = 283.08993 ([M+H]+, C16H15N2OS: required = 283.08996).
6-(4-Bromophenyl)-4-phenyl-3,4-dihydropyrimidine-2(1H)-thione,  219.  Yield:  80%,  1.370  g  (white 
solid);  mp (ºC): 221-223; 1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.581 (1H, bs, NH-1), 8.899 (1H, bs, 
NH-3), 7.452 (4H, bs, Ph), 7.352-7.342 (4H, m, Ph), 7.275-7.255 (1H, m, Ph), 5.219 (1H, s, CH-5), 5.124 (1H, s,  
CH-4);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ,  ppm = 174.683, 143.649, 133.388, 132.390, 130.759, 128.142, 
127.498, 127.095,  126.324,  121.913,  100.782,  55.080;  HR-MS (ESI):  m/z  = 345.00513 ([M+H]+,  C16H14N2SBr: 
required = 345.00556).
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6-(4-Chlorophenyl)-4-phenyl-3,4-dihydropyrimidine-2(1H)-thione,  220.  Yield:  84%,  1.320  g  (white 
solid); mp (ºC): 215-217;  1H NMR (400 MHz, CCl4/(CD3)2SO):  δ, ppm = 9.670 (1H, bs, NH-1), 8.960 (1H, bs, 
NH-3), 7.516 (2H, d, J = 8.8, Ph), 7.362-7.338 (4H, m, Ph), 7.327 (2H, d, J = 8.8, Ph), 7.288-7.268 (1H, m, Ph),  
5.256 (1H, d, J = 4, CH-5), 5.130 (1H, s, CH-4); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 174.722, 143.698, 
133.456,  133.271,  131.938, 128.180, 127.83,  127.306, 127.126,  126.262,  100.922,  54.918; HR-MS (ESI):  m/z  = 
301.05636 ([M+H]+, C16H14N2SCl: required = 301.05607).
4. Oxidation of Biginelli 3,4-Dihydropyrimidin-2(1H)-Ones
A mixture of the selected Biginelli 3,4-dihydropyrimidin-2(1H)-one (1 mmol) and potassium peroxydisulphate 
(1.2 mmol, 324 mg) in acetonitrile/distilled water (3:2 v/v, 5 ml) was thoroughly mixed in an appropriate 10 ml 
thick-walled glass vial. This was tightly sealed with a Teflon cap and the reaction mixture was stirred and heated  
at 100 ºC for 10 minutes, under microwave irradiation, with an initial power setting of 80 W. After cooling to  
room  temperature,  the  reaction  product  was  washed  with  brine  (50  ml)  and  extracted  with  ethyl  acetate 
(2x25 ml). The organic phase was collected, dried over anhydrous sodium sulphate, filtered and evaporated under  
reduced pressure and the yellow solid obtained was  recrystallised in  diethyl  ether or  ethyl  acetate/n-hexane, 
yielding the desired Biginelli pyrimidin-2(1H)-one as a yellow solid (221-238).
Methyl 6-methyl-4-phenylpyrimidin-2(1H)-one-5-carboxylate, 221. Yield: 85%, 205 mg (yellow solid); 
mp (ºC): 205-207; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 7.448-7.429 (5H, m, Ph), 3.468 (3H, s, OCH3), 
2.408 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 166.049, 160.703, 155.157, 137.761, 129.614, 
127.599, 127.227, 108.460, 51.216, 18.035; GC-MS (EI): m/z (tR, min) = 244 (12.05) (M+).
Methyl  6-methyl-4-(naphthalen-1-yl)pyrimidin-2(1H)-one-5-carboxylate,  222.  Yield:  80%,  235  mg 
(yellow solid); mp (ºC): 217-219; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 7.975-7.958 (2H, m, Ph), 7.835 
(1H, d, J = 7.8, Ph), 7.583-7.511 (3H, m, Ph), 7.406 (1H, d, J = 7.8, Ph), 3.096 (3H, s, OCH3), 2.555 (3H, s, CH3); 
13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 165.161, 155.105, 132.680, 130.313, 129.801, 128.925, 127.936, 
126.172, 125.704, 124.939, 124.680, 124.508, 108.938, 50.921, 19.182; MS (ESI): m/z = 295 ([M+H]+).
Methyl 6-methyl-4-(phenanthren-9-yl)pyrimidin-2(1H)-one-5-carboxylate, 223. Yield: 83%, 285 mg 
(yellow solid); mp (ºC): 248-250; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 8.793 (1H, d, J = 7.8, Ph), 8.755 
(1H, d, J = 8, Ph), 7.960 (1H, d, J = 8, Ph), 7.819 (1H, d, J = 8, Ph), 7.738-7.572 (5H, m, Ph), 3.022 (3H, s, OCH 3), 
2.558 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 165.059, 155.203, 130.307, 129.922, 129.515, 
128.876, 128.786, 127.188, 126.683, 126.454, 126.022, 125.439, 122.701,  122.379,  110.079,  50.894, 17.519; MS 
(ESI): m/z = 354 ([M+H]+).
Methyl  4-(2-bromophenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate,  224. Yield:  81%,  260  mg 
(yellow solid); mp (ºC): 188-190; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 12.585 (1H, bs, NH), 7.580 (1H, 
d, J = 7.6, Ph), 7.412 (1H, t,  J = 7.6, Ph), 7.318-7.252 (2H, m, Ph), 3.419 (3H, s, OCH 3),  2.536 (3H, s,  CH3); 
13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 164.218, 161.786, 161.665, 154.824, 154.752,  131.630, 129.560, 
128.889, 126.765, 119.525, 108.385, 51.108, 18.775; MS (ESI): m/z = 323 ([M+H]+).
Methyl  4-(2-chlorophenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate,  225.  Yield:  83%,  230  mg 
(yellow solid); mp (ºC): 197-199; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 12.580 (1H, bs, NH), 7.378-7.353 
(3H,  m,  Ph),  7.315-7.294 (1H,  m,  Ph),  3.427  (3H,  s,  OCH3),  2.534 (3H,  s,  CH3);  13C NMR (100 MHz,  CCl4/
(CD3)2SO): δ, ppm = 164.324, 154.886, 130.327, 129.587, 129.104, 128.460, 126.307, 108.638, 51.094, 18.850; MS 
(ESI): m/z = 279 ([M+H]+).
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Methyl  4-(2,6-dichlorophenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate,  226.  Yield:  80%, 
250 mg (yellow solid); mp (ºC): 156-158; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 7.441-7.344 (3H, m, Ph), 
3.475 (3H, s, OCH3), 2.588 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 163.451, 154.857, 137.195, 
131.630, 129.594, 127.265, 107.848, 51.198, 19.717; MS (ESI): m/z = 313 ([M+H]+).
Methyl 4-mesityl-6-methylpyrimidin-2(1H)-one-5-carboxylate, 227. Yield: 80%, 230 mg (yellow solid); 
mp (ºC): 162-164; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 6.828 (2H, s, Ph), 3.391 (3H, s, OCH3), 2.446 
(3H, s, CH3), 2.303 (3H, s, CH3), 2.062 (s, 6H, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 165.044, 
155.273,  135.895,  133.836,  127.379,  126.833,  109.981,  51.171,  20.750,  19.161,  19.087;  MS  (ESI):  m/z  =  287 
([M+H]+).
Methyl-6-methyl-4-(3-nitrophenyl)pyrimidin-2(1H)-one-5-carboxylate,  228.  Yield:  87%,  250  mg 
(yellow solid); mp (ºC): 191-193; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 8.327 (1H, d, J = 7.8, Ph), 8.308 
(1H, s, Ph), 7.849 (1H, d, J = 7.8, Ph), 7.725 (1H, t, J = 7.8, Ph), 3.538 (3H, s, OCH3), 2.475 (3H, s, CH3); 13C NMR 
(100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 169.431,  165.530, 161.865,  154.969, 147.472,  139.796,  133.597,  129.461, 
124.345, 122.243, 108.215, 51.654, 18.227; MS (ESI): m/z = 290 ([M+H]+).
Methyl 4-(3-methoxyphenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate, 229.  Yield: 85%, 235 mg 
(yellow solid); mp (ºC): 127-129; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 12.356 (1H, bs, NH), 7.310 (1H, t, 
J = 8, Ph), 7.041 (1H, s, Ph), 6.981 (2H, d, J = 8, Ph), 3.843 (3H, s, OCH 3), 3.505 (3H, s, OCH3), 2.410 (3H, s, 
CH3);  13C  NMR  (100  MHz,  CCl4/(CD3)2SO):  δ,  ppm  =  166.266,  158.957,  155.298,  128.775,  128.739,  119.510, 
115.940, 112.942, 108.761, 54.850, 51.462, 18.284; MS (ESI): m/z = 275 ([M+H]+).
Methyl  4-(4-t-butylphenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate,  230. Yield:  87%,  260  mg 
(yellow solid); mp (ºC): 158-160; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 7.418 (4H, s, Ph), 3.511 (3H, s, 
OCH3),  2.398 (3H,  s,  CH3),  1.355  (9H,  s,  C(CH3)3);  13C NMR (100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 168.164, 
166.393,  155.332,  152.801,  127.346,  124.556,  108.654,  51.356,  34.429,  30.918,  18.386;  MS  (ESI):  m/z  =  301 
([M+H]+).
Methyl 6-methyl-4-p-tolylpyrimidin-2(1H)-one-5-carboxylate, 231. Yield: 85%, 220 mg (yellow solid); 
mp (ºC): 177-179; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 7.381 (2H, d, J = 7.6, Ph), 7.212 (2H, d, J = 7.6, 
Ph), 3.507 (3H, s, OCH3), 2.417 (3H, s, CH3), 2.400 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, ppm = 
169.436,  166.347,  161.452,  155.307,  139.672,  134.823,  128.368,  127.515,  108.474,  51.308,  21.024,  18.258;  MS 
(ESI): m/z = 259 ([M+H]+).
Methyl  4-(4-bromophenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate,  232.  Yield:  90%,  290  mg 
(yellow solid); mp (ºC): 186-187; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 12.430 (1H, bs, NH), 7.562 (2H, 
d, J = 8.4, Ph), 7.398 (2H, d, J = 8.4, Ph), 3.523 (3H, s, OCH 3), 2.419 (3H, s, CH3);  13C NMR (100 MHz, CCl4/
(CD3)2SO):  δ, ppm = 165.764, 164.554, 160.865, 155.010, 137.028, 130.691, 129.158, 123.806, 108.053, 51.277,  
17.887; GC-MS (EI): m/z (tR, min) = 322 (12.87) (M+).
Methyl  4-(4-chlorophenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate,  233.  Yield:  87%,  245  mg 
(yellow solid); mp (ºC): 165-167; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 12.428 (1H, bs, NH), 7.470 (2H, d, 
J = 8.4, Ph), 7.403 (2H, d, J = 8.4, Ph), 3.519 (3H, s, OCH 3), 2.420 (3H, s,  CH3);  13C NMR (100 MHz, CCl4/
(CD3)2SO): δ, ppm = 165.799, 155.023, 136.503, 135.370, 128.937, 127.757, 108.090, 51.248, 17.932; GC-MS (EI): 
m/z (tR, min) = 278 (12.40) (M+).
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Methyl  4-(4-fluorophenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate,  234. Yield:  85%,  225  mg 
(yellow solid); mp (ºC): 151-153; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 12.382 (1H, bs, NH), 7.524 (2H, 
dd, J = 8.4, 5.6, Ph), 7.163 (2H, t, J = 8.4, Ph), 3.528 (3H, s, OCH3), 2.417 (3H, s, CH3); 13C NMR (100 MHz, CCl4/
(CD3)2SO): δ, ppm = 169.273, 166.106, 163.302 (C, d, J = 248), 161.238, 155.157, 134.073, 129.777 (2xCH, d, J = 
8.6), 114.861 (2xCH, d, J = 21.7), 108.369, 51.483, 18.166; MS (ESI): m/z = 263 ([M+H]+).
Methyl-6-methyl-4-(4-nitrophenyl)pyrimidin-2(1H)-one-5-carboxylate,  235.  Yield:  90%,  260  mg 
(yellow solid); mp (ºC): 220-222; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 8.283 (2H, d, J = 8.6, Ph), 7.690 
(2H, d, J = 8.6, Ph), 3.512 (3H, s, OCH3), 2.480 (3H, s, CH3);  13C NMR (100 MHz, CCl4/(CD3)2SO):  δ, ppm = 
169.776, 165.303, 162.027, 154.926, 148.076, 144.485, 128.611, 122.899, 108.103, 51.453, 18.248; MS (ESI): m/z = 
290 ([M+H]+).
Methyl 4-(4-methoxyphenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate, 236.  Yield: 88%, 240 mg 
(yellow solid); mp (ºC): 189-191; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 12.227 (1H, bs, NH), 7.451 (2H, d, 
J = 8.4, Ph), 6.918 (2H, d, J = 8.4, Ph), 3.842 (3H, s, OCH3), 3.535 (3H, s, OCH3), 2.377 (3H, s, CH3); 13C NMR 
(100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 166.475,  160.920,  155.202,  129.494, 129.179,  113.096,  108.153,  54.734, 
51.298, 18.120; GC-MS (EI): m/z (tR, min) = 274 (13.09) (M+).
Methyl 4-(2,4-dichlorophenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate, 237. Yield: 83%, 260 mg 
(yellow solid); mp (ºC): 197-199; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 12.645 (1H, bs, NH), 7.428 (1H, s, 
Ph), 7.389 (1H, d, J = 8.6, Ph), 7.326 (1H, d, J = 8.6, Ph), 3.494 (3H, s, OCH 3), 2.540 (3H, s, CH3);  13C NMR 
(100 MHz,  CCl4/(CD3)2SO):  δ,  ppm = 164.111,  154.573,  137.589,  134.129,  131.332,  130.676,  128.075,  126.659, 
108.311, 51.161, 18.783; MS (ESI): m/z = 313 ([M+H]+).
Methyl  4-(3,5-dimethoxyphenyl)-6-methylpyrimidin-2(1H)-one-5-carboxylate,  238.  Yield:  85%, 
260 mg (yellow solid); mp (ºC): 200-201; 1H NMR (400 MHz, CCl4/(CD3)2SO): δ, ppm = 6.576 (2H, s, Ph), 6.507 
(1H, s, Ph), 3.800 (6H, s, OCH3), 3.532 (3H, s, OCH3), 2.394 (3H, s, CH3); 13C NMR (100 MHz, CCl4/(CD3)2SO): δ, 
ppm = 166.313, 160.021, 155.335, 139.357, 108.894, 105.168, 102.208, 54.920, 51.497, 18.190; MS (ESI): m/z =  
305 ([M+H]+).
F. Spectral & Photophysical Studies
Absorption and fluorescence emission spectra of the selected 3,5-diaryl-2-methyl-1H-pyrroles were recorded 
at room temperature (293 K) on a Shimadzu UV-2100 and a Horiba-Jobin-Ivon Fluorolog 3-22 spectrometer,  
respectively, using methylcyclohexane as solvent. Ground state or singlet molar extinction coefficients (εS) were 
obtained  according  to  the  Beer-Lambert  law from absorption  measurements  using  solutions  of  six  different  
concentrations. Fluorescence quantum yields (ΦF) were measured utilising quinine sulphate in a 0.5 M H2SO4 
solution as reference (ΦF=0.545). The  experimental  set-up used in  order to  obtain  room temperature  triplet 
absorption spectra and triplet formation quantum yields (ΦT) has been described elsewhere.[28, 29] Special care 
was taken in determining the latter, namely to have optically matched dilute solutions (absorbance ≈ 0.2 in a 1 cm 
square cell) and low laser energy (< 2 mJ) to avoid multiphoton and triplet-triplet annihilation effects. The triplet 
molar  extinction  coefficients  (εT)  were  found  either  by  the  singlet  depletion[30]  or  the  partial  saturation 
methodology.[30,  31]  Phosphorescence  emission spectra  of  the  selected  3,5-diaryl-2-methyl-1H-pyrroles  were 
registered in methylcyclohexane glasses at 77 K using a Horiba-Jobin-Ivon Fluorolog 3-22 spectrometer equipped 
with a 1934 D phosphorimeter. Phosphorescence quantum yields (ΦP) were determined utilising benzophenone 
(ΦP=0.84)  as  standard.[32]  All  fluorescence  and  phosphorescence  emission  spectra  were  corrected  for  the 
wavelength response of the system. Room temperature singlet oxygen phosphorescence was detected at 1270 nm 
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using  a  Hamamatsu  R5509-42  photomultiplier,  cooled  to  193  K in  a  liquid  nitrogen  chamber  (Products  for 
Research model PC176TSCE-005), following laser excitation of the aerated solutions at 266 nm or 355 nm, with 
an adapted Applied Photophysics flash kinetic spectrometer, as reported elsewhere.[33] Biphenyl in cyclohexane 
(λexc=266 nm, Φ∆=0.73) or phenalen-1-one in toluene (λexc=355 nm, Φ∆=0.93) were employed as standard.[34, 35]
G. Cytotoxicity Studies
MCF7, HCC1806, WiDr and A375 cell cultures were incubated with different solutions of the selected Biginelli-
type 3,4-dihydropyrimidine-2(1H)-thiones, concentration values ranging from 1 to 100 μM. After 48 hours of 
incubation, cell proliferation was assessed by the  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT)  colorimetric  assay.[36]  Two  control  experiments  were  performed  in  all  tests:  untreated  cultures  and 
cultures treated solely with dimethylsulfoxide (DMSO), the administration vehicle of the compounds. Cytotoxicity 
was  expressed  as  the  inhibition  percentage  of  cultures  subjected  to  the  compounds  correlated  with  cultures  
treated only with DMSO. Dose-response curves were obtained using the OriginPro 8.0 software by fitting to a  
sigmoidal  curve,  the  concentration  inhibiting  the  proliferation  of  the  cells  in  50%  (IC50)  being  calculated. 
Differences  between  concentration-response  curves  were  determined  through  one-way  ANOVA  followed  by 
Bonferroni's post hoc analysis for pairwise comparisons. The statistical significance level was set at 0.05.
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